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The aim of this thesis was to understand the demand and uptake of private optometric community 
services outside the scope of traditional services having the outcome of supplying spectacles, and of 
locally commissioned shared care schemes. Dry eye is known to reduce quality of life, be highly 
prevalent, underdiagnosed and clinically significant. Dry eye is a condition with poor association 
and discordance between signs and symptoms, and so is poorly managed. Dry eye does not 
command priority in secondary care where patients sometimes present when self-help measures fail, 
considering it is generally not sight threatening.  
 
The global consensus on dry eye have recommended a tiered management approach highlighting 
advanced pharmacological care options that could be applied by optometrists with an independent 
prescribing qualification. Emerging technologies also show promise in advanced dry eye diagnostics 
and management but the investments required means that practices need to develop a strong business 
plan to make them commercially viable.  
 
This research was based on a single independent optometric practice and two hospitals with a 
relationship to the practice. Service blueprinting was applied to the dry eye service to demonstrate 
its usefulness in optometric service innovation. Decision tree analysis and principal component 
analysis were used to discriminate between people self-reporting dry eye, to predict severity, and to 
identify clinical tests to explain the variability between those with predominately evaporative dry 
eye from a sample of patients. Despite having signs of dry eye, there were no differences in visual 
outcomes post-lens surgery based on dry eye sign status, and there were no strong trends to link 
discontinuation of contact lens wear to dry eye. Dry eye is a condition that presents to the local eye 
casualty department that can be managed within the community along with other conditions that 
may have an acute or recurring presentation.    
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The National Health Service (NHS) that provides government-funded medical and health care 
services for UK residents at the point of use is often reported as overstretched due to insufficient 
financing and the growing health needs of an ageing population. There is a general trend towards an 
older patient base in line with the ageing population in the UK with around 20.7% of the UK 
population (estimated at 66 million in mid-2017) expected to be aged 65 years or over by the year 
2027, compared with 15.9% reported in 2007 (ONS, 2018).  In order to address the burden on the 
NHS, there has been a shift of services into the primary sector. Primary care providers including 
pharmacists, dentists and optometrists have seen changes to their traditional roles and scope of 
practice in order to address current needs. This thesis relates to the expanding role of optometrists, 
but the next few sections will briefly discuss the expanding role of pharmacists, dentists and 
optometrists. Some of the examples provided represent the expanding roles of primary care 
providers outside of the UK.  
 
 
1.1: Expanding role of pharmacists  
There has been a shift in the pharmacist’s role from dispensing or preparation and supply of 
medicines to  patient-centred clinical care in many countries with differences based on regulatory, 
economic and organisational contexts (Schindel et al., 2017). Murphy et al. (2018) evaluated an 
incentivized service in Canada referred to as the Bloom Programme, which used a capitation funding 
model to help improve patient outcomes including those related to treatment optimization, reducing 
polypharmacy, and facilitating withdrawal from medications for patients living with mental illness 
and addictions (Murphy et al., 2018). It was concluded that pharmacists are well placed in facilitating 
confidential medication management in mental illness and addiction care (Murphy et al., 2018). 
There has been noted effectiveness for UK pharmacist-led services including smoking cessation 
counselling, prescriber education, medication review and medication review in nursing homes 
(Silcock et al., 2004). Additionally, immunization privileges allow pharmacists to offer expanded 
prescriber services, such as the administration of influenza vaccines to the public (Gerges et al., 
2018). 
 
Clinical or non-dispensing (NDP) pharmacists have a collaborative role in general practice framed 
as quality management (Hazen et al., 2019). NDP pharmacists conduct clinical medication reviews 
especially for elderly patients with polypharmacy and multi-morbidities, mobilise pharmaceutical 
evidence as required such as active mechanism and possible side effects, and offer tailored solutions 
with the expertise to deviate from a prescription guideline or to suggest a non-pharmaceutical 
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alternative (Hazen et al., 2019). Tan et al. (2014) report that NDPs within Australian primary health 
care clinics were effective in identifying and resolving medication-related problems, such as 
polypharmacy and improving medication adherence. 
 
 
1.2: Expanding role of dentists 
There is renewed interest in expanding the role of oral health care professionals (OHCPs) that is 
dentists, dental therapists, oral health therapists, dental hygienists, dental assistants, and dental 
nurses in smoking cessation interventions, anthropometric assessments and obesity management 
(Brown et al., 2019; Arora et al., 2019). Childhood obesity is an increasingly prevalent worldwide 
public health concern with guidelines suggesting general practitioners (GPs) should routinely 
identify and address overweight and obesity among children (Villarosa et al., 2018). In reality, 
research suggests screening for overweight status through the use of Body Mass Index percentile 
charts is not prioritsed by GPs (Villarosa et al., 2018). OHCPs are well placed in the community 
having regular contact with children and their families to address risk factors, such as a high sugar 
diet to prevent dental caries, peridontal disease and obesity (Arora et al., 2019). The main perceived 
barriers for OHCPs in provision of nutrition and behaviour modification-related counselling services 
in routine clinical practice included lack of training in anthropometry and counselling skills, fear of 
offending or appearing judgmental towards patients, insufficient clinical time to deliver such 
services, patients’ rejection of weight loss advice or feelings of embarassment, lack of 
reimbursement, and lack of framework for appropriate referrals (Arora et al., 2019). 
 
The desire to enhance one’s physical appearance and smile at any age perhaps influenced by popular 
media, has led to the continued growth and increased demand for elective aesthetic dental services, 
such as tooth whitening and veneers (Theobald et al., 2006). As part of their regular clincal practice, 
some dentists have engaged in the delivery of non-surgical facial aesthetics such as the use of dermal 
fillers, and botulinum toxin for cosmetic application and to treat temporomandibular joint disorders, 
migraines and teeth grinding (Walker et al., 2017). Similar to dentistry, there are examples of 
optometric practices that have incorporated aesthetic services, namely non-invasive procedures 
utilising radiofrequency to improve periorbital skin tautness, and the prescribing of drugs and serums 
to help thicken and lengthen eyelashes (https://www.visionoptique.com/anti-aging-eyecare/). 
Ocular cosmetic procedures including limbal-defining contact lenses (CL), tattooed permanent eye 
makeup, blepharoplasty, laser removal of iris pigment, and eyelash extensions are also becoming 
more popular. The global false eyelashes market alone is expected to garner 1,883 million US dollars 




1.3: Expanding role of optometrists  
Adoption of advanced equipment to improve detection and monitoring of eye disease, and electronic 
records and communication to facilitate practice efficiency, clinical record keeping and co-
management with secondary care, has widened the scope of optometric practice (Dabasia et al., 
2014). Dabasia et al. (2014) noted the use of newer imaging modalities such as OCT imaging were 
more commonly found at independent practices, and that practitioners using newer imaging 
modalities were more likely to use other specialist equipment and participate in locally 
commissioned shared care schemes. Changes to UK statutory legislation in 1999 meant that 
community optometrists could manage patients with ocular conditions without referring to a medical 
practitioner, and further amendments in 2005 meant that optometrists could refer patients to the care 
of optometrist colleagues with a higher specialism or qualifications (Baker et al., 2016). Medicine 
legislation has also changed to enable community optometrists to manage ocular conditions using 
pharmacological interventions (Baker et al., 2016).  
 
Community optometry and ophthalmology-optometry partnerships may help alleviate the demand 
on the hospital eye services, considering ophthalmology are one of the largest outpatient specialties 
in the NHS (NHS Digital, 2018). Ophthalmology saw the highest recorded number of attendances 
for an outpatient specialty with 7.6 million attendances in 2017-2018 (NHS Digital, 2018). 
Alternative models of care are being explored with the expanding role of community optometrists 
at the forefront of strategies to reduce the burden on overstretched ophthalmology services (Baker 
et al., 2016). In a virtual clinic for example, data from ophthalmic subspecialties are collected and 
triaged by trained staff who are not necessarily medically trained, and analysed and acted upon by 
an optometrist-ophthalmologist partnership or ophthalmologist team at a different point in time 
(Wright & Diamond, 2015; Trikha et al., 2012; Tsaousis et al., 2016). The increasing availability of 
wide field imaging devices enables the possibility of virtual clinics that have the potential to reduce 
waiting times for a clinic appointment, reduce unnecessary follow-ups, and offer a new strategy to 
cope with the challenge of the ageing population. Virtual clinic reviews as an alternative mode of 
health care delivery have been largely accepted by patients with diabetic retinopathy and 
maculopathy, and glaucoma (Ahnood et al., 2018; Court & Austin, 2015; Kotecha et al., 2017).  
 
Findings by Gazzard et al. (2019) suggest selective laser trabeculoplasty (SLT) should be offered as 
first-line treatment for open angle glaucoma and ocular hypertension rather than use of ocular 
therapeutics, which could significantly impact current care pathways and the role of optometrists. A 
rise in the number of SLT procedures performed and possible demand for SLT would mean a 
requirement for optometrists to discuss and offer SLT as a management option for eligible patients. 
There are currently a small number of optometrists who perform SLT under medical supervision, 
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and an increase in demand for SLT could result in greater uptake of further training to enable more 
optometrists to deliver this service and to continue with participation in monitoring schemes.   
 
The emergence of multi-disciplinary clinics to address patient needs and improve overall wellness 
and health include chiropractic and optometry services (http://specsandspines.com/), concussion 
rehabilitation co-management (https://www.gvtc.ca/), and integration of audiology services. The 
University Health Network’s Multidisciplinary Sjögren’s Syndrome Clinic in Toronto, Ontario, 
Canada sees a collaboration amongst specialists in rheumatology, ophthalmology/optometry, 
otolaryngology and dentistry to seek a diagnosis of Sjögren’s Syndrome for patients 
(https://www.uhn.ca/Arthritis/PatientsFamilies/Clinics_Tests/Sjogren_Clinic). The Visual 
Perception Clinic in the Newcastle Eye Centre, UK, provide a multidisciplinary service that 
addresses complex visual problems in older people with management plans formulated through 
discussions amongst specialists in ophthalmology, neurology, and psychiatry with support from 
optometrists, orthoptists and radiologists (Han et al., 2012). Along with a higher prevalence of visual 
comorbidities with increasing age, there is also a higher prevalence of neurological and cognitive 
impairment (Jackson & Owsley, 2003; Clemons et al., 2006). A one-stop service for patients with 
atypical presentations of neurodegenerative disease in the presence or absence of eye pathology 
could help prevent frequent visits of patients to multiple practices, delays to diagnosis and 
disconnected referrals to different specialties (Han et al., 2012).  
 
Hearing loss affects approximately 40% of people aged over 50 years in the UK (Age UK, 2019), 
and there is a growing trend of optometric practices introducing audiology services either through 
employing an in-house audiologist, or partnering with an audiology business or an independent 
provider. Following completion of the KTP project at BBR Optometry Ltd. (discussed in section 
1.6), the practice began to offer audiology services with the help of the Hearing Care Partnership. 
The Hearing Care Partnership launched in July 2017 is the UK’s sole “optician only” hearing care 
company that connects audiology with independent optometry by providing the audiologist, training 
to the optometric team and marketing (OT, 2019). The Hearing Care Partnership operates a non-
compete business model meaning that it will not integrate its services into more than one practice in 
the same town, and through the relationship with Leightons Opticians & Hearing Care also shares 
business insight to support optical retail services (OT, 2019). Audiology services available at BBR 
Optometry Ltd. include complimentary hearing tests, ear wax removal, tinnitus consultations and 
hearing protection. 
 
Community-enhanced services or enhanced optometric services (EOS) are any optometrist delivered 
service within primary care outside the scope of the GOS contract, which provides for routine sight 
testing (Baker et al., 2016). Scotland have a unique GOS contract different from elsewhere in the 
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UK that has been in operation since April 2006, and offers all Scotland residents, not just those 
belonging to specified groups, an NHS funded eye examination and a supplementary eye exam for 
further testing or monitoring if clinically required (Shickle et al., 2015). This thesis will focus on 
community optometric practice and EOS in England. EOS are negotiated and commissioned locally 
according to community needs and priorities, and differ by patient eligibility, training requirements 
for participating practitioners, and fee structures (Shickle et al., 2015). EOS aim to enhance referral 
quality and reduce false positive referrals to the hospital eye service (HES), to ease capacity on the 
HES by monitoring chronic ocular disease, and to make use of optometric expertise (Baker et al., 
2016). An example of an EOS that has expanded the traditional role of an optometrist is the Healthy 
Living Optician (HLO) scheme rolled out in Dudley, UK, in 2015 (Dudley LOC, 2019). Following 
the success of a Health Living Pharmacy service in the area, the HLO allows optometrists to offer 
health and lifestyle-related advice including alcohol screening, weight management, smoking 
cessation, NHS health checks and referral into support services (Dudley LOC, 2019). EOS in 
Herefordshire where the current study is based includes cataract post-operative assessments, cataract 
referrals, children’s vision, glaucoma referral refinement, glaucoma repeat readings, ocular 
hypertension monitoring, low vision, and minor eye conditions service described in more detail in 
chapter six.  
 
Participation in EOS offer credibility to optometrists as eye health professionals rather than 
salespersons perhaps leading to better continuity of care and practice loyalty (Shickle et al., 2015). 
Although EOS are well received by stakeholders and patients perhaps due to a reduction in waiting 
times and loss to follow-up from HES, their long-term sustainability is not established (Baker et al., 
2016). A challenge to private specialist optometric services in the UK is the patient’s perception of 
value given free or subsidised eyecare in the UK is available through the NHS. Wolffsohn et al. 
(2011) determined that although there was high interest for a specialist service to manage ocular 
allergy amongst a large sample of patients attending practices in the West Midlands, UK, only about 
one quarter of patients were willing to pay for such services. There was poor distinction between 
ocular and systemic allergy, with almost all patients feeling their current self-management was 
effective (Wolffsohn et al., 2011).  
 
Leamon et al. (2014) conducted focus groups consisting of population groups at increased risk of 
preventable sight loss including Pakistani, Black Caribbean and white socio-economically deprived 
communities across five UK locations, and found that the demand for optometric services was 
mainly in response to visual symptoms and was associated with the purchase of spectacles rather 
than eye health. Factors influencing people’s attitudes and behaviours towards optometric services 
in the UK include (Bell & O’Brien, 1997; Cross et al., 2007; Patel et al., 2006; Awobem et al., 2009): 
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• There is limited knowledge regarding the function of regular eye examinations in 
preventative health care  
• Expense or concern about the cost of spectacles  
• Fatalism or acceptance that deteriorating eyesight is part of the ageing process  
 
Leamon et al. (2014) suggest that uptake of optometric services may be improved through co-
production of non-retail services that resonate with local communities. 
 
Service blueprinting, described in chapter two, could be applied to the development of shared or 
EOS to enhance accountability between stakeholders and improve service quality by defining 
clinical pathways and administrative processes, training requirements, fees, and key performance 
indicators (KPIs). For example, there is currently no standardisation of cataract clinical pathways in 
the UK (Bowes et al., 2018). Bowes et al. (2018) describe successful outcomes against KPIs agreed 
under a service-level agreement between the HES and community optometrists with an accreditation 
scheme in the Cambridgeshire cataract shared care scheme. Notably, there was an improvement in 
the listing and feedback return rates, and reduction in unsuitable referrals (Bowes et al., 2018).  
 
Dry eye is topical considering it is known to impact vision, quality of life, mental health and work 
productivity (Stapleton et al., 2017; Miljanovic et al., 2007; Han et al., 2017; Sun et al., 2017; 
Matthews et al., 2017; van Landingham et al., 2014). Dry eye is known to be highly prevalent, 
underdiagnosed and clinically significant. This thesis aims to evaluate the local need for a private 
speciality dry eye service and demonstrates the implementation of such a service at BBR Optometry 
Ltd. There is currently no clear guidance on how to set up a speciality dry eye clinic. There is also 
no standardisation of clinical care for dry eye patients although the non-profit organization, the Tear 
Film and Ocular Surface Society (TFOS), have created the Dry Eye Workshop II (DEWS II) report 












1.4: Dry eye background  
The global definition of dry eye is:  
“a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the 
tear film, and accompanied by ocular symptoms, in which tear film instability and 
hyperosmolarity, ocular surface inflammation and damage, and neurosensory 
abnormalities play etiological roles.” (Craig et al., 2017)   
 
Dry eye has been reported as one of the most common ocular conditions affecting women more than 
men with increasing age, and has a global estimated prevalence of 5% to 50% (Stapleton et al., 
2017). The prevalence, that is the proportion of dry eye within a population at a given time, varies 
depending on the definition of dry eye used with diagnosis based on symptoms with or without signs, 
and the features of the population analysed (Stapleton et al., 2017). A retrospective analysis using 
an algorithm to identify a dry eye population based on medical diagnostics code claims indicative 
of dry eye disease and prescriptions of cyclosporine ophthalmic emulsion from 9.7 million Military 
Health System beneficiaries in the American Department of Defense, found annual dry eye 
prevalence and incidence increased with age starting at ages 18 to 39 (Dana et al., 2019b). It would 
appear from the dry eye criteria or threshold questionnaire values outlined earlier that more women 
account for a higher proportion of self-reported symptomatic dry eye with 60% and 70% of 
respondents being women from the OSDI and SPEED respectively. However, it is also important to 
note that more women than men completed the questionnaires. Approximately 57% of OSDI 
respondents and 66% of SPEED respondents were women. In Herefordshire, females outnumber 
males at almost all ages over 40 with 98 men for every 100 women, and differences more evident 
once ages approach the late seventies (Herefordshire Council, 2018).  
 
Understanding the natural history, prevalence and incidence of a condition is important when 
planning to develop a specialist service to address the needs of the target user of the service. There 
is currently limited study on the area relating to the natural history of treated and untreated dry eye 
disease, which requires further research (Stapleton et al., 2017; McDonnell et al., 2017). Bron et al. 
(2009) suggest dry eye is a progressive condition with stages of initiation, reflex compensation and 
loss of the compensatory response that may result in a hybrid state of combination aqueous deficient 
and evaporative dry eye. This theoretical model suggests that dry eye worsens without intervention 
over time and plateaus at a certain point in time, supporting the view of early prophylactic care. 
Conversely, findings in a retrospective study by Lienert et al. (2016) showed the most common 
perception of subjects with dry eye was that there was no change in their dryness or visual symptoms. 
The authors propose that dry eye progresses despite treatment in cases where severe symptoms are 
present at diagnosis (Lienert et al., 2016). The average duration of dry eye disease was 14.5 ± 7.7 
years in women aged 61.2 to 89.9 years, and 10.5 ± 9.5 years in men aged 60.2 to 97.3 years (Lienert 
et al., 2016). At a statistically significant level (P < 0.0001), more women than men had experienced 
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severe symptoms (Lienert et al., 2016). Factors other than a history of severe symptoms associated 
with a worsening of dry eye symptoms and social impact were monthly spending on treatments 
valued at over twenty US dollars, a history of blepharitis or Meibomian gland dysfunction and use 
of systemic beta-blockers (Lienert et al., 2016).  
 
There are a limited number of studies reporting on the incidence or rate of new cases of dry eye 
disease over a given time frame (Stapleton et al., 2017). Moss et al. (2008) determined using a 
population of mainly Caucasian residents between the ages of 48 and 91 from Beaver Dam, 
Wisconsin, USA that 21.6% (95% confidence interval 19.9-23.3%) of individuals developed 
symptomatic dry eye disease over 10 years. There were 2412 subjects identified as persons at risk 
for incidence of dry eye, and women composed 56% of the cohort (Moss et al., 2008). After adjusting 
for age, incidence of dry eye was greater in women (25.0%) compared to men (17.2%, p < 0.001) 
and incidence was also higher in subjects aged 80 years or older (Moss et al., 2008).  The profile of 
these subjects is similar to those in the current analysis in terms of age, ethnicity and socioeconomic 
class, however, it is important to note that in the Moss et al. (2008) study, no objective testing was 
performed to determine the presence of dry eye and determination of dry eye status relied on self-
reports alone. Dry eye was described as a foreign body sensation accompanied by itching and 
burning not related to allergy and experienced for a minimum of three months (Moss et al., 2008). 
It was of the authors’ opinion that subjects with dry eye are best placed to judge the presence of the 
condition, considering tests commonly performed to diagnose dry eye lacked in sensitivity and 
specificity (Moss et al., 2008). The challenges practitioners face in diagnosing dry eye are discussed 
in chapter three. Moss et al. (2008) also noted use of diuretics, antidepressants, and oral steroids 
were associated with a greater risk of dry eye incidence. A British population-based cross-sectional 
association study (Vehof et al., 2014) of 3824 women from the Twins UK cohort aged 20 to 87 years 
used a questionnaire to evaluate dry eye disease and associated risk factors, and estimated the 
incidence of dry eye as defined by the Beaver Dam Eye study (Moss et al., 2008). Vehof et al. (2014) 
determined that the incidence of symptomatic dry eye was 10.4% (95% confidence interval 9.1- 
11.7%) over a two-year time period.  
 
Stapleton et al. (2017) present the risk factors for dry eye disease categorized according to being 
modifiable or non-modifiable, and the level of evidence as consistent, probable or inconclusive. 
Table three from the TFOS DEWS II epidemiology report has been replicated and presented in table 
2.8.  Knowledge of these risk factor could help identify people from the general practice population 
who may benefit from a dry eye service. Dry eye by nature has a heterogeneous disease process with 
numerous extraneous variables that are challenging to grade or measure and can affect signs and 
symptoms of dry eye (Foulks, 2003; Skelly et al., 2012). Knowledge of these extraneous variables 
both modifiable and non-modifiable could help with identifying those that may benefit from a dry 
 26 
eye service. For example, demographics such as age and sex (Stapleton et al., 2017; Eisner, 2015; 
Schaumberg et al., 2009), as well as geographical factors including seasonal pollen exposure, levels 
of humidity and air pollution, which may affect dry eye disease (Novack et al., 2017).  
 
Visual display terminals have shown to suppress blinking and alter tear dynamics leading to 
increased tear evaporation and dry eye (Tsubota & Nakamori, 1995; Nakamori et al., 1997; Uchino 
et al., 2008; Kojima et al., 2011; Uchino et al., 2013). Lid abnormalities including entropion, 
ectropion, paralysis and thyroid eye disease can result in signs and symptoms of dry eye 
(McMonnies, 2007), and so objective testing for dry eye following screening with a questionnaire 
at the time of an eye examination may help segment those customers who may benefit from a more 
in-depth dry eye assessment and onwards ophthalmology referral. Corneal staining, which is a 
relatively late manifestation of dry eye and common outcome measure of dry eye studies, and 
neuropathic corneas can result when there is a history of viral keratitis or corneal refractive surgery 
(Kheirkhah et al., 2015; Gallar et al., 2004; Novack et al., 2017). Therefore, taking a comprehensive 
history could help in selecting potential customers of the service. Other external factors that can 
influence dry eye status include use of systemic medications such as steroids, immunosuppressants, 
parasympathomimetic agents, and antihistamines, and local therapies including hypotensive, 
antimicrobial, cyclosporine, and autologous serum tear drops (Urzua et al., 2012; Quinto et al., 2008; 
Gomes et al., 2017; Dana et al., 2019a). Contact lenses also have the potential to influence dry eye 



















Consistenta Probableb Inconclusivec 
Non-modifiable Aging  
Female sex 
Asian race 
Meibomian gland dysfunction 




Viral infection  
Thyroid eye disease 
Psychiatric conditions 
Pterygium  




Modifiable  Androgen deficiency 
Computer use 
Contact lens wear 
Hormone replacement therapy 
Hematopoietic stem cell 
transplantation  
Environment: pollution, low 


















Table 2.8: Risks factors for dry eye diseases replicated from the TFOS DEWS II epidemiology report 
a Consistent evidence implies the existences of at least one adequately powered and otherwise well-
conducted study published in a peer-reviewed journal, along with the existence of a plausible 
biological rationale and corroborating basic research or clinical data.; b Suggestive evidence implies 
the existence of either inconclusive information from peer-reviewed publications or inconclusive or 
limited information to support the association, but either not published or published somewhere 
other than in a peer-reviewed journal.; c Inconclusive evidence implies either directly conflicting 
information in peer-reviewed publications, or inconclusive information but with some basis for a 
biological rationale.  
A mostly consistent non-modifiable risk factor for dry eye disease is Asian ethnicity (North and 
South East Asian) (Stapleton et al., 2017). In studies using the same diagnostic criteria, gender and 
age range, there appears to be a higher estimated abnormal tear function amongst Asians compared 
to Caucasians perhaps due to differences in susceptibility to dry eye or due to geographical 
differences (Stapleton et al., 2017). However, research in Singapore does not show that there is a 
significant difference in prevalence of symptomatic dry eye between Asians and Caucasians (Tong 
et al., 2009; Tan et al., 2015). All of the customers involved in completing the dry eye questionnaires 
in the current analysis were Caucasian, once again reflecting the characteristics of the population in 
the area. The ethnic composition of Herefordshire according to a 2011 consensus was 93.7% white 
English, Welsh, Scottish, Northern Irish, British compared to 80.5% in England (Herefordshire 
Council, 2018). 
There is currently no consensus on a gold standard for assessment of dry eye severity although the 
primary determinant for management strategy chosen is based on the severity of disease (Behrens 
et al., 2006; B. Sullivan, 2014). It is well established that perceived symptom severity or self-
reported symptoms may not equate to clinical signs of dry eye and vice versa, which may be due to 
diurnal variation or changes in symptoms over time and the influences of age, sex and ethnicity on 
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symptoms (B. D. Sullivan et al., 2014; Cardona et al., 2010; Tran et al., 2013; Schaumberg et al., 
2003). The concept of a clinically important difference is likely to be more important than a 
numerical statistically significant difference when it comes to health or quality of life for people 
affected by a particular condition (Copay et al., 2007; Jaeschke et al., 1989). So, although there are 
statistical differences between different dry eye symptom classification groups, what may be most 
meaningful is the minimum clinically important difference threshold value or the smallest change 
that is important to patients (Stratford et al., 1998; Novack et al., 2017). Miller et al. (2010) used 
observational data from the Restasis Review of Efficacy and Safety vs Tears in the Relief of Dry 
Eye (RESTORE) registry to estimate the minimal clinically important difference for the OSDI 
questionnaire to range from 4.5 to 7.3 for mild or moderate dry eye, and from 7.3 to 13.4 for severe 
dry eye cases. 
 
 
1.5: Dry eye diagnostics & management 
The new definition for dry eye disease amended by the Tear Film and Ocular Surface Society 
(TFOS) Dry Eye Workshop (DEWS) II, and presented in section 1.4, does not indicate that specific 
signs of dry eye must be present for diagnosis. The definition characterizes dry eye as a multifactorial 
disease of the ocular surface with a loss of homeostasis or the body’s ability to maintain equilibrium, 
and sequelae associated with tear film instability (Craig et al., 2017). Dry eye disease can be sub-
categorized on a spectrum where the signs are predominately evaporative or aqueous-deficient in 
origin, as overlapping between components often occurs (Craig et al., 2017). An evaporative element 
to dry eye due to conditions affecting the eyelids or the ocular surface is thought to be more common 
than an aqueous deficient one due to conditions affecting the lacrimal gland, with Meibomian Gland 
Dysfunction (MGD) considered the main cause of evaporative dry eye in clinic and population-
based studies (Lemp et al., 2012; Viso et al., 2011; Tong et al., 2010). The predominately evaporative 
dry eye sub-classification including cases of MGD, is thought to have a prevalence ranging from 
38% to 68% in different populations (Schaumberg et al., 2011; Foulks et al., 2012; Lemp & Nichols, 
2009; Lemp et al., 2012; Stapleton et al., 2017).  
 
There is currently no one sign or symptom that correlates absolutely with dry eye disease, in part 
due to the dynamic nature of dry eye with signs and symptoms that can fluctuate over time, and vary 
in severity (Sullivan et al., 2012; Sullivan et al., 2010). The traditional approach to evaluating new 
diagnostic tests required dry eye and normal subjects to satisfy all criteria within a series of sensitive 
thresholds, despite evidence that signs and symptoms are uncorrelated across the wider population, 
and do not develop at the same time (Kallarackal et al., 2002; Moore et al., 2009; Begley et al., 2003; 
Nichols et al., 2004; Mizuno et al., 2010; Fuentes-Paez et al., 2011; Sullivan et al., 2014). As 
discussed previously, it is common to encounter a patient who is very symptomatic, but does not 
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exhibit any signs of dry eye and vice versa.  Studies excluding a large number of dry eye patients 
because they do not satisfy certain criteria prevents randomization, and gaps in the inclusion criteria 
introduce sampling bias and spectrum bias respectively (Wolffsohn et al., 2017). The DEWS II 
Diagnostic Methodology Subcommittee outlined the recommended diagnostic homeostatic marker 
tests for dry eye disease, and additional metrics for the identification of dry eye disease subtypes 
(Wolffsohn et al., 2017). It is advised to perform tests from least to most invasive as the sequence 
of tests can affect results (Foulks, 2003). 
 
The DEWS II Diagnostic Methodology Subcommittee advised the administration of a validated 
symptom questionnaire at the start of a patient interaction to establish whether additional dry eye 
evaluation is clinically necessary (Wolffsohn et al., 2017). Similar to clinical signs of dry eye 
disease, quantifying symptoms accurately rather than reporting during non-scripted verbal 
interviews is important to monitor the progression of dry eye and response to treatments. Dry eye 
questionnaires assessing symptoms have been used to screen for dry eye disease, to grade disease 
severity in practical settings, and for epidemiological studies (Chia et al., 2003; Lee et al., 2002; 
McCarty et al., 1998; Moss et al., 2000; Schaumberg et al., 2003; Schein et al., 1997; Doughty et 
al.,1997; Begley et al., 2002; McMonnies & Ho, 1987; Schiffman et al., 2000). A scale characteristic 
required for a questionnaire to be considered a measurement is called unidimensionality, where 
items measuring a single underlying trait should produce data that varies along a simple number line 
with large measurements representing a large quality of the trait and vice versa (Ngo et al., 2013). 
Dimensionality can be determined using principal component, factor, and Rasch analyses (Ngo et 
al., 2013). Two commonly used questionnaires for dry eye symptoms assessment, the OSDI and the 
Standardized Patient Evaluation of Eye Dryness (SPEED), are included in the consultation for dry 
eye assessment at BBR Optometry Ltd. All clinical tests conducted at BBR Optometry Ltd. and 
included in this chapter’s analyses are outlined in table 3.1. 
 
The OSDI questionnaire developed by the Outcomes Research Group at Allergan Inc (Irvine, CA) 
has been shown to be a valid and reliable tool for grading the severity of eye disease with good 
sensitivity and specificity in distinguishing between those with and without dry eye, and it can be 
used as an endpoint in clinical trials to test the efficacy of new dry eye treatments (Schiffman et al., 
2000; Simpson et al., 2008). The OSDI is the most widely used questionnaire for dry eye disease 
clinical trials, and was chosen by the Diagnostic Methodology Subcommittee of the Tear Film and 
Ocular Surface Society (TFOS) as one of the recommended symptom questionnaires for practitioner 
use (Wolffsohn et al., 2017). The Report of the TFOS International Dry Eye Workshop (DEWS II) 
is a global consensus concerning multiple aspects of dry eye disease created by 12 sub-committees 
made up of 150 experts from 23 countries (Nelson et al., 2017). The other recommended symptom 
questionnaire in the consensus view of the committee was the Dry Eye Questionnaire (DEQ-5) for 
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its short length and discriminative ability (Chalmers et al., 2010).  There are 12-items in the OSDI 
relating to frequency of dry eye symptoms, and issues with visual functioning and environmental 
triggers related to dry eye. The total OSDI score can range from 0 to 100 and is derived from the 
formula: (sum of scores) x 25/ (no. of questions answered), where each question item is scored 0, 1, 
2, 3, 4 for none, some, half, most or all of the time respectively. For questions regarding visual 
functioning and environmental triggers there is the option of selecting not applicable. The total OSDI 
questionnaire score can be used to classify the severity of dry eye with scores of 0-12 representing 
normal or non-dry eye status, total scores ranging from 13-22 indicating mild dry eye, total scores 
ranging from 23-32 indicating moderate dry eye, and total scores ranging from 33-100 indicating 
severe dry eye (Miller et al., 2010). 
 
The SPEED questionnaire is an eight-item validated dry eye questionnaire designed by TearScience 
(Morrisville, NC) that has been shown to have good internal consistency, good discriminant validity 
using the OSDI, and correlates well with clinical tests of Meibomian gland functionality, age, 
corneal staining, and lipid layer thickness (Ngo et al., 2013; Asiedu et al., 2016; Finis et al., 2014a). 
The total SPEED score can range from 0 to 28 and is derived from the summation of the frequency 
and severity parts of the questionnaire. The symptoms asked by SPEED are dryness or grittiness or 
scratchiness, soreness or irritation, burning or watering and eye fatigue reported and scored with a 
Likert scale as 0, 1, 2, 3 for never, sometimes, often and constant respectively. SPEED also asks 
whether these symptoms pose no problems, were tolerable, uncomfortable, bothersome and 
intolerable scored as 0, 1, 2, 3, 4 respectively. The SPEED questionnaire as defined by the OSDI 
questionnaire has been shown to differentiate between asymptomatic and dry eye symptomatic 
groups (Ngo et al., 2013). There are no agreed criteria for symptomatic dry eye for screening or 
classification of symptom severity for SPEED, although total SPEED scores ≥ six and three 
symptom categories including no symptoms (total SPEED 0), mild to moderate (total SPEED 1-9) 
















Symptom Assessment Ocular Surface Disease Index 
(OSDI) questionnaire (Allergan 
Inc, Irvine, CA, USA) 
 12 items 
Ocular symptoms (0-4) Vision-related 
function (0-4 or not applicable) 
Environmental triggers (0-4 or not 
applicable) 
Total score (0-100) = (sum of scores) 
x 25/ (no. of questions answered) 
 
Standard Patient Evaluation of 
Eye Dryness (SPEED) 
questionnaire (TearScience, 
Morrisville, NC, USA) 
 
8 items  
Severity score (0-12) 
Frequency score (0-16) 
Total score (0-28) 
 
Tear Osmolarity  
 
 TearLab (TearLab 
Corporation, San Diego, CA, 
USA)  
 
Tear osmolarity (mOsm/L) 
Tear Film 
Interferometry and 
number of partial and 
complete blinks  
LipiView II Ocular Surface 
Interferometer with Dynamic 
Meibomian Imaging 
(TearScience, Morrisville, NC, 
USA) 
Average Lipid Layer Thickness (nm) 
Number of partial blinks 
Total number of blinks  
Percentage of partial blinks= (number 
of partial blinks/ total number of 
blinks) x 100  
 
Meibography  LipiView II Ocular Surface 
Interferometer with Dynamic 
Meibomian Imaging 
(TearScience, Morrisville, NC, 
USA) 
 
MeiboGrade Gland dropout (0-3) 
MeiboGrade Gland duct dilation (0-3) 
Meibomian Gland 
Expressibility  
Korb Meibomian Gland 
Evaluator (TearScience, 
Morrisville, NC, USA) 
Total number of functional glands at 
the lower lid margin temporally, 




Fluorets and saline (Bausch & 
Lomb, Rochester, NY, USA) 
 
Tear breakup time (seconds) 
Table 3.1: Clinical dry eye diagnostics used at BBR Optometry Ltd. and included in the current 
analyses. 
  
Tear osmolarity is a measure of tear film composition with variations affecting tear film stability. 
Tear osmolarity is an objective marker for dry eye disease frequently reported as the best measure 
to diagnose dry eye across the various severity levels and subtypes (Wojtowicz et al., 2011; 
Kanellopoulos & Asimellis, 2016; Lemp et al., 2011; Potvin et al., 2015). Hyperosmolarity arising 
as a result of water evaporation from the exposed ocular surface in situations of excessive 
evaporation or reduced aqueous tear flow, or a combination of these events causes a loss of goblet 
cells, disturbance of mucin expression, and initiates a release of inflammatory mediators into the 
tears resulting in damage to the ocular surface (Wolffsohn et al., 2017). Physiological stress on the 
cornea caused by hyperosmolarity can also lead to nerve damage (Hirata et al., 2015). Studies have 
shown that current measurement techniques can be highly variable with some commercially 
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available systems requiring at least three measures to achieve reliable results (Bunya et al., 2015; 
Szczesna-Iskander, 2016). The TearLab system (TearLab Corporation, San Diego, CA, USA) is 
used at BBR Optometry Ltd. and evaluates tear osmolarity from 50 nL samples collected from the 
lower lid tear meniscus of both eyes. The literature proposes threshold values ranging from 305 
mOsm/L to 316 mOsm/L with reported sensitivities of 64% to 91%, specificities from 78% to 96%, 
and positive predictive values of 85% to 98.4% (Versura et al., 2010; Jacobi et al., 2011; Schargus 
et al., 2015a; Schargus et al., 2015b; Khanal et al., 2008; Tomlinson et al., 2010). The cut-off value 
of 308 mOsm/L has been widely accepted for use in clinical practice to help diagnose mild- moderate 
dry eye. Inter-eye variability in tear osmolarity has been shown to be greatest in people with dry eye 
disease, and larger inter-eye differences have been found in more severe cases (Jacobi et al., 2011; 
Gibard et al., 1978; Lemp et al., 2011). Transient increases in tear osmolarity have been observed 
under conditions of tear instability when tear evaporation increases leading to tear breakup, such as 
prolonged interblink periods or due to exposure to increased humidity and wind speed (Liu et al., 
2009; Peng et al., 2014). An inter-eye difference in tear osmolarity greater than 8 mOsm/L is 
considered to be potentially indicative of a loss in tear film homeostasis suggestive of dry eye disease 
(Sullivan, 2014). 
 
The LipiView II Ocular Surface Interferometer with Dynamic Meibomian Imaging used at BBR 
Optometry Ltd. (TearScience, Morrisville, NC, USA) employs interferometry to measure the 
thickness of the lipid layer in 20 seconds by analysing the tear film over the lower half of the cornea 
(Wolffsohn et al., 2017). The tear film is measured using an interferometry colour assessment by 
specular reflection with an estimation of the lipid layer thickness based on the observed mean 
interference colours (Eom et al., 2013). The patient is positioned on the forehead and chin rest, and 
instructed to maintain fixation on an internal target (three light-emitting diodes) whilst continuing 
to blink. The operator then adjusts the camera focus prior to capturing the image. The instrument 
has a sensitivity of 65.8% and a specificity of 63.4% using a threshold value of 75 nm to identify 
MGD (Finis et al., 2013). The LipiView II also captures blink dynamics with a high-resolution 
video, analysing blink patterns, and detecting partial blinks. Partial or incomplete blinking can lead 
to symptoms, and corneal staining signs of dry eye (Wolffsohn et al., 2017). The function of a 
complete blink is to distribute meibum for re-formation of the tear film lipid layer, clear debris and 
provide mechanical protection to the eye (Knop et al., 2009; Linton et al., 1961; Knop & Knop, 
2009; Doane, 1981; Tutt et al., 2000; Bron et al., 2004; McMonnies, 2007; Cruz et al., 2011; Carney 
& Hill, 1982; Forst, 1987; Nakamori et al., 1997; Rambold et al., 2002). High-definition imaging of 
the Meibomian gland morphological structure is possible using the LipiView II. The MeiboGrade 
score from TearScience for the lower lids only was used in the current analyses to quantify the 
degree of Meibomian gland atrophy referred to as dropout, and Meibomian gland duct dilation with 
0, 1, 2, 3 corresponding to none, mild, moderate and severe changes respectively, based on 
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previously described histopathologic changes in the Meibomian glands (Jester et al., 1981; Mathers 
et al., 1981; Robin et al., 1985; Gutgesell et al., 1982; Jester et al., 1989).  
 
Meibomian gland expressibility is thought to be a measure of the function of the Meibomian glands 
embedded within the tarsal plate of the eyelids, which secrete a component of the lipid layer of the 
tear film called meibum required for ocular surface health (Wolffsohn et al., 2017). The eyelid is 
compressed against the globe using an instrument called the Korb Meibomian Gland Evaluator 
(TearScience, Morrisville, NC, USA) to simulate forced blinking, and the consistency and colour of 
the secretion as well as an absence of a secretion are documented qualitatively (Korb & Blackie, 
2008; Blackie & Korb, 2009). The Korb Meibomian Gland Evaluator applies a standard force of 
1.25 g/mm2 to the external surfaces of the lower eyelid, and the exact area of contact surface is 8.76 
x 4.45 mm = 38.95 mm2 (Blackie & Korb, 2010). Using 16x magnification on the slit lamp, five 
consecutive Meibomian gland orifices in the temporal, central and nasal sections of the lower lids 
are expressed using the Korb Meibomian Gland Evaluator for no longer than 10 seconds. The total 
number of Meibomian glands yielding liquid secretion is then scored from 0 to 15.  
 
Fluorescein tear breakup time remains one of the most commonly used tests for assessing tear film 
stability in clinical practice, despite it being a subjective metric with fluorescein itself possibility 
reducing tear film stability, and having uncertain diagnostic value for people with mild to moderate 
dry eye disease (Cardona et al., 2011; Downie et al., 2013; Turner et al., 2005; Graham et al., 2010; 
Smith et al., 2008; Lemp et al., 2011; Sullivan et al., 2012; Mengher et al., 1985a; Mooi et al., 2017). 
Sodium fluorescein is instilled in the eye using an impregnated strip to enhance the visibility of the 
tear film. The tear film is observed using a slit lamp biomicroscope through cobalt blue illumination 
and a Wratten-12 yellow barrier filter. The interval of time in seconds that elapses between a 
complete blink and the appearance of the first break or dark patch in the tear film is known as the 
fluorescein tear breakup time (Lemp et al., 1970; Norn, 1969). A value of less than 10 seconds 
indicates a dry eye diagnosis, but if small more controlled volumes of fluorescein are used, the 
reference value can be five seconds (Lemp & Hamill, 1973; Abelson et al., 2002; Abelson et al., 
2012). Considering the effect of fluorescein on tear film stability as well as factors including 
temperature, humidity, and air circulation, non-invasive tear breakup time (NIBUT) is becoming a 
more popular, preferred dry eye metric in clinical practice and academia (Wolffsohn et al., 2017). 
Automated systems can detect and map locations of tear breakup over time, and specific software 
can measure NIBUT as indicated by surface irregularities and localised changes in corneal power 
(Best et al., 2012; Hong et al., 2013; Goto et al., 2004; Goto et al., 2003; Kojima et al., 2004; Gumus 
et al., 2011).  
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An evidence-based management algorithm was proposed by Jones et al. (2017) with the intention 
of assisting eye health care practitioners given the complex nature of dry eye that varies in severity 
and amongst those affected. The algorithm, seen in appendix 1.1, developed by TFOS was not meant 
to be rigid or formulaic, and it was anticipated that it would need to be adapted to suit individuals. 
The first level of treatment begins with conventional over-the-counter products, and when the 
customer no longer responds to treatment or exhibits a greater level of disease severity, the next 
level of management is recommended and sometimes the previous therapy may also continue (Jones 
et al., 2017). BBR Optometry Ltd. offer various step two level in-practice treatment options as 
outlined in the TFOS DEWS II staged management and treatment algorithm for dry eye (appendix 
1.1), which are described in detail in appendix 1.2. Additionally, BBR Optometry Ltd. are unique in 
that the practice employs aspiring and current independent prescribing optometrists, who can 
provide private prescriptions for pharmacological management of dry eye where required. Careful 
review to ensure compliance with recommended management options and to establish 
improvements in symptoms, and signs of dry eye should take place from one to three months 
following initiation of management with the exception of cyclosporine given therapeutic action can 
take several months to occur (Jones et al., 2017).  
 
 
1.6: BBR Optometry Ltd. 
BBR Optometry Ltd. is located in the city of Hereford, which has an estimated population of 60,800 
residents (Herefordshire Council, 2018). Hereford is the centre for most facilities in the 
predominately rural county of Herefordshire situated in the south-west of the West Midlands region 
bordering Wales (Herefordshire Council, 2018). Herefordshire has an older age profile compared to 
England and Wales as a whole with 24% versus 18% of the population aged 65 years and over, and 
a high proportion of residents in their early fifties and above thought due to the baby booms 
following World War II and in the 1960s (Herefordshire Council, 2018). 
 
BBR Optometry Ltd. is a large independent optometric practice with five consulting rooms, two 
patient waiting areas, a pre-screening room, an imaging room and large shop floor area for spectacle 
dispensing. The practice is easily accessible via public transport, and nearby the County Hospital 
Victoria Eye Unit, local general practitioner and dental surgeries, pharmacies, and other small 
independent businesses. There are three pay and display car parks located in the vicinity of the 
practice, and limited pay and display parking on the street where the practice is situated.  
 
Three national chain optometric practices are also located in the city of Hereford. BBR Optometry 
Ltd. distinguishes itself from local competitors by offering longer consultation durations than usual, 
professionally qualified dispensing staff, participation in all local community-enhanced services, 
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and private specialist services. Private specialist services include optical coherence tomography 
(OCT), ultra-wide field imaging, therapeutic management, specialist CL fitting, dry eye 
consultations and access to novel in-practice treatments for dry eye. The business model at BBR 
Optometry Ltd. is orientated around a lower volume of sales, but a higher average revenue per 
patient via professional fees and optical products.  
 
In regards to explicit service promises, BBR Optometry Ltd. have a mission statement that 
summarises the aims and values of their firm, and reflects the desire of the practice directors to 
uphold a reputation for clinical excellence. The mission statement is “to deliver the best standard of 
eye care to all our patients in a friendly, professional environment,” and tangibles listed on the 
practice website include: 
• Optician Awards Winner 2015, the enhanced services award 
• Rodenstock Centre of Excellence 2015 first place 
• Rodenstock Solitaire 2 Category lenses first place 
• Optician Awards Finalist 2018  
• Registered with the General Optical Council 
• Investors in People- Gold 
• World Council of Optometry Supporter 
• ISO 9001 Quality Management Certification via QSL ISO Quality Services Ltd. 
• Member of Herefordshire & Worcestershire Chamber of Commerce  
 
This research was part of a wider collaborative Knowledge Transfer Partnership (KTP) project 
between BBR Optometry Ltd. and Aston University’s Business Partnership Unit. The KTP project 
was intended to grow BBR Optometry Ltd. as a business and optometric practice by applying 
knowledge and insights derived from the research presented in this thesis. The final achieved 
objective for the KTP project was to embed a service for the non-routine patient to establish BBR 
Optometry Ltd. as capable of diagnosing and managing complex, chronic eye conditions at the 
highest level, whilst introducing new revenue streams. The dry eye service required re-structuring 
in terms of fees, timings, standards of care, and possible outcomes, ultimately differentiating BBR 
Optometry Ltd. from local competition and future-proofing the business. The KTP project was part 
funded by BBR Optometry Ltd. and by Innovate UK. The certificate of KTP project completion, 






1.7: Research aims and objectives  
Presently, the literature on dry eye concerns specific clinical tests and management options, but does 
not focus on how a practitioner can set up a speciality service, and sustain a dry eye clinic in 
community optometric practice. Optometric practices offer varying levels of dry eye care from 
consultations using traditional or modern diagnostic tests, and different staged treatment options 
depending on practice investment in in-practice therapies, including those that are device-assisted, 
and in higher education to offer prescription medication. Dry eye services are not currently part of 
traditional EOS to the best of the author’s knowledge, and tend to be privately funded by patients. 
Chapter two will use a single optometric practice site, BBR Optometry Ltd. described in section 1.6, 
to investigate the local demand for establishing a dry eye service, demonstrate the usefulness of 
service blueprinting, and evaluate the possible tangible benefits of implementing a dry eye service 
on other aspects of an optometric business. Chapter three will use a retrospective analysis and 
objective statistical methods to determine the most important clinical screening questions and tests 
that are predictive of dry eye from a sample of patients from BBR Optometry Ltd., where an 
advanced dry eye service in terms of offering the latest diagnostics and therapies was implemented.  
 
Dry eye is thought to impact the success of other optometric services including the outcome of 
referrals for cataract surgery and the success of CL fittings. Chapter four explores retrospectively, 
the possible effect of dry eye on visual and clinical outcomes at a private hospital where optometrists 
from BBR Optometry Ltd. commonly refer patients for lens replacement surgery. Chapter five will 
determine retrospectively whether dryness and ocular discomfort are main reasons for CL dropout 
at BBR Optometry Ltd., and perhaps offer evidence for the utility of prophylactic dry eye care prior 
to surgery and CL fitting, which can impact the tear film and ocular surface, and impede ocular 
wellness. Dry eye is a condition that does not command priority in the HES with overstretched and 
limited resources for effective long-term management. Chapter six aims to provide a glimpse into 
the possible number of dry eye cases attending a local hospital for dry eye-related concerns, and 















CHAPTER 2 ABSTRACT 
Application of service experience management concepts for the development of specialist 
community optometric services 
 
PURPOSE: To determine the local need for establishing a private dry eye service at BBR 
Optometry Ltd., and to demonstrate the usefulness of service blueprinting in the context of an 
optometric practice. A third aim was to provide insight into the dry eye service user at BBR 
Optometry Ltd. by assessing whether utilisation of the dry eye service would lead to: conversion to 
EyelifeTM membership or EyelifeTM upgrades, more structured dry eye product purchasing 
behaviour, and fewer clinical attendances for dry eye related concerns.  
 
METHODS: Customers aged 18 years and over attending for an eye examination were asked to 
randomly complete one of two validated dry eye questionnaires, the Ocular Surface Disease Index 
(OSDI) or the Standard Patient Evaluation of Eye Dryness (SPEED) survey. Kruskal- Wallis tests 
were conducted using a commercially available statistical software package (SPSS for Mac, version 
24.0, IBM-SPSS, Chicago, IL, USA) to determine if there were differences in OSDI scores, SPEED 
scores, and ages between groups of respondents with different OSDI and SPEED symptom severity 
classifications.  
 
Service blueprinting is an element of service quality management that relates to the design of 
standards for new services, and to reduce provider gaps outlined in the Gaps model of service quality 
(Parasuraman et al., 1985). The role of a service blueprint is to aid strategic implementation of new 
services with existing services, and to avoid process and delivery errors. BBR Optometry Ltd.’s Tear 
clinic was used as a case study to demonstrate how service blueprinting can be applied to optometric 
practice as a template for new optometric service provision and integration into existing systems.  
 
Data including EyelifeTM status, dry eye product and spectacle transactions, and number of practice 
attendances, were analysed for customers who had a dry eye consultation and compared from a time 
period of one year prior to the consultation, and one year following the dry eye review appointment. 
 
RESULTS: 25% (67/274) of customers identified as having symptomatic dry eye with the widely 
accepted criterion of OSDI ≥ 13, and 39% (198/506) of customers identified as having symptomatic 
dry eye with the criterion of SPEED ≥ six. Overall, the average age of respondents was 64.47 ± 
14.57 and 65.60 ± 15.25 for the OSDI and SPEED questionnaires respectively. Focusing on the 
results of the pairwise comparisons, there were statistically significant differences in the distribution 
of total OSDI scores between the normal OSDI classification group and all other symptomatic OSDI 
groups. There were no statistically significant differences in the total OSDI score distributions 
between the mild and moderate, mild and severe, and moderate and severe groups. For the 
distribution of total SPEED scores, the pairwise comparisons across SPEED classification groups 
were statistically significant for all possible combinations. There were no statistically significant 
differences in the age distributions across symptom severity classifications for either of the 
questionnaires.  
 
The average age of customers attending for a dry eye consultation was 65.71 ± 12.72, and 67 were 
females and 27 were males. Overall the majority of customers utilising the dry eye service were 
exisitng BBR Optometry Ltd. customers and of the new customers, only two of the 26 converted to 
EyelifeTM. Customers utilising the dry eye service preferred to purchase products at point of sale 
versus subscribing to a monthly direct debit system, and were more likely if at all to purchase 
spectacles following their eye examination irrespective of when they had a dry eye consultation. 
 
CONCLUSIONS: Understanding and applying concepts from the service experience management 
sector complements clinical work, and future studies could assess the effectiveness of a service 
blueprint in an optometric setting including analysis of service quality audits, assessment of 
customer lifetime value, and measures of service conversions and usage.  
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CHAPTER 2 
Application of service experience management concepts for the development of specialist 
community optometric services 
 
2.1: Introduction  
Dry eye is a commonly occurring ocular condition that drives people to seek professional advice 
(Bradley et al., 2019; Stapleton et al., 2017). Anecdotally, optometrists at BBR Optometry Ltd. had 
noticed that numerous customers attending for annual eye examinations or perceived ocular 
emergency appointments had described symptoms of ocular discomfort as their main concern or 
requested advice regarding intermittent ocular discomfort. Developing an advanced dry eye service 
offering aimed to differentiate BBR Optometry Ltd. from competitors in the industry, and also allow 
enough time to fully and efficiently formally investigate customer concerns related to dry eye.  It 
has been demonstrated that too little clinic time spent with customers to explain management 
threatens customer motivation for maintaining therapy and compliance (Lim & Ngah, 1991; Gascon 
et al., 2004; Moore et al., 2004; Lawson et al., 2005). A secondary aim was also to reduce walk-in 
emergency or multiple excessive appointments in general, and ensure EyelifeTM monthly direct debit 
fees (described in section 2.2.3) were cost effective and not overstretched.  
 
Customer participation is important in health care services with the desired outcome of met needs 
and benefits potentially possible if the customers perform their roles effectively (Bowen, 1986). The 
topics of adherence and compliance will be discussed in this chapter. The “service bottom line” is 
business profitability and sustainability, which is frequently a result of customer purchasing 
behaviour and attitudes towards a service provider. Service quality is one of the fundamental 
predictors of business performance (Wilson et al., 2016). Consistent quality service delivery 
performances and strategies to achieve these are important to ensure longevity in the market.  
 
This chapter aims to:  
• Identify whether there is a need or demand for establishing a dry eye service at BBR 
Optometry Ltd.  
• Demonstrate the usefulness of service blueprinting in the context of an optometric practice 
• Identify purchasing behaviour of dry eye customers at BBR Optometry Ltd., and determine 
whether customers utilising the dry eye service subscribe to other aspects of the practice  
 
For the purposes of this chapter, users of BBR Optometry Ltd.’s dry eye service will be referred to 
as ‘customers’. The term ‘client’ or the synonym ‘customer’ as opposed to ‘patient’ to denote a 
recipient of healthcare was introduced in the mid-twentieth century in order to avoid a connotation 
of disability, impairment or being ill (Shevell, 2009). The modern individual is informed and 
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participative in their healthcare and wellbeing, rather than a passive acceptor as the term ‘patient’ 
implies. Deber et al. (2005) surveyed Canadian outpatient clinical populations of people with breast 
cancer, prostate disease, fracture and HIV who found the term ‘patient’ much less objectionable than 
alternatives suggested by the authors including ‘client’, ‘customer’, ‘consumer’, ‘partner’ and 
‘survivor’ because it did not incorporate an assumption of a market relationship. Other studies have 
shown that individuals preferred to be referred to as ‘patients’ albeit they did not permit participants 
to specify that they liked more than one term (Nair, 1998; Lloyd et al., 2001; Wing, 1997). Perhaps 
for people with suspect dry eye issues especially in mild forms, ‘customer’ is a more appropriate 
term than ‘patient’ considering the individual may not perceive themselves as sick or injured, and 
are able to compare costs and benefits of service providers.  
 
 
2.1.1: Optometric market in the UK 
Traditional services in optometric practice are a combination of professional and retail with elements 
of the eye examination including advice and referral, and the dispensing of spectacles and contact 
lenses. The acquiring of Tesco Opticians by Vision Express at the end of 2017 meant introduction 
of the brand to more than 200 supermarket sites, and Asda’s own optometric services operation is 
likely to gain from the proposed merger of the supermarket with Sainsbury’s (Mintel, 2019). 
Although online sales of spectacles remain underdeveloped compared with other retail sectors, 
growth is expected due to advances in technology that will help online customers visualise the 
appearance and fit of their chosen frames (Mintel, 2019). Additionally, many of the online selling 
pioneers have been bought by Essilor, and stores like Superdrug are entering the online market for 
prescription spectacles (Mintel, 2017).  
 
The cornerstone of promotional strategy in the optometric industry has been conspicuous 
discounting (e.g. 2 for 1 glasses offer via Specsavers Opticians). However, the actual current trend 
observed has been brand building by large chains including opticians within John Lewis in 
conjunction with Luxottica, in order to reduce the focus on discounting (Mintel, 2017). The market 
share for independent practices therefore is continuing to be depleted. In order to differentiate 
themselves and compete with local competition and online retailers, practices can become involved 
in enhanced local community scheme services such as the Minor Eyecare Conditions Services 
(MECS) described in chapter six, add related services such as domiciliary and hearing care to their 
portfolio of services, and offer private specialist services.  
 
Private optometric services currently exist for dry eye management, pre- and post-operative care for 
laser refractive and clear lens extraction surgeries, EyePrint prosthetics for bespoke scleral lenses to 
manage keratoconus (https://eyeprintpro.com/), myopia control, orthokeratology, orthoptics, sports 
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vision, and for dyslexia and reading difficulties. The key in the eye care industry market is to provide 
the appropriate product that creates value and addresses the customer’s needs from therapeutics, eye 
glasses, contact lenses and services. The components of each private specialist service will vary 
between practices and ultimately excellent service quality will enable a practice to stand out against 
competition. Community optometry practices have the necessary task of establishing themselves as 
the practice of choice in the customer’s mind in order to achieve key organisational goals such as 
long-term survival and profitability. Practices need to differentiate themselves from their 
competitors in their service element as having excellent products alone is not sufficient, and 
companies cannot compete on price alone (Boulding et al., 1993).  
 
 
2.1.2: The concept of Service quality  
Service quality is a measure of how well customer needs and requirements are met, and how well 
customer expectations and service level delivery align (Wilson et al., 2016). The basic characteristics 
of services make it challenging to deliver consistent quality including being heterogeneous across 
time, organizations and people with customers having unique demands, and no two services being 
performed precisely alike (Fisk et al., 1993; Lovelock & Gummesson, 2004; Wilson et al., 2016; 
Vargo et al., 2004). Fluctuations in demand can be difficult to manage as a service is intangible and 
cannot be inventoried or trialled before purchase (Bitner et al., 2008). The eye examination itself is 
an example of the intangible nature of a service in the optometric industry. Generally, the quality of 
the service and customer satisfaction depends on what happens during the transaction since services 
are simultaneously produced and consumed (Reimer & Kuehn, 2005). Clues to the likely quality of 
the service lie within tangible evidence, such as décor and ambience. Demand forecasting or capacity 
utilisation is critical for services which are perishable, meaning services cannot be saved, stored, 
resold or returned (Wilson et al., 2016). Prior to implementing a service for dry eye management, 
BBR Optometry Ltd. were interested in the prevalence of dry eye amongst their customer base and 
a demographic profile analysis was conducted.  
 
Service quality reflects the customer’s perception of the service dimensions namely, reliability, 
responsiveness, assurance, empathy and tangibles (Parauraman et al., 1988). Customers compare 
their perceptions of service experiences relating to their level of satisfaction, with their expectations 
of what the service performance should be when judging service quality (Parauraman et al., 1988). 
Desired service is often shaped by those personal needs essential to the physical or psychological 
wellbeing of the customer (Wilson et al., 2016). The Gaps model of service quality is a framework 
for understanding and improving service delivery (Parasuraman et al., 1985), seen in figure 2.1. The 
Gaps model suggests that the customer perception of service quality is driven by differences between 
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customers’ expectations about the performance of a general class of service providers, and their 
evaluation of the actual performance of a specific firm within that class (Cronin & Taylor, 1992).  
The service provider gaps involved in delivering and marketing a service are (Parasuraman et al., 
1985): 
• Provider gap one/ Knowledge gap: Not knowing what customers expect. This is the
difference between customer expectations of a service and the company’s understanding of
those expectations.
• Provider gap two/ Standards gap: Not selecting the right service quality designs and
standards
• Provider gap three/ Delivery gap: Not delivering to service designs and standards
• Provider gap four/ Communication gap: Not matching performances to promises
• Gap five/ Customer or Service gap: the difference between customer expectations and
perceptions that is a function of the four provider gaps
Figure 2.1: The Gaps model of service quality (Parasuraman et al., 1985) 
The SERVQUAL instrument or scale published by Parauraman et al. in 1988 is used to 
operationalise the Gaps model from the service user perspective. For more information on the 
SERVQUAL instrument and applications to optometric businesses refer to appendix 2.1. The 
Grönroos model published in 1984 is another model of service quality that is less widely known 
compared to the one developed later by Parasuraman et al. (1985), and identifies technical quality 
(i.e. what customers receive), functional quality (i.e. how customers receive the service) and 
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corporate image as principal components of service quality (Woodall, 2001). The SERVPERF is 
another approach to measure service quality other than the SERVQUAL that only uses the 
performance dimension of the Parasuraman et al. (1985) model (Cronin & Taylor, 1992).  
 
Service blueprinting, which will be discussed in this chapter, is an effective tool used in service 
development and design to help avoid provider gap two. Provider gap two is reduced by having 
services that are designed well, clear customer-driven standards and appropriate physical evidence 
and surroundings in place (Bitner et al., 2008). One of the most important ways to avoid provider 
gap two is to clearly design services free of subjectivity, bias, oversimplification, and 
incompleteness (Wilson et al., 2016). The Mayo Clinic with health service centers in Minnesota, 
Florida and Arizona in the US is the largest multi-speciality group practice in the world. In 2002, 
the Mayo Clinic initiated a programme for service delivery innovation called the SPARC 
(see/plan/act/refine/communicate) Innovation Programme (Duncan & Breslin, 2009). Live 
prototyping through SPARC has provided more information on the patient journey than structured 
questionnaires and focus groups, highlighting the importance of service planning and experiential 
learning when it comes to health care delivery and meeting patient needs (Duncan & Breslin, 2009).  
 
The extent to which customers recognise and are willing to accept variations in the desired service 
to adequate service is called the zone of tolerance (Johnston, 1995; Yap & Sweeney, 2007). When 
the service performance falls outside this zone, the customer views the service in either a positive 
or negative way (Johnston, 1995; Yap & Sweeney, 2007). The zone of tolerance can expand and 
contract between customers and for the same customer, influenced by multiple factors including 
company-controlled factors such as price (Johnston, 1995; Yap & Sweeney, 2007). For example, 
customers with time pressures in their professional and or personal lives on any given day, desire 
short wait times in general and a hold a restricted range for the length of acceptable wait times. If 
the customer’s appointment does not commence when expected it can influence their judgment of 
adequate service. However, recognition of situational factors such as an ocular emergency requiring 
attention prior to the customer’s appointment and requiring more time by the service provider may 
widen the zone of tolerance. The amount of time spent in the waiting room at the last optometric 
visit may also affect the zone of tolerance. Customers can estimate what will happen in the next 
service encounter, referred to as predicted service, from previous experiences. Therefore, some 
customers may expect an additional amount of time, separate from their eye examination, spent in 
the waiting area or undergoing preliminary tests before seeing the optometrist. 
 
When customers perceive that alternative services exists, the level of service the customer finds 
acceptable rises, consequently narrowing the zone of tolerance (Johnston, 1995; Yap & Sweeney, 
2007). Examples of alternative services include other dry eye specialist care providers or self-service 
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through trial and error of over-the-counter dry eye products. It is important to learn about service 
alternatives the customer views as comparable, rather than just those in the business’ competitive 
set as it is likely to include more than just other optometric practices and is a factor in influencing 
the level of perceived adequate service. This activity is important in order to reduce provider gap 
one, also referred to the knowledge gap, to understand what customers expect and to improve service 
delivery (Parasuraman et al., 1985). Optometrists in their dry eye service marketing may wish to 
highlight the frustration of trial and error of ocular lubricants by customers in attempts to self-treat 
or suggested by their pharmacist or general practitioner (GP) due to their perception that they need 
tear replacement rather than solutions for evaporative dry eye, which is the most common form of 
dry eye described further in chapter one. Initially self-treating with over-the-counter products may 
be a viable option to address potential dry eye concerns that the customer finds easier, more 
convenient and less costly than identifying a dry eye service provider.  Also, when fees are high and 
tangibles such as diagnostic technology are impressive, customers expect quality reliable service 
and tend to be less tolerant of poor service (Johnston, 1995; Yap & Sweeney, 2007). 
 
 
2.1.3: The concept of customer satisfaction  
Customer satisfaction can be defined as the overall attitude towards a service provider or an 
emotional reaction to a discrepancy in what the customer anticipates and what is experienced in 
regards to fulfilment of some need, goal or desire (Hansemark & Albinsson, 2004). Parasuraman et 
al. (1994) clarify that customer satisfaction is specific to each transaction, while service quality is 
the customer’s general attitude towards the business. 
 
A German study sought to determine the extent of agreement or congruence between optometric 
service provider’s perceptions of customer satisfaction and customer-reported satisfaction using 
mail surveys (Yavas et al., 2008). The importance being that accurate knowledge about customers 
and assessment of customer perceptions can lead to customer retention as well as stronger business 
performance and success. A list of 28 attributes customers use in evaluating core optometric services 
relating to basic facilities, product and service offerings, core services such as diagnosis of the 
eyesight problem, and after-sales services including warranties and guarantees were generated from 
focus groups with the two target respondent group types (Yavas et al., 2008). Customer respondents 
were asked to indicate their level of satisfaction with these attributes on a five-point scale, and 
members of a professional association of German optometrists were asked to indicate how satisfied 
they thought their customers were using the same scale and set of attributes (Yavas et al., 2008). 
The survey used was not a validated instrument. Data collected was analysed separately for the 
groups using principal components analysis, which is a technique that was used and is explained in 
chapter three.  
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Results from the Yavas et al. (2008) study showed a discrepancy between optometrists and their 
customers with the medical service dimension emerging as the most important factor for 
optometrists but appearing second for customers. This is another example of provider gap one, 
whereby service providers have inaccurate perceptions of what customers actually expect 
(Parasuraman et al., 1985). The only other dimension or factor approaching congruence was 
customer commitment/store design, which appeared second for optometrists and third for customers 
as the most important element for evaluating optometric services (Yavas et al., 2008). Items 
pertaining to selection on lenses and frames, and offers by the store were the most important to 
customers suggesting customers put more emphasis on functional rather than technical quality of 
optometric services (Yavas et al., 2008). That is, the production and delivery of services were more 
important than what the customer received, which is the end result of the service. Health care service 
providers tend to judge core service quality by adherence to standards or generally accepted 
procedures. However, customers may not be aware of these nor use the same criteria in deciding 
how satisfied they are with the service provided (Harvey, 1998). McColl-Kennedy et al. (2017) 
suggest that in a health care setting, where customers can experience heightened emotions due to 
risks associated with health, service providers can enhance wellbeing and the overall service 
experience by creating a supportive culture from the design of the physical environment to the design 




This study received approval from the Life and Health Sciences Ethics Committee at Aston 
University (Project #1276), and adhered to the tenets of the Declaration of Helsinki. 
 
 
2.2.1: Identification of dry eye customers using two validated dry eye questionnaires 
To determine the prevalence of dry eye symptoms presenting at BBR Optometry Ltd., customers 
aged 18 years and over attending for an eye examination were asked to randomly complete one of 
two validated dry eye questionnaires, the Ocular Surface Disease Index (OSDI) or the Standard 
Patient Evaluation of Eye Dryness (SPEED) survey, and consented to having their data itemised for 
research regarding service enhancement. The questionnaires used were discussed in chapter one and 
can be found in appendix 2.2. An initial explanation was given to the customer, and the questionnaire 
was self-completed voluntarily by the customer. The questionnaires were completed by 
consecutively presenting customers to avoid bias of subject selection.  
 
The SPEED questionnaire was administered over a six-month period from April to September 2015, 
and the OSDI questionnaire was used for a further six-month timeframe from October 2015 to March 
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2016. The total OSDI and SPEED score, age and sex for each anonymised customer were recorded 
in Microsoft Excel (Microsoft Corporation, Redmond, Washington, USA).  The age recorded was 
that of the customer when one of the questionnaires was completed. Kruskal- Wallis tests were 
conducted using a commercially available statistical software package (SPSS for Mac, version 24.0, 
IBM-SPSS, Chicago, IL, USA) to determine if there were differences in OSDI scores, SPEED 




2.2.2: Developing a Service blueprint for new services  
The new product development process and implementation stage for manufactured goods tends to 
be more structured compared to service firms due to the challenges of coordinating human resources, 
technology, internal processes and facilities within already existing systems (Griffin, 1997; Thomke, 
2003). Incorporating BBR Optometry Ltd.’s dry eye service into existing systems rather than 
treating it as a standalone service was challenging due to the complexities of internal processes. 
Front end planning involves idea generation for the new service, which can include learning about 
competitor’s offerings, collaborating with third parties, and developing licensing agreements and 
joint ventures (Rigby and Zook, 2002). BBR Optometry Ltd. utilised existing relationships with 
Scope Ophthalmics who were current providers of dry eye diagnostics, and management options 
namely, the TearLab osmolarity system, the Hycosan ocular lubricant range and BlephExTM to 
further develop the service concept. The next step was to estimate the economic feasibility of the 
new service and potential profit implications. The activity-based costing method introduced to the 
practice by Dr Patel and discussed in her PhD thesis (2015) was applied to produce more precise 
cost allocations in determination of fees for the dry eye service (Baird et al., 2004).  
 
The second aspect of the service innovation and development process after front-end planning is 
implementation (Wilson et al., 2016).  A detailed service blueprint represents the implementation 
plan for the new service that is refined and evolves with input from stakeholders such as contact 
employees. Unfortunately, there was no pilot run of the service to ensure that operational details 
were functioning smoothly in the development process. This was most likely due to overexcitement 
from the practice directors who were keen to implement the service, and had a false sense that staff 
with prior dry eye training but limited experience with the dry eye diagnostics were well equipped 
to deliver the intended service. Mistakes or service failures in the design are more difficult to correct 
when the actual market introduction is the first test of whether the service functions as planned. 
Some difficult encounters with customers could have been avoided if this step was not overlooked.  
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There is a greater risk for customer dissatisfaction when problems occur early in the service 
encounter. Situations that resulted in uncomfortable and challenging encounters for the practitioner 
delivering the service included customers being told to attend for further tests but not understanding 
they had been booked for a dry eye consultation with associated additional fees, and customers not 
being told what to expect at the consultation which in turn affected the accuracy of clinical test 
results. In particular, customers would attend wearing their contact lenses, and one customer’s 
partner had organised annual leave to drive the customer to their consultation, believing that one of 
the clinical tests would involve dilation impeding the customer’s own ability to drive. Prior to the 
formalisation of the service, in-practice diagnostics and treatments were initiated haphazardly, and 
at the early stages of service development senior practitioners continued to operate in this manner, 
which was a source of frustration for the practitioner delivering the service and confusion to 
customers.  
The service blueprint outlines all steps involved in the service process so that all employees 
understand the process and are aware of their roles in its delivery (Shostack, 1984; Shostack, 1987). 
Service blueprinting is not a set of rigid rules for designing services, it is defined as “a tool for 
simultaneously depicting the service process, the points of customer contact and evidence of service 
from the customer’s point of view” (Wilson et al., 2016). Service blueprinting overcomes the 
problems of relying on words alone to describe service processes because everyone can visualise 
the process exactly as it was intended. The key components of service blueprints are shown in figure 
2.2 and explained below (Wilson et al., 2016; Bitner et al., 2008; Fließ & Kleinaltenkamp, 2004; 
Patrício et al., 2008).  
Figure 2.2: Service blueprint components (Wilson et al., 2016) 
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Service blueprint components (Wilson et al., 2016): 
• Customer actions: it includes steps, choices, activities and interactions that customers 
perform in the process of purchasing, consuming and evaluating the service depicted 
chronologically across the top of the blueprint. 
• Onstage employee actions: steps and activities the contact employees perform that are 
visible to the customer. In technology delivered services like self-service websites and 
interactive kiosks, this area can be relabelled or divided into two distinct spaces including 
onstage/visible technology, and the backstage contact person action area would be 
irrelevant.  
• Backstage employee actions: steps and activities that occur behind the scenes to support 
onstage activities  
• Support processes: covers the internal services, steps and interactions that take place to 
support the contact employees in delivering the service. There is no customer contact in 
these steps. 
• Physical evidence: tangible things that a customer can see, hear, smell or touch as they go 
through the service experience typically listed above each point of contact  
 
The four key action areas are separated by three horizontal lines (Wilson et al., 2016): 
• Line of interaction: direct interactions between the customer and organization. A service 
encounter has occurred whenever a vertical line crosses the horizontal line of interaction. 
• Line of visibility: this line separates all service activities that are visible to the customers 
from those that are not visible 
• Line of internal interaction: separates contact employees from those of other service support 
activities and people  
 
The boxes shown in figure 2.2 represent the steps performed or experienced by the person at that 
level. The chronology of the actions conducted by the service customer and provider are represented 
along the horizontal axis, and the different areas of actions are distinguished along the y-axis (Fließ 
& Kleinaltenkamp, 2004). Creation of the service blueprint starts with the customer’s view of the 
process and their experience, and involves collaboration with all employees to gain the benefit of 
different perspectives. The whole process needs to be easy, convenient and timely from the 
customer’s point of view. The basic steps involved in building a service blueprint can be found in 
figure 2.3 (Bitner et al., 2008). Service blueprints are not meant to be inflexible, and Wilson et al. 
(2016) note that services are always changing whether or not it is deliberate or unplanned to enhance 
quality from the customer’s point of view. The creation of a blueprint allows clarification of the 
service concept, development of a shared vision for those involved in delivery, highlighting of 
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complexities that were not initially obvious, and delineation of responsibilities (Wilson et al., 2016; 
Bitner et al., 2008).  
Figure 2.3: Steps involved in building a service blueprint (Wilson et al., 2016) 
Successful execution of a service is just as important as innovation to drive growth for a business 
(Noble and Mokwa, 1999; Walker et al., 2002; Cadwallader et al., 2010). Changes in service delivery 
may affect an employee’s role, and the motivation of employees to participate in implementing a 
service will determine whether they serve as facilitators who embrace, execute and promote the 
service or serve as barriers in its success (Cadwallader et al., 2010). Collaboration when creating 
service blueprints from all departments including frontline staff can avoid internal problems caused 
by lack of employee commitment, and understanding of individual capabilities to best deliver the 
service (Averett, 2001).  Lack of sufficient support for frontline staff can result in provider gap three, 
whereby guidelines for service delivery do not lead to high quality service delivery (Parasuraman et 
al., 1985). Lack of understanding about the service offering and the way it is delivered can also result 
in provider gap four, considering customer expectations are fashioned by external communications 
of an organisation (Parasuraman et al., 1985).  Efforts to reduce provider gaps three and four 
associated with service design, delivery and marketing, in turn affect gap five (Parasuraman et al., 
1985).   
Studies have shown employees are more disposed towards a task and feel more positive towards an 
innovation if they are empowered to choose to act (task autonomy), and understand their role in the 
service process (Saavedra & Kwun, 2000; Dodd & Ganster, 1996; Whitaker et al., 2007; 
Cadwallader et al., 2010). Frontline employees who have greater role clarity about new services 
having received additional training and exposed to internal promotion, are more likely and motivated 
to recommend it to customers. Providing employees with resources such as training tools, and time 
to integrate new services to cope with internal process change refers to agent enablement, and is 
required to reduce aversion due to potential additional stress associated with changes to existing job 
routines and increase adoption of innovations (Umashankar et al., 2011). The speed of new service 
development and the amount of information collected about customer problems has been shown to 
increase in services where collaboration between employees in service innovation exists (Ordanini 
& Parasuraman, 2011).  
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Servicescape is a commonly used term to describe the physical surroundings of a service company, 
which includes exterior and interior design, ambient conditions such as temperature, noise, odour as 
well as other tangible aspects of the business such as leaflets and all communication material 
(Reimer & Kuehn, 2005). The servicescape is the designed places calculated to produce 
commercially significant actions (Arnould et al., 1998). The effects of servicescape can be 
conceptualised using the Stimulus-Organism-Response paradigm that suggests environmental 
stimuli from the servicescape has an effect on organic states like emotions, which then influences 
customer reactions (Dedeoglu et al., 2018). Customers only spend as much time in the service 
provider’s environment as necessary for utilitarian services such as insurance, retail banking, dry 
cleaning, dental clinics and optometric practices (Reimer & Kuehn, 2005). It is thought tangibles in 
utilitarian services are of significantly less important than in hedonic services (i.e. services for fun 
and pleasure), however, the servicescape has been shown to have a direct and indirect effect on the 
perceived service quality (Reimer & Kuehn, 2005). The objective of the blueprint presented in 
section 2.3.2 was primarily to communicate the general nature of the dry eye service, and 
demonstrates use of blueprinting for private optometric service innovation.  
 
 
2.2.3: Evaluation of customer activity following use of new services 
BBR Optometry Ltd. introduced new practice management software, I-clarity (I-clarity, Radyr, 
Cardiff), and fee structure in 2012, including a premium fee for an eye examination with the senior 
optometrist. BBR Optometry Ltd. have a monthly direct debit payment plan for professional care 
available to customers called EyelifeTM. There are three tiers of EyelifeTM shown in table 2.1, which 
differ by monthly fees and levels of discounts on products.  EyelifeTM members are encouraged to 
have annual as opposed to two-yearly eye examinations. The professional care packages include: 
• Priority appointments to see preferred optometrist or dispensing optician 
• Exclusive access to premieres of new eyewear and services  
• As many extended eye examinations as required irrespective of the length of each visit  
• Extended eye examinations include supplementary tests such as fundus photography using 
Optomap ultra-wide field imaging, optical coherence tomography (OCT) and corneal 
topography  
• Discount off spectacles and sunglasses on as many pairs as wanted  
• 50% off repairs and replacement spectacles 
• Contact lens trial  
• Family Discount  
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Additional benefits for a Dry EyelifeTM member include annual dry eye review appointments and 
eligibility for home delivery of products with an additional fee depending on the products used. An 
additional fee is added to the EyelifeTM price if the customer is a contact lens wearer due to the 
likelihood of more frequent consultations at £2 extra per month for standard contact lens wearers 
and £4 per month for complex contact lenses (extended wear, keratoconus, multifocals).  This 
additional amount does not include any contact lenses or cleaning solutions, although customers 
have the option to combine EyelifeTM with any contact lens product. The minimum EyelifeTM 
contract period is 18 months and discounts apply to products purchased throughout the time of being 
an EyelifeTM member. 
 
Monthly Payment Plan Monthly Direct Debit Spectacle Discount 
EyelifeTM Optimum £11.50 20% 
EyelifeTM Elite £16.00 35% 
Dry EyelifeTM £20.00 35% 
Table 2.1: A summary of monthly payment plans offered to spectacle only wearers at BBR 
Optometry Ltd. (Fees as of April 18, 2019). 
 
Dry eye diagnostics and treatments were introduced to the practice in January 2014, but 
implemented in an impromptu manner until 2015. Return on investment was recouped for dry eye 
diagnostics TearLab and LipiView II, and the LipiFlow treatment unit and consumables by 
incorporating it into the monthly direct debit fee. The fees for the dry eye service and in-practice 
treatments seen in tables 2.2 and 2.3 reflect the fees at the time of the analysis. BBR Optometry Ltd. 
partnered with Scope Ophthalmics to re-brand the service as Tear Clinic, and hosted a launch event 
in July 2017. The Tear Clinic was officially opened by the Mayor of Hereford in September 2017.   
 
The Tear Clinic leaflet can be found in appendix 2.3. Information regarding the Tear Clinic 
consultation for customers at the time of the analysis read: 
“Your optometrist suspects you are experiencing symptoms of ocular surface disease and 
have recommended a Tear Clinic consultation. The 40-minute consultation will involve 
measuring the saltiness of your tears with a TearLab osmolarity test, the thickness of your 
tear film’s oil layer, and the number of partial blinks over a 20-second interval. Your oil 
producing glands will be imaged using LipiView II Dynamic Meibomian Imaging 
technology and your lashes, lids and ocular surface will be carefully assessed using 
diagnostic stains that will not affect your ability to drive. The optometrist will recommend 
a management plan tailored to your needs, which may require a combination of in-practice 
and at-home therapies. A 20-minute review appointment is usually scheduled four weeks 
later. We will monitor your ocular surface health using appropriate tests and questionnaires 









EyelifeTM £80.00 P × 
Non- EyelifeTM £190.00 P P 
Table 2.2: Customer information on dry eye consultation fees and what is included at BBR 
Optometry Ltd. at the time of the analysis.  
 
 
Treatment EyelifeTM Non-EyelifeTM 
LipiFlow Thermal Pulsation for two eyes £499.00 
BlephExTM microblepharoexfoliation £24.00 
 
£52.00 
Dissolvable punctal plugs 
 
£60.00 £109.00 
Permanent punctal plugs 
 
£200.00 £234.00 
Demodex 40-day (includes two boxes of 
Cliradex) 
£144.00 £228.00 
Table 2.3: In-practice treatments available at BBR Optometry Ltd. at the time of the analysis.  
 
 All dry eye consultations at BBR Optometry Ltd. are followed by a review appointment 
recommended one month later. The mainstay of early treatment for dry eye remains to be over-the-
counter lubrication although very few randomized controlled trials have compared inter-product 
superiority. Moreover, future studies on the impact of different formulations on tear film 
composition by sub-type of dry eye disease are required (Jones et al., 2017). It is important to be 
aware of the local clinical commissioning group prescribing guidelines, and the formulary for dry 
eye in order to predict what products customers may have trialled previously having visited their GP 
for dry eye concerns, and aware of products that can be requested on NHS prescription for customers 
if required. The formulary is designed on a tiered system according to prescription costs, and is not 
reflective of what is commercially available. Approximately £25.79 worth of products for step one 
level dry eye management (heat mask, lid cleanser, ocular lubricant) were factored into the fee 
charged to non-EyelifeTM customers for a dry consultation and review appointment.  
 
Nutritional supplements available at BBR Optometry Ltd., namely Omega Eye capsules containing 
omega-3 oils and vitamin D3 from purified fish oil, were not included in the analysis of expected 
products spend. This is because the cost of Omega Eye is not covered in the dry eye consultation 
fee, and some customers may have already been using a form of omega-3 fatty acid (n-3 fatty acids) 
supplementation sourced elsewhere or preferred to modify their dietary habits versus using 
supplements. Education regarding potential dietary modifications including oral essential fatty acid 
supplementation is listed in step one of the recommended staged management and recommendation 
for dry eye developed by the TFOS DEWS II management and therapy subcommittee (Jones et al., 
2017). Since the publication of DEWS II, a multicentre, double-blind clinical trial found that patients 
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with moderate to severe dry eye disease randomly assigned to receive a daily oral dose of 3000 mg 
of fish derived n-3 eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) for 12 months did 
not have significantly better outcomes than those who were assigned to receive an olive oil placebo 
(Asbell et al., 2018).  
 
Prior to July 2015, there was no way of easily tracking customers who were attending the practice 
outside their routine eye examination for dry eye concerns and dry eye treatments until analysis 
codes identifying customers with dry eye were utilised on the practice management software. 
Customers segmented as having had a dry eye consultation or in-practice treatment could then be 
easily identifiable. The intentions behind this feature were to empower practice staff to actively 
enquire about replenishing dry eye products when customers attended the practice, and to aid 
notifying these customers when the practice was altering recommendations in accordance with the 
latest literature or introducing a new element such as a diagnostic or treatment to enhance the service 
offering. Similarly, customer records include an analysis code identifying which tier of EyelifeTM 
they subscribe to, if at all.  
 
The aim of the retrospective analysis was to assess whether utilisation of the dry eye service would 
lead to: 
• Conversion to EyelifeTM or EyelifeTM upgrades 
• More structured dry eye product purchasing behaviour 
• Fewer clinical attendances for dry eye related concerns  
 
Data was analysed for customers who had a dry eye consultation from a time period of one year 
prior to the consultation and one year following the dry eye review appointment, which typically 
occurs one month post-consultation. Electronic records of dry eye customers were analysed at the 
practice site. The customer’s age was derived from the date of birth to time of the dry eye 
consultation. All data collected was anonymised and tabulated in Microsoft Excel (Microsoft 




2.3.1: Determining the demand for a dry eye clinic and patterns of presentation 
A total of 506 SPEED questionnaires and 274 OSDI questionnaires were itemised for analysis. 
Approximately 3861 patients attend the practice for eye examinations every 6 months, representing 
a response rate of 13.1% for the SPEED and 7.1% for the OSDI questionnaire. There were 67 
customers identified as having symptomatic dry eye (25%) with the widely accepted criterion of 
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OSDI ≥ 13 (discussed in chapter one). The mean OSDI score for symptomatic dry eye using this 
criterion was 23.72 ± 11.66. The mean, median, and mode ages of these customers were 62.30 ± 
15.53, 64, and 76 respectively. Ages ranged from 26 to 89 years, and the age distribution can be 
seen in figure 2.4. There were more females than males (40:27). 
 
 
Figure 2.4: Prevalence of dry eye in the sample defined as total OSDI score ≥ 13  
 
There were 198 customers identified as having symptomatic dry eye (39%) with the criterion of 
SPEED ≥ six. The mean SPEED score for symptomatic dry eye using this criterion was 10.40 ± 
4.45. The mean, median, and mode ages of these customers were 65.13 ± 15.91, 67, and 63 
respectively. Ages ranged from 19 to 111 years, and the age distribution can be seen in figure 2.5. 
There were more females than males (139:59).  
 
Figure 2.5: Prevalence of dry eye in the sample defined as total SPEED score ≥ six  
 
The customer questionnaire data was segmented by previously described classification categories 
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 Normal Mild  Moderate Severe 
Total OSDI score range 0 - 12 13 - 22 23 - 32 33 - 100 
Sample size 207 37 16 14 
Mean OSDI score  2.62 ± 3.33 15.70 ± 2.76 25.86 ± 2.90 42.46 ± 9.73 




63.44 ± 12.32 63.86 ± 
15.12 
Age range (years) 20 - 89 26 - 89 41 - 81 43 - 86 
Number of females 115 21 10 9 
Number of males  92 16 6 5 
Table 2.4: The breakdown of customer data in each OSDI symptom category  
 
A Kruskal-Wallis test was run to determine if there were differences in OSDI scores between four 
groups of participants with different OSDI symptom severity classifications:  "normal" (n = 207), 
"mild" (n = 37), "moderate" (n=16) and "severe" (n=14). Distributions of OSDI scores were not 
similar for all groups, as assessed by visual inspection of a boxplot (see appendix 2.4). The 
distributions of OSDI scores were statistically significantly different between groups, χ2(3) = 
163.371, p < 0.0005.  
 
Subsequently, pairwise comparisons were performed using Dunn's (1964) procedure with a 
Bonferroni correction for multiple comparisons in order to reduce the risk of a Type I error (Laerd 
Statistics, 2017). A Type I error is when a result is declared as statistically significant when it is not, 
and can increase with every pairwise comparison made thereafter (Laerd Statistics, 2017). The 
procedure described by Dunn (1964) uses the entire data set when making each pairwise comparison 
in a manner analogous to post hoc tests following a one-way ANOVA (Laerd Statistics, 2017). A 
one-way ANOVA was not conducted as all assumptions could not be met as outlined by Laerd 
Statistics (2017). There was a genuinely unusual outlier, and the dependent variables were not 
normally distributed for each group of the independent variable as indicated by the Shaprio-Wilk 
test (i.e. p<0.50 indicating the assumption of normality is violated). Another method for pairwise 
comparisons that was not used, is to run multiple separate Mann-Whitney U tests with a correction 
for multiple comparisons, which only use the data involved in each specific pairwise comparison. 
There is no agreement on which method should be used for pairwise comparisons and it is possible 
that results from the two methods could disagree substantially, indicating the need for replication 
studies using larger samples (Sheskin, 2011). Adjusted p-values are presented. This post hoc 
analysis revealed statistically significant differences in OSDI scores between the normal (mean rank 
= 104.00) and mild (mean rank = 226.00) (p<0.0005), normal and moderate (mean rank = 252.50) 
(p<0.0005), and normal and severe (mean rank = 267.50) (p<0.0005) OSDI classification groups, 
but not between any other group combinations.  
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A Kruskal-Wallis test was conducted to determine if there were differences in age between groups 
that differed in their OSDI classification. The distribution of age was not statistically significant 
across the categories of OSDI classification, χ2(3) = 1.647, p = .649. 
 
 No symptoms Mild to moderate  Severe  
Total SPEED score range 0 1 - 9 10 - 28 
Sample size 103 312 91 
Mean SPEED score  0 ± 0 4.48 ± 2.25 14.22 ± 3.83 
Mean age (years) 67.76 ± 15.47 64.96 ± 15.13 65.35 ± 15.20 
Age range (years) 20 - 94 20 - 111 19 - 100 
Number of females 61 203 70 
Number of males  42 109 21 
Table 2.5: The breakdown of customer data in each SPEED symptom category  
 
A Kruskal-Wallis test was run to determine if there were differences in total SPEED scores between 
three groups of participants with different SPEED symptom severity classifications: "no symptoms" 
(n = 103), "mild to moderate" (n = 312), and "severe” (n = 91) symptoms. The dependent variables 
were not normally distributed for each group of the independent variable as indicated by the Shaprio-
Wilk test. Distributions of SPEED scores were not similar for all groups, as assessed by visual 
inspection of a boxplot (see appendix 2.5). The distributions of SPEED scores were statistically 
significantly different between groups, χ2(2) = 384.968, p < 0.0005. Subsequently, pairwise 
comparisons were performed using Dunn's (1964) procedure with a Bonferroni correction for 
multiple comparisons. Adjusted p-values are presented. This post hoc analysis revealed statistically 
significant differences in SPEED scores between no symptoms (mean rank = 52) and the mild- 
moderate symptom group (mean rank = 259.50) (p < 0.0005), no symptoms and severe symptoms 
group (mean rank = 461) (p < 0.0005), and the mild-moderate and severe symptom group (p < 
0.0005).  
 
A Kruskal-Wallis test was conducted to determine if there were differences in age between groups 
that differed in their SPEED classification. The distribution of age was not statistically significant 
across the categories of SPEED classification, χ2(2) = 4.290, p = .117. The post hoc statistical power 
calculation of the presented sample size was 99% for OSDI and SPEED data (appendix 2.6 & 2.7; 
Faul et al., 2009). 
 
 
2.3.2: Service blueprinting and implementation of a dry eye clinic at BBR Optometry Ltd. 
Explicit service promises are statements made about the service by the organization to the customer 
either verbally or in written materials that can influence customer expectations (Wilson et al., 2016). 
Members of the organization may overpromise to obtain business or inadvertently by stating their 
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estimates of predicted service delivery that may be remedied by using a service blueprint (Wilson et 
al., 2016). The service blueprint created to communicate the general nature of the dry eye service, 
and that demonstrates use of blueprinting for private optometric service innovation can be seen in 
figure 2.6.  
 
Under-promising may make customer expectations seem more realistic, but may also reduce the 
competitive appeal of the service and have the inadvertent effect of lowering customer perceptions 
of the service, particularly for new customers (Wilson et al., 2016; Boulding et al., 1993). 
Additionally, some members of an organization may not know the appropriate promises to make 
because services are customized in the context of a dry eye service and treatment outcomes are not 
easily defined and repeated due to the nature of dry eye. A specialist service is difficult to evaluate 
before purchase and direct experience of the service with customers often relying on online and 
offline word-of-mouth communication via recommendations, testimonials, reviews on social media 
or blogs to shape their expectations (Wilson et al., 2016). Businesses must consistently exceed the 
adequate service level and reach the desired service level to develop and intensify customer loyalty 













The rebranding of the dry eye service to Tear Clinic in July 2017 and launch event provided the 
opportunity to showcase BBR Optometry Ltd.’s dry eye diagnostics in the form of mini-
consultations. Existing BBR Optometry Ltd. patients were encouraged to bring family members and 
friends to the event. A specialist service is difficult to evaluate before purchase and direct experience 
of the service, and so the launch event provided a glimpse into the new service, and led to a spike in 
Tear Clinic activity. A study by Hindi et al. (2019b) found that patients felt the most effective 
promotional strategies to enhance the credibility of extended pharmacy services were first-hand 
experience and word-of-mouth. The Tear Clinic launch event in July 2017 followed by a visit from 
the mayor in September 2017 led to an exponential increase in dry eye related activity net profit and 
LipiFlow treatments.  
 
BBR Optometry Ltd. adopted a strategy that focused on existing customers due to new customer 
acquisition being costlier. Mittal and Lassar (1998) reported that acquiring new customers can cost 
five times more than the costs of retaining current customers, and so it is more profitable to 
concentrate efforts on retaining current customers. In cases where services are long-term, such as in 
optometric care, customers rely heavily on credence qualities, that is perceived value of health 
advice, for service evaluation and employees have the potential to develop more personal 
connections with customers from building rapport over the years leading to greater customer 
relational value and satisfaction (Yoon et al., 2004; Chan et al., 2010; Fleming et al., 2005). 
Customers may have a greater incentive to remain involved with the company providing 
professional services, that is, affective commitment, if friendly and enjoyable interpersonal 
relationships add value for the customer (Patterson & Smith, 2003). Distribution of dry eye 
questionnaires to existing customers utilising BBR Optometry Ltd.’s current services was an attempt 
to gauge the need for a dry eye service. Leaflets regarding the service were placed in the waiting 
area visible to customers, and clinicians proactively distributed the leaflet to customers they deemed 
would benefit from the service. Clinicians were encouraged to engage in a conversation regarding 
the service if screening SPEED questionnaires completed on arrival to the practice prior to the eye 
examination totalled a score greater than zero, and if symptoms and signs of dry eye were noted. 
 
Initially, the focus of service development was on customer acquisition via external referrals from 
fellow primary care and ophthalmology colleagues. Ophthalmology colleagues and nurses working 
in the hospital eye department were made aware of the dry service and were given leaflets to signpost 
and provide to patients attending eye casualty for non-urgent matters including suspect dry eye. In 
chapter six, we see that a proportion of people self-refer to eye casualty for advice regarding dry eye 
concerns. Dry eye is chronic but not sight threatening, so does not command priority in hospital 
practice. At first, the target for marketing the dry eye service were ophthalmic consultants within an 




the idea of a mobile dry eye service led by BBR Optometry Ltd. and to begin a discussion amongst 
ophthalmology colleagues regarding possible interest and need for a mobile LipiFlow treatment 
service. Secondly, an educational open house style evening session was organised for local 
pharmacists and GPs at the practice to spread awareness of the Tear Clinic. Unfortunately, there was 
lack of engagement by eye health professional stakeholders for both planned activities. Thus, the 
focus shifted from capturing people for entry into the service by external clinical recommendation 
to redirecting marketing strategies towards the customer. Other BBR Optometry Ltd. activities that 
attempted to acquire new customers included: 
• Demonstrated components of a dry eye consultation including use of LipiView II and 
performed a LipiFlow procedure on a customer for an audience of optometrists at the 
Nuffield Bristol.   
• Provided a LipiFlow mobile service for consultants at the Midland Eye hospital, Solihull  
• Attempted to contact the local firefighter department for community outreach and media 
exposure  
• Created dry eye service leaflets for distribution at The Courtyard Centre for the Arts, which 
is the leading arts provider in Herefordshire and a registered charity. BBR Optometry Ltd. 
are “Friends of the Courtyard”, members of the Courtyard’s business club and provided 
sponsorship for the Director’s chair appeal initiative.  
• Utilised marketing services from Scope Ophthalmics and Pepperneck Ltd. to generate 
leaflets (see appendix 2.3) and event invitations.  
• Presented on experiences in delivering a dry eye clinic at the 2017 BCLA international 
conference, and at the 2018 Herefordshire Local Optical Committee Annual General 
Meeting to further BBR Optometry Ltd.’s reputation as a provider of advanced dry eye care.  
 
In the service blueprint presented in figure 2.6, all clinical examinations were carried out by the 
same optometrist. However, increasingly automated technology allows diagnostic testing such as 
corneal topography and optical coherence tomography, to be carried out by practice support staff 
rather than by the optometrist. Using practice support staff to carry out some functions, such as 
Tearlab testing and Lipiview II analysis, would allow the optometrist more time to spend on the 
interpretation of the results, emphasizing the SERVQUAL dimensions of assurance and empathy by 
explaining to the customer the importance of the test, its relevance to them and long-term 
management options.  
 
The dry eye service continues to be reviewed in terms of process and physical layout using the 
service blueprint presented as a guide. There was an early issue with the optometrist inadvertently 




empathy, and perhaps yielded intangible benefits for the practice but at the actual expense of the 
practice. The automatic redirection of dry eye clinic related queries and acceptance of these phone 
calls by the optometrist was time-consuming for the clinician and did not always lead to a 
consultation booking. At the outset, these over the phone consultations gave the optometrist insight 
into customer concerns, and allowed rehearsal and trial of dialogue for both dry eye as a chronic 
condition explanations and discussions regarding treatment options. Further ongoing staff training 
in group and one-to-one settings both internally and via dry eye product suppliers, and creation of 
electronic and print resource materials to support staff and for customer information put an end to 
lengthy conversations outside of clinical time.  
 
As a backstage action, it is important to have administration time allocated for the practitioner 
delivering the service. This dedicated time allows the completion of personalised reports and allows 
the practitioner to educate themselves with current literature to ensure evidenced-based management 
recommendations are given to customers. In the area of dry eye, new products and novel treatments 
are being developed to manage customer symptoms. For example, newer lubricants attempt to 
replace specific aspects of the tear film that are believed to be deficient, with the aim of stabilising 
the tears, protecting the ocular surface and reducing the level of ocular surface inflammation. The 
practitioner may need to attend workshops and conferences to learn about the latest research, and 
then find ways to adapt these findings into practical solutions for their customers to deliver the 
highest level of service quality.  
 
Optional inclusions for a service blueprint include time indicators to assess service efficiency and 
whether or not customer expectations are being met, quality key performance indicators (KPIs), 
customer’s emotional state, and sketches where words are not enough (Interaction Design 
Foundation, 2019). Depth can also be added to the service blueprint by noting moments of truth, 
internal and external pain points, and opportunities for improvement (Bitner et al., 2008): 
• A moment of truth is the interaction between the customer and organization that must go 
right in order for the customer to have a quality experience. Moments of truth are critical 
encounter points with an organization that can shape a customer’s impression (Duncan & 
Breslin, 2009).  
• Internal pain points refer to gaps felt inside the organization that the customer is unaware 
of but leads to internal friction and inefficiencies. 






For example, the automatic redirection of dry eye queries to one optometrist was an internal pain 
point, which was soon resolved. Another internal pain point was the location of the TearLab 
Osmolarity system (TearLab Corp., San Diego, CA, USA), which consists of 3 components: a pen 
powered by a rechargeable battery, a test card with microchip, and system reader (NICE, 2015b). 
The TearLab osmolairty system was CE marked as an In Vitro Diagnostics Device (Class IIa) in 
October 2008, and is used at point of care to measure tear osmolarity (discussed in chapter 1), help 
diagnose dry eye and aid monitoring treatment (NICE, 2015b). The pen holds the test card that 
collects and analyses 50 nanolitres of tear fluid from the inferior lateral meniscus (NICE, 2015b). 
The system reader is a countertop unit that calculates and displays the tear osmolarity measurement 
on a liquid crystal display screen (NICE, 2015b). When a tear sample has been successfully 
collected, the user has a finite time (40 seconds) to return the pen to the system reader dock before 
the test information is lost (TearLab Corp, 2017). The system reader is affected by temperature and 
must not be placed in an area that can be influenced by external heating or cooling sources, such as 
adjacent to a computer or other equipment that gives off heat, next to an air conditioning or heating 
duct, or next to a window (TearLab Corp, 2017).  
 
The TearLab system reader was originally located in a central room with other optometric 
diagnostics for routine eye examinations on the second floor of the practice building as it was used 
haphazardly, and a central location was key for potential use by four optometrists with consultation 
rooms on the same floor level. BBR Optometry Ltd. had a practice refurbishment in April 2016 and 
a room on the ground level (first floor) was allocated for dry eye related appointments along with 
the LipiView II Ocular Surface Interferometer with Dynamic Meibomian Imaging diagnostic unit 
(TearScience, Morrisville, NC, USA), which is also a countertop unit, although the TearLab 
osmolarity system remained on the second floor. This was an internal pain point for the practitioner 
delivering the service as well as a potential external pain point given the order of clinical tests 
(discussed in chapter one) and the journey of the customer through the practice in order to deliver 
the dry eye service were disjointed. Customers would arrive at reception, climb the practice stairs, 
have a few clinical tests, and be guided back down the stairs to the designated dry eye room where 
the remainder of the consultation would take place. These issues were soon remedied by relocating 
all dry eye diagnostics in one temperature controlled windowless room, and using the only 
consulting room with a reclining chair for in-practice treatments to improve customer comfort. One 
of the backstage actions of frontline staff is to calibrate the TearLab Osmolarity system prior to the 
start of clinics each day. The two pens are tested with an electronic check card each day to verify 
that the system is working within manufactured calibration specifications (NICE, 2015b). The 
optometrist delivering the service, tests each new batch of test cards with the normal and high 
osmolarity control solutions to verify the quantitative functioning of the osmolarity test cards (NICE, 




In the practice’s aim to be completely paperless for physical evidence of technological prowess and 
professionalism, and to improve the practice aesthetic, Microsoft surface tablets in addition to 
desktop computers were introduced. The primary uses of the tablets were to create appointments 
and carry out spectacle orders, and there was an attempt at one stage to trial paperless dry eye 
questionnaires via Qualtrics Survey Software. Utilisation of the Qualtrics Survey Software would 
have been useful in gathering information from consenting customers to monitor service demand in 
a manner less labour intensive than analysing hard copies of questionnaires. However, from direct 
observation and staff feedback, it was determined that the print physical copies of the questionnaire 
often served as a reminder for front staff to prompt customers to complete it. Although there was a 
practice network desktop link for the questionnaire, it was not being completed and often the tablets 
were misplaced.  
 
BBR Optometry Ltd. established contact with a third-party supplier via Scope Ophthalmics, Adaro 
Optics in 2016 to maintain existing direct debits for clinical care, enhance service for contact lens 
customers and allow scope for home delivery of dry eye products. Adaro Optics are mentioned in 
figure 2.6, behind the line of visibility. The set-up of monthly direct debits is an example of a 
moment of truth, whereby dissatisfaction can follow if customers are incorrectly charged a given 
fee. Other moments of truth include customer travel to the appointment, and can take place at 
registration, in the waiting area, and during the consultation.  
 
It is possible customer satisfaction can be affected by travel costs as for most customers, specialist 
services are not local (Steinbach, 2018). At BBR Optometry Ltd. there are several pay and display 
parking areas on the street where the practice is situated, and car parks nearby a pedestrian 
passageway. Travelling to an unfamiliar area for specialist consultations and competitively priced 
novel treatments can be stressful enough for a customer who may already be stressed about their 
health condition. Practice staff are trained to offer directions and guide customers to the practice 
website, which highlights these parking areas nearest the practice.  
 
At the point of inquiry or appointment booking, it is important for minimum call holding time and 
for staff to have a friendly, helpful, and polite tone. Practice staff should be able to answer questions 
about products and procedures or refer questions as needed for immediate answer, ask customers for 
time and date preferences, encourage customers to check the practice website, and verbalise how the 
practice looks forward to seeing the customer. At the point of reception and being seated in the 
waiting area, it is important for customers to experience a clean, attractive and comfortable area with 
educational materials displayed to stimulate queries. Reception staff should immediately welcome 
customers and have a professional appearance. At the point of consultation, the optometrist should 




any clinical tests, explain the purpose of each test in layman’s language as performed, emphasize 
concern for the customers’ long-term ocular health, encourage questions, summarize findings, 
hypothesize as to the cause of expressed problems, and recommend the best solution to the 
customer’s need. Most customers want their concerns to be addressed with practical solutions, and 
feel they are being listened to and treated as an individual.  
 
The process of report generation is automated with templates on the practice software created to 
improve the ease of recording clinical test results and presenting outcomes to customers in the form 
of a report that can be printed or emailed. Customers who do not have internet access are given paper 
copy, tear away, management plans that can be individualised from templates created by Scope 
Ophthalmics including images of the products recommended and tick boxes identifying the 
recommended products whilst they are waiting for the full report to arrive in the post. At present, 
BBR Optometry Ltd. does not use any formal measurement techniques to ensure the level of service 
quality that management is striving to achieve and relies on customer complaints.  The service design 
does not currently provide any opportunities to gather customer feedback.  
 
 
2.3.3: Retrospective analysis of customer activity following use of the dry eye service at BBR 
Optometry Ltd. 
In total, there were 94 customer records analysed retrospectively. Data was analysed for customers 
who had a dry eye consultation from a time period of one year prior to the consultation and one year 
following the dry eye review appointment, which typically occurs one-month post-consultation. 
There were 39 customers with available information for one year prior and one year following the 
review visit. There were 68 customers with available information for one year prior and less than 
one year following the review visit. The average post-dry eye review appointment time period for 
these customers was 5.22 ± 2.66 months. There were 13 records excluded from the analysis because 
these customers were also contact lens wearers, and contact lens wearers by nature may require 
multiple appointments depending on whether they are new or existing wearers.  
 
The average age of customers attending for a dry eye consultation was 65.71 ± 12.72, and 67 were 
females and 27 were males. Approximately 37% (35/94) of customers were seen for a dry eye 
consultation less than one month following their eye examination, and 42% (39/94) were seen 
between one to six months later. There were three customers seen on the same day for a combined 
eye examination and dry eye consultation appointment, an unknown time frame for nine customers, 
and the remaining eight customers were seen for a dry eye consultation over eight months following 




At the time of the dry eye consultation, 24% (23/94) of customers were EyelifeTM members. Overall, 
28% (26/94) of customers were new to the practice and attending specifically to utilise the dry eye 
service. The distribution of customers’ EyelifeTM status prior to and following their dry eye 
consultation can be seen in figure 2.7. 
 
 
Figure 2.7: Distribution of customers’ EyelifeTM status prior to and following their dry eye 
consultation. 
 
EyelifeTM conversions and upgrades occurred for 11% (n=10) of customers following their dry eye 
review appointment, whilst others continued as Non-EyelifeTM members or on their current tier of 
EyelifeTM without upgrading. Half of these upgrading customers were non-EyelifeTM members at the 
time of consultation, and two of these were new customers to the practice and upgraded to Dry 
EyelifeTM. The breakdown can be seen in table 2.6.  
 
EyelifeTM Conversions & Upgrades No. of customers 
Non-member to Elite 1 
Non-member to Dry  4 
Optimum to Dry 1 
Elite to Dry  4 
Table 2.6: Summary breakdown of EyelifeTM conversions and upgrades following the dry eye review 
appointment at BBR Optometry Ltd.  
 
Customers purchase their first supply of recommended dry eye products at the time of the dry eye 
consultation (included or additional fee based on EyelifeTM status), and often purchase additional 
products, including ocular lubricant at the time of their one-month review appointment. There is also 
the option of signing up to Dry EyelifeTM and having home delivery of products. For traditional at-
home therapies supplied at BBR Optometry Ltd., most 7.5 ml bottles of ocular lubricant offer a one 
month’s supply of product, and lid cleanser about two months’ worth of product. Most 




at-home therapies to the customer were calculated for each customer based on their specific product 
recommendations and expected frequency of use.  
 
In regards to dry eye product transactions, where full year post-consultation information was 
available (n=37): 
• The actual annual total value of product transactions fell below what was expected 
consistently. 
• 17 customers did not purchase any product outside what was included in their dry eye 
consultation fee 
• All customers who did not purchase any dry eye product outside of their dry eye 
consultation, that is one year before or after, were all non-EyelifeTM members. Only six of 
these 17 customers were new to the practice.  
• 13 customers purchased more dry eye products post-dry eye consultation (eight Non-
members, one EyelifeTM Optimum, four EyelifeTM Elite). Three of the non-member 
customers were new to the practice and two of these became Dry EyelifeTM members  
• Seven customers purchased less dry eye products post- dry eye consultation (four Non-
members, one EyelifeTM Optimum, two EyelifeTM Elite) 
 
Following a dry eye consultation and review appointment, an annual dry eye review appointment 
outside the routine eye examination is recommended. The recommendation is that most adults 
should have their eyes tested every two years, however, an optometrist may recommend an eye 
examination for adults more often than every two years if the person has been diagnosed with 
diabetes, are aged 40 years or over with a family history of glaucoma, are aged 70 years or over, or 
if it is deemed clinically necessary by the practitioner (NHS, 2016). EyelifeTM members tend to have 
eye examinations yearly. In regards to the number of clinical appointments, where full year post-
consultation information was available (n=37), the customers could be split into thirds based on 
changes in their attendance seen in table 2.7. For customers attending for more appointments post-












 Greater attendances 
 
Fewer attendances No change 
Number of Customers 
 
12 12 13 
EyelifeTM pre-consult status ratio 
(Non-member: Optimum: Elite) 
 





Dry eye review (n=4) 
Due for eye 
examination 
Pre- and post-operative 
cataract surgery 
appointment  
Not due or overdue for eye 
examination  
Prior to dry eye 
consultation had post-
operative cataract surgery 
or glaucoma referral 
refinement appointment 
Previously attended for 1-
3 additional 20 minute 
clinical visits  
 
Lost to follow-up after 
LipiFlow treatment 
Attended practice for 
dry eye consultation & 
review only   
 
Table 2.7: Comparing number of clinical appointments one-year following a dry eye review 
appointment to visits in a one-year time period prior to the dry eye consultation.  
 
In regards to spectacle purchase transactions, where full year post-consultation information was 
available (n=37): 
• There were nine customers who had more spectacle purchase transactions following their 
dry eye review than prior to their dry eye consultation. All but two were non-EyelifeTM 
members prior to the dry consultation (one EyelifeTM Optimum the other, Elite). The average 
spectacle dispense value for this group was £459.14 ± £350.12. This seemed to be related 
to customers purchasing spectacles following their eye examination within the one year time 
frame following their dry eye review. One non-member customer who became a EyelifeTM 
Elite member following their dry eye consultation had purchased spectacles at a transaction 
value of £429.00 in the one-year period prior to the dry eye consultation and in the year 
following the dry eye review at a transaction value of £592.82. More than half of this group 
also converted or upgraded their EyelifeTM status (Non-member to Elite: one; Non-member 
to Dry: two; Optimum to Elite: one; Optimum to Dry: one).  
• There were nine customers who had less spectacle purchase transactions following their dry 
eye review than prior to their dry eye consultation. Prior to their dry eye consultations, there 
were four Non-members, one EyelifeTM Optimum, and four EyelifeTM Elite members. There 
was only one customer from this group who upgraded from EyelifeTM Optimum to Elite, 
whilst all others did not change their EyelifeTM status. This seemed to be related to these 
customers having their eye examinations in the one year period prior to their dry eye 
consultation.  
• There were no changes in spectacle purchasing behaviours noted for the remaining 
customers (n=19) who did not purchase spectacles and were all non-members with the 
exception of one customer who was an EyelifeTM Optimum member at the time prior to the 





2.4.1: Identifying the local demand for a dry eye service and the dry eye customer 
Completed questionnaires were analysed retrospectively and requirements for reception staff to 
provide clarification on any questionnaire items was not reported. There was a larger number of 
completed SPEED versus OSDI questionnaires collected over a similar timeframe, which may be 
due in part to greater customer engagement with a questionnaire having fewer items. Questionnaires 
can be tedious and time-consuming for some respondents, and chapter three will also explore 
methods to determine the most important items from the SPEED and OSDI in a sample of dry eye 
sufferers. Additionally, the number of completed questionnaires could have been limited by factors 
such as customers arriving late for their appointments with not enough time allocated to participate 
or by varying levels of staff co-operation in administering the questionnaire. The current contact 
lens wearing status of questionnaire respondents were not determined, which may reflect a limitation 
to the study. The potential relationship between ocular discomfort and contact lens wear will be 
discussed in chapter five.  
 
Focusing on the results of the pairwise comparisons, there were statistically significant differences 
in the distribution of total OSDI scores between the normal OSDI classification group and all other 
symptomatic OSDI groups. Approximately half of the customers segmented in the normal OSDI 
classification scored a total of zero, meaning these participants self-reported no symptoms of dry 
eye whatsoever. There were no statistically significant differences in the total OSDI score 
distributions between the mild and moderate, mild and severe, and moderate and severe groups. For 
the distribution of total SPEED scores, the pairwise comparisons across SPEED classification 
groups were statistically significant for all possible combinations. There were no statistically 
significant differences in the age distributions across symptom severity classifications for either of 
the questionnaires.  
 
There were a higher proportion of normal cases identified by the OSDI questionnaire, and a higher 
proportion of mild to moderate dry eye cases identified by the SPEED questionnaire. The time of 
year from which the questionnaires were collected may partially account for this observation, 
considering the location of BBR Optometry Ltd. in Hereford as a trading centre for a wider 
agricultural and rural area. Hay fever, an allergy caused by pollen or dust, can cause considerable 
ocular discomfort including watery eyes, which can mimic dry eye symptoms and is an item 
appearing only on the SPEED questionnaire (“burning or watering”). A greater number of pollen 
types have peak release periods that occur in the months when the SPEED questionnaire was 
administered (April-September) compared to when the OSDI was administered (October- March) 
(College of Optometrists, 2018). Ideally all customers would have completed both questionnaires or 




objectives of this study was to determine the local demand for a dry eye clinic versus a detailed 
comparative analysis of the OSDI and SPEED questionnaires. Finis et al. (2014a) in a retrospective 
analysis determined that although both the OSDI and SPEED were found to be suitable for detecting 
symptoms of dry eye that the results of the questionnaires could not be used interchangeably. 
 
The proportion of customers self-reporting absolutely no dry eye symptoms, scoring zero, from the 
completed questionnaires was 38% for the OSDI and 20% for the SPEED. Therefore, the majority 
of respondents reported some degree of ocular discomfort whether or not the symptoms transpired 
to be attributed to a dry eye problem, which is not known from the current analysis. Overall, the 
average age of respondents was 64.47 ± 14.57 and 65.60 ± 15.25 for the OSDI and SPEED 
questionnaires respectively, which may reflect the age demographic of the practice location. The 
number of people aged 85 or over has increased by 50% between 2001 and 2016 in Herefordshire 
compared to 38% nationally (Herefordshire Council, 2018). Some research shows an increase in dry 
eye prevalence with age (McCarty et al., 1998; Lee et al., 2002; Schaumberg et al., 2003; 
Schaumberg et al., 2009; Farrand et al., 2017; Caffery et al., 2019), whilst others do not (Schein et 
al., 1997; Chia et al., 2003; Lin et al., 2005) perhaps due to use of samples with a narrower age 
range. It has been postulated that the higher incidence and prevalence of dry eye in women may be 
due to sex-related differences attributed to the effects of hormones and also disparities in care-
seeking behaviours related to gender (McCarty et al., 1998; Moss et al., 2000; Chia et al., 2003; 
Moss et al., 2008; Mather et al., 1998; Smith et al., 2004; Sullivan et al., 2017).  
 
Grouping customers with needs or priorities in common and strategizing to target them is a 
marketing technique referred to as market segmentation (Toor, 2014). For example, adolescents or 
teenagers were identified as a segment of the contact lens market who were the most promising 
category to achieve growth by penetration (Toor, 2014). Therefore, tactics such as special discounts, 
digital promotion, and promotion of daily disposable contact lenses for convenience were employed 
to target this segment of the market (Toor, 2014). Perhaps based on the demographic profile, and 
differentiation of the severity types of dry eye from a sample of BBR Optometry Ltd. customers 
attending for a full eye examination, a different marketing mix in terms of product or service, price, 
promotion and place could be used to target potential benefactors of the dry eye service, i.e. more 
people with mild-moderate dry eye symptoms, and women over the age of 60. 
 
 
2.4.2: Using a service blueprint to facilitate customer focused optometric services 
In the service marketing literature, affective responses have been associated with behavioural 
intentions such as loyalty, recommendation and willingness to pay more in hedonic (e.g. tourism, 




services (Bigné et al., 2008; Chan et al., 2015; Jani & Han, 2015; Koenig-Lewis & Palmer, 2014; 
Ladhari, 2009; Ng & Russell-Bennett, 2015; Ladhari et al., 2017). It is thought that emotions act as 
the mediator in the service process with customers’ emotional reactions influenced by perceived 
service quality and servicescape, and in turn customers’ emotional reactions impact perceptions of 
product quality and behavioural intentions (Ladhari et al., 2017). In an optometric setting emotions 
can be elicited by customer interactions with optometrists and support staff, which will most likely 
be positive and favourable if the staff present as competent, credible, reliable, and empathetic whilst 
offering a personalized service (Ladhari et al., 2017). An understanding of the service blueprint can 
contribute to staff feeling confident in regards to service delivery. Customers are more motivated to 
recommend the service either by word-of-mouth or via social media if they had a positive service 
experience.  
 
Ladhari et al. (2017) investigated the role of emotional satisfaction in a Canadian optometry clinic 
and found perceived service quality (service reliability, empathy, assurance and responsiveness) had 
a greater effect on customer emotions than did the service environment for traditional services. 
Reliability refers to the extent to which optometrists and practice staff offer the promised service 
correctly the first time, assurance reflects the aptitude of staff to inspire trust with their knowledge, 
responsiveness refers to the willingness to provide prompt service, and empathy refers to the level 
of individualised attention the practice staff offers customers (Ladhari et al., 2017). Ambiance in the 
form of light and odour, and layout also influenced emotional satisfaction and purchase intentions 
(Ladhari et al., 2017). In an increasingly competitive environment, optometric practices need to 
continue to create value for their customers by differentiating their product and service offerings, 
and by providing a satisfying experience, which can be achieved through the use of structured 
planning with a service blueprint. There are various online resources for the busy practitioner to 
learn about principles regarding services (appendix 2.8).   
 
A qualitative study conducted by Hindi et al. (2019b) in Greater Manchester, England, used 
marketing theory to investigate factors which could influence the utilisation and integration of 
community pharmacy services for patients with common long-term conditions, namely type-II 
diabetes, asthma, or chronic obstructive pulmonary disease. Data collection and analysis from focus 
groups including patients with type-II diabetes and respiratory conditions, pharmacists and GPs were 
framed using the “7Ps” extended marketing mix that an organization should account for to 
successfully market their service to target customers which are “product, price, place, promotion, 
people, process, and physical evidence.” (Hindi et al., 2019b) Appropriate distribution of services 
within primary care, improvements in communication and incentivising joint working between 
pharmacies and GP practices, enhancing consistency and quality of pharmacy services, and 




integration of community pharmacy services within the primary care pathway for long-term 
conditions (Hindi et al., 2019b).  
 
Patients with long term conditions, such as dry eye, require regular monitoring of their health and 
management regimens in order to ensure appropriate use of medication or products and lifestyle 
education (Hindi et al., 2019b). The recommendations from stakeholders in the Hindi et al. (2019b) 
study could be extended to optometric services. For example, pharmacy services with clear 
specifications focusing on specific interventions to reduce variability in the service process were 
preferred by stakeholders, highlighting the importance of a service blueprint and communication of 
a condensed version for fellow health care providers and customers to understand the service 
workflow or customer journey intended to deliver quality care. Similar to the recognition of the 
capabilities of community optometrists by ophthalmologists to be discussed in chapter six, the added 
value of pharmacy services for patient convenience and freeing up GP time to focus on more 
complex cases was noted although inter-professional tensions arising from funding conflicts was 
thought to be a barrier for collaboration between GPs and pharmacists. The physical evidence in 
regards to limited space and poor-quality consultation rooms affected the lack of confidence view 
adopted by patients and GPs in community pharmacies’ ability to expand services, which could 
apply to optometric services depending on whether practices are perceived as more commercial or 
retail than clinical. 
 
Community optometry services have traditionally been separate from pharmacy and GP services, 
which is perhaps why primary care colleagues may not be aware of or necessarily supportive of 
private specialist services due to concerns about financial motives, competencies and encroachment 
on professional boundaries as seen with extended pharmacy services (Bradley et al., 2012). 
Considering many patients seek endorsement of specialist services by their GP, a lack of GP 
awareness or support could greatly impact the awareness, demand and use of that service as also 
seen with pharmacy services (Hall et al., 2018; Hindi et al., 2019a). For this reason, the primary 
focus for customer acquisition was through primary care colleagues, and BBR Optometry Ltd. hand 
delivered invitations to local GP surgeries and pharmacies for educational, ’service taster’ events 
hosted at the practice. There was little uptake, however, existence of an appropriate system to share 
relevant information with GPs was noted in the creation of the service blueprint to improve 
integration of services (Hindi et al., 2019b).  
 
There is an automated system and protocol of generating reports with clinical test results and planned 
management following each dry eye consultation. The customer often requests a copy of the report 
be sent to their GP for both information, and to request prescriptions for recommended products. It 




eye reports, and access to novel treatments will raise the profile of BBR Optometry Ltd. as a 
specialist dry eye service provider in the community. It is protocol for optometrists participating in 
their locally commissioned ocular emergency service (described in chapter six) to provide GPs with 
a letter outlining the nature of the service user’s visit and exam outcome. When the service user is 
deemed to have a dry eye problem, a Tear Clinic leaflet for information on the dry eye service is 
given to the individual and also sent to the GP with the exam outcome report. 
 
Attempts at service expansion by providing a mobile service for other optometric practices who 
could not afford dry eye diagnostics and novel treatments but wished to offer these services to their 
customers was met by conflicting views. The mobile service offered a viable alternative to customers 
with signs and symptoms of evaporative dry eye secondary to Meibomian Gland Dysfunction 
(MGD) without the need for large capital investment in a unit and the continued expense of stocking 
consumables by eye health care providers. There were fears from optometrists that customers would 
switch providers due to the perception that their practice was inferior to the mobile service provider’s 
practice. The plan for a mobile service could potentially still be feasible and profitable for the 
practice in private hospital settings for pre- and post-operative refractive surgery care depending on 
the lead ophthalmologist’s approach to ocular surface health.  
 
TearScience, a privately held medical device manufacturer dedicated to evaluating Meibomian gland 
health and treating MGD and suppliers of BBR Optometry Ltd.’s LipiView II and LipiFlow were 
acquired by Johnson & Johnson Vision’s surgical vision operating company, Abbott Medical Optics, 
in 2017. BBR Optometry Ltd. were early adopters of the TearScience technology and now with the 
backing of Johnson & Johnson Vision, a well-known global leader in eye health, there may be more 
UK representation for support and exposure to enhance and promote the dry eye service. Other future 
endeavours for the business would be to capitalize on digital media and offer online booking for all 
appointments to improve the ease and convenience of the service.  
 
Retail aspects of an optometric service can be monitored with KPIs such as same day conversion, 
profit, and average spend per customer, whilst customer service aspects can be measured using 
questionnaires including the SERVQUAL, SERVPERF and SERVPEX (Parasuraman et al., 1988; 
Cronin & Taylor, 1992; Robledo, 2001). A common question used in patient questionnaires to 
measure patient satisfaction levels is “how likely are you to recommend our service to friends and 
family if they needed similar care or treatment?” (Steinbach, 2018) The possible answers include 
“extremely likely, likely, neither likely or unlikely, unlikely, extremely unlikely, and don’t know”, 
which give a good indication of a patient’s experience in routine patient surveys (Steinbach, 2018). 




detailed picture of what customers think about the dry eye service at BBR Optometry Ltd. rather 
than a few items regarding customer service. 
 
Perceived service quality can be measured in terms of ratings with respect to specific attributes 
relating to the customer’s experience using a five-point Likert scale ranging from very 
dissatisfied to very satisfied, which can be used to improve overall satisfaction and increase 
loyalty (Lonial & Raju, 2015). Customer care attributes could be the optometrist’s explanation 
of the customer’s condition and treatment, explanation of expected outcomes from treatment, 
the optometrist’s willingness to include the customer in decisions about care and treatment, the 
thoroughness of care, and willingness of the optometrist to answer questions. The current BBR 
Optometry Ltd. dry eye service design does not provide any opportunities to gather customer 
feedback other than from customer complaints or direct feedback to the optometrist carrying out the 
consultation in the form of praise or criticism.  
Examples of feedback from customers:   
• “Why is the specialist performing all the tests?”  
The practitioner originally envisaged the service to function as seen in other specialist 
clinics, where the specialist interprets the findings and communicates recommendations 
rather than collecting data or conducting the required tests. From this viewpoint, customers 
may judge the actual specialist nature of the practice if the specialist is taking part in all 
aspects of the customer journey similar to if a chef acts as the host, waiter and chef in a 
restaurant setting. The collection of data by another member of staff gives the practitioner 
time to digest findings, and to explain and communicate findings rather than seeming 
rushed to complete all tasks. Additionally, treatments such as BlephExTM 
microblepharoexfoliation could be conducted by clinical support staff with sufficient 
training, likened to a dental hygienist. This treatment can be standalone or performed in 
conjunction as a priming procedure prior to LipiFlow by the practitioner.  
• “I was happy with the consultation and clinical review but not the booking process.”  
This point highlighted training needs for staff. In one particular case, the customer was 
wrongfully given the standard advice for those attending regular eye examinations which 
was the chance they could be dilated and not to drive prior to their appointment. This advice 
led to great disruption to the customer including having her partner take time off work to 
drive her to the practice being located outside the county.  
 
Some large chain optometric practices (referred to as multiples), deliver electronic surveys to their 
customers following an eye examination with incentives such as entry into a draw to win £100 worth 
of vouchers or a gift card for completion of the survey. Other optometric practices simply list a 




programmes like sporadic mystery shopping or customer polling with satisfaction index ratings can 
be useful for service improvements but can also be labour intensive, costly, and may not produce 
information to help service providers make a practical difference to their business (Yavas et al., 
2008). Jill Clark, Specsavers Director of Customer Services, comments in a case study for Maze 
Feedback Ltd. that use of the Maze System software enables collection of customer feedback at store 
level on a daily basis and connects this to company strategic imperatives to further reduce provider 
gap one (Maze Feedback Ltd., 2019; Parasuraman et al., 1985). 
 
Training materials to target key strategic themes such as reducing waiting times have been developed 
from customer engagement with the Maze system, and there is specific focus on neutral responses 
from surveys to understand the customer’s response in order to rectify matters arising and provide 
immediate remedies where appropriate. The Maze System allows stores to motivate their employees 
on a daily basis through short morning meetings offering praise, defining focus areas, and identifying 
challenges and solutions that can be actioned. The Maze System provides a process of continuous 
improvement and learning for store colleagues, and can be exploited across other areas of the 
business including internal surveys covering employee engagement. The “bottom line” business 
benefit from utilising a system like Maze is to retain customer loyalty for future needs and to convert 
customers to ambassadors of the brand.  
 
Operational issues highlighted in the generation of the service blueprint included:  
• Products issued to Non-EyelifeTM customers at the time of their Tear Clinic consultation 
that are factored into the consultation fee were not being scanned through the practice 
management system in order to keep an accurate record of stock. Staff were trained and 
resource materials provided with step by step, screen by screen instructions on how to enter 
products onto the practice management system. A backstage action of staff is to keep stock 
of all diagnostic and treatment consumables as well as product inventory. 
• Optometrists offering treatments prior to full dry eye work up in an ad hoc fashion, putting 
the clinician performing the treatment at risk and in an uncomfortable situation. There was 
a need to alter the practice culture and to close gaps within the service. On one occasion, a 
customer attended for an in-practice treatment (Demodex tea tree oil) with an optometrist 
who did not recommend the treatment and in the absence of any preliminary dry eye testing. 
The customer noted there was no prior discussion of fees, timings, what to expect and no 
written information given for the customer to make an informed choice regarding the 
treatment suggested. The fact that the customer attended as she was told despite 
understanding why, demonstrates the level of trust that some customers have within the 
practice. However, this incident resulted in 20 minutes of wasted clinical time as the 




complete a full consultation. The practitioner could not justify charging the patient for a 
discussion that should have occurred at the time of the recommendation.  
• Additionally, there was an issue with optometrists citing special fees for certain customers, 
which in turn diminished the service structure and offering. These customers offered a 
consultation at a reduced fee did not return for dry eye follow-up or interact in any other 
capacity with the practice business. The practice management software now incorporates 
coloured coded labelled buttons that automatically generate the appropriate fees when 
selected on the onscreen till to avoid any confusion.   
 
It is now standard procedure for all those 18 years old or over presenting for an eye examination to 
complete a SPEED questionnaire in order to identify those people who may benefit from a Tear 
Clinic consultation and to bring their attention to the Tear Clinic service. Reception staff actively 
engage with customers they notice purchasing dry eye related products who have not had Tear Clinic 
consultations by discussing the service and providing written material to promote awareness of the 
service. Often reception and clinical assistant staff are multi-tasking and it is not possible to discuss 
the service completely, which is why a leaflet and two-page document outlining what to expect if 
you book an appointment, fees, and the “do’s and don’ts” prior to attending your appointment was 
created. The trifold leaflet does not contain any fees, however the document accessible on all practice 
desktops is printable and changeable when needed. Similarly, the practice website contains specific 
consultation and treatment fees in a PDF document, which can be altered as the market changes by 
management staff.  
 
Reception staff include the SPEED questionnaire with the customer’s record as one of the results of 
the pre-assessments presented to the optometrist. The presenting complaint may or may not be dry 
eye related but the results of the SPEED questionnaire can facilitate a conversation on the Tear 
Clinic service offering if self-reported symptoms of dry eye could not be addressed in full or these 
symptoms were secondary to a primary concern. Development of the blueprint also led to the 
realisation of a need for consent forms for in-practice treatment to ensure customers are making a 
voluntary informed decision about whether or not to proceed with treatment that was recommended 
by an eye health practitioner and accept the risks associated with the treatment including the 
possibility of no effect. The forms are signed by both the customer and performing optometrist, and 
scanned to the customer’s record.  
 
A service blueprint can be simple or intricate and complex with diagrams for each step and fully 
developed internal processes to isolate problems in the service process (Wilson et al., 2016). Various 
purposes for a service blueprint can be seen in table 2.9 (Fließ & Kleinaltenkamp, 2004). Service 




measurement and feedback in the service process, and facilitate a platform for innovation (Wilson 
et al., 2016; Bitner, 2008). Service blueprinting allows visualisation of the entire service system to 
enhance understanding of the process, and provides opportunities for discussions on service design 
which may involve agreements and compromises. Analysing a blueprint helps direct discussions 
regarding a service, and makes it is easier to suggest changes in the patient journey that may result 
in better service quality and gauge efficiency of work within an organization. For example, 
upskilling staff to carry out the dry eye diagnostics in order to save clinical chair time, and allow the 
optometrist to be the interpreter of clinical tests and explainer for management of a complex dry eye 
problem.  
 
Customer participation refers to the degree of effort and involvement required to produce and deliver 
the service. The level of customer participation in a dry eye service involves following pre-
appointment instructions, providing information to the service provider on ocular and relevant 
medical history and symptoms, and following agreed recommendations. Despite written 
instructions, some customers attended dry eye consultations wearing their contact lenses, which can 
affect the assessment of the tear film. In one case, the customer was happy to rebook their 
appointment but this resulted in wasted clinical chair time. Customers are now also reminded 
verbally when confirming their appointment of not to use any drops or wear contact lenses prior to 
their appointment. Future technological advancements may mean customers can book their own 
appointments and replenish their dry eye products via an online account with the practice. One of 
the aims of customer participation is to reduce the costs associated with delivering the service 

















Purpose of the service blueprint Area of focus & Questions that may be asked  
Understand the customer’s view of the 
process or the customer experience 
Read the blueprint from left to right in the customer action area 
• How is the service initiated by the customer?
• What choices does the customer make?
• Is the customer highly involved in creating the service or are
few actions required of the customer?
• What is the physical evidence of the service from the
customer’s point of view?
• Is the evidence consistent with the organization’s strategy and
positioning?
Understand contact employee’s roles  Read the blueprint from left to right directly above and below the line of 
visibility 
• How rational, efficient and effective is the process?
• Who interacts with customers, when and how often?
• Is one person responsible for the customer or is the customer
passed off from one contact employee to another
Understand the integration of the various 
elements of the service process or to 
identify where particular employees fit 
into the bigger picture  
Analyse the blueprint vertically 
• What actions are being performed backstage to support critical
customer interaction points?
• What are the associated support actions?
• How are handoffs from one employee to another taking place?
Service redesign Look at the blueprint as a whole 
• How might the complexity of the process be changed?
• How will changes from the customer’s point of view impact
the contact employee and other internal processes and vice
versa?
• Could the service system be changed to improve overall
efficiency and productivity?
• Are there likely bottlenecks or failure points in the service
process where improvement measures can be introduced and
failures tracked to avoid recurrence?
Table 2.9: Excerpt adapted from Wilson et al. (2016) that demonstrates a service blueprint can be 
read in different ways depending on the purpose.  
Once a service process has been successfully implemented, continual evaluation is required to ensure 
continued effectiveness and efficiency for the business. It is important that customer feedback or the 
customer perspective is considered in the future to understand customers’ expectations and deliver 
high quality service. There is evidence in the literature demonstrating that frequently, researchers do 
not report outcomes valued by patients, referred to as customers in this discussion, who are the most 
important stakeholders directly affected by the findings (Saldanha et al., 2018; Saldana et al., 2017; 
Alkhaffaf et al., 2017; Le et al., 2016; Glasziou et al., 2014; Chalmers & Glasziou, 2009).  
There are many examples of service innovation in optometric care and it is important that services 
remain customer focused or centred. Wright & Diamond (2015) introduced a new model of 
glaucoma service delivery whereby technicians and optometrists triage people with glaucoma into 
groups defined by risk of blindness, allowing virtual review via an internet-based virtual clinic of 
those at higher risk by a glaucoma specialist. This shared care glaucoma programme aims to reduce 




Although the responsibility for commissioning vision screening for children lies with local 
authorities and it is not mandated, the UK National Screening Committee recommends children aged 
four to five years old undergo vision screening in an orthoptist-led programme to detect amblyopia 
(PHE, 2017). Donaldson et al. (2018) distributed online surveys and questionnaires to parents of 
children in primary school reception and year one classes from 14 schools across five London 
boroughs to investigate the attitudes of parents towards eye care for their young children and possible 
barriers to accessing eye care for this age group. The study found that only 15% of families whose 
children attended a school with a screening programme in place knew of its existence, and there 
were parental misconceptions around eye care, which highlighted the need for marketing efforts to 
spread awareness of the service and to improve education around the importance of utilising existing 
vision screening programmes (Donaldson et al., 2018).  
 
Subtle macular abnormalities are often the cause of an unhappy patient following an optimal surgical 
outcome for cataract surgery (Klein et al., 2016; Hirnschall et al., 2016). A prospective, 
interventional case series conducted by Sudhalkar et al. (2019) aimed to determine the utility of 
routine preoperative OCT examination to detect asymptomatic macular pathologies in those 
scheduled for cataract surgery. Subclinical macular changes detected with OCT were found in 9.21% 
of eyes scheduled for cataract surgery, which in turn influenced the choice of intraocular lens (IOL) 
or choice of concurrent therapy (Sudhalkar et al., 2019). Although the asymptomatic lesions did not 
seem to significantly influence postoperative visual acuity in the short term for the case series 
presented, it was recommended that OCT may be appropriate for those considering multifocal IOL 
implantation for preoperative counselling and to manage patient expectations (Sudhalkar et al., 
2019). 
 
Multiple performance measures may be considered in predicting the success of a new service 
including financial performance in regards to revenue growth, profitability and return on investment, 
and relationship enhancement referring to the impact of a new service on customer loyalty and image 
enhancement (Normann, 2000). Utilitarian services tend to focus on service quality and operational 
metrics such as waiting time to predict customer satisfaction and customer loyalty, and the role of 
emotions should also be considered (Rychalski & Hudson, 2017). The innovation and adoption of 
new services is a planned process with elements of improvisation and anarchy as development and 
delivery of the service often occur simultaneously (Edvardsson et al., 1995). A service blueprint can 
help facilitate the design of a new community optometric service as demonstrated in this case study 






2.4.3: Service utilisation, customer switching, customer engagement and business 
recommendations for BBR Optometry Ltd.’s dry eye service  
Overall the majority of customers (72%) utilising the dry eye service were exisitng BBR Optometry 
Ltd. customers and of the new customers to BBR Optometry Ltd., only two of the 26 converted to 
EyelifeTM members (both to Dry EyelifeTM) demonstrating the difficulties associated with acquiring 
new customers. Dr Patel, in her doctoral thesis (2015), demonstrated that monthly payments offer 
an alternative business model to the traditional loss leading model for high street optometric practice, 
and enables optometric services to be self-sustainable without cross subsidy with optical product 
sales. The loss leading business strategy attempts to attract customers by offering low-priced private 
eye examination fees in the hope that customers will purchase high- margin spectacles and relies on 
a high volume of sales. This strategy works well for refraction based traditional eye examinations 
but may form a barrier to widening the scope of clinically oriented services within optometric 
practices.  
 
Dr Patel (2015) determined from a sample of BBR Optometry Ltd. customers that EyelifeTM Elite 
members generated greater clinical service revenue and profits compared to customers paying fees 
at point of sale. EyelifeTM Elite members had a significantly greater mean spectacle dispense rate 
compared to the non-member group, with 63% of members as opposed to 30% non-members 
purchasing more than one pair over the course of the 18-month retrospective audit (Patel, 2015). 
The initial average spend on spectacles before discount was found to be statistically greater for 
EyelifeTM Elite members suggesting the discount incentive EyelifeTM offers, encourages customers 
to upgrade to higher priced products (Patel, 2015). In regards to the dry eye service, the majority of 
new customers had travelled from outside the county as far as London and Singapore to specifically 
utilise the service for consultaitons or novel treatments, and therefore did not plan to interact with 
any other aspects of the business. These customers did not see the benefit of subscribing to EyelifeTM 
due to geographical reasons, which would not allow convenient regular access to the practice for 
future services.  
 
New customers attending as a result of their own online research or at the recommendation by 
primary or secondary care colleagues tended to be geographically based outside of Hereford (e.g. 
Gloucestershire, Daventry, Dudley, Coventry, Bristol, London, Solihull, Northampton, Cyprus, 
Powys), and so failed to return for follow-up. Customers failing to attend their review appointments 
were contacted via telephone by the optometrist who conducted the consultation to determine 
reasons for failing to attend. One customer from Wolverhampton opted out of returning for the 
review appointment because there was symptomatic improvement after following the recommended 
management plan. The customer thanked the optometrist for their care and stated she would return 




treatment because although there was “slight” symptomatic improvement, it was not at a level of 
improvement the customer had hoped or expected.  
 
In the current analysis, only 11% of customers (4/37) attended for a dry eye review one year 
following their initial dry eye consultation and review appointment. In a prospective telephone 
survey for people who were lost to follow-up (i.e. discontinued visits for > two years) in a dedicated 
hospital-based dry eye clinic, three broad categorization groups emerged to explain failure to attend: 
stabilized dry eye condition, personal/social factors and perceived insufficiency of healthcare 
delivery (Poon et al., 2014). Poon et al. (2014) determined from a cohort of dry eye patients that loss 
to follow-up was relatively common, with females and older patients less likely to fail to attend. The 
most common reason for loss to follow-up was stabilized dry eye condition where the condition 
could be self-managed, especially for patients younger than 50 years of age, and more likely due to 
personal/social reasons in patients older than 50 years of age (Poon et al., 2014). Personal and social 
reasons included perceived obstacles to attending further visits, such as direct and indirect costs, and 
the inconvenience of commuting as there is only one national center with a dedicated dry eye service 
in Singapore (Poon et al., 2014).  Patients in the dry eye clinic with other pressing systemic diseases 
considered dry eye to have a lower priority in their hospital visits, and conditions such as anxiety 
and depression associated with dry eye were also found to affect a decision to return to the dry eye 
clinic for review (Poon et al., 2014). Dry eye as a condition may itself be explanatory for loss to 
follow-up, as it is known to fluctuate in severity with customers failing to attend for review if there 
is a substantial symptom-free period or symptoms are perceived to be tolerable (Poon et al., 2014). 
Poon et al. (2014) postulate that dry eye patients suffering from severe symptoms or anxiety may 
require more consultations for immediate relief or reassurance beyond what existing resources can 
provide, leading to frequent switching of providers and loss to follow-up.  
 
Customer switching behaviour is a result of increased competition and the ability to shop 
comparatively whereby customers continue to use the service category but switch from one service 
provider to another (Keaveney & Parthasarathy, 2001; Nasir & Nasir, 2005). It is important to 
analyse customer satisfaction and service quality to predict potential defection causes, and develop 
strategies for customer retention and loyalty (Nasir & Nasir, 2005; Lonial & Raju, 2015). Russ 
(2008) suggests monthly payment plans may increase customer retention by introducing a switching 
barrier whereby customers are more likely to continue at the current practice because choosing to 
cancel the direct debit means contacting the practice or bank first. In a retrospective audit of BBR 
Optometry Ltd. customers wearing daily disposable soft contact lenses over a fixed period of 18 
months, Patel et al. (2015) determined eye examination service uptake and volume of lens purchases 
were greater for customers that were members of EyelifeTM compared to non-members. Members of 




was not a significant difference in the spectacle sale revenue or profits between the groups despite 
accompanying discounts with the monthly payment plan (Patel et al., 2015). One of the main 
implications from the audit was that charging appropriately for professional services provides an 
opportunity for high street optometrists to compete with online contact lens suppliers and supply 
products at competitive prices to encourage customer loyatly to the practice (Patel et al., 2015). The 
authors noted advantages of adopting this pricing structure with a higher professional fee and lower 
commodity cost are that monthly payment plans allow services to become self-sustainable without 
relying on cross-subsidy with products, and income generated from services are VAT exempt (Patel 
et al., 2015).  
 
Customer satisfaction is a key element in any customer retention approach as are strategies of 
developing strong interpersonal relationships or introducing switching service provider costs to 
create barriers to customer defection (Jones et al., 2000). Switching barriers are factors which make 
it more challenging or costly for a customer to change providers (Jones et al., 2000). Jones et al. 
(2000) after surveying customers regarding their banking and hairstyling/barbering service 
providers found that switching barriers had no influence on repurchase intentions when satisfaction 
was high, and positively affected repurchase intention when satisfaction was low. Therefore, 
switching barriers may allow a business to rectify short term fluctuations in service quality or sub-
optimal performances that might have otherwise have resulted in customer defection. Switching 
barriers may be appropriate for businesses who generally satisfy their customers but want a form of 
insurance against switching behaviours when their customers experience the occasional perhaps 
unavoidable service failure (Tax et al., 1998). However, services with switching barriers and 
ongoing customer dissatisfaction can lead to failure as customers may feel entrapped, and engage in 
negative word-of-mouth (Jones et al., 2000). Additionally, high turnover in service personnel could 
result in high turnover of customers when strong interpersonal relationships exist and the customer 
feels more loyal to the personnel rather than the service firm (Beatty et al., 1996).  
 
Repurchase intention is a form of loyalty behaviour that can be related to high affective commitment 
and is defined as the customer’s judgment about engaging in future activity with a service provider 
and what form the activity will take (Bayraktar et al., 2012). Customer satisfaction has a significant 
effect on customer retention and repurchase intention in a range of services (Liao et al., 2017; 
Larivière et al., 2016).  However, rated satisfaction has also been shown to be completely unrelated 
to repurchase behaviour due to levels of response bias, and customer satisfaction is not always a 
sufficient condition for future intentions (Mittal & Kamakura, 2001; McDougall & Levesque, 2000; 
Blut et al., 2014). Chen & Chen (2017) in the context of professional financial insurance services 
found affective commitment was a stronger predictor of repurchase intention, and no relationship 




who participate in services demonstrate higher repeat purchase behaviour and low sensitivity to price 
increases, in turn creating a competitive advantage for the service provider that is difficult for 
competitors to match (Hsieh & Yen, 2005; Prahalad & Ramaswamy, 2004).   
 
Disappointment which arises from comparison between the obtained results and the outcome that 
could have been achieved if the service provider’s actions had been different, is a predictor of word-
of-mouth and switching behaviour (Zeelenberg et al. 1998; Zeelenberg & Pieters, 2004).  It is 
thought co-production, that is customer participation in service specification and delivery, could 
lead to lower disappointment and dissatisfaction levels and less negative word-of-mouth and 
switching behaviours because customers take part of the responsibility for a service failure (Yen et 
al., 2004; Pacheco et al., 2017). Examples of co-production include requesting an off the menu meal 
at a restaurant, designing a workout programme with a personal trainer at the gym, and being 
involved in creating a dry eye management plan. Although the results were based on restaurant and 
gym service contexts, co-production was positively related to perceived control and decreased 
customer negative emotion reactions towards the service provider when there were service failures 
(Pacheco et al., 2017).  
 
Purchasing decisions can become automatic when habits form, however, repurchasing decisions 
regarding relatively expensive goods such as jewellery, houses and bespoke spectacle frames are 
scrutinised intensely as they are high involvement products (Petty & Cacioppo, 1984). Customers 
can easily search online for information on all dry eye products, novel treatments and dry eye service 
providers to evaluate alternatives, and use other providers as external reference points to influence 
post-consumption assessment of the service purchased and repurchase decisions (Yim et al., 2007).  
Customer loyalty can be a major driver of success, and source of sustained growth and profit with 
loyal customers more likely to positively endorse the business, and display willingness to pay 
premium costs (Wien & Olsen, 2014; Zeelenberg & Pieters, 2004; Reichheld & Schefter, 2000).  
 
There was absolutely no uptake of the home delivery of products option for Dry EyelifeTM members. 
Customers expressed preferring to pay as and when products were needed. It would seem that 
customers utilising the dry eye service preferred to purchase products at point of sale versus 
subscribing to a monthly direct debit system. Perhaps an initial bulk supply is more useful and should 
be explored or trialled in the future to help with dry eye management compliance given the 
fluctuating nature of dry eye and potential disuse of products in times when no symptoms are 
experienced. Product bundling is when several items are promoted as a bundle rather than as 
sold separately, and price bundling is when separate products are sold in a package at a discount 




drawback of such an option is if the customer wants the choice of buying the desired product 
and only a few of the optional items included in the bundle (Arora, 2008).  
 
Arora (2008) found that a bundling pricing approach for whitening dental care and 
complementary products was effective for purchase intention, which perhaps could be applied 
to the selling of dry eye products and promotion of novel dry eye treatments at BBR Optometry 
Ltd. As indicated in the disparity between expected and actual annual product customer spending, 
customers are not using the products as recommended given the lack of replenishment in the time 
period expected. For example, the Mono Dose System (COMOD®) of Scope Ophthalmics’ 
preservative and phosphate free ocular lubricant range stocked at the practice predicts monthly 
replacement if used four times daily, and control tip pumps of some lid cleansers supplied at the 
practice predict two-monthly replacement for daily use. These findings led to the introduction of 
automatically generated emails issued to Tear clinic customers one month after their reviews or at 
the expected review time reminding them of direct debit options for products or option of having 
products purchased in bulk due to the trend observed that patients do not return for products. This is 
to improve practitioner-customer communication when it comes to explaining the chronicity of dry 
eye and enforcing preventative practice. Reception staff have also been trained to ensure details are 
taken and a record created for “walk-in” customers who purchase products but do not attend the 
practice for clinical appointments in order to communicate the potential benefits of a dry eye 
consultation or to notify of new products or treatments.  
 
It was hypothesized that there would be more structured purchasing behaviour post-dry eye 
consultaiton for dry eye products but this was not the case. Almost half of customers (46%), who 
also happened to be non-EyelifeTM members did not purchase any dry eye product outside what was 
provided at the dry eye consultation, that is either one year prior or one year following their initial 
dry eye review appointment. It is unclear as to whether these customers did not value the 
recommendations given, felt their dry eye condition was under control, decided to purchase products 
online or elsewhere at more competitive prices, or whether those customers new to the practice 
returned to their local practitioner for ongoing care. Another factor to consider is whether customers 
were successful in having recommended ocular lubricants issued on prescription by their GP 
according to the local dry eye formulary. For example, Scope Ophthalmics offer two identical 
products in different sized bottles with the larger 10 ml bottle available on the NHS (Hycosan Extra= 
Hyloforte).  
 
Attractiveness of alternatives is another factor in customer defection, which refers to customer 
perceptions regarding the availability of viable competing alternatives in the marketplace. It has 




levels of retention and repurchase intentions as the perceived benefits of defecting or switching 
would be relatively low (Jones et al., 2000). Perhaps the dry eye customers seen at BBR Optometry 
Ltd. were content with the consultation and were attracted by lower product prices including exam 
fees and spectacles elsewhere. Anecdotally, some customers express preferring to be seen by an 
independent practitioner for a “proper eye examination” at a practice that invests in the latest 
technology and diagnostics, and are willing to pay for care or a supplemental fee outside what is 
covered by the NHS eye examination but then purchase products elsewhere at a reduced cost. In the 
future, customer feedback measures should be used to enhance the service, and develop ways to 
retain customers.  
 
Temporal reframing of price (TRP), unit pricing (UP) and usage-based UP are tactics that do not 
involve changes or reductions to retail prices but rather reframing to a different form to create 
favourable price perceptions and purchasing decisions from customers (Carlson et al., 2007; 
Hardesty et al., 2007; Kwortnik et al., 2006). TRP reframes the price as smaller amounts based on 
time units to aid price perception in the context of stand-alone decisions, whilst UP reframes the 
price based on units, volume or servings for value-conscious customers comparing similar items 
(Shirai, 2017). In a charitable donation scenario, Gourville et al. (1998) showed that the likelihood 
of donation was higher in the TRP form, which encouraged the retrieval of small daily expenses 
such as $1 per day for coffee, lunch, or taxi fare, compared to the aggregate annual amount. TRP 
can generate higher perceived price attractiveness but also has been shown to generate negative 
customer perceptions including higher perceived complexity of the price structure and greater 
feeling of being manipulated (Bambauer-Sachse & Mangold, 2009). TRP has been shown to be most 
effective in positively affecting purchase intention when even price endings were used, when it was 
applied to higher prices and shorter time periods and among customers with low calculation affinities 
(Bambauer-Sachse & Grewal, 2011).  
 
Shirai (2017) found in a laboratory experiment involving students and a print advertisement for tea 
leaves packed in tin boxes that usage-based UP was evaluated as better than TRP and measure-based 
UP because it was the most understandable and preferential as the information relates to actual 
consumption. It may be more effective to use TRP to reframe the costs of dry eye treatments which 
may be similar to the cost of varifocals or bespoke spectacles, and usage based UP to reframe the 
costs of dry eye products. For example, Kwortnik et al. (2006) found that in addition to usage-based 
UP, information on the usage count or consumption speed gave more credibility to the UP 
information for favourable evaluations of laundry detergent brands such as the number of uses per 
washing load. If customers are aware of how many drops are in each bottle or are aware of how long 
a bottle should last them in terms of supply, they can assess and gauge their usage of the product 




The manner in which a price is communicated to the market, referred to as framing, can mediate 
purchase intentions (Arora, 2008). Positively framed messages emphasize product or service 
benefits such as efficacy and in comparison, with competitor offerings or gains to the customer.  
Negatively framed messages concentrate on the benefits foregone or the adverse consequences 
of not using a product or service (Arora, 2008). Marketers use both positively or gain-based, 
and negatively or loss framed messages as a communication strategy to persuade customers to 
purchase in promotional appeals, and the literature is mixed on which is more effective at 
gaining compliance (Arora, 2008). The study referenced previously by Arora (2008) suggested 
that using positively framed messages for teeth whitening products were more effective in 
gaining compliance. In health care decisions regarding prevention of a risky consequence, 
positively framed messages are thought to be preferred (likelihood of surviving surgery), whilst 
negatively framed messages are thought to be more effective in detection of a risky 
consequence (Rothman & Salovey, 1997). Utilisation of video capture on the LipiView II unit 
allows practitioners and customers to review blinking habits during the consultation, and the 
dynamic Meibomian gland imaging function of the unit captures high-definition images of the 
oil-producing glands. Perhaps in addition to presenting physical evidence of structural changes 
to the Meibomian glands due to the progression of evaporative dry eye to customers utilising 
the service, marketing materials with these images and negatively framed messages (“people 
with suspect dry eye related concerns who do not have a consultation have a decreased chance 
of treating a more manageable stage of dry eye”) could be generated, and their effect on 
purchase intention analysed.   
 
In terms of clinical attendance, it was hypothesized that customers attending multiples appointments 
per year prior to their Tear Clinic consultation would have fewer attendances following their 
consultation after a targeted approach was taken to manage their ocular surface health issues. 
However, this could not be determined accurately in the current analysis given previous history of 
new customers was unknown. It was not known how many practitioners or health care providers the 
customer had actually seen prior to attending BBR Optometry Ltd. for a dry eye consultation. 
Reasons for customers attending the practice for multiple clinical appointments following the dry 
eye consultation within the one-year window include uptake of novel treatments and dry eye review 
appointments or because they were due an eye examination or required pre- and post-operative care 
following cataract surgery.  
 
Reasons for customers attending the practice for less clinical appointments following the dry eye 
consultation within the one-year window include they were not quite due for their yearly or two-
yearly eye examination, perhaps multiple appointments were no longer necessary because 




There were six customers who had fewer practice attendances for clinical appointments one year 
after their dry eye review appointment, with previous multiple visits due to emergency appointments 
in addition to routine eye examinations. One customer in particular attended the practice on three 
occasions with issues related to dry eye prior to their dry eye consultation. For reasons unknown, 
the customer had not returned for any further appointments at the time of the analysis. Reasons for 
no changes in attendance were potentially due to the regularity of eye examinations as EyelifeTM 
Optimum members were in this category, or because customers were attending the practice for the 
purpose of utilising the dry eye service only. It seems customers are more likely if at all to purchase 
spectacles following their eye examination irrespective of when they have a dry eye consultation.  
Dry eye is a chronic condition requiring at present regular and long-term use of recommended 
regimens to achieve sustained symptomatic relief. However, the therapeutic potential of self-applied, 
at-home therapy will be limited by compliance that is often influenced by financial costs, preference, 
perceived efficacy, convenience and adverse effects (Jin et al., 2008). In regards to ocular conditions, 
treatment adherence may be limited by the ability to instil eye drops (Stone et al., 2009). Therapeutic 
compliance considers compliance with other advice including following suggested environmental 
and dietary changes such as avoiding exposure to tobacco smoke and improving general hydration, 
and factors such as uptake of cosmetic procedures outside the practitioner’s control can also impact 
on dry eye status (Jones et al., 2017; Gomes et al., 2017).  
 
It has been estimated that the rate of compliance for short-term therapy is much higher than both 
long-term medication therapies and lifestyle changes (Jin et al., 2008). Reported types of non-
compliance (Vermiere et al., 2001; Cummings et al., 1982; Cramer et al., 1990; Feinstein, 1990; 
Burnier et al., 2003; Blaschke et al., 2011) applicable to dry eye management are: 
• Missed doses  
• Stopping treatment too soon or lack of persistence  
• Delaying in seeking healthcare 
• Non-participation in clinic visits 
• Failure to follow the practitioner’s instructions 
• “Drug holidays” where customers stop the therapy for a while and then restart, and  
• “White-coat compliance” which means customers are compliant to the regimen around the 
time of clinic appointments  
 
Patient-centred factors such as age and gender have been identified in therapeutic compliance with 
studies showing those over the age of 55 years and women to have both increased and decreased 
compliance or no effect at all (Jin et al., 2008). It has been hypothesized that cognitive and physical 




often non-intentional (Jin et al., 2008). There are dropper aids available commercially, and supply 
and open display or access to these within an optometric practice may make customers more 
compliant with therapies. A negative contributing factor to poor compliance in those with long-term 
illnesses is the fear of dependence on long-term medication, the worry of diminishing effectiveness 
of medication over time, low motivation to change behaviours, and negative attitude towards therapy 
(Apter et al., 2003; Bender & Bender, 2005; Lim & Ngah, 1991; Hernandez-Ronquillo et al., 2003; 
Spikman et al., 2003; Jin et al., 2008).  In regards to dry eye, anecdotally customers seem to have a 
negative attitude towards therapy especially if it is something they have trialled or been 
recommended previously. People with conditions similar to dry eye that fluctuate in their severity 
or do not have severe symptoms in the initial phase, such as asthma and hypertension, have been 
shown to demonstrate poor compliance (Hungin et al., 1999; Kyngas & Lahdenpera, 1999; Vlasnik 
et al., 2005). Perceived health status has also been shown to effect compliance with customers 
conducting their own cost-benefit analysis of therapy such as whether benefits outweigh constraints 
seen on their daily life like using a warm compress or applying ocular lubricant (Jin et al., 2008). It 
is important for customers to understand their condition and the role they play in their treatment to 
aid compliance.  
 
Not all dry eye products are available on prescription, and so the cost of long-term management 
constitutes a large portion of a customer’s disposable income. There are currently reimbursements 
from the National Health Service for two heating masks only: Eyebag and Meibopatch. It is 
estimated that the annual cost associated with the management of dry eye sufferers by 
ophthalmologists in the UK is about $11,000.00 US per person (Clegg et al., 2006). Typically, dry 
eye sufferers will self-treat with over-the-counter products or are managed in primary care but cases 
can present to hospital eye casualty departments as demonstrated in chapter six, and a proportion of 
severe cases may require management by an ophthalmologist. Compliance to therapy is threatened 
if the customer feels the cost of management is a financial burden (Jin et al., 2008), and customers 
may choose to stretch their drops past their discard date although most remain sterile six months 
from opening, or may be tempted to purchase cheaper inferior products that could lead to drop 
toxicity or other problems.  
 
In the current analysis, there were instances of customers wanting quick fixes where at present one 
cannot be offered for dry eye. Intuitively, it would seem likely that compliance would be enhanced 
with commercially available solutions such as impregnated sterile pads for eyelid hygiene and 
blepharitis management, however, cost seems to be a factor where products are not available on 
NHS prescription and customers incur a fee. For example, an average customer price for Johnson’s 
Baby Shampoo is £2.50 for 500ml, and so if 5ml is used per day in a 1:10 dilution then the annual 




mainstay of blepharitis management advice, which may be a familiar recommendation to dry eye 
customers. Commercially available wipes used at BBR Optometry Ltd. cost the customer about 50p 
each, which amounts to around £180 per year assuming one treatment every day and using a different 
area of the same wipe for the fellow eye (Jones et al., 2017). For customers, the benefits of the 
product may need to justify the price or the perceived convenience of a product may offset the 
difference in financial costs between two treatment options. Improvements could be made in regards 
to communication of outcomes from novel treatments and information on efficacy given the nature 
of these options as not being widely available, and perhaps lack of knowledge or scepticism on the 
part of fellow health care colleagues affecting uptake.  
 
The following points outline the “bottom line” for BBR Optometry Ltd.’s dry eye service: 
• A net profit of over £40,000.00 was generated from the dry eye clinic in under three years. 
• Over 150 dry eye consultations performed since implementation in July 2015. 
• BBR Optometry Ltd. now offer the equivalent of a half day dry eye clinic per week with 
numbers increasing due to greater exposure and awareness of the service. 
• Appointment types, times, and fees are embedded into the practice management software 
giving staff the confidence to book and suggest dry eye consultations. 
• Templates for testing, reports, consent forms, setting up product direct debits, booking 
information and fees are embedded into the practice management software. Marketing 
materials and Tear Clinic performance tracking (i.e. Number of patients seen monthly, Tear 
clinic turnover, costs etc.) are readily accessible as are all dry eye resources on the practice 
desktop under the “Dry eye specialty service” folder. 
• BBR Optometry Ltd. has established itself as a provider of advanced dry eye care with more 
than one independent-prescribing optometrist able to provide more advanced 
recommendations for complex cases.  
• Changes to costs of LipiFlow consumables and remaining stock meant offering treatments 
at a lower fee to generate higher volume of sales and awareness for the treatment given the 
initial equipment costs were amortised. Johnson and Johnson acquired Tear Science in 2017 
and representation in the UK may result in improved support for marketing and clinical 
affairs. The introduction of a reusable cable with disposable activator for LipiFlow treatment 









2.5: Management recommendations  
The Gaps model is a useful framework for understanding service quality (Parasuraman et al., 1985). 
The most critical service quality gap to close is the customer gap (gap five), which is the difference 
between customer expectations and perceptions. The four provider gaps that occur in organizations 
are responsible for the customer gap, and organizations must decide where to start or in what order 
to proceed, to reduce the customer gap and make it as narrow as possible. The work presented in 
this thesis highlighted the use of service blueprinting in private optometric service innovation, which 
pertains to the Gaps model as a means to reduce provider gap two. A summary of the activities 
undertaken, and that could be undertaken to close the provider gaps are presented in table 2.10. 
 
Provider gap Activities to reduce the Provider gap 
 
1) Knowledge gap:  
Not knowing what 
customers expect  
• Learn about service alternatives the customer views as comparable, such 
as other dry eye service providers, and over-the-counter products or self-
treatments 
• Determine whether there is a local need for a given service via surveys or 
questionnaires 
• Facilitate communication between reception and clinical support staff 
with optometrists and managers to understand what customers expect  
• Collect structured customer feedback regarding certain aspects of a 
private service 
 
2) Standards gap:  
Not selecting the right 
service quality designs 
and standards 
• Develop a service blueprint designed to correspond to customer 
expectations, for e.g. having dry eye concerns addressed with a structured 
exam using the latest diagnostics, and a discussion on findings and 
management options 
• Create a service standard using evidence-based clinical practice and/or 
global consensus 
• Provide clear fees and timings, and outline precisely what will need to 
take place prior to the consultation, as well as what to expect during and 
after the consultation  
• The dry eye customer journey at BBR Optometry Ltd.  was enhanced by 
relocating all appropriate diagnostics to one room  
• Provide physical evidence of the service offering with appropriate 
signage, leaflets and TV loop in the customer waiting areas that do not 
contain jargon, and use a dry eye questionnaire for screening purposes as 
part of the pre-assessment protocol for eye examinations.    
• Consider multiple measures of success to track service quality goals: 
financial performance (profitability), relationship enhancement (customer 
loyalty & effect on other services or products), and market development 
(potential to apply to new customer segments, such as dry eye evaluation 
for contact lens wearers and those referrable for lens replacement) 
 
3) Delivery gap:  
Not delivering to 
service designs and 
standards 
 
• Provide sufficient support for frontline staff including one-to-one training, 
access to concise reference documents, and role play. It is important for 
employees to understand how dry eye impacts the lives of customers, the 
tests conducted to determine type of dry eye, and the tiers of management 
delivered by the practice. 
• Utilisation of service intermediaries to enhance employees’ dry eye 
product knowledge, and confidence in calibration and performing dry eye 
diagnostics  
• More than one optometrist was trained to deliver the dry eye service, in 
order to account for appointment availability and demand fluctuations. 
Optometrists are provided with reference documents, grading scales, and 






4) Communication gap:  
Not matching 
performances to 
promises   
• Provide external messages for customers to return and create more 
structural bonds e.g. EyelifeTM 
• Provide reminders to customers to replenish products or consider in-
practice treatments one-month following their review appointment, given 
dry eye is a chronic condition  
• Schedule regular meetings with all staff to communicate any changes to 
the current dry eye service offering, and to identify any training needs 
 
Table 2.10: Summary of the activities undertaken, and that could be undertaken to close provider 
gaps one to four from the Gaps model of service quality (Parasuraman et al., 1985). 
  
Management of any service requires a way to audit the service performance and capabilities of an 
organization, which can be done using the Service quality Gaps model audit shown in appendix 2.9.  
Future work could examine all factors that affect the size of each provider gap for private optometric 
services, such as the Tear Clinic, using the Service quality Gaps model audit (appendix 2.9). 
Organizations could also perform a SERVQUAL audit (see appendix 2.1), to assess service quality 
management from an internal point of view in order to highlight points which need to be addressed 
with input from members of staff representing all service roles including managers, clinical 
assistants and optometrists. An additional SERVQUAL audit could include customers, in order to 
yield a more detailed picture of what customers think about private optometric services, namely the 
dry eye service. These activities are worthwhile for those businesses who seriously wish to improve 
service quality in a crowded optometric market.  
 
 
2.6: Conclusion  
There is currently no cure for dry eye disease with the mainstay of management focusing on 
palliative relief. However, BBR Optometry Ltd. aim to use a targeted approach to determine the sub-
classification of dry eye, and use the DEWS II staged management algorithm as the basis for 
recommendations. Approximately 26% of BBR Optometry Ltd. adult customers attending for an 
eye examination and voluntary completed a dry eye questionnaire, self-reported some degree of dry 
eye. After identifying a local service need, considering the customer’s point of view in developing 
a service blueprint and implementing the service, the service is continually reviewed. Chapter three 
looks at determining the most efficient clinical tests for the dry eye service.  
 
Service blueprinting can be used for the development and implementation of other possible 
optometric care pathways in the community, for example myopia control and specialist contact 
lenses, sports vision, and concussion rehabilitation. Service blueprinting lays the framework for the 
intended service that can be used as a reference when changes may cloud direction for practices that 
are attempting to differentiate themselves from competition in the market. A service blueprint is not 
rigid and can be altered with the goal of avoiding provider gap two, and improving service quality. 




being the centre of focus, and including customers in the process. By analysing purchase behaviour 
patterns, practices can learn more about their customers at an operational level in order to plan 
changes to their current service, re-direct focus, brainstorm strategies to retain or acquire new 
customers, and determine where to direct energy in terms of time, development and further 
resources. There is a business case for a dry eye service at BBR Optometry Ltd. in terms of primary 
profitability, secondary profitability (conversion to EyelifeTM), and reputation for clinical 
excellence. Another challenge in the implementation of new services is to identify or segment 
customers who would benefit from the new services, and this will be explored further in chapters 












































CHAPTER 3 ABSTRACT 
 Application of decision tree analysis and principal component analysis to dry eye 
questionnaires and clinical tests  
 
PURPOSE: The current analysis aimed to identify objectively, which combination of commercially 
available clinical tests invested in by BBR Optometry Ltd. should be included in dry eye 
consultations for predicting evaporative dry eye, and to create a more efficient dry eye consultation.  
 
METHODS: Multivariate analysis was performed using SPSS version 24.0 (IBM SPSS Statistics, 
Chicago, IL), and involved decision tree analysis (DTA) using the Chi-squared Automatic 
Interaction Detection (CHAID) tree growing method (Kass, 1980). DTA was used in the current 
analysis to explore whether clinical tests (lipid layer thickness, percentage of partial blinks, 
Meibomian gland evaluator score, fluorescein tear breakup time, Meibomian gland dropout and 
Meibomian gland duct dilation), or the variables age and sex were predictive of dry eye symptom 
status i.e. having some degree of dry eye symptoms or none at all in a clinical population of patients 
from an independent optometric practice attending for an eye examination or a dry eye consultation. 
A second DTA was applied to explore whether there were clinical tests predictive of dry eye 
symptom severity according to the OSDI score amongst dry eye patients with a predominantly 
evaporative component. 
 
Principal Component Analysis (PCA) was performed. The aim of PCA is to arrive at a simple 
structure, meaning each variable loads strongly onto only one principal component (>0.40), and each 
principal component includes a number of strongly loading variables (Pallant, 2016). According to 
Pallant (2016), there should be three or more items loading onto each component. An exploratory 
factor analysis approach was taken to determine which items from the SPEED and OSDI dry eye 
questionnaires were the most important questions to explain variation in evaporative dry eye cases 
seen at BBR Optometry Ltd. In a second PCA, all clinical tests (as analysed with DTA) including 
total SPEED and total OSDI dry eye scores were listed as variables to determine which were key to 
explaining variation amongst the evaporative dry eye cases seen. The later analysis was re-run with 
the total SPEED and OSDI scores replaced by the “Jessica score,” which was derived from the first 
PCA, consisting of the most important items from the two dry eye questionnaires. 
 
RESULTS: Important predictive questions for dry eye included those relating to frequency of 
soreness or irritation, and the impact on visual functioning for daily tasks. Based on the right eye 
DTA model, the selection of clinical tests available at BBR Optometry Ltd. that are potentially 
predictive of predominately evaporative dry eye in order of importance include: fluorescein tear 
breakup time especially if it is ≤ to 9 seconds, there is some degree of Meibomian gland dropout, 
and a total Meibomian gland evaluator score that is between 1 and 9. Sex may also be a predictive 
factor for dry eye status if the fluorescein tear breakup time is between 9 and 12 seconds, with 
women more likely to be affected with dry eye. 
 
According to a two-factor solution (simple structure), the most important dry eye questions were 
SPEED item 2, and OSDI item 6. In the second PCA, the most important clinical tests identified 
were Meibomian gland duct dilation, OSDI total score, fluorescein TBUT and percentage of partial 
blinks. In the third PCA, the tests identified as the most responsible for the variability observed 
amongst predominantly evaporative dry eye cases were: Meibomian gland duct dilation, percentage 
of partial blinks, fluorescein tear breakup time, and the “Jessica score”. 
 
CONCLUSIONS: These results derived objectively using statistical means suggest that asking 
certain questions regarding dry eye symptoms, performing an accessible, quick test of fluorescein 
tear breakup time, and utilising technology invested in by the practice could deliver a sufficient level 








 Application of decision tree analysis and principal component analysis to dry eye 
questionnaires and clinical tests  
 
3.1: Introduction 
Optometrists are at the forefront of providing long-term management of dry eye and so accurate 
diagnosis is fundamental. Practitioners are tasked with choosing from a battery of clinical tests, 
where one test may affect the results of a subsequent test, to provide high quality care to dry eye 
patients when it has been demonstrated there is relatively poor association and often discordance 
between signs and symptoms (Johnson, 2009; Downie & Keller, 2015; Sullivan et al., 2014; 
Baudouin et al., 2014; Nichols et al., 2004a; Schein et al., 1997; Hay et al., 1998). Self-reporting of 
dry eye symptoms has shown to be more reliable and accurate than results of dry eye clinical tests 
(Schiffman et al., 2000; Nichols et al., 1999; McMonnies, 1986; Lee & Hyun, 1988; Nichols et al., 
2004a). It is thought neural mechanisms may underlie the complexity of dry eye symptoms with 
desensitization of the cornea to stimuli in severe or longstanding dry eye corresponding to a 
reduction in symptoms of ocular discomfort (Baudouin et al., 2014; Savini et al., 2008).  
Hyperalgesia or heightened sensitivity to pain may have the opposite effect, causing an individual 
to be considerably symptomatic in the absence of clinical signs in early or mild cases of dry eye 
(Rosenthal & Borsook, 2012; Belmonte et al., 2004a).  
 
Dry eye disease affects up to 50% of adults and is one of the most common reasons that people seek 
care from an optometrist or ophthalmologist (Stapleton et al., 2017; Barabino et al., 2016). There is 
currently no gold standard test for diagnosing dry eye disease, and so various clinical tests are 
conducted and there is considerable variation in self-reported clinical care approaches among 
optometrists and ophthalmologists. The dry diagnostics used at BBR Optometry Ltd. are described 
in chapter one. A study using an online survey regarding current practice patterns for the evaluation 
of dry eye patients sent to ophthalmologists affiliated with the Scheie Eye Institute or Wills Eye 
Hospital in Philadelphia, USA, found the most common clinical test conducted was corneal 
fluorescein staining, the most frequently used newer diagnostic test was tear osmolarity, and that the 
majority of respondents felt there was a need for an evidence-based standardized screening tool to 
decide which patients should be referred for a Sjögren’s syndrome workup (Bunya et al., 2018). 
Sjögren’s syndrome is a chronic autoimmune disease characterized by irreversible damage to the 
lacrimal and salivary glands leading to aqueous deficient dry eye associated with a significant 
reduction in tear production and ocular surface inflammation, and loss of saliva production (Ramos-
Casals et al., 2012; Vitali et al., 2002; Segal et al., 2009; Kassan & Moutsopoulos, 2004). 
Unfortunately for those affected, there is an average delay in diagnosis of up to seven years from 
the onset of symptoms due to the nonspecific nature of early manifestations (Kassan & 




of respondents to the online survey reported that they do not routinely use a standard severity grading 
scale in their everyday practice to assess dry eye because they felt it was too time consuming or that 
is was not clinically useful (Bunya et al., 2018). A retrospective review of records from North 
American optometric practices to assess customary methods in the monitoring of dry eye disease in 
Sjögren’s syndrome found practitioners based in private practice were more likely to use symptom 
questionnaires and grading scales, and to describe anterior blepharitis, whilst those based in 
academic settings were more likely to record tear breakup time and tear meniscus height (Acs et al., 
2018).  
 
An online survey distributed to optometrists with a special interest in anterior eye disease and/or 
contact lenses in Australia and the United Kingdom (UK) aimed to compare the self-reported clinical 
practice behaviours, and found practitioners in both regions deemed symptom assessment as the 
most important diagnostic (Downie et al., 2016). UK practitioners used conjunctival signs and tear 
meniscus height evaluations more than Australian optometrists to diagnose dry eye, whilst 
Australian optometrists placed more emphasis on fluorescein tear breakup time (Downie et al., 
2016). A similar cross-sectional survey was used to evaluate self-reported clinical practices of New 
Zealand optometrists and ophthalmologists (Xue et al., 2017). Patient symptoms were also ranked 
as one of the most valuable diagnostic approaches in dry eye, in addition to the evaluation of the 
Meibomian glands by 90% of respondents (Xue et al., 2017). Most practitioners selected six or more 
techniques within any single dry eye assessment, and the use of validated dry eye questionnaires and 
standardised grading scales were infrequent (Xue et al., 2017). 
 
The purpose of the current study was to objectively determine the most valuable clinical tests 
conducted at BBR Optometry Ltd. to:  
1) Discriminate between people self-reporting dry eye from those that do not report dry eye 
symptoms, and  
2) Predict the Ocular Surface Disease Index (OSDI) dry eye severity amongst patients with 
predominately evaporative dry eye using decision tree analysis.  
 
Principal component analysis was applied to a dataset of patients with predominantly evaporative 
dry eye at BBR Optometry Ltd. to:  
1) Determine which questions regarding dry eye symptoms were the most important from 
two validated questionnaires, and  
2) Determine which clinical tests including total questionnaire scores are key to explaining 





The findings of these analyses could help inform changes in the design of the current dry eye service 
at BBR Optometry Ltd. to improve efficiency from the layout of the practice to utility of certain 
tests for objective screening of dry eye at eye examinations and preliminary assessments for contact 




This study received approval from the Life and Health Sciences Ethics Committee at Aston 
University (Project #1276) and adhered to the tenets of the Declaration of Helsinki. This was a 
retrospective analysis of anonymised patient records with all data collected in an independent 
practice with a dedicated dry eye service (BBR Optometry Ltd., Hereford, England). The objective 
was to determine the clinical tests that were predictive of dry eye at BBR Optometry Ltd. All data 
were collected by the author, and the same examination room and equipment were used throughout. 
The dry eye group consisted of all patients scoring greater than zero on the SPEED questionnaire 
and presenting for privately funded dry eye consultations. There were 149 patients seen in the dry 
eye clinic. This was a retrospective analysis of pre-collected data, so the number of eyes available 




3.2.1: Decision Tree Analysis  
Decision Tree Analysis (DTA) was considered in favour of previously used statistical methods, as 
it considers all factors at the same time. DTA is a form of multivariate analysis widely used since 
1959, which automatically identifies a hierarchy of independent discrete and continuous variables 
regardless of the frequency distribution of the continuous variables in order to predict an outcome 
(IBM, 2016). DTA can be used to identify cases likely to be members of a particular group, to assign 
cases into one of several categories, to create rules that predict future events, to select predictors 
from a large set of variables, to identify relationships between subgroups, and determine the most 
useful classification of independent variables (IBM, 2016). DTA has been applied to medical 
diagnostic classification problems including breast cancer detection, thyroid nodular lesion detection 
and otoneurological diseases  (Kuo et al., 2001; Nagy et al., 1999; Viikki et al., 1999).  
 
Multivariate analysis was performed using SPSS version 24.0 (IBM SPSS Statistics, Chicago, IL), 
and involved DTA using the Chi-squared Automatic Interaction Detection (CHAID) tree growing 
method (Kass, 1980). DTA is presented graphically as a branching diagram that eases interpretation. 
At each step, the CHAID algorithm chooses the independent variable that has the strongest 




the first branches of the tree followed by the next most important independent variable with each 
subsection within the lower branch referred to as a child node. CHAID uses p-values of the Chi-
square as the splitting criteria, and so detects the factors that are statistically best at segmenting the 
population as per the intended classes (Guillon & Maissa, 2005b). Findings in this analysis were 
tested for statistical significance at the 95% level (P<0.05). The CHAID algorithm allows binary 
and multi-way splits, and branching ceases once there are no other independent variables that can 
influence the dependent variable. The CHAID algorithm does not produce a fixed model and allows 
a combination of factors to identify differences in subgroups (Guillon & Maissa, 2005b).   
 
DTA has been applied previously in ophthalmic research (Yu et al., 2011; Frick et al., 2009; Guillon 
& Maissa, 2005a; Guillon & Maissa, 2005b; Twa et al., 2005; Chiang et al., 2011; Rushton et al., 
2016; Dunstone et al., 2013; Pancholi et al., 2018). In a study estimating the annual direct and 
indirect costs of treating dry eye in the United States, a decision tree analytical model was used to 
differentiate between patients obtaining medical care, and those who self-managed (Yu et al., 2011). 
The subgroups were further split into the severity classification of dry eye, the various treatments 
used, and their associated costs (Yu et al., 2011). The authors preferred this method of analysis for 
the ease of updating data, and reanalysing data over time to estimate future health care budget 
requirements (Yu et al., 2011). Frick et al. (2009) used DTA to compare cost-effectiveness of two 
methods of screening for refractive error in urban and rural India.  
 
A study by Guillon and Maissa (2005b) used DTA and CHAID with Answer Tree Software to 
determine the diagnostic value of individual questions of the McMonnies questionnaire to detect dry 
eye in daily soft contact lens wearers and non-wearers. The most predictive question for the detection 
of dry eye in both lens wearers and non-wearers was the frequency of ocular dryness with 
scratchiness, symptoms of burning and sensitivity to cigarette smoke identified as additional 
indicators of dry eye problems (Guillon & Maissa, 2005b). The authors comment that using CHAID 
statistical analysis in the study made it possible to reduce the number of questions, and identify the 
questions that best predicted dry eye symptoms in routine clinical practice without needing to 
administer a full dry eye questionnaire, which can be time-consuming (Guillon & Maissa, 2005b). 
The same authors used CHAID in a different study examining bulbar conjunctival staining with 
sodium fluorescein and lissamine green dyes in contact lens wearers and non-wearers to identify 
discriminant factors and associated cut-off values for dryness symptoms amongst the clinical 
findings (Guillon & Maissa, 2005a). Subjects were identified as asymptomatic or symptomatic based 
on their McMonnies questionnaire score. Staining with both dyes were discriminating factors for 
symptomatic subjects who did not wear contact lenses, and amongst daily soft contact lens wearers 
only Lissamine green staining was a discriminating factor (Guillon & Maissa, 2005a). The authors 




lissamine green staining for contact lens wearers, and non-wearers complaining of dry eyes in a 
work-up for ocular surface disease (Guillon & Maissa, 2005a).  
 
Using the WEKA C4.5 Java based program to generate a decision tree, a study by Twa et al. (2005) 
discriminate between normal and keratoconic corneal shapes in an objective way. The authors note 
the advantages of this approach to quantify videokeratography data to support clinical decision 
making, which include quick computational speed, scalability for analysis of large volumes of data 
and interpretability (Twa et al., 2005). Chiang et al. (2011) used DTA to overcome limitations 
associated with missing data using logistic regression, that is often a common issue with postal 
surveys in survey-related research. Chiang et al. (2011) applied DTA to the area of eye care service 
delivery, and identified the most important predictors related to better low vision coverage. Rushton 
et al. (2016) used DTA to determine influencers on the relationship between unaided vision and 
refractive error in order to develop new equations useful in simulators for teaching purposes. DTA 
ruled out variables including sex, contact lens wear, iris colour and axis of astigmatism as having a 
significant effect on unaided vision, and so were not included in further regression analysis (Rushton 
et al., 2016). Dunstone et al. (2013) used DTA in their investigation into the habits and attitudes of 
UK optometrists to retinoscopy. The authors found DTA to be the most appropriate statistical 
analysis due to its hierarchical element compared to multiple regression and multiple discriminant 
analysis, which have no explicit hierarchy in determining the potential influencing factors, such as 
date of qualification and practice type on the habits and attitudes to retinoscopy (Dunstone et al., 
2013). Pancholi et al. (2018) used DTA to identify the most and least influential variables on self-
assessment accuracy in relation to clinical decision-making learning objectives for two cohorts of 
second-year optometry students, where one group utilized virtual patient software.  
 
DTA was used in the current analysis to explore whether clinical tests or the variables age and sex 
were predictive of dry eye symptom status i.e. having some degree of dry eye symptoms or none at 
all in a clinical population of patients from an independent optometric practice attending for an eye 
examination or a dry eye consultation. A second DTA was applied to explore whether there were 
clinical tests predictive of dry eye symptom severity according to the OSDI score amongst dry eye 
patients with a predominantly evaporative component.  
 
 
3.2.2: Principal Component Analysis 
Principal Component Analysis (PCA) is a data reduction technique that makes no distinction 
between independent and dependent variables unlike DTA, which can be used for data reduction 
and reduces the number of independent variables needed to predict a dependent variable. PCA 




independent and dependent variables the same. PCA summarises a large set of variables using a 
smaller set of factors or components by identifying groups among the intercorrelations of the original 
sample. That is, PCA is used to determine whether the relationships between variables can be 
explained by a smaller number of components, also referred to as factors (Armstrong & Eperjesi, 
2008). The first principal component accounts for the maximum variance, whilst the remaining 
successive principal components explain decreasing proportions of the residual variance (Armstrong 
& Eperjesi, 2008). PCA can be performed on a set of intercorrelated continuous or polychotomous 
ordinal variables.  
 
PCA is one of the simplest and most commonly used methods for extracting a few important 
questions from several questionnaires or a few important clinical tests from a large battery of tests. 
Researchers use factor analytic techniques to develop and evaluate tests and scales, refining and 
reducing a large number of questions and scale items to develop a smaller number of subscales. 
Additionally, factor analysis techniques are useful prior to multiple regression or multivariate 
analysis of variance analyses in order to isolate a manageable number of related variables from a 
large set of data (Pallant, 2016).  
 
Application of PCA in ophthalmic research may include describing and summarising differences or 
variations in quantitative measures of relevant clinical and pathological features of patients with a 
specific disease, such as age-related macular degeneration (Armstrong & Eperjesi, 2008). An 
objective might be to determine whether clusters of features might represent distinct subtypes of a 
disease or to establish which of the features best explain the pattern of heterogeneity (Armstrong & 
Eperjesi, 2008). An investigator might have a hypothesis for the underlying factors that might 
explain variation in clinical features among people with a particular condition, and can use PCA to 
test this hypothesis. The variables under study in PCA could also be questions that form part of a 
questionnaire to verify whether the items included are actually assessing the aspect under 
investigation or in other words, to validate questionnaires attempting to relate subjective aspects of 
a patient’s experience with more objective measures (Armstrong & Eperjesi, 2008). The following 
are examples of factor analytic techniques used in ophthalmic research and further examples are 
provided in appendix 3.1. 
 
Relating to Dry Eye: 
• Borchman et al. (2012) used PCA to detect subtle differences in nuclear magnetic resonance 
spectroscopic data that quantified the composition of human meibum including hydrocarbon 
chain moieties and products of lipid oxidation, and to assess whether or not spectra of 
meibum from those with MGD according to the criteria of Foulks and Bron (2003), differed 




• Asiedu (2017) conducted a hospital based cross –sectional study of 127 glaucoma patients 
with dry eye identified by having a clinical diagnosis of dry eye (no subtype specified) or 
OSDI score ³13 to investigate if the SPEED questionnaire acts as a measure of dry eye 
severity, and whether it is unidimensional as previously reported (Ngo et al.., 2013) using 
Rasch analysis. Previous analyses used fit statistics alone on a smaller sample to claim 
unidimensionality, which has been criticised with the recommendation to perform PCA on 
the standardised model residuals. PCA of the standardized model residuals was a useful 
alternative to detect multidimensionality in the study as well as unidimensionality in a 
proposed six-item SPEED questionnaire, that removed eye fatigue items to include items 
pertaining to only the symptoms reported the most (Williamson et al., 2014; Asiedu, 2017).  
 
Relating to Assessment of Questionnaires: 
• Barker & Mansberger (2019) used PCA to determine construct validity of a reduced version 
of the Glaucoma Treatment Compliance Assessment Tool (GTCAT), which was translated 
to Brazilian Portuguese. A sample of 76 glaucoma patients was used, and it was determined 
that 14 questions loaded onto seven principal components accounting for 73.5% of the 
variance in responses. The results were consistent with the Health Belief Model that 
characterizes health behaviour including adherence with glaucoma therapy (Barker & 
Mansberger, 2019). The results suggested that the sample size was adequate because 
orthogonal rotation determined that the GTCAT converged into the same number of 
components as the original questionnaire after excluding statements if they did not have a 
factor loading >0.50 on any component, if there was only a single statement on any 
component or if they cross-loaded >0.30 onto multiple components (Barker & Mansberger, 
2019).  
• The Amblyopia and Strabismus 26 item questionnaire (A&SQ) was developed to assess 
quality of life in amblyopia and/or strabismus. van de Graaf et al. (2009) used PCA with 
orthogonal Varimax rotation, and data from 296 respondents to determine the pattern of 
correlations between responses, and confirmed the a priori hypothesized dimensions 
including social contact and cosmetic problems, near distance estimation, diplopia, visual 
disorientation, fear of losing the better eye and far distance estimation. 
 
There are three steps involved in PCA: 
1. Assessment of the suitability of the data for PCA.  
PCA assumptions include: 
• Adequate sample size: Armstrong & Hilton (2011) suggest a minimum of five cases per 




tends to be less reliable with small samples (Pallant, 2016). Tabachnick and Fidell 
(2007) recommend a minimum sample size of 150, and a ratio of at least five cases for 
each of the variables.  
 
• Factorability: that the variables can usefully be reduced to a smaller number of principal 
components. That is, the strength of the relationship between the variables needs to be 
considered (Pallant, 2016). The sample will be deemed suitable for PCA if the following 
three criteria are met: 
a. Variable intercorrelations of greater than ± 0.3 should be frequent.  
b. The Kaiser-Meyer-Olkin (KMO) test of sampling adequacy is a measure of the 
shared variance in the items and should exceed 0.6. 
c. Bartlett’s test of sphericity, which uses the chi-square distribution, should be 
statistically significant (p<0.05). This test is overly sensitive and so p<0.05 
indicates checking of the other indicators prior to deciding on suitability.  
• Linearity: that the intercorrelations between variables are linear and not curvilinear. 
Tabachnick and Fidell (2007) suggest a spot check of some combination of variables 
rather than checking multiple scatterplots.   
• Minimal outliers: PCA can be sensitive to outliers so measures should be taken to ensure 
that extreme values are removed (Pallant, 2016). 
 
2. Extraction of principal components that contribute the most to the explanation of the 
variance in the data set. Kaiser’s criterion is a commonly used technique whereby only 
components with eigenvalues of one or more are selected. Each principal component is 
associated with an eigenvalue, which is a measure of how much variance in the data is 
explained by each principal component. Kaiser’s criterion has been criticised for retaining 
too many components (Pallant, 2016). The Catell’s scree test is another technique to assist 
in the decision concerning the number of components to select. It is a graphical 
representation of the components that make up the x-axis, and their corresponding 
eigenvalues which make up the y-axis. SPSS can be used to plot each of the eigenvalues of 
the components in descending order, and the components that fall above a break in the plot 
where the shape of the curve changes direction, and becomes horizontal are retained. The 
Catell’s scree test also tends to overestimate the number of components, considering the 
precise cut-off point is quite subjective leading to over-extraction of components (Pallant, 
2016; Henson & Roberts, 2006). Armstrong & Eperjesi (2008) note that the first principal 
component will often contain a disproportionate amount of the variance and that is it not 




3. Rotation and interpretation of principal components. PCA determines the correlations 
between each variable and the extracted principal components, and these are referred to as 
factor loadings (Armstrong & Eperjesi, 2008). In an ideal situation, each of the variables 
should load onto a single principal component, but variables are often complex and load 
onto multiple principal components (Armstrong & Eperjesi, 2008). Rotation is the name of 
a process designed to ease the detection of patterns, and includes orthogonal and oblique 
methods. The investigator must choose which method- orthogonal (uncorrelated) or oblique 
(correlated)- is used. Orthogonal methods fail if there are correlations between principal 
components. Varimax is the most frequently used orthogonal method offered in SPSS. 
Oblique methods still work if there are correlations between principal components. Direct 
Oblimin is the most frequently used oblique method offered in SPSS (Pallant, 2016). When 
the pattern of correlations between the items is clear, the two methods often result in similar 
solutions (Tabachnick & Fidell, 2007). Results from orthogonal rotations tend to be easier 
to interpret and report, but assume that the underlying constructs are not correlated and 
independent (Tabachnick & Fidell, 2007). Many researchers conduct both types of 
rotations, and choose the clearest output to interpret. It is suggested to use the oblique 
rotational technique initially, as it provides information about the degree of correlation 
between the components (Pallant, 2016).  
 
The aim of PCA is to arrive at a simple structure, meaning each variable loads strongly onto only 
one principal component (>0.4), and each principal component includes a number of strongly 
loading variables (Pallant, 2016). According to Pallant (2016), there should be three or more items 
loading onto each component. The procedure of choosing a variable whose loading was larger than 
a certain value as significant does not take into account sample size, and is arbitrary. Guidelines vary 
within the literature on this point, with three to five components with strong loadings considered at 
>0.50 to >0.70, and no cross loading onto another factor with a loading of >0.32 or >0.40 (Beavers 
et al., 2013). A communality loading of ³0.70, where communality is a measure of how much a 
variable’s variance is explained from PCA ranging from 0 to 1 prior to rotation, is considered ideal 
because it suggests that about half of the variance of that item is accounted for by the factor (Beavers 
et al., 2013). The number of components that are retained influence the communality values and so 
interpretation should take place once the components to be retained have been decided (Pallant, 
2016). Stevens method is a more rigorous way to test the factor loadings statistically, and is given 
for a sample size of ‘N’ by the equation: Critical value = 5.152/√(N-2) (Armstrong & Eperjesi, 
2008).  Therefore, any variable whose factor loading exceeds this critical value, may be deemed 
significantly correlated with a principal component. Pett et al. (2003) recommend removing weak 
items, which include those with <0.30 correlation with other factors and does not provide a 




than one factor. Pett et al. (2003) suggest factoring the data after removing the weak items for a 
stronger structure or PCA output.  
 
 The adequacy of a sample size can be determined after the analysis has been conducted, with 
principal components having three or more factor loadings of 0.60 or higher reducing the influence 
of the sample size (Guadagnoli & Velicer, 1988; Fabrigar et al., 1999; MacCallum et al., 2001). 
However, Hogarty et al. (2005) suggest a large sample to decrease sampling error, and Beavers et 
al. (2013) recommend planning to collect a sample of at least 150 cases for initial structure 
exploration. There is no definitive method for determining the minimum sample size for studies 
using PCA. A method to generate a rough estimate of the sample suggested by Dunne in DTA would 
not be useful in the current analysis, as it does not alter the findings of the PCA (M.C.M. Dunne, 
personal communication, August 2, 2018). The rule of thumb suggested by Armstrong and Hilton 
(2011) of using a minimum of five cases per variable if there are at least 100 cases was used.  
 
An exploratory factor analysis approach was taken to determine which items from the SPEED and 
OSDI dry eye questionnaires were the most important questions to explain variation in evaporative 
dry eye subjects seen at BBR Optometry Ltd. In a second PCA, all clinical tests including total 
SPEED and total OSDI dry eye scores were listed as variables to determine which were key to 
explaining variation amongst the evaporative dry eye subjects seen. The later analysis was re-run 
with the total SPEED and OSDI scores replaced by the “Jessica score,” which was derived from the 




3.3.1: Decision Tree Analysis to predict symptomatic dry eye status  
There were 149 patients seen in the dry eye clinic. Data from patients who were contact lens wearers, 
(n=21), not classified as having predominantly evaporative dry eye (n=12), and had missing values 
(n=14) were excluded from the analysis.  For CHAID, missing scale and ordinal independent 
variables are included in the analysis as a single combined category (IBM, 2016). The algorithm 
decides whether to merge the missing category with its most similar category or to keep it as a 
separate category (IBM, 2016), and so to avoid confusion, the cases with missing data were 
excluded. The normal group consisted of 63 patients who were presenting for a routine eye 
examination, did not self-report any symptoms of dry eye via the SPEED questionnaire used as a 
screening tool for dry eye at BBR Optometry Ltd. i.e. scored zero, and volunteered to take part in 
the analysis. Data from normal patients who were contact lens wearers were excluded from the 





 Dry Eye Normal 
Number 102 60 
Male: Female 23: 79 28: 32 
Mean age (years) 66.21 ± 10.82 67.25 ± 12.31 
Median age (years) 67.5 69.5 
Mode age (years) 74 75 
Age range (years) 28-93 21-87 
Table 3.2: Population demographics  
 
Decision tree analysis was carried out, using the chi-squared automatic interaction detection tree 
growing method, to determine the influence of age, sex, lipid layer thickness, percentage of partial 
blinks, Meibomian gland evaluator score, fluorescein tear breakup time, Meibomian gland dropout 
and Meibomian gland duct dilation on symptomatic dry eye status. Tree growth was limited to a 
minimum of 16 cases in each parent node, eight cases in each child node and a maximum tree depth 
of eight. The tree growth levels for CHAID control the maximum number of levels of growth 
beneath the root node or in other words, the amount of tree branching levels that are allowed. By 
default, SPSS automatically sets this to a depth of three for CHAID, although it is possible for the 
eight independent variables to exert their effects at eight branching levels. In order to allow for this, 
and to avoid artificially restricting tree growth, a custom value of eight was entered. The CHAID 
default settings for minimum parent and child nodes specify a sample size of 100 for parent nodes 
and 50 for child nodes. There were only 162 cases, meaning only one level of branching would be 
possible with these settings. A rule of thumb is that the smallest node should be no smaller than 5% 
of the total sample (0.05 x 162), so the parent node was set to 16, and the child node to eight 
(Morrison-Fokken, PhD thesis 2017). 
 
For nominal dependent variables, the likelihood ratio chi-square statistic is more robust than the 
Pearson method, and is the preferred method for smaller samples (IBM, 2016). The Bonferroni 
correction to adjust significance values was not used in the detailed analysis of right eye and left 
data to avoid a type II error, and for the purposes of exploratory testing. Armstrong (2014) suggests 
that the use of the Bonferroni correction in this type of DTA, reduces the power of the statistical 
test. The Bonferroni correction was initially applied given all the independent variables were being 
tested for any significant comparisons, and the results were not going to be used as hypotheses for 
further study (Armstrong, 2014). Armstrong (2014) notes how authors comparing the results of 
correcting and not correcting significance values can potentially complicate interpretation of their 
data. Table 3.3 outlines the results of the current analysis with and without the Bonferroni correction 
applied for the right eye and left eye data. Adjusting significance values using the Bonferroni method 
led to reduced tree growth for both eyes, however, the accuracy of the model for the right eye data 
did not change at 75%, with the same order of influence for three independent variables. An 




took precedence over the independent variable sex. The two models generated for the left eye with 
and without the correction were similar in strength, having two independent variables in common.  
 
The child nodes were adjusted for results without application of the Bonferroni correction for right 
and left eye data to determine whether doing so would result in similar findings between the eyes 
(see Table 3.4). Fluorescein tear breakup time was the first and most important independent variable 
listed in all decision tree analyses, albeit with different branch splitting criteria between the eyes. 
Up until the minimum number of cases in the child node was increased in number by 15, fluorescein 
tear breakup time and Meibomian gland dropout both were independent variables included in right 
and left eye DTA. DTA (CHAID) automatically determined that Meibomian duct dilation and lipid 
layer thickness were not important predictors of symptomatic dry eye status for both right and left 
eye data. Age appeared in left eye DTA only.  
 
Data was analysed from each eye separately to avoid the problem of rejecting useful data 
(Armstrong, 2013). In some ophthalmic research where either eye could have been chosen for study, 
the eye is often self-selected on clinical grounds as the eye in which the signs and symptoms of 
disease were most evident (Armstrong, 2013). This was not possible for the dry eye subgroup due 
to the complex nature of dry eye with most patients unable to identify the most or least symptomatic 
eye. In the normal subgroup, where no dry eye was self-reported, one eye could not be selected over 
the other for analysis. It is also possible that there may be systematic differences between right and 
left eyes with a condition being more prevalent in one versus the other (Armstrong, 2013). A study 
by Yenice et al. (2006) showed a correlation between site of glaucomatous visual field defect, and 
headache involvement supporting the hypothesis that a migraine attack could impact the ipsilateral 
optic nerve supply. Therefore, if early visual field defects favour the right eye in right-sided migraine 
attacks, selecting the right eye only for analysis may provide a random sample of right eyes but 














 RE with 
Bonferroni 
correction 
RE without Bonferroni 
correction 





Number of nodes 8 14 7 11 
Number of Terminal nodes 5 9 4 7 
Depth 2 4 3 4 
Risk estimate 0.253 0.253 0.259 0.272 


















Table 3.3: DTA results for both eyes separately, with and without the Bonferroni correction applied. 
All DTA branches were statistically significant (p<0.05). RE= right eye; LE= left eye; TBUT= 
Fluorescein tear breakup time; MG DO= Meibomian Gland Dropout; MGE= Meibomian gland 
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Table 3.4: Results of right eye (RE) and left eye (LE) data without Bonferroni correction applied. 
For exploratory purposes, the child nodes were adjusted by increments of 5 to determine whether 
doing so would results in similar decision trees between the eyes. All DTA branches were 
statistically significant (p<0.05). TBUT= Fluorescein tear breakup time; MG DO= Meibomian 
Gland Dropout; MGE= Meibomian gland evaluator score; %PB= Percentage of partial blinks.  
 
The Bonferroni correction to adjust significance values was not used in the following detailed 
analysis of right eye and left eye decision trees for reasons explained previously. The right eye DTA 
will be reported on first, as this was the strongest model and had the greatest number of nodes and 
terminal nodes. The Model summary table seen in figure 3.1 confirms the specifications selected, 
and summarises the results of the DTA by the CHAID method. It was noted that five of the eight 
independent variables were included, and this is what is meant by data reduction in DTA. DTA 




dilation were not important predictors of dry eye status. The depth of the resulting tree (four) was 
less than what was allowed for (eight), so decision tree growth was not artificially restricted.  
 
 
Figure 3.1: Model summary for right eye DTA by the CHAID method 
 
Figure 3.2 shows the DTA for right eye data. Fluorescein tear breakup time was the most important 
predictor of dry eye status: Chi-square (2, n = 162) = 28.65, p < 0.001. The other predictors of dry 
eye status in order of importance included: 
• Meibomian gland dropout: Chi-square (1, n = 118) = 12.02, p < 0.05 
• Meibomian gland evaluator score: Chi-square (2, n = 85) = 12.19, p < 0.05  
• Percentage of partial blinks: Chi-square (2, n = 59) = 10.18, p < 0.05 










The independent variables age, lipid layer thickness and Meibomian gland duct dilation did not show 
a statistically significant influence. The decision tree classified 75% of the subjects correctly, and 
had 9 terminal nodes: 
• The first (9.3% of the sample) included those with a fluorescein tear breakup time greater 
than 12 seconds and showed 87% of subjects were from the normal subgroup.  
• The second (20.4% of the sample) included those with a fluorescein tear breakup time less 
than or equal to 9 seconds, no Meibomian gland dropout, and showed a similar proportion 
of dry eye and normal subjects (51.5% and 48.5% respectively).  
• The third (10.5% of the sample) included those with a fluorescein tear breakup time between 
9 and 12 seconds who were women, and showed a slightly greater proportion of dry eye 
subjects (58.8%).  
• The fourth (7.4% of the sample) included those with a fluorescein tear breakup time between 
9 and 12 seconds who were men, and showed a greater proportion of normal subjects (83%). 
• The fifth (6.8% of the sample) included those with a fluorescein tear breakup time less than 
or equal to 9 seconds, had some degree of Meibomian gland dropout, and a total Meibomian 
gland evaluator score less than or equal to one, and showed a greater proportion of dry eye 
subjects (64%). 
• The sixth (9.3% of the sample), included those with a fluorescein tear breakup time less than 
or equal to 9 seconds, had some degree of Meibomian gland dropout, and a total Meibomian 
gland evaluator score greater than 9, and showed a greater proportion of dry eye subjects 
(60%). 
• The seventh (8% of the sample), included those with a fluorescein tear breakup time less 
than or equal to 9 seconds, had some degree of Meibomian gland dropout, a total Meibomian 
gland evaluator score between 1 and 9, and less than or equal to 12.5% partial blinking rate, 
and comprised 100% of dry eye subjects.  
• The eighth (11.1% of the sample), included those with a fluorescein tear breakup time less 
than or equal to 9 seconds, had some degree of Meibomian gland dropout, a total Meibomian 
gland evaluator score between 1 and 9, and a partial blinking rate of between 12.5% and 
45.5%, and showed predominately dry eye subjects (78%).   
• The ninth (17.3% of the sample), included those with a fluorescein tear breakup time less 
than or equal to 9 seconds, had some degree of Meibomian gland dropout, a total Meibomian 
gland evaluator score between 1 and 9, and a partial blinking rate greater than 45.5%, and 







It would appear that five of the nine terminal nodes are based on less than or equal to 15 observations, 
which may render the model prone to spurious observations. The Risk table provides an estimate of 
the proportion of incorrectly classified cases, and its standard error (IBM, 2016). A risk estimate 
close to zero indicates an optimum decision tree model, and can be used to compare decision tree 
models. The Classification table shows the number of cases classified correctly and incorrectly for 
each category of the dependent variable, and also provides the overall percentage accuracy of the 
decision tree (IBM, 2016). The risk and classification table for the right eye DTA can be seen in 
figure 3.3, showing the model is highly sensitive (96% of dry eye subjects identified as having dry 
eye), and overall 75% accurate.  
 
 






Figure 3.3: Risk and Classification table for right eye data.  
 
The Model summary table and DTA for left eye data can be found in appendix 3.2. The left eye 
DTA considered separately is less sensitive and more specific than the right eye DTA, although 
these values do not reach above 90%.   
 
G*Power is a tool used to compute statistical power analyses. G*Power does not include sample 
size calculations for DTA, however, a rule of thumb that applies to analyses such as DTA has been 
suggested by Armstrong & Hilton (2011). It is suggested to use a minimum of five cases per 
independent variable, if there at least 100 cases. This rule indicates that the sample of 162 cases used 
in the current analyses are sufficient, as there are over 100 cases, and five cases multiplied by 8 
independent variables only requires 40 cases.  
 
Another method suggested by Dunne for sample size calculations, involves simulating duplication 
of the original sample size and re-running the DTA, maintaining all original data variations including 
the minimum number of cases in child and parent nodes, and keeping the custom maximum tree 
depth to reflect the number of independent variables to be tested (M.C.M. Dunne, personal 
communication, August 2, 2018). The process is repeated until all independent variables are 
included in the decision tree, to produce a rough estimate of the required minimum sample size for 
future studies. The pitfalls of this estimation include the risk of creating an over-fitted decision tree 
with branches having strict rules and sparse data, and it does not guarantee that a larger study on 
different cases will necessarily include all independent variables. Nevertheless, when I tried this 
method for dry eye status as a nominal dependent variable, all independent variables were included 
with a sample size of 324 for right eye data (Table 3.5). The risk estimates did improve, as indicated 




nodes reflects how the tree becomes more complicated as the sample grows. The order in which 
independent variables are included in the decision tree roughly indicates those variables most likely 




Terminal Depth Risk Independent variables included in order of influence 
162 
 
9 4 0.253 TBUT, MG DO, MGE, %PB, Sex  
324 
 
24 4 0.148 TBUT, %PB, MG DO, Sex, MG DDil, MGE, Age, LLT 
Table 3.5: Determining the minimum sample size for future studies using right eye DTA. Terminal= 
number of decision tree terminal nodes from Model Summary table; Depth= depth of decision tree 
from Model Summary table; Risk= risk estimate from Risk tables; TBUT= Fluorescein tear breakup 
time; MG DO= Meibomian Gland Dropout; MGE= Meibomian gland evaluator score; %PB= 
Percentage of partial blinks; MG Dil= Meibomian gland duct dilation; LLT= Lipid layer thickness  
 
 
3.3.2: Decision Tree Analysis to predict total OSDI score for dry eye patients 
The second objective was to apply DTA to investigate which clinical tests, if any, were predictive 
of the total OSDI questionnaire score i.e. OSDI dry eye severity amongst predominantly evaporative 
dry eye patients at BBR Optometry Ltd. DTA was carried out, using the chi-squared automatic 
interaction detection tree growing method, to determine the influence of age, sex, TearLab 
osmolarity, lipid layer thickness, percentage of partial blinks, Meibomian gland evaluator score, 
fluorescein tear breakup time, Meibomian gland dropout and Meibomian gland duct dilation on 
OSDI dry eye severity.  
 
The data from the dry eye group in the first DTA was used, and a further 19 cases excluded because 
the total OSDI questionnaire score or the additional independent variable, TearLab osmolarity, were 
not recorded. TearLab osmolarity was not a clinical test included in the collection of normative data 
in section 3.3.1, given the cost of TearLab consumables. The total OSDI questionnaire score can be 
used to classify the severity of dry eye with scores of 0-12 representing normal or non-dry eye status, 
total scores ranging from 13-22 indicating mild dry eye, total scores ranging from 23-32 indicating 
moderate dry eye, and total scores ranging from 33-100 indicating severe dry eye (Miller et al., 
2010). The distribution and population demographics of the sample are presented in table 3.6. Tree 
growth was limited to a minimum of eight cases in each parent node, four cases in each child node 
(0.05 x 83), and a maximum tree depth of nine (number of independent variables). For reasons 
explained previously, the likelihood ratio chi-square statistic was used, and the Bonferroni correction 







OSDI Classification Normal Mild Moderate Severe 
Average score 
 
8.05 ± 2.93 16.84 ± 2.42 27.48 ± 2.51 50.52 ± 15.22 
Number 
 
13 (15.7%) 22 (26.8%) 13 (15.7%) 35 (42.2%) 
Male: Female 
 
3:10 6:16 5:8 4:31 
Mean age (years) 
 
68.85 ± 10.13 63.32 ± 10.85 68.54 ± 11.40 65.31 ± 10.29 
Median age (years) 
 
70 67 71 67 
Mode age (years) 
 
66 71 66 74 
Age range (years) 
 
46-86 39-81 46-93 28-84 
Table 3.6: Population demographics for BBR Optometry Ltd. dry eye patients grouped based on 
OSDI classification where total scores ranging from 0-12 indicate normal/ non-dry eye status, total 
scores ranging from 13-22 indicate mild dry eye, total scores ranging from 23-32 indicate moderate 
dry eye, and total scores ranging from 33-100 indicate severe dry eye.  
 
The Model summary table seen in figure 3.7, confirms the specifications selected, and summarises 
the results of the DTA by the CHAID method for right eye findings. It was noted that two of the 
nine independent variables were included. DTA (CHAID) automatically determined that age, sex, 
lipid layer thickness, percentage of partial blinks, fluorescein tear breakup time, Meibomian gland 
dropout and Meibomian gland duct dilation were not important predictors of OSDI dry eye severity. 
The depth of the resulting tree (two) was less than what was allowed for (nine), so decision tree 
growth was not artificially restricted.  
 
 
Figure 3.7: Model summary for right eye DTA  
 
Figure 3.8 shows the DTA for right eye data. Meibomian gland evaluator score was the most 
important predictor of OSDI classification i.e. OSDI dry eye severity amongst BBR Optometry Ltd. 




dry eye severity amongst evaporative dry eye patients was TearLab osmolarity: Chi-square (2, n = 
16) = 10.85, p < 0.05. None of the other independent variables listed in figure 3.7 showed a 
statistically significant influence. The decision tree classified 46% of the subjects correctly, and had 
four terminal nodes: 
• The first (70% of the sample) included those with a total Meibomian gland evaluator score 
less than or equal to eight, and showed 40% of subjects were from the severe OSDI 
classification.  
• The second (10.8% of the sample) included those with a total Meibomian gland evaluator 
score greater than 11, and showed 33% of subjects were from the mild OSDI classification. 
• The third (7.2% of the sample) included those with a total Meibomian gland evaluator score 
between eight and 11, TearLab osmolarity less than or equal to 298 mOsm/L, and showed 
50% of subjects were from the moderate OSDI classification. 
• The fourth (12% of the sample) included those with a total Meibomian gland evaluator score 
between eight and 11, TearLab osmolarity greater than 298 mOsm/L, and showed 90% of 
subjects were from the severe OSDI classification. 
 
Figure 3.8: Decision tree for right eye showing which clinical tests can predict OSDI dry eye severity 





Three of the four terminal nodes are based on less than or equal to 10 observations, which may 
render the model prone to spurious observations. The risk and classification table for the right eye 
DTA can be seen in figure 3.9, showing the model is overall 46% accurate, and highly sensitive in 
predicting subjects with severe OSDI classification only. 
 
 
Figure 3.9: Risk and Classification table for right eye data.  
 
In regards to sample size calculations, and the rule of thumb applied to DTA suggested by Armstrong 
& Hilton (2011), the sample of 83 subjects used in the current analysis was not sufficient as there 
were not over 100 subjects. Using Dunne’s method to produce a rough estimate of the required 
minimum sample size for future studies, it was found that increasing the original sample size for 
right eye decision trees did not include all independent variables. The majority of independent 
variables (eight out of nine) were included when the sample size was 249 for right decision trees 
with models, showing the estimated risk of 0.169.  The model had the following independent 
variables included: Meibomian gland evaluator score, age, lipid layer thickness, Meibomian gland 
dropout and duct dilation, TearLab osmolarity, fluorescein tear breakup time, and percentage of 
partial blinks.  
 
 
3.3.3: Principal Component Analysis: Questionnaire items  
Twenty dry eye questionnaire item variables were subjected to PCA using SPSS version 24. There 
were 149 patients seen in the dry eye clinic at BBR Optometry Ltd., and 84 of these had complete 
composite scores recorded for both the SPEED (eight items) and OSDI (12 items) dry eye 
questionnaires. Nine of these subjects were excluded as they were not diagnosed as having 
predominantly dry eye, and a further 10 subjects were excluded because they were contact lens 




PCA, the adequacy of the sample size was assessed using the rule of thumb suggested by Armstrong 
and Hilton (2011), which is to use a minimum of five subjects per variable if there are at least 100 
cases. This rule indicated that the sample of 65 subjects used above was insufficient. However, PCA 
was carried out regardless for exploratory purposes, considering the view that the influence of the 
sample size reduced when principal components were found to have three or more factor loadings 
of 0.60 or higher after the PCA was conducted (Guadagnoli & Velicer, 1988; Fabrigar et al., 1999; 
MacCallum et al., 2001). The factorability of the data was also assessed prior to performing PCA 
(Pallant, 2016). Inspection of the correlation matrix showed that correlation coefficients between the 
questionnaire items did not often exceed ± 0.30 with about 33% (62/190) exceeding ± 0.30. Bartlett’s 
test of sphericity was statistically significant: chi-square (190, n = 65) = 809.30, p<0.001. The 
Kaiser-Meyer-Olkin value was above 0.60 (0.668). The PCA was carried out as two of the three 
indicators supported the factorability of the data.  
 
 Predominately Evaporative Dry Eye Subjects 
with composite SPEED & OSDI dry eye scores 
Number 65 
Male: Female 17: 48 
Mean age (years) 66.78 ± 11.65 
Median age (years) 69 
Mode age (years) 71 
Age range (years) 28-93 
Table 3.7: Population demographics  
 
Principal component analysis revealed the presence of six principal components with eigenvalues 
exceeding one, using the Kaiser’s criterion. These explained 31%, 14%, 9%, 8%, 7 %, and 5% of 
the variance respectively, a cumulative total of 74%. Inspection of the Catell’s scree test plot  (figure 
3.10) did not reveal a clear break, which could be taken as after the second component, after the 
third component or after the sixth component. Nevertheless, the six principal components were 
retained.  
 




Direct Oblimin rotation was performed to aid in the interpretation of these six components. The 
Pattern Matrix, which arises from Direct Oblimin rotation, shows the rotated factor loadings of each 
of the questionnaire items on the six extracted principal components. The Structure Matrix tables, 
which is unique to Direct Oblimin rotation, provides information about the correlation between 
questionnaire items and the principal components. The Communalities output table gives 
information about how much of the variance in each item is explained by the principal components 
with values of <0.30 indicating that an item might not fit well with the other items in its component, 
and that the analysis should be repeated without the item, especially if the purpose of the PCA was 
to improve or refine a scale. None of the items showed values <0.30, and 70% (14/20) had 
communalities >0.70, suggesting half of the variance of those items are accounted for by the 
principal component (Beavers et al., 2013). The results can be seen in table 3.8.  
 
 
Table 3.8: Pattern and Structure Matrix for PCA with Direct Oblimin Rotation of Six Factor Solution 
of SPEED & OSDI dry eye questionnaire items. Loadings with coefficients greater than ± 0.30 for 
each item are bolded.  
 
The Stevens method was used to determine the critical value for which factor loadings exceeding 
this value would be deemed significantly correlated with a principal component, i.e. Critical value 
= 5.152/√(N-2 where N = 65. Therefore, if the factor loading was >0.60, it was deemed significantly 
correlated with a principal component, and referred to as having a strong loading. Additionally, weak 
items which included those with <0.30 correlation with other factors, and variables that cross-loaded 
>0.40 onto more than one factor were not considered. Dry eye questions SPEED 2, SPEED 6, 
SPEED 8, SPEED 4 and OSDI 3 had strong loadings on principal component one, that could be 
interpreted as the frequency and severity of soreness or irritation, and fatigue symptoms. Variables 
OSDI 4, OSDI 6, OSDI 5 and OSDI 9 had strong loadings on principal component 2, that could be 




loading on principal components 3-6, so this solution was not optimal, and a simple structure did 
not arise.  
• Variables SPEED 3 and SPEED 7 regarding frequency and severity of burning or watering 
had strong loadings on principal component 3.  
• Variables OSDI 12 and OSDI 11 regarding exacerbation of ocular discomfort in areas that 
are air conditioned or in areas with low humidity had strong loadings on principal 
component 4. 
• Variables SPEED 5 and SPEED 1 regarding severity and frequency of dryness, grittiness or 
scratchiness had strong loadings on principal component 5. 
• Variable OSDI 1 regarding experiencing symptoms of eyes that are sensitive to light had a 
strong loading on principal component 6.  
 
The Component Correlation Matrix in table 3.9 shows the strength of the relationship between 
principal components (Pallant, 2016). Absolute values of less than ± 0.30 indicate that it is 
reasonable to assume both principal components are not related, which is the assumption underlying 
the use of the Varimax i.e. orthogonal rotational method. Only principal components one and five 
showed a correlation slightly above the threshold at 0.331, and it is likely the findings of the Direct 
Oblimin rotation would be similar to those of the Varimax rotation.      
 
Table 3.9: Component Correlation Matrix  
 
If one considers principal components 1-6, despite knowing that principal components 3-6 each had 
less than three loadings, then the most important dry eye questions from the OSDI and SPEED 
questionnaires would be: 
1. SPEED 2: How frequently do you experience soreness or irritation in your eyes?  
2. OSDI 4: Have you experienced blurred vision during the last week? 
3. SPEED 3: How frequently do you experience burning or watering?  
4. OSDI 12: Have your eyes felt uncomfortable in areas that are air conditioned during the 
last week? 
5. SPEED 5: How severe are your symptoms of ocular dryness, grittiness or scratchiness?  




The Likert scale options used for SPEED frequency of symptoms responses include never, 
sometimes, often and constant, and the options used for SPEED severity of symptoms responses are 
no problems, tolerable, uncomfortable, bothersome and intolerable. OSDI Likert scale options for 
experiencing symptoms of dry eye include none, some, half, most or all of the time, and questions 
regarding environmental-specific exacerbations of dry symptoms include the item “not applicable.”  
 
Otherwise, if one considers those principal components having more than three items with factor 
loadings that are >0.60, then the most important questions come from principal components 1 and 
2, which are questions SPEED 2 and OSDI 4. Re-consideration of the SPSS output for the 
Component Matrix showed the unrotated loadings of each of the items on the six components, with 
most of the items loaded at a level >0.40 on the first two components. As the default, SPSS uses the 
Kaiser criterion to retain all components with eigenvalues above one (Pallant, 2016). Very few items 
loaded on components 3-6, suggesting that a two-factor solution might be more appropriate. The 
Pattern Matrix showed three or more items with loadings greater than the critical value of 0.60 on 
principal components 1 and 2, further supporting the decision to re-run the analysis after retaining 
only two components.  
 
For the two-factor solution, only 56.6% of the variance was explained, compared with 74% 
explained by the six-factor solution. Principal component 1 contributed to 37% of the variance and 
principal component 2 contributed to 19% of the variance. After rotating the two-factor solution 
(Direct Oblimin), new matrices were generated and can be seen in figure 3.11, table 3.10 and table 
3.11. In order to arrive at the final two-factor solution, items were removed that had values less than 
0.30 in the Communalities table, and the analysis was repeated. The six question items removed 
included: SPEED 3, SPEED 7, OSDI 1, OSDI 10, OSDI 11 and OSDI 12. Most of these items 
appeared in principal components 3-6 in the six-factor solution. The final rotated two-factor solution 
revealed the presence of a simple structure with both components showing a number of strong 






                   
Figure 3.11: Output generated from SPSS including table of unrotated loadings from the Component 




Table 3.10: Pattern and Structure Matrix for PCA with Direct Oblimin Rotation of Two Factor 
Solution of SPEED & OSDI dry eye questionnaire items. Loadings with coefficients greater than ± 
0.30 for each item are bolded.  
 
 
Table 3.11: Component Correlation Matrix for the two-factor solution  
 
Dry eye questions SPEED 2, SPEED 6, OSDI 3, OSDI 2, SPEED 4, SPEED 8, SPEED 1, and 




and severity for symptoms of soreness or irritation, grittiness, fatigue, dryness or scratchiness. The 
most important question in principal component 1 was the same for both the two- and six-factor 
solution, as well as the SPEED items, but in a different order of importance. An additional SPEED 
and OSDI item appeared in the two-factor solution. The only SPEED items that were not included 
were symptoms regarding the frequency and severity of burning or watering. It was interesting that 
the order of importance followed the format of the questionnaire with questions on frequency first, 
followed by questions on the severity of the symptom experienced.  
 
Variables OSDI 6, OSDI 7, OSDI 4, OSDI 9, OSDI 8 and OSDI 5 had strong loadings on principal 
component 2 that could be interpreted as the effect of dry eye on limiting visual performance or the 
effect of dry eye on visual functioning for everyday tasks including reading, driving at night, 
watching TV, and using a computer or bank machine. The most important question in principal 
component 2 differed between the solutions with OSDI 4 in the six-factor solution, and OSDI 6 in 
the two-factor solution although both loaded strongly on component 2, and dealt with the effect of 
dry eye on quality of vision. Once again, the two-factor solution had the same items listed in different 
order of importance, and included two additional variables. Therefore, the most important dry eye 
questions from the OSDI and SPEED questionnaires considered together were: 
1. SPEED 2: How frequently do you experience soreness or irritation in your eyes? 
2. OSDI 6: Have problems with your eyes limited you in reading during the last week?  
 
There was a weak positive correlation between the two components (r = 0.253) in the two-factor 
solution, and it is reasonable to assume that both principal components were not related. Therefore, 
rotating a smaller number of components led to a more optimal solution.  
 
In a separate PCA to follow looking at all clinical tests in section 3.3.5, the “Jessica score” will be 
introduced which is the sum of questions SPEED 2 and OSDI 6 that has a minimum score of 0 and 
a maximum score of seven, with higher scores indicating subjects who experience symptoms of 
soreness or irritation more often that limits their ability to read most of the time. The distribution of 
the “Jessica score” can be seen in figure 3.12, where the average score was 3.00 ± 1.78 with a mode 





Figure 3.12: Distribution of the “Jessica Score” in a sample of predominately evaporative dry eye 
subjects presenting to BBR Optometry Ltd. 
 
 
3.3.4: Principal Component Analysis: Total questionnaire scores and clinical test items 
Principal component is based on the eigendecomposition of a cross-product matrix, and thus requires 
complete data sets without missing values (Dray & Josse, 2015). When there is incomplete data, a 
popular approach is to delete individuals, and/or variables containing missing vales prior to applying 
PCA, which can lead to an important loss of information including the detection of patterns (Dray 
& Josse, 2015). The standard PCA algorithm can be adapted so that missing vales are not considered 
in the computations. One strategy is the mean imputation method, which replaces missing values for 
each variable by the mean of the observed values. A complete data set is obtained, and can then be 
analysed by a standard PCA. The issue with this method is that the variance of the imputed variables, 
and the correlations between variables are reduced as the distribution of the data is distorted (Little 
& Rubin, 2002). The listwise exclusion method omits an entire case with missing values on any of 
the variables, and is the default setting in SPSS. In the pairwise exclusion method, the statistical 
procedure cannot include a particular variable when it has a missing value but can still use the case 
when analysing other variables with non-missing values. The pairwise exclusion method allows one 
to use more of their data, however, this strategy can cause problems with the computation of 
correlation matrices with outputs of negative eignenvalues due to statistical analyses based on a 
different subset of subjects (IBM Support, 2019). Of the 149 patients attending for a dry eye 
consultation at BBR Optometry Ltd., 21 subjects were excluded due to contact lens wear and a 
further 12 as they did not represent predominantly evaporative dry eye subjects. Therefore, a total 
of 116 subjects were used in the current PCA, although there were missing entries for some of the 
nine variables. The pairwise exclusion method was utilized, and the right and left eyes were 
considered separately.  
 
Nine clinical test variables were subjected to PCA using SPSS version 24. The population 




the adequacy of the sample size was assessed utilising the rule of thumb suggested by Armstrong 
and Hilton (2011), which is to use a minimum of five subjects per variable if there are at least 100 
subjects. This rule indicated that the sample of 116 subjects was sufficient. The factorability of the 
data was also assessed. Inspection of the correlation matrices showed that correlation coefficients 
between the clinical test items for right eye data did not often exceed ± 0.30 with about 11% (4/36) 
exceeding ± 0.30. Bartlett’s test of sphericity was statistically significant: chi-square (36, n = 116) 
= 89.17, p<0.001 for right eye data. The Kaiser-Meyer-Olkin value was less than 0.60 for right eye 
at 0.586. Only one of the three indicators supported the factorability of the data indicating that the 
sample is probably not suitable for data factor analysis. For exploratory purposes, although the 
suitability of the sample remains questionable for two criterions, factor analysis proceeded. 
 
 Predominately Evaporative Dry Eye Subjects  
 
Number 116 
Male: Female 28: 88 
Mean age (years) 66.69 ± 12.10 
Median age (years) 68 
Mode age (years) 74 
Age range (years) 26-97 
Table 3.12: Population demographics  
 
PCA revealed the presence of four principal components with eigenvalues exceeding one. These 
explained a proportion of the variance with a cumulative total of about 66%. The percentage of 
variance for each component can be seen in table 3.13. 
 
Principal Component Extraction Sums of 
squared loadings 






 Table 3.13: Percentage of variance for principal components for right eye data.  
 
Inspection of the Catell’s scree test plots did not reveal clear breaks, which could be taken at the 
fifth component for each PCA. Nevertheless, the four principal components were retained and 
oblimin rotation was performed to aid in the interpretation of these components.  
 
Table 3.14 shows the pattern coefficients, structure coefficients and communalities for each clinical 
test variable for right eye data, in relation to the four principal components. The meibography clinical 




loadings (> ±0.60) on principal component 1 that could be interpreted as measures of Meibomian 
gland structure. The variables total OSDI and total SPEED questionnaire scores had strong loadings 
on principal 2 that could be interpreted as measures of dry eye symptoms. The variables fluorescein 
tear breakup time and TearLab tear osmolarity had strong loadings on principal component 3 that 
could be interpreted as measures of tear film stability. The variable percentage of partial blinks had 
a strong loading on principal component 4 that could be interpreted as measure of dynamic eyelid 
aspects.  
 
In the PCA for right eye data, the variable average lipid layer thickness loaded strongly on 
component 4, which would make sense as it is also a dynamic measure of posterior eyelid aspects. 
The variable of total Meibomian gland evaluator score loaded on principal component 1 and 4 (1>4) 
for right eye data although both at levels less than ±0.60 indicating it as a weak item. Unfortunately, 
a simple structure did not arise.  
 
 
Table 3.14: Pattern and Structure Matrix for PCA with Direct Oblimin Rotation of Four Factor 
Solution of BBR Optometry Ltd. clinical test items for right eye data. Loadings with coefficients 
greater than ± 0.30 for each item are bolded.  
 
If only the first items from each of the components are considered, the most important clinical tests 
in order of importantce are Meibomian gland duct dilation, OSDI total score, fluorescein tear 
breakup time, and percentage of partial blinks respectively. There was a weak correlation between 
the four factors (r < ±0.30), and hence the assumption that each principal component are not related 
holds true so the findings of Oblimin rotation would be similar to those of the Varimax rotation.  
 
 
3.3.5: Principal Component Analysis: Total “Jessica score” and clinical test items 
Recall the “Jessica score” derived from the two-factor solution in 3.3.3, which is the sum of 
questions SPEED 2 and OSDI 6 that has a minimum score of zero, and a maximum score of seven 
with higher scores indicating subjects who experience symptoms of soreness or irritation more often 
that limits their ability to read most of the time. The later analysis in 3.3.4 was re-run for right eye 
data, with the total SPEED and OSDI scores replaced by the “Jessica score” for the sample presented 




SPEED scores reported.  The rule of thumb suggested by Armstrong and Hilton (2011) indicated 
that the sample of 65 subjects was insufficient. The factorability of the data was also assessed. 
Inspection of the correlation matrices showed that correlation coefficients between the clinical test 
items for right eye data did not often exceed ± 0.30 with about 18% (5/28) exceeding ± 0.30. 
Bartlett’s test of sphericity was statistically significant: chi-square (28, n = 65) = 75.20, p<0.001 for 
right eye data. The Kaiser-Meyer-Olkin value was greater than 0.60 for right eye data at 0.614. Only 
two of the three indicators supported the factorability of the data, indicating that the sample may not 
be suitable for factor analysis. For exploratory purposes, although the size and suitability of the 
sample remains questionable for one criterion, factor analysis proceeded. 
 
PCA revealed the presence of four principal components with eigenvalues exceeding one. These 
explained a similar proportion of the variance with a cumulative total of about 72%. The percentage 
(%) of variance for each component can be seen in table 3.15. 
 
Principal Component Extraction Sums of 
squared loadings 






 Table 3.15: Percentage (%) of variance for principal components for right eye data.  
 
Inspection of the Catell’s scree test plots did not reveal clear breaks, with the possibility of a first 
break at component 2 for each PCA. Nevertheless, the four principal components were retained, and 
oblimin rotation was performed to aid in the interpretation of these components.  
 
Table 3.16 shows the pattern coefficients, structure coefficients and communalities for each clinical 
test variable for right eye data, in relation to the four principal components. The meibography clinical 
test variables assessing Meibomian gland duct dilation and Meibomian gland dropout had strong 
loadings (> ±0.60) that could be interpreted as measures of Meibomian gland structure. The variable 
total “Jessica score” had a strong loading on principal 4 that could be interpreted as measure of dry 
eye symptoms. The variables fluorescein tear breakup time, and TearLab tear osmolarity had strong 
loadings on principal component 2 with right eye data that could be interpreted as measures of tear 
film stability. The variable percentage of partial blinks had a strong loading on principal component 
3 with right eye data that could be interpreted as measure of dynamic eyelid aspects. The variable 
average lipid layer thickness cross-loaded onto 2 principal components interpreted as relating to 




±0.40). The variable TearLab tear osmolarity loaded onto three principal components relating to tear 
film stability, and weakly (<±0.60) to dry eye symptoms, and Meibomian gland structure. 
Unfortunately, a simple structure did not arise.  
 
 
Table 3.16: Pattern and Structure Matrix for PCA with Direct Oblimin Rotation of Four Factor 
Solution of BBR Optometry Ltd. clinical test items including the “Jessica score” for right eye data. 
Loadings with coefficients greater than ± 0.30 for each item are bolded.  
 
If only the first items from each of the components are considered, the most important clinical tests 
or dry eye diagnostics at BBR Optometry Ltd. include Meibomian gland duct dropout, percentage 
of partial blinks, fluorescein tear breakup time, and the “Jessica score”. There was a weak correlation 
between the four factors (r < ±0.30), and hence the assumption that each principal component are 
not related holds true so the findings of Oblimin rotation would be similar to those of the Varimax 
rotation. All component matrices, Catell’s scree test plots and component correlation matrices can 




3.4.1: Decision Tree Analysis to predict symptomatic dry eye status 
Subjects were allocated to the dry eye group on the basis that they scored greater than zero on the 
SPEED questionnaire, attended for a dry eye consultation, and were attending of their own free will 
due to concerns regarding a possible dry eye condition. Subjects allocated to the normal group were 
those BBR Optometry Ltd. patients attending for an eye examination, who did not identify as having 
a dry eye problem based on their SPEED dry eye questionnaire scores. It is possible that these 
subjects had pre-symptomatic dry eye or had come to accept symptoms related to dry eye as normal 
age-related changes or associated with environmental conditions or use of cosmetics, and so did not 
identify as having a dry eye problem. 
 
The current analysis applies to predominantly evaporative dry eye subjects, and so cannot comment 
on other forms of dry eye i.e. predominantly aqueous deficient dry eye subjects. The sample is biased 
towards inclusion of evaporative dry eye subjects, and perhaps more severe cases of dry eye since 




predominantly evaporative dry eye subjects were confirmed as self-reporting more severe 
symptoms, i.e. scoring over 33 on the OSDI questionnaire, in section 3.3.3. Previous studies have 
shown that a common form of evaporative dry eye, MGD, may play a role in severe dry eye 
conditions such as Sjögren’s syndrome with these patients presenting with impaired Meibomian 
gland function when compared to non-dry eye controls although the mechanism is unclear (Kang et 
al., 2018).  
 
There were no specific criteria used for the diagnosis of predominately evaporative dry eye, and 
subjects were classified as such retrospectively based on notes of plugging of the Meibomian gland 
orifices, turbid Meibomian gland secretions, the presence of telangiectasia on the posterior eyelid 
margin, and recommendations for lid hygiene, warm compresses and lid hygiene according to the 
DEWS II staged management and treatment recommendations for dry eye (Jones et al., 2017). 
Previous studies have used cut-off values for questionnaire results such as OSDI ³13 or 20 to define 
a dry eye sample or simply stated that a subjective evaluation of dry eye symptoms or a clinical 
diagnosis of dry eye was made without specifying a sub-classification or inclusion criteria (Ngo et 
al., 2013; Asiedu, 2017; Simpson et al., 2008; Stapleton et al., 2017). The current analysis involved 
a clinical sample, and no active recruitment of subjects meeting set inclusion criteria. The same 
practitioner (the author) carried out the dry eye consultations, and collected data for the normal 
group. Therefore, knowledge of the patient symptoms assessed prior to clinical testing may have 
biased the practitioner when performing dry eye tests to expect either more or less severe test 
outcomes. However, given the nature of the current analyses where patients are privately funding 
dry eye consultations, a masked examiner would not be feasible as a practitioner requires all 
information on signs and symptoms in order to make decisions on clinical management. No subjects 
with Steven-Johnson syndrome, vitamin A deficiency, rheumatoid arthritis, Wegener 
granulomatosis, sarcoidosis, leukaemia, Riley-Day syndrome, systemic lupus erythematosus or 
Sjögren’s syndrome were included in any of the analyses in order to report on predominately 
evaporative dry eye as other studies have done (Ngo et al., 2013).  
 
Previous studies have established that ocular symptoms are much more frequent in soft contact lens 
wearers than in noncontact lens wearers, and a different aetiology for dry eye amongst these groups 
has been suggested (Guillon & Maissa, 2005b; McMonnies & Ho, 1986; Vajdic et al., 1999). The 
two terms for dryness related to contact lens wear are contact lens induced dry eye (CLIDE) whereby 
signs and symptoms of dry eye did not exist before contact lens wear, and contact lens associated 
dry eye (CLADE) where pre-exisitng dry eye cannot be discounted (Gomes et al., 2017). There are 
reported discrepancies with the association between contact lens wear and MGD, perhaps due to 
limitations in methodology, small sample sizes, and lack of information on contact lens replacement 




Machalinska et al., 2015; Arita et al., 2009). However, structural changes including meibomian 
gland duct shortening has been detected in contact lens wearers with symptoms related to dry eye 
(Arita et al., 2009). Therefore, contact lens wearers were excluded from the analysis. The potential 
relationship between dry eye and discontinuation of contact lens wear is discussed in chapter five.  
 
Fluorescein tear breakup time was the consistent, most important discriminator for dry eye status 
(RE DTA: ≤ 9, 9-12 and >12). Tear breakup results when evaporation due to external factors, such 
as a dry or windy environment leads to a lowering of the ocular surface temperature, and an increase 
in cation and protein concentration (Mori et al., 1997). These changes are detected by temperature-
sensitive and chemical receptors on the cornea, which stimulate a blink to reform the tear film 
(Belmonte et al., 2004b; Caterina, 2007; Lee & Caterina, 2005; Schepers & Ringkamp, 2009; 
Lawrenson et al., 2005). As expected, there were a larger number of normal subjects when 
fluorescein tear breakup time was at its greatest level, and a small number of subjects with dry eye 
in these nodes. Ngo et al. (2013) noted that fluorescein tear breakup time was not statistically 
different between symptomatic (OSDI ³13) and asymptomatic groups. However, in the 
asymptomatic group, there was large variation observed in measured fluorescein tear break up time, 
as well as in conjunctival staining with fluorescein and lissamine green, and in measures of tear 
volume with Schirmer’s strips (Ngo et al., 2013). The DEWS II methodology subcommittee have 
identified tear breakup time as a critical diagnostic test for dry eye diagnosis, although non-invasive 
methods versus use of fluorescein if available are recommended with a value of <10 seconds taken 
to be a positive marker for loss of homeostasis (Wolffsohn et al., 2017). Fluorescein tear breakup 
time measurements followed tear osmolarity testing for dry eye patients considering the invasive 
nature of applying fluorescein to the tear film. Ideally, three objective measurements of tear breakup 
would be taken non-invasively with the median value recorded using an automated algorithm. 
Positive tests for dry have found to be as low as 2.7 seconds, though cut off values of up to 10 
seconds have been found subjectively (Hong et al., 2013; Mengher et al., 1985b).  
 
Meibomian gland dropout was the second most important discriminator for right eye DTA (RE 
DTA: ≤ normal, > normal). Anatomically, the Meibomian glands are modified sebaceous glands 
embedded in the tarsal plate of the eyelids that are regulated neurally, and hormonally to secrete a 
mixture of various polar and nonpolar lipids, phospholipids, sterol esters, wax esters, and cholesterol 
(Blackie et al., 2010). Histopathological evidence from animals and humans suggest that MGD is 
characterized by hyperkeratinisation of the Meibomian gland duct epithelium, resulting in narrowing 
of ducts and obstruction of individual glands due to the sloughing of keratinized cells into the ducts 
(Blackie et al., 2010). Other changes that can result from stagnation of the Meibomian glands include 




(Tomlinson et al., 2011; Baudouin et al., 2016; Knop et al., 2011; Korb & Henriquez, 1980; Blackie 
et al., 2010). Meibography allows imaging of the silhouette of the Meibomian gland structure. It has 
been suggested that meibography should be interpreted in the context of other clinical parameters, 
rather than a standalone indicator for the diagnosis of MGD (Pult & Riede-Pult, 2012; Arita et al., 
2009; Finis et al., 2015; Lemp et al., 2012). A positive correlation between tear fluid secretion and 
area of severe Meibomian gland atrophy has been shown, and thought to be part of a compensatory 
mechanism in patients with MGD (Arita et al., 2015). Structural changes to the Meibomian glands 
are less marked in those with aqueous deficient dry eye than evaporative dry eye, according to 
studies utilising meibography (Arita et al., 2015; Arita et al., 2010).  
 
Total Meibomian gland evaluator score was the third most important predictor for dry eye status for 
right eye DTA (RE DTA: ≤ 1, 1-9, > 9). The three discriminators in the DTA reflect how both 
structural and functional changes to the Meibomian glands can predict evaporative dry eye status, 
and how the model is good at identifying more advanced cases of dry eye. A cross-sectional study 
of 538 meibomian gland dysfunction patients and 21 healthy controls in a Norwegian cohort 
conducted by Adil et al. (2018) found the mean dropout meibogrades, similar to the scale used in 
the current analysis, were significantly higher in the patients with meibomian gland dysfunction, 
and the sensitivity and specificity of the meibograde as a diagnostic metric using a cut-off value of 
0.50 was 96.7% and 85% respectively. Interestingly, symptoms qualified using the OSDI score did 
not correlate with the measure of Meibomian gland morphology (Adil et al., 2018). Other studies 
have also shown inconsistent results when exploring the relationship between Meibomian gland 
structural changes, and clinical tests for dry eye (Pult & Riede-Pult, 2012; Feng et al., 2014; Arita 
et al., 2009; Cuevas et al., 2012; Jie et al., 2009; Srinivasan et al., 2012).  
 
Interestingly, there was a similar proportion of normal and dry eye subjects in right eye DTA when 
there was a reduced fluorescein tear breakup time, and no Meibomian gland dropout (node 4). 
Similarly, there was an even number of dry eye and normal subjects for those with a reduced 
fluorescein tear breakup time, less than or equal to 74 years old, had a reduced number of functional 
Meibomian glands, and no or mild Meibomian gland dropout (node 9). Perhaps where there is tear 
film instability, and mild or no structural changes to the Meibomian glands, there is an individual 
threshold for dry eye status or dry eye symptoms. Nonobvious Meibomian gland dysfunction 
describes the precursor to obstructive Meibomian gland dysfunction that may be present with 
minimal or absent signs of inflammation and pathology, and can be detected with physical 
expression of the Meibomian glands and reports of excess blinking to maintain clear vision (Blackie 
et al., 2010). Symptoms are not usually present in milder forms of evaporative dry eye or Meibomian 




temperature of the environment, prolonged use of computers or contact lens use (Foulks & Bron, 
2003; Borchman et al., 2009; Fenga et al., 2008; Henriquez & Korb, 1981).   
 
DTA (CHAID) automatically determined that Meibomian duct dilation and lipid layer thickness 
were not important predictors of symptomatic dry eye status, which was unexpected. The lipid layer 
formed by the secretion of the Meibomian glands has many known functions including: 
• Reducing the loss of tears from evaporation (Mishima & Maurice, 1961) 
• Stabilising the aqueous component of the tear film (Holly, 1985) 
• Reducing the surface tension of tears by drawing water into the tear film (Lemp et al., 1970) 
• Thickening the aqueous component of the tears, providing a smooth optical surface (Bron 
& Tiffany, 2004) 
• Preventing the overflow of tears, maceration of the skin at the eyelid margin, and 
contamination by sebaceous gland secretions from facial skin (Blackie et al., 2010) 
 
A reduction in the tear film lipid layer thickness measured with LipiView interferometer has been 
associated with upper and lower eyelid Meibomian gland atrophy leading to a shorter tear breakup 
time, and with increased friction during the action of a blink (Eom et al., 2013; Tung et al., 2014). 
Infrared spectroscopic studies suggest that stiffer, more ordered viscous meibum lipid arrangements 
in meibomian gland dysfunction are unlikely to spread on the tear film, and impede meibum flow 
with less lipid on the lid margin leading to increased tear evaporation (Borchman et al., 2011). A 
small study using lipid absorbent Sebutape to collect meibum has suggested that the amount of lipid 
on the lid margin may not affect tear stability because there is 17 times more pooled lipid than is 
required to cover the ocular surface even with MGD (Ashraf et al., 2011). A cross-sectional study 
of 139 patients with evaporative dry eye classified as having obstructive or non-obstructive 
Meibomian gland dysfunction, determined that lipid layer thickness measurements and tear 
meniscus height measurements could be useful in the differential diagnosis of these subtypes (Sang 
et al., 2018). A classification of obstructive Meibomian gland dysfunction was made in the presence 
of altered gland secretion, and changes in lid morphology including plugging of the orifices and 
poor meibum expression by digital pressure application as per the universally accepted diagnostic 
criteria proposed by the International Workshop on Meibomian gland dysfunction (Sang et al., 2018; 
Tomlinson et al., 2011). Although there was no assessment of healthy controls, the authors proposed 
the hypothesis that non-obstructive or nonobvious Meibomian gland dysfunction may be due to a 
hyposecretory mechanism that does not involve inflammation, given that fewer expressing glands 
was associated with a thinner lipid layer thickness (Sang et al., 2018). Higher median lipid layer 
thickness values were found in patients with obstructive Meibomian gland dysfunction as reported 




suggesting tear film evaporation may not necessarily be correlated with lipid layer thickness (Sang 
et al., 2018). It has been postulated that bacterial lipolytic exoenzymes produced by commensal 
bacteria in patients with Meibomian gland dysfunction can alter the composition of normal lipid 
components, and induce eyelid and ocular surface inflammation, ultimately affecting the lipid layer 
thickness (Sang et al., 2018). 
 
The interpretation of epidemiological study results is complicated by the absence of a validated 
combination of clinical tests to confirm a diagnosis of dry eye and its subtypes, and previously a 
lack of standardized or agreed definitions (Stapleton et al., 2017). A meta-analysis by Stapleton et 
al. (2017) found that the prevalence of dry eye disease including MGD increases with age from aged 
50, and more markedly beyond the age of 80 with signs showing a greater increase per decade than 
symptoms. There are also studies that do not show a significant association between age and dry eye 
disease, which is not the major reported finding (Tong et al., 2009; Han et al., 2011; Tan et al., 2015; 
Schein et al., 1997; Lin et al., 2003). The authors of the DEWS II Epidemiology report also 
acknowledge the limited number of prevalence studies in younger populations (Stapleton et al., 
2017). There may be overlap between normal and dry eye subjects with studies showing an 
association between older age, and an increase in positive signs of dry eye, such as low tear 
production or tear instability indicated by a tear break up time ≤10 seconds in a normal population 
(Lu et al., 2008; Guo et al., 2010; Uchino et al., 2006; Ozdemir & Temizdemir, 2010; Cho & Brown, 
1993). Studies have shown age-related differences with a decline in the number of Meibomian 
glands after the age of 30 (Artia et al., 2008), as well as Meibomian gland expressibility by about 
half at 80 years old (Mathers & Lane, 1998; Norn, 1987). Other age-related changes to Meibomian 
gland and lid anatomy that tend to increase in those over 50 years old include lid margin vascularity, 
keratinization, and telangiectasia (Den et al., 2006; Hykin & Bron, 1992). Tear osmolarity and 
meibum opacity are other variables that have been shown to increase with age (Mather et al., 1996; 
Mathers & Lane, 1998). The pathological threshold for changes in tear instability and production 
with age is not established, although the DEWS II diagnostic subcommittee consider ± two standard 
deviations from the mean value as the cut-off value for accepted tests (Stapleton et al., 2017). 
Prevalence rates by sex seem to become significant only with age, with women more likely to be 
impacted by dry eye than men (Stapleton et al., 2017).  
 
There was higher proportion of women than men seen for dry eye consultations at BBR Optometry 
Ltd. Although some studies have shown otherwise (Tong et al., 2009; Guo et al., 2010; Tan et al., 
2015; Onwubiko et al., 2014; Pouyeh et al., 2012), female sex has been consistently associated with 
dry eye disease (Uchino et al., 2011; Ahn et al., 2014; Um et al., 2014; Moss et al., 2008; Jie et al., 
2009; Han et al., 2011; Viso et al., 2009; Hashemi et al., 2014; Malet et al., 2014; Paulsen et al., 




2012; Basak et al., 2012; Li et al., 2015). Numerous sex-related differences in the anatomy, 
physiology, and pathophysiology of structures in the eye have been identified with the variation 
attributed to the effects of sex steroids, hypothalamic-pituitary hormones, glucocorticoids, insulin, 
insulin-like growth factor 1, thyroid hormones, sex chromosome complement, sex-specific 
autosomal factors and epigenetics (Sullivan et al., 2017). In a cross-sectional study involving 3824 
British female twins from the TwinsUK cohort, there was a peak increase in dry eye prevalence in 
the 40 to 50-year-old group (Vehof et al., 2014). Important risk factors for dry eye disease in this 
group were identified as immune-mediated disease, ocular surgery history and chronic pain 
syndromes, such as irritable bowel syndrome and fibromyalgia (Vehof et al., 2014). It is 
hypothesized that chronic pain in dry eye disease may be due to neuropathic pain, and sex-
differences may be due to different underlying biological mechanisms (Sullivan et al., 2017). The 
impact of sex on dry eye status is uncertain for Meibomian gland dysfunction (Stapleton et al., 2017). 
In the current analysis, 77% of patients within the dry eye group were female, and 53% of subjects 
within the normal group were female. The right eye decision tree branches from having a fluorescein 
tear breakup time between 9 and 12 seconds based on sex to two terminal nodes, with subjects more 
likely to have dry eye if they were female (node 6, n=17), and less likely if they were male (node 7, 
n=12).  
 
In addition to sex, defined as distinguishing a person based on their biological characteristics, gender 
which is rooted in biology but shaped by socially constructed characteristics can also affect dry eye 
disease risk and presentation of the disease (Sullivan et al., 2017). A cross-sectional study of 755 
patients from a tertiary dry eye clinic found significantly higher symptom scores in women 
compared to men with similar severity levels in clinical signs, similar to results of a previous study 
(Vehof et al., 2018; Schaumberg et al., 2013). Vehof et al. (2018) also found lower correlation 
between symptoms and signs in women. Some studies have shown increased ocular surface 
sensitivity in women compared to men (Golebiowski et al., 2008; Golbiowski et al., 2012; du Toit 
et al., 2001; Acosta et al., 2006; Teson et al., 2012), which may explain the findings of Vehof et al. 
(2018) and others that do not find any sex differences (De Paiva & Pflugfelder, 2004; Bourcier et 
al., 2005). Future work is required to determine the role of corneal and conjunctival sensitivity in 
the symptoms of dry eye disease, and possible sex-differences. Sex-related differences have been 
found in reported impact of dry eye disease on visual quality indicators, and visual activities with 
women reporting greater levels of impact and women also more likely to report greater feelings of 
depression than men (Schaumberg et al., 2003). Depression is a risk factor for dry eye, and a 
comorbidity of which women are more at risk, with non-ocular studies suggesting depression can 
lead to increased pain (Fillingim et al., 2009). Another explanation for observed increased symptoms 
in women might be that as part of the feminine gender role, women are more likely to report pain 




Branching in the right eye decision tree following findings of TBUT ≤ 9 seconds, some degree of 
Meibomian gland dropout, and a total Meibomian gland evaluator score ranging from one to nine 
was based on percentage of partial blinks in a way that was not expected (three-ways). Node 11 
(n=13) representing subjects where there was ≤12.5% of partial blinking, and node 13 (n=28) 
representing subjects where there was >45.45% of partial blinking, show 100% of subjects were 
identified as dry eye. However, both nodes represent opposite sides of the spectrum with a partial 
blinking rate of 40% or greater indicating blinking exercises may be encouraged, and related to 
evaporative dry eye. Node 12 (n=18) representing subjects where there was between 12.5% and 
45.45% of partial blinking showed the subjects were predominately dry eye (78%). Therefore, the 
percentage of partial blinks does not seem to be a great discriminator for dry eye status, but perhaps 
represents an artefact from the CHAID algorithm. Of note, were the 22% or four subjects identified 
as normal in node 12, perhaps due to the small sample numbers or showing how although dry eye 
symptoms may not be present, there is a possibility that signs of dry eye disease could be present.  
 
Based on the stronger model (RE DTA), the selection of clinical tests available at BBR Optometry 
Ltd. that are potentially predictive of predominately evaporative dry eye in order of importance 
include: fluorescein tear breakup time especially if it is ≤ to 9 seconds, there is some degree of 
Meibomian gland dropout, and a total Meibomian gland evaluator score that is between 1 and 9.  
Sex may also be a predictive factor for dry eye status if the fluorescein tear breakup time is between 
9 and 12 seconds, with women more likely to be affected with dry eye.  
 
 
3.4.2: Decision Tree Analysis to predict total OSDI score for dry eye patients 
Therapy for dry eye is based upon disease severity according to the staged management algorithm 
proposed by members of the DEWS II Management and Therapy Subcommittee (Jones et al., 2017). 
DTA was applied to determine which clinical tests were predictive of OSDI dry eye severity amongst 
patients with predominately evaporative dry eye. It would appear that three of the four terminal 
nodes in the right eye DTA were based on less than or equal to 10 observations, which may render 
the entire model prone to spurious observations. The model is also under 50% accurate, and highly 
sensitive for severe OSDI classifications. Overall, the weak model would suggest that the total 
Meibomian gland evaluator score (value ≤ eight) or functionality of the Meibomian glands is a 
predictive factor for predominately evaporative dry eye sufferers identifying as having severe 
symptoms based on the OSDI questionnaire classification. However, the sample size was not 
sufficient to draw conclusions. The full set of data collected could not be used in DTA due to missing 
values, which can be a problem with data collection in a busy clinical setting, especially when data 
is analysed retrospectively. Some questionnaires were not completed in full, and there were few rare 




of the dry eye consultation. Considering the same data set was used, albeit with slightly more 
subjects, the model generated in 3.3.2 may only apply when considering severe dry eye subjects.  
 
There are several external factors that can impact the tear film and risks for dry eye, hence prior to 
attending for a dry eye consultation at BBR Optometry Ltd., patients are advised to: 
• Cease use of any drops or ointment for at least 24 hours or at least four hours prior to the 
appointment if there is use of hypotensive drops.  
• Avoid use of oil-based facial cosmetics around the eye on the day of assessment. 
• Not swim in a chlorinated pool for at least 12 hours prior to the appointment. 
• Bring a list of current medication. 
• Bring in a list of products used to manage dry eye or the actual products used at present. 
 
It is interesting to find that 16% of patients using BBR Optometry Ltd.’s services for dry eye 
concerns, and who were offered management options for evaporative dry eye, scored normal in the 
OSDI classification. Overall there were more severe OSDI classifications (42%) than mild 
classifications (27%), followed by a similar proportion of normal and moderate subjects reflecting 
the patient’s perception of their dry eye status or symptom severity.  The average age was 65.84 ± 
10.80 with a similar age distribution across all OSDI classifications, and there more females than 
males (65:18).  
 
Meibomian gland evaluator score was the most important variable for right eye DTA in predicting 
dry eye severity amongst predominately evaporative dry eye patients. The Meibomian gland 
evaluator score was also consistently listed as the most important independent variable for right eye 
DTA when using Dunne’s suggested method to produce a rough estimate of the required minimum 
sample size for future studies. Previously for right eye DTA, Meibomian gland evaluator score was 
also an important independent variable (third most important) in predicting dry eye symptom status 
with different discriminating values of ≤1, 1-9 or >9. The first terminal node (node 1) in the current 
analysis comprised of predominately severe OSDI classifications (40%) when the Meibomian gland 
evaluator score was ≤8, followed by mild subjects, and then moderate and normal subjects equally, 
which is not what one would expect. The discriminating values for this DTA were ≤ 8, 8-11 or > 11. 
Perhaps these odd findings are due to the small sample size.  
 
The Meibomian gland evaluator score otherwise known as the Meibomian gland yielding liquid 
secretion is a measure of Meibomian gland expressibility, which is thought to reveal information on 
the status of Meibomian gland activity and/or function (Wolffsohn, 2017). The number of 




and central regions of the lower eyelid found in subjects with a SPEED score ³10 (Korb & Blackie, 
2008). According to the DEWS II Diagnostic Methodology Subcommittee, the diagnostic value of 
Meibomian gland expressibility, and duct appearance has not yet been established in dry eye disease 
although it is recommended to be performed alongside meibography for subtype classification of 
dry eye disease (Wolffsohn et al., 2017; Tomlinson et al., 2011). In patients with severe Meibomian 
gland dysfunction, the meibum can be opaque and have a tooth-paste like consistency rather than 
being clear and easily expressed in people without Meibomian gland dysfunction (Wolffsohn, 2017). 
Variation in the expressibility of Meibomian glands has also been noted in a small group of normal 
young subjects, and it is thought that only a proportion of the glands are actively secreting at any 
point in time with the nasal glands being the most active followed by the central, and then the 
temporal glands (Tomlinson et al., 2011; Blackie & Korb, 2010). It has been reported that on average 
six to 10 of the Meibomian glands of the lower lid secrete liquid at any given time (Norn, 1987; 
Korb & Blackie, 2008). Previous research has shown that individual Meibomian glands require 
about two hours of recovery time to express liquid secretion after being drained of its contents, which 
can be done in eight to 20 seconds upon application of a constant force of 1 g/mm2 (Blackie & Korb, 
2009). Therefore, the replenish rate of a Meibomian gland could be a confounding variable when 
using the Meibomian gland evaluator score as a dry eye diagnostic, and the effects of touching, 
rubbing or squeezing the eyelids on total scores should be considered.  
 
It has been postulated that only the function of a proportion of the total number of glands are required 
to maintain the marginal lipid reservoirs (Blackie et al., 2010), and that a reduction in Meibomian 
gland expressivity is an indicator of dry eye disease (Pflugfelder et al., 1998). The difficulty for the 
practitioner is deciding whether a gland is not expressible for physiological reasons or for 
pathological reason, such as the presence of Meibomian gland dysfunction. A major contributor of 
Meibomian gland dysfunction pathogenesis is the hyperkeratinisation of the meibomian gland 
orifice and gland obstruction that could lead to an increase in intra-ductal pressure and duct dilation 
although a lack of meibum secretion is also an explanation for observed increase in gland thickness 
(Adil et al., 2018; Baudouin et al., 2016; Knop et al., 2011; Bron & Tiffany, 2004).  The Meibomian 
gland evaluator score is not a standalone diagnostic with current techniques, although having a 
standardized measure of controlled force and specifying the location of functional glands from the 
temporal-central-nasal sections of the lower lid introduces consistency.  
 
Additionally, the second predictor accounting for only 16 subjects with evaporative dry eye was 
TearLab tear osmolarity, which branched into two nodes from subjects having Meibomian gland 
evaluator scores between 8 and 11 with ≤298 or >298 mOsms/L as the splitting factor. A value >308 




loss in tear film homeostasis and representing ocular surface disease (Bron et al., 2014). The current 
DTA did not generate the diagnostic cut-off value of 308 although a measure of 298 mOsms/L falls 
within the range of tear osmolarity normal classification (Wilcox et al., 2017). In the third terminal 
node (node 4) with TearLab tear osmolarity ≤298 mOsms/L there were three, two and one case of 
moderate, normal and severe OSDI classifications respectively. In the fourth terminal node (node 5) 
with TearLab tear osmolarity >298 mOsms/L there were predominately severe OSDI classifications 
(90%, n=9), and one single normal OSDI classification. Tear osmolarity has been shown previously 
to be the clinical test with the highest correlation to disease severity with values of 302.2 ± 8.3 
mOsm/L, 315.0 ± 11.4 mOsm/L, and 336.4 ± 22.3 mOsm/L corresponding to a classification of 
normal, mild to moderate, and severe respectively (Sullivan et al., 2010; Willcox et al., 2017). 
 
Considering the higher tear osmolarity value of the two eyes may be more indicative of the dry eye 
disease process (Wolffsohn et al., 2017). This approach has been approved by the Food and Drug 
Administration for commercially available tests to assess treatment efficacy due to larger observable 
changes, instead of using the average or single eye values (Sullivan et al., 2012; Keech et al., 2013; 
Downie & Keller, 2015). The inter-ocular difference in tear osmolarity as an independent variable 
considering an 8 mOsms/L inter-eye difference is also thought to provide insight about the stability 
of the tear film (Lemp et al., 2011).  
 
When re-running the right eye DTA with the same CHAID settings to include tear osmolarity 
interocular difference and removing TearLab tear osmolarity as an independent variable, the same 
results for the first branching level were generated, and Meibomian gland dropout was identified as 
the second most important variable but not at a significant level (p=0.05).  Severe OSDI 
classifications dominated both terminal nodes branching from subjects with Meibomian gland 
evaluator scores between 8 and 11, but with an odd discriminant value and two-way split (≤ 0.5 and 
> 0.5). The new model was less accurate with a risk estimate of 0.566, compared to the model in 
figure 3.8, and more highly sensitive for the severe OSDI classification (94.3%). In a large cross-
sectional study, TearLab tear osmolarity was found to be significantly increased in subjects with 
Meibomian gland dysfunction compared to controls (Adil et al., 2018), which has been noted 
previously (Mather et al., 1991; Mathers et al., 1996; Gilbard et al., 1989; Baudouin et al., 2013). It 
is thought that lower tear osmolarity values in the early phase of Meibomian gland dysfunction or 
where Meibomian gland atrophy exists, might be due to a compensatory increase in tear film 
production that eventually leads to exhausted Meibomian and lacrimal glands in advanced disease, 
when an overlap between evaporative and aqueous-deficient dry eye results (Adil et al., 2018; Arita 





Considering OSDI scores and correlation with clinical tests for dry eye patients, McAlinden et al. 
(2017) found that there were weak correlations between OSDI scores and best corrected logMAR 
visual acuity, fluorescein tear breakup time, Schirmer I testing, and corneal fluorescein staining 
using Spearman’s rank correlation coefficient in a sample of 238 participants with a confirmed 
diagnosis of dry eye disease. Participants were recruited from the Eye Hospital of Wenzhou Medical 
University, and there was no differentiation in terms of the subtype of dry eye disease.  
 
 
3.4.3: Principal Component Analysis: Questionnaire items 
Questionnaires are often validated for their discriminative ability using patient groups with Sjögren’s 
Syndrome versus non- Sjögren’s Syndrome aqueous-deficient dry eye, and/or healthy controls, with 
little focus on evaporative dry eye, which is considered the most common form of dry eye 
(Wolffsohn et al., 2017). The OSDI is identified as a vision- related quality of life questionnaire, 
whilst the SPEED is a dry eye symptom questionnaire (Guillemin et al., 2012). Previous factor 
analysis to determine dimensionality of the questionnaires discussed in this chapter revealed three 
subscales interpreted as vision-related function, ocular symptoms, and environmental triggers for 
the OSDI (Schiffman et al., 2000), and three factors interpreted as dryness, burning, and 
fatigue/soreness accounting for 70.8% of variance in the data for the SPEED that was based on a 
small sample (n=50) of symptomatic dry eye and asymptomatic subjects (Ngo, 2013). There may 
be criticism for applying PCA to both SPEED and OSDI items in a single analysis, however, a high 
correlation between the two questionnaires has been shown, as well as measurement invariance 
suggesting people with a high OSDI score will also have a high SPEED score, and vice versa (Ngo, 
2013). 
 
PCA can be used to characterize the dataset, and potentially offer diagnostic direction in the context 
of evaporative dry eye. The first principal component in PCA explains the variation seen in the 
sample the most. From the initial PCA it would appear that SPEED and OSDI questions concerning 
the frequency and severity of ocular discomfort described as soreness, irritation, grittiness, fatigue, 
dryness, and scratchiness account for or explain most of the variation seen in the sample of 
predominately evaporative dry eye patients at BBR Optometry Ltd. The first component might 
explain the differences in severity classification of evaporative dry eye or more generally, the first 
component might explain the variation seen in the current sample. From the results presented in 
section 3.3.3 it is known that the majority of predominately evaporative dry eye subjects had severe 
OSDI classifications so perhaps the questions identified in principal component 1 explain the 






According to the two-factor solution, dry eye questions SPEED 2, SPEED 6, OSDI 3, OSDI 2, 
SPEED 4, SPEED 8, SPEED 1 and SPEED 5 had strong loadings on principal component 1 that 
could be interpreted as the frequency and severity for symptoms of soreness or irritation, grittiness, 
fatigue, dryness or scratchiness. Variables OSDI 6, OSDI 7, OSDI 4, OSDI 9, OSDI 8 and OSDI 5 
had strong loadings on principal component 2 that could be interpreted as the effect of dry eye on 
limiting visual performance or the effect of dry eye on visual functioning for everyday tasks 
including reading, driving at night, watching TV and using a computer or bank machine. The most 
important dry eye questions from the OSDI and SPEED questionnaires considered together were: 
1. SPEED 2: How frequently do you experience soreness or irritation in your eyes? 
2. OSDI 6: Have problems with your eyes limited you in reading during the last week?  
 
Nichols et al. (2004b) found that the most commonly reported symptom of dryness amongst dry eye 
patients was dryness followed by ocular fatigue, grittiness, redness and soreness, which is in 
agreement with other studies (Nichols et al., 1999; Shimmura et al., 1999; Toda et al., 1993; Begley 
et al., 2001). Prior to generating this optimal two-factor solution, six items were removed from the 
analysis because the communalities table showed these items had values <0.30 indicating that they 
might not fit well with the other items in its component. The six questions removed included: SPEED 
3, SPEED 7, OSDI 1, OSDI 10, OSDI 11 and OSDI 12. The SPEED question items are regarding 
the frequency and severity of symptoms of burning or watering. The OSDI question items relate to 
whether one experiences eyes that are sensitive to light or to possible environmental triggers for 
uncomfortable eyes such as windy conditions, areas with low humidity that are very dry, and areas 
that are air conditioned. An online survey sent to 400 eye health care professionals including 
ophthalmologists, corneal specialists, and optometrists in North Carolina was used to assess the 
perceptions of dry eye management in clinical practice and with a 25% response rate, reported 
burning was the most frequent symptom described by patients followed by foreign body sensation, 
and tearing (Williamson et al., 2014). The SPEED questionnaire asks about burning whilst this 
frequently reported symptom is not asked about in the OSDI, and was not deemed an important 
questionnaire item in the current analysis. Respondents to the survey (Williamson et al., 2014) were 
found to be more likely to use patient history to guide their clinical decisions rather than objective 
signs, which has also been reported elsewhere (Korb, 2000; Nichols et al., 2000). 
 
The sample size of 65 was insufficient according to the rule of thumb suggested by Armstrong and 
Hilton (2011) previously, however, it has been noted that the influence of the sample size reduces 
when principal components are found to have three of more factor loadings of 0.60 or higher after 
the PCA is conducted, which was reported in the current analysis. According to the two-factor simple 
and optimal solution, there were more SPEED questions in the first principal than OSDI items, and 




Frequently reported symptoms of dry eye such as grittiness and burning are nonspecific to dry eye, 
and share commonalities with a range of other ocular conditions. The DEWS II Diagnostic 
methodology subcommittee recommends the use of eight triaging questions seen in table 3.17 to aid 
in the differential diagnosis of dry eye, considering signs and symptoms of other conditions can 
mimic dry eye disease (Wolffsohn et al., 2017). 
 
How severe is the eye discomfort? Unless severe, dry eye patients with signs of irritation such 
as dryness and grittiness rather than ‘pain.’ If pain is present, 
investigate for signs of trauma/ infection/ ulceration. 
 
Do you have any mouth dryness or 
enlarged glands? 
 
Trigger for Sjögren’s syndrome investigation  
How long have your symptoms 
lasted and was there any triggering 
event? 
Dry eye is a chronic condition, present from morning to 
evening but generally worse at the end of the day, so if 
sudden onset or linked with an event, examine for trauma/ 
ulceration/ infection. 
 
Is your vision affected and does it 
clear on blinking? 
Vision is generally impaired prolonged staring, but should 
largely recover after a blink; a reduction in vision which 
does not improve with blinking, particularly with sudden 
onset, requires an urgent ophthalmic examination.  
 
Are the symptoms or any redness 
much worse in one eye than the 
other? 
Dry eye is generally a bilateral condition, so if symptoms or 
redness are much greater in one eye than the other, detailed 
eye examination is required to exclude trauma and infection. 
 
Do the eyes itch, are they swollen, 
crusty or have they given off any 
discharge? 
 
Itching is usually associated with allergies while a 
mucopurulent discharge is associated with ocular infection. 
 
Do you wear contact lenses? Contact lenses can induce dry eye signs and symptoms and 
appropriate management strategies should be employed by 
the contact lens prescriber.  
 
Have you been diagnosed with any 
general health conditions 
(including recent respiratory 
infections) or are you taking any 
medications? 
 
Patients should be advised to mention their symptoms to the 
health professionals managing their condition, as modified 
treatment may minimise or alleviate their dry eye.  
 
Table 3.17: Initial triaging questions for the differential diagnosis of dry eye disease recommended 
by the DEWS II Diagnostic methodology subcommittee (Wolffsohn et al., 2017). 
 
 
3.4.4: Principal Component Analysis: Total questionnaire scores and clinical test items 
Only one of the three indicators supported the factorability of the data, indicating that the sample is 
probably not suitable for data factor analysis. For exploratory purposes, although the suitability of 




clinical test variables assessing Meibomian gland duct dilation and Meibomian gland dropout had 
strong loadings (>0.60) on principal component 1 that could be interpreted as measures of 
Meibomian gland structure. The variables total OSDI and total SPEED questionnaire scores had 
strong loadings on principal 2 that could be interpreted as measures of dry eye symptoms. The 
variables fluorescein tear breakup time and TearLab tear osmolarity had strong loadings on principal 
component 3 that could be interpreted as measures of tear film stability. The variable percentage of 
partial blinks had a strong loading on principal component 4 that could be interpreted as measure of 
dynamic eyelid aspects.  
 
The variables fluorescein tear breakup time and tear osmolarity had strong loadings on principal 
component 3 for right eye data that could be interpreted as measures of tear film stability. A cross-
sectional study of non- contact lens wearers and soft contact lens wearers recruited from an 
American university campus with a mean age of 28, found there were no clinically significant 
relationships between TearLab tear osmolarity and fluorescein tear breakup time, non-invasive tear 
breakup time or dry eye symptoms (Yeh et al., 2015). Perhaps these tests are assessing different 
aspects of tear film stability. Yeh et al. (2015) comment that the osmolarity of tears collected at the 
tear meniscus may not be the same as localized areas of evaporation on the exposed regions of the 
cornea. It is also important to consider that measurements in the current analyses were collected at 
only one point in time at the dry eye consultation, and may not reflect fluctuations.  
 
Percentage of partial blinks was an important test in right eye DTA with three cut-off categories of 
≤12.5%, 12.5%-45.5%, and >45.5% although it was not a good discriminator for dry eye status with 
only four normal subjects found in the second category. Percentage of partial blinks was found in 
the fourth principal component for right eye data PCA on clinical tests, interpreted as measures of 
dynamic eyelid aspects, and responsible for a proportion of observed variability amongst 
evaporative dry eye patients at BBR Optometry Ltd. According to the DEWS II Diagnostic 
Methodology Subcommittee, the appropriate diagnostic cut-off values or threshold as well as 
sensitivity and specificity figures for incomplete blinking still require investigation (Wolffsohn et 
al., 2017). The variable average lipid layer thickness also loaded onto the fourth principal component 
perhaps justifying the use of the LipiView II diagnostic for dry eye consultations at BBR Optometry 
Ltd., which measures both lipid layer thickness and partial blinking. Incomplete blinking has been 
suggested as a predisposing factor towards the development of evaporative dry eye, given it has been 
shown to relate to Meibomian gland morphology and lipid layer thickness (Craig et al., 2016; Wang 
et al., 2018).  
 
An age, gender and ethnicity-matched cross-sectional study by Wang et al. (2018), found incomplete 




greater levels of Meibomian gland dropout, and poorer tear film lipid layer thickness were found in 
participants exhibiting incomplete blinking (Wang et al., 2018). The 154 participants in the study 
conducted at the University of Auckland clinic were not informed about the blink assessment during 
the initial consenting process, and the presence of incomplete blinking was determined by slow 
motion playback of a 2-minute infra-red video recording using the Keratograph 5 M (Oculus, 
Germany) or by clinical observation during history-taking (Wang et al., 2018). The percentage of 
partial blinks has also been correlated to symptoms, and lid parallel conjunctival folds (Berry et al., 
2008; Pult et al., 2013). 
 
In the literature, there is a wide range for the percentage of incomplete blinks in a population of 
healthy, non- dry eye individuals varying from 10% to 80%, which may be explained by differences 
in methodology (Doane, 1981; Carney & Hill, 1982; Abelson & Holly, 1977; Doane 1980; Collins 
et al., 2006). The interblink interval is variable between subjects, and can be altered by systemic 
conditions associated with Meibomian gland dysfunction such as Parkinson disease, cranial nerve 
VII palsy, and Grave’s orbitopathy (Karson et al., 1984; Shah et al., 2012; Takahashi & Kakizaki, 
2015; Wan et al., 2016; Kim et al., 2015),  and tasks involving visual concentration like computer 
work (Tsubota & Nakamori, 1993; Cardona et al., 2011; Hirota et al., 2013; Portello et al., 2013; 
Himebaugh et al., 2009; Patel et al., 1991). The time lapse between blinks can be decreased in dry 
eye disease, and can be increased with the use of artificial tears (Pult et al., 2013; McMonnies, 2007; 
Tsubota et al., 1996). Incomplete blinking is a potentially modifiable behaviour with repeated 
forceful blinking reported to increase the thickness of the tear film lipid layer (Korb et al., 1994), 
and use of blinking training such as an animation to encourage blinking in computer users has shown 
to improve dry eye symptoms (McMonnies, 2011; McMonnies, 2007; Jones et al., 2017; Nosch et 
al., 2015).  
 
For all of the factor solutions, symptoms only loaded onto one component at a level of >0.30 and so 
perhaps should be considered independently. Ngo et al. (2013) characterized the psychometric 
properties of SPEED showing it to be repeatable and valid for the measurement of dry eye 
symptoms, and found clinical measures of fluorescein and lissamine green staining of the cornea, 
and measures of Meibomian gland function including Meibomian gland score and Meibomian gland 
yielding liquid secretion score correlated significantly (p< 0.05) with SPEED scores.  
 
 
3.4.5: Principal Component Analysis: Total “Jessica score” and clinical test items 
Considering right eye datasets for the most important principal component items, the tests identified 
as the most important and responsible for the variability observed amongst predominantly 




percentage of partial blinks and assessment of dry eye symptomology with either the total OSDI 
score or total “Jessica score”. The variable total Meibomian gland evaluator score did not appear in 
the PCA including the “Jessica score” as the most important item of any principal component. 
Interestingly, all the tests to account for dry eye variability included lid and tear parameters, and 
symptoms.    
 
According to the DEWS II Diagnostic Methodology Subcommittee, after symptom screening with 
the dry eye questionnaire five (DEQ-5) or OSDI, the three recommended tests are tear breakup time 
(ideally non-invasive), tear osmolarity and ocular surface staining with fluorescein and lissamine 
green staining observing the cornea, conjunctival and eyelid margin (Wolffsohn et al., 2017). The 
next most important recommended tests are tear volume assessment with tear meniscus height 
evaluation, and assessments of lipid thickness and dynamics for Meibomian gland dysfunction to 
help distinguish between predominately evaporative and aqueous deficient dry eye, which informs 
management of the condition (Wolffsohn et al., 2017). Prior to DEWS II, the multinational 
ODISSEY European Consensus group comprising of ophthalmologists, used a consensus-based 
approach to assess 14 commonly used dry eye severity criteria, and agreed symptom-based 
assessment and corneal fluorescein staining were sufficient to diagnose severe dry eye disease 
(Baudouin et al., 2014). The group designed an algorithm to assist practitioners when there is 
discordance between the two criteria, and the presence of one out of eight criteria in addition to 
having an OSDI ≥33 and a corneal fluorescein score ≥3 on the Oxford scheme, such as tear 
osmolarity >328 mOsm/L indicates a diagnosis of severe dry eye disease (Baudouin et al., 2014). 
An example of a commercially available tool to aid practitioners with dry eye diagnosis is the 
electronic tablet app created for professionals called the “Dry Eye Tool Box” that incorporates a 
screening algorithm for dry eye, and assesses dry eye likelihood and classification, but is yet to be 
validated (Pult, 2014).  
 
Use of novel tools may be better suited to extract information in complex diseases where 
understanding the disease phenotype will help in identifying specific biomarkers, and thus new 
treatment targets. Baldini et al. (2018) compared results in discriminating different subsets of 
Primary Sjögren’s syndrome using a data mining tool based on a novel fourth generation artificial 
neural network called Auto Contractive Map (AutoCM) versus conventional PCA. Primary 
Sjögren’s syndrome is a complex chronic disorder, and there is a need to develop clear disease 
phenotypes for more effective, specific, and targeted treatments (Baldini et al., 2018). There were 
no subjects with Sjögren’s syndrome in the current analyses. In the Baldini et al. (2018) study, the 
analysis was restricted to 37 demographic, clinical and laboratory variables for a cohort of 542 
subjects. Although both analyses confirmed associations between autoantibody positivity, and 




linear relationships between variables, and not immediately evident graphical representations 
(Baldini et al., 2018). AutoCM allowed discrimination between patients with predominant glandular 
manifestations, and no or mild extra-glandular features from those with a more severe clinical 
profile, and highlighted rheumatoid factor as a risk factor associated with the development of 
mucosa-associated lymphoid tissue lymphoma of the salivary glands, besides other traditional 
lymphoproliferative risk factors (Baldini et al., 2018).  
 
Deep machine learning or a special type referred to as, deep convolutional neural networks 
optimized for images, can objectively uncover previous unknown associations between an array of 
parameters from vast datasets without the need for a clear hypothesis at the outset (Poplin et al. 
(2018). Poplin et al. (2018) showed how trained deep learning models could be applied to retinal 
fundus images to predict cardiovascular risk factors such as age, gender, smoking status, and cardiac 
health from anatomical features not previously thought to be present or quantifiable in retinal 
images. Similar application of deep learning has been able to diagnose melanoma and diabetic 
retinopathy from medical images at a level comparable to human experts (Esteva et al., 2017; 
Gulshan et al., 2016). Computer-based deep machine learning and artificial intelligence will impact 
teaching and clinical optometric practice both supporting and complimenting the optometrists with 
possible implications for dry eye management in the shift towards precision medicine, whereby 
healthcare is customised for the individual. Computer led intelligence advancements could aid in 
the screening and diagnosis of eye conditions, leaving optometrist- patient interactions focused on 
explaining conditions, prognosis and treatment options.  
 
 
3.5: Conclusion  
The reality of confirming a dry eye diagnosis, let alone management, is complex. The current 
analysis explored the possibility of identifying objectively, which combination of commercially 
available clinical tests invested in by BBR Optometry Ltd. should be included in dry eye 
consultations conducted at the private optometric practice for predicting dry eye, namely of 
evaporative aetiology. Based on the stronger model (RE DTA), the selection of clinical tests that are 
potentially predictive of predominately evaporative dry eye in order of importance include:  
• Fluorescein tear breakup time, especially if it is ≤ nine seconds and/or between nine and 12 
seconds in women. 
• Meibography to determine if there is some degree of Meibomian gland dropout. 
• Meibomian gland expressibility with a total Meibomian gland evaluator score cut-off that 





Fluorescein tear breakup time is a simple test that can be incorporated into most eye examinations, 
and is a standard test for contact lens trials and assessments at BBR Optometry Ltd. This metric 
appeared in all the DTA and PCA results as an important test, and contributor of variability amongst 
evaporative dry eye patients. The use of LipiView II to screen for dry eye, and to communicate 
management recommendations could improve efficiency within the practice from avoiding 
spectacle remakes related to unstable tear films, and fluctuating vision, to possibly improving lens 
surgery outcomes which will be investigated in chapter four. The LipiView II incorporates 
meibography for assessment of Meibomian gland dropout and duct dilation, and analyses blink 
patterns and quantifies the number of complete and partial blinks. All of these tests in addition to 
symptom assessment, appeared as important tests in DTA and PCA with questions regarding 
frequency of soreness or irritation, and the effect on visual functioning for everyday tasks, such as 




































CHAPTER 4 ABSTRACT 
Tear homeostasis and lens surgery outcomes 
 
PURPOSE: Patients considering private lens replacement surgery represent a segment of the patient 
population who may benefit from an optometric dry eye service. Lens replacement surgery can be 
postponed, with reported same day cancellations, until the ocular surface is deemed healthy in order 
to reduce the chance of infection following surgery. The aim of this chapter was to retrospectively 
explore the possible effect of dry eye on visual and clinical outcomes for patients managed at a 
private hospital. Specifically, at a hospital where optometrists from BBR Optometry Ltd. frequently 
refer patients for private lens replacement surgery. 
 
METHODS: The clinical manager generated a list of private lens replacement surgery consultations 
with operations carried out by one ophthalmologist from January 1st 2017 to April 14th 2018 who 
began requesting preoperative tear measures in 2017, namely TearLab tear osmolarity and 
fluorescein tear break-up time (TBUT). Patients were classified as having normal or abnormal tears 
based on their pre-surgery tear metrics in line with the recommended Tear Film and Ocular Surface 
Society (TFOS) Dry Eye Workshop (DEWS) II dry eye disease diagnostic test battery for 
homeostasis markers (Wolffsohn et al., 2017). If one of the operated eyes had a TBUT < 10 seconds 
and/or tear osmolarity ≥ 308 mOsm/L or interocular difference > 8 mOsm/L, the patient was 
classified as having abnormal tears. Multiple Mann-Whitney U tests were conducted to determine if 
there were differences in dependent variables between the abnormal tears and normal tears groups. 
The dependent variables were: age, spherical equivalent refraction and logMAR equivalent distance 
visual acuity (VA) before and after surgery for both eyes, and baseline fluorescein TBUT and 
TearLab tear osmolarity. 
 
RESULTS: There were no statistically significant differences in pre-operative distance VAs with 
most patients not having a distance logMAR VA worse than 0.5 (6/19), perhaps reflecting how 
patients attending the private clinic valued a spectacle or contact lens free option versus 
demonstrating a clinical need or visual impairment for cataract surgery. Visual outcomes (spherical 
equivalent refraction and logMAR equivalent distance VA) after surgery were not affected by dry 
eye status with no statistically significant difference found between the two groups. There were new 
cases of dry eye following lens surgery in the normal (42%) and abnormal (32%) tears group as 
determined by notes from the clinician conducting the pre- and post-operative assessments. 
Complications in both tear groups were infrequent. There were no cases of ocular infection post-
lens surgery for either groups. 
 
CONCLUSIONS: Although the study was inconclusive, it does show dry eye needs to be managed 
at least following anterior eye surgery, and protocols for post-operative care should involve dry eye 



















Tear homeostasis and lens surgery outcomes 
 
4.1: Introduction 
Cataract surgery is the most commonly performed operation in the National Health Service (NHS) 
with more than 400, 000 procedures undertaken annually (RCOphth, 2017). The Way Forward 
project commissioned by the Royal College of Ophthalmologists (RCOphth) predicts that the 
demand for cataract surgery will rise by 25% over the next 10 years and by 50% over the next 20 
years using the National Eye Health Epidemiological Model (NEHEM), population projections 
derived from the Office of National Statistics (ONS), and after making several assumptions 
(RCOphth, 2017). The increase in number of cataract operations performed are based on 
assumptions that diagnosis and referral will continue to take place in primary care, thresholds for 
surgical eligibility remain unchanged, and the proportion of patients wishing to proceed are stable 
(RCOphth, 2017). Refractive Lens Exchange or Clear Lens Extraction (CLE) also involves replacing 
the natural crystalline lens with an intraocular lens (IOL) but for the purpose of reducing the need 
for spectacles or contact lenses rather than to correct blur or light scatter.  
 
RCOphth guidelines on cataract surgery (2010) have been supplemented by guidance from the 
National Institute for Health and Care Excellence (NICE) for the management of cataracts in adults 
on 26 October 2017. Recommendations for on the day of cataract surgery previously included an 
external eye examination and delaying surgery if concurrent infection existed (RCOphth, 2010). 
Current guidance simply states “the eye to be operated on has been checked and clearly marked.” 
(NICE, 2017). Surgery can be postponed until the ocular surface is optimised in order to reduce the 
risk of infection. Endophthalmitis is a serious complication of cataract surgery with the patient’s 
own external microbial flora a frequent source of the infecting organism, suggesting an emphasis on 
efforts in infection control and interventions for prevention (Speaker et al, 1991). Same day 
cancellation of lens surgey due to concurrent infection is distressing for patients, and further 
increases the workload and financial burden for NHS trusts. Stead et al. (2010) determined that 
introducing a blanket policy of lid hygiene advice to all pre-operative cataract patients led to a 
significant reduction in the incidence of cancellations due to blepharitis, and an estimated saving of 
£11, 000 over a four-month period.  
 
Dry eye is not listed as a possible post-operative complication of cataract surgery in consent and 
information for patients in Appendix B but does mention how it is normal to feel mild discomfort, 
fluid discharge, itching and sticky eyelids for a non-specified period of time (“few days”) that will 
self-resolve (RCOphth, 2010). The new guidance on pre-operative assessment and biometry for 
cataract surgery does not include dry eye metrics or external examination of the lids and lashes 




patients who represent a segment of the populaiton with a higher incidence of pre-exisitng dry eye 
(Moss et al., 2004). Tear film lipid layer thickness measured using the LipiView interferometer and 
meibomian gland (MG) expressibility have shown to be reduced at one and three months post- 
cataract surgery respectively, reflecting an alteration to MG function but not structure (Kim et al., 
2018; Han et al., 2014). Reduction in tear film stability using tear breakup time (TBUT) and ocular 
surface staining measures demonstrating a worsening of dry eye signs post-operatively have been 
observed with resolution or return to pre-operative values after about three months (Cetinkaya et al., 
2015; Li et al., 2007; Cho et al., 2009; Kasetsuwan et al., 2013). The hypothesized 
pathophysiological mechanisms underlying cataract surgery-related dry eye are (Sutu et al., 2016; 
Cho & Kim, 2009; El-Harazi & Feldman, 2001; Chee et al., 1999; Oh et al., 2012; Donnenfeld et 
al., 2003; Kohlhaas, 1998; Han et al. 2014; Ipek et al., 2018): 
• Use of topical eyedrops with and without preservatives and topical anaesthetics, and 
exposure dessication 
• Possible light toxicity from the operating microscope 
• Intraoperative sterilisation of the surgical field with povidone- iodine solution  
• Transection and denervation of the corneal nerves by corneal incisions leading to 
abnormal blinkng and tear reflexes  
• Vigorous irrigation intraoperatively and damage to the corneal epithelium  
• Elevation of inflammatory factors following surgical trauma and ocular surface damage  
• Loss of goblet cell density and associated conjunctival cell squamous metaplasia  
• Meibomian Gland Dysfunction (MGD) 
 
Tear film instability can affect ocular biometry and IOL power calculation resulting in higher 
likelihood of unexpected refractive error, suboptimal refraction and patient dissatisfaction post-
operatively. Epitropoulos et al. (2015) found that subjects presenting for cataract surgery with 
“hyperosmolar” tears (≥ 316 mOsm/L in at least one eye) versus “normal” tears (≤ 308 mOsm/L in 
both eyes) had statistically significant higher variability in average keratometry measurements and 
greater proportion of eyes with a one diopter (D) or more difference in the measured anterior corneal 
astigmatism between two visits, which in turn affected IOL power calculations. The purpose of the 
current retrospective analysis was to determine whether patients with clinically observable signs of 
dry eye indicating a loss of homeostasis, had poorer early visual outcomes and more post-operative 
complications compared to patients without signs of dry eye following lens replacement surgery in 








This retrospective analysis was conducted at a private eye hospital in Solihull, UK. The clinical 
manager generated a list of private lens replacement surgery consultations with operations carried 
out by one ophthalmologist from January 1st 2017 to April 14th 2018 who began requesting pre-
operative tear measures in 2017, namely TearLab tear osmolarity and fluorescein TBUT. These 
clinical tests were described in chapter one. The age was derived from the date of birth to the date 
of analysis (May 1st 2018), and the patient records were anonymised.  There were 29 CLE and 39 
cataract surgery procedures conducted. Over half of patients (65%) were fitted with a multifocal 
intraocular implant (MF), which allow two or three separate areas in focus simultaneously and 
reduced dependency on reading spectacles post-operatively.  
 
Patients were classified as having normal or abnormal tears based on their pre-surgery tear metrics 
in line with the recommended Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop 
(DEWS) II dry eye disease diagnostic test battery for homeostasis markers (Wolffsohn et al., 2017). 
If one of the operated eyes had a TBUT < 10 seconds and/or tear osmolarity ≥ 308 mOsm/L or 
interocular difference > 8 mOsm/L, the patient was classified as having abnormal tears. Surgeries 
were performed using standard phacoemulsification or the LENSAR femtosecond laser system. The 
target refraction was not consistently documented and assumptions of plano (0 D) to achieve 
emmetropia were not made. This study received approval from the Life and Health Sciences Ethics 
Committee at Aston University (Project #1276) and adhered to the tenets of the Declaration of 
Helsinki. Analyses were deemed as clinical audits, and full hospital ethical approval was not 
required. However, tenants of Helsinki were adhered to and anonymised information was audited. 
The online decision tool from the NHS Health Research Authority also determined that approval 
from the NHS Research Ethics Committee was not required. 
 
 
4.2.1: Pre- and post-operative examinations  
Refraction and distance visual acuities (VA) before and after lens surgery were noted in the patient 
records. The spherical equivalent refraction was determined using the formula: half of cylindrical 
power + spherical power. Snellen VA was converted to Logarithm of the Minimum Angle of 
Resolution (logMAR) VA using a VA comparison chart (NHS, 2018). All post-operative details 
were taken from the latest post-operative appointment. It is conventional for patients seen at the 
clinic to have five follow-up visits at the following time intervals: one to five days, one week, one 
month, three months and six months post-surgery. If the surgeon deemed necessary, intense 
regulated pulsed light (IRPL) treatment (E > Eye, E-Swin, Paris, France) was recommended at the 
time of the consultation, and two further treatments separated by one to two weeks with a view to 




in 2014 for the management of MGD that has demonstrated therapeutic potential (Craig et al., 2015; 
Rong et al., 2018; X. Jiang et al., 2016). Following uncomplicated cataract surgery, patients are 
issued a prescription for Tobradex (0.3% tobramycin and 1% dexamethasone, Alcon, Fort Worth, 
USA) eyedrops to be used four times daily, and Yellox (0.9 mg/ml bromfenac sodium sesquihydrate, 
Bausch & Lomb, Surrey, UK) eyedrops to be used twice daily for 21 days. Details for optometrists 
performing post-operative care can be seen in appendix 4.2. 
 
 
4.2.2: Statistical analysis 
Statistical analysis was performed using SPSS version 24.0 (IBM SPSS Statistics, Chicago, IL). The 
Independent-samples t-test was not conducted because there were either outliers in the two groups 
that were genuinely unusual, and/or the dependent variables were not approximately normally 
distributed for each group of the independent variable (Laerd Statistics, 2015a). The first three 
assumptions in order to run a Mann-Whitney U test that relate to study design were met as well as 
the fourth assumption reflecting the nature of the data (Laerd Statistics, 2015b). A statistical 
significance level of 0.05 and 95% confidence intervals equating to declaring statistical significance 
at the p <0.05 level was chosen. The option of “exclude cases test by test” option was selected 
meaning that only dependent variable values that are missing for a given Mann-Whitney U test were 
removed from the analysis (Laerd Statistics, 2015b). The dependent variables were: age, spherical 
equivalent refraction and logMAR equivalent distance VA before and after surgery for both eyes, 
and baseline fluorescein TBUT and TearLab tear osmolarity for both eyes. Multiple Mann-Whitney 
U tests were conducted to determine if there were differences in dependent variables between the 




Data analysis was carried out on 68 anonymised records and 32 records were excluded for several 
reasons represented in figure 4.1. Records were excluded if there were no tear metrics taken (n=9), 
if the patient did not proceed with lens surgery following a consultation (n=5), if the post-operative 
care was performed elsewhere (n=5), if the record from the clinical list was not available (n=12), or 
if the case was too complex (n=1; complicated surgery requiring Artisan lens insertion and IOL 
exchange). The analysis consisted of 35 females and 32 males (one unknown). The mean ± standard 
deviation age was 64.8 ± 9.9 years and age range 50 to 90.2 years at the time of the analysis. The 
average time frame between the date of the operation and the latest appointment from which results 





Figure 4.1: Reasons for excluding data from 32 records in the current analysis.  
 
There were 20 patients in the normal tears group and 48 in the abnormal tears groups, and the 
distribution of surgeries conducted can be seen in table 4.1 and 4.2. There were three monocular 
surgeries for the normal tears group and six for the abnormal tears group. IRPL was conducted for 
three patients in the normal tear group and six patients in the abnormal tears group pre-operatively. 
Only 17% (4/23) of patients who had both baseline TearLab tear osmolarity and TBUT recorded 
were positive for both homeostasis markers indicating dry eye. 29% (14/48) of patients were 
categorised into the abnormal tears group based on abnormal TearLab tear osmolarity measures and 
63% (30/48) based on reduced TBUT alone.  
 
NORMAL TEARS CLE Cataract Total 










Total 10 10 20 
Table 4.1: Distribution of private lens surgeries for the normal tears group (CLE= clear lens 
extraction; MF= multifocal). 
 
ABNORMAL TEARS CLE Cataract Total 









1 Toric MF  
2 Toric  
1 Monofocal 
23 
Total 19 29 48 
Table 4.2: Distribution of private lens surgeries for the abnormal tears group (CLE= clear lens 




The average baseline TearLab tear osmolarity and TBUT were 291.7 ± 8.2 and 10.6 ± 1.2 for the 
normal tear group, and 301.1 ± 17.4 and 8.0 ± 2.3 for the abnormal tear group respectively. The 
results of multiple Mann-Whitney U tests to determine if there were differences in dependent 
















Age 484 0.054 0.957 Retain null hypothesis 34.58 34.30 
RE SER Before  421.50 -0.788 0.431 Retain null hypothesis 33.28 37.42 
LE SER Before  464.50 -0.209 0.835 Retain null hypothesis 34.18 35.27 
RE DVA Before  388.50 -1.004 0.315 Retain null hypothesis 31.95 37.08 















RE SER After 435 1.149 0.250 Retain null hypothesis 32.12 26.41 
RE DVA After 237.50 -0.464 0.642 Retain null hypothesis 25.42 27.54 
LE DVA After 310 0.347 0.728 Retain null hypothesis 27.95 26.33 
Table 4.3: Results of Mann-Whitney U tests where distributions of the dependent variables for both 
groups were not similar as assessed by visual inspection. The null hypothesis is that the distribution 
of variables for the two groups are equal. (Asym= Asymptotic; RE= right eye; LE= left eye; SER= 
spherical equivalent refraction; Before= before surgery; After= after surgery; DVA= logMAR 
equivalent distance visual acuity; TBUT= fluorescein tear break up time).  
 
As seen in table 4.3, there were only statistically significant differences in left eye (LE) logMAR 
equivalent distance VA before surgery, and baseline TBUT for both eyes between the two groups. 
In the normal tears group, entries for baseline right eye (RE) and LE TBUT entered as >10 were not 
registered by SPSS statistics (n=12 for both dependent variables). Distributions of the LE spherical 
equivalent refraction after surgery for both groups were similar, as assessed by visual inspection. 
LE spherical equivalent refraction after surgery was not statistically significantly different between 
the normal (Mdn= -0.13) and abnormal (Mdn= 0.07) tear groups, U= 362, z= 0.168, p= .867. 
 
Distributions of the RE and LE TearLab tear osmolarity readings for the abnormal and normal tear 
group were not similar, as assessed by visual inspection. RE TearLab tear osmolarity readings for 




significantly different, U= 138.50, z= 1.016, p= .316, using an exact sampling distribution 
for U (Dineen & Blakesley, 1973). LE TearLab tear osmolarity readings for abnormal tears (mean 
rank= 20.33) and normal tears (mean rank= 13.00) were not statistically significantly different, U= 
171, z= 1.812, p= .073, using an exact sampling distribution for U (Dineen & Blakesley, 1973). It is 
generally considered that the asymptotic p-value is a good enough approximation to the real p-value 
when both groups have more than 20 cases, where “asymptotic” means that the p-value approaches 
the real value as the sample size increases. SPSS Statistics will run an exact p-value test if there are 
20 or less cases in each group (Laerd Statistics, 2015b). It is recommended to report the asymptotic 
significance level in cases when two or more participants have identical values on the dependent 
variable, referred to as ties in the data (Laerd Statistics, 2015b). The method used to calculate the 
exact p-value or exact statistical significance level does not correct for ties in the data, and so the 
exact p-value can be inflated in these situations (Laerd Statistics, 2015b). Thus, for the dependent 
variable, baseline TBUT, the asymptotic significance level was reported. The post hoc statistical 
power calculation of the presented sample size was 82% (appendix 4.1; Faul et al., 2009). Therefore, 
despite uneven sample sizes between groups, the study had high statistical power for rejecting the 
null hypothesis. 
 
Considering there were no statistically significant differences in spherical equivalent refraction 
following lens surgery for RE and LE data between groups, the residual post-operative refractive 
error of eyes was analysed for the entire sample and the distribution can be seen in figure 4.2.  
 
 
Figure 4.2: Distribution of residual post-operative refractive error for the sample. (D= Dioptres). 
 
There were on average 3.5 ± 2.0 and 3.2 ± 1.3 number of follow-up visits for the normal and 
abnormal tears groups respectively. Post-operatively, there were instances of refraction fine-tuning 




Aluminium-Garnet (YAG) laser capsulotomy performed on patients in both groups. Complications 
in both tear groups were infrequent and included post-operative inflammation, and cystoid macular 
oedema leading to one case of subsequent small full thickness macular hole from the normal tears 
group and one case of retinal detachment from the abnormal tears group. In the normal tears group, 
there was one case of allergic conjunctivitis and eight records indicating a need for dry eye 
management.  In the abnormal tears group, there were few cases requiring IOL rotation, 
repositioning and exchange, one case of raised intraocular pressure, and 16 records indicating a need 
for dry eye management. There were no cases of ocular infection post-lens surgery for either groups.  
 
Pre-operative dry eye was indicated in the clinical records by use of the terms “demodex, 
telangiectasia, IRPL, BlephexTM, Cliradex, meibomitis, dry eye and blepharitis.” 30% and 42% of 
patients were identified as having pre-operative dry eye in the normal and abnormal tears groups 
respectively. Where both pre- and post-operative data were available to indicate dry eye status for 
both tear groups, an analysis was run to determine the proportion of new cases of dry eye following 
surgery where there was no pre-existing dry eye noted, cases suggesting no dry eye issues, cases 
where patients had continued to experience dry eye related issues following surgery, and cases where 
there was pre-existing dry eye but no dry eye noted at the latest post-operative appointment. The 
results can be seen in figure 4.3. Post-operative dry eye was deemed existent if the clinical notes 
stated the diagnosis explicitly or if dry eye management options were recommended including IRPL, 
lid hygiene techniques, and use of specific ocular lubricants or heating masks.   
 
 









The majority of abnormal tear cases were categorised based on reduced TBUT (63%), and a 
statistically significant difference in baseline TBUT between groups, but not TearLab tear 
osmolarity was found. There were no statistically significant differences in pre-operative distance 
VAs with most patients not having a distance logMAR VA worse than 0.5, perhaps reflecting how 
patients attending the private clinic valued a spectacle or contact lens free option versus 
demonstrating a clinical need or visual impairment for cataract surgery. Visual outcomes (spherical 
equivalent refraction and logMAR equivalent distance VA) after surgery were not affected by dry 
eye status with no statistically significant difference found between the two groups. Pre- and post-
operative VAs measured in this study were recorded at one point in time, and there is no indication 
of whether the vision recorded was stable or fluctuated. The morphological cataract type was not 
recorded, and measures of visual function including contrast sensitivity and glare sensitivity were 
not assessed before or after surgery that can affect the intention for cataract surgery and patient 
satisfaction with an operation (Elliott et al., 1989). The majority of patients from the entire sample 
had small myopic residual postoperative refractive errors (65% had ≤1.00D), and 20% had no 
residual refractive error. At the study site, it is common for patients to be left slightly myopic to help 
with reading unaided with patients expecting to be out of spectacle wear 80% to 90% of the time. It 
is clinic policy that LASEK can be considered at six to 12 weeks post-surgery if the visual outcome 
is disappointing to the patient and if the uncorrected logMAR distance VA is < 0.30 for laser fine 
tuning. LASEK was conducted postoperatively in patients from both groups. Previous studies have 
assessed corneal refractive surgery induced dry eye focusing mainly on laser in situ keratomileusis 
(LASIK) surgery (Gomes et al., 2017).  
 
Patient compliance in terms of attendance for the recommended five postoperative visits was good 
especially for patients having CLE operations. Lens surgery fees to patients at the clinic cost over 
£2800.00 per eye with additional fees if it is a CLE versus cataract operation or the patient chooses 
femtosecond laser-assisted surgery, and if the patient proceeds with dry eye testing and IRPL 
treatment. Perhaps patients attended as directed because they wanted to achieve the best visual 
results having invested in their lens surgery, and recognised the value of close monitoring post-
surgery. Some patients had fewer follow-up visits because they preferred to be seen for later stage 
review appointments by their local optometrist for convenience as they did not live in close 
proximity to the ophthalmic clinic.   
 
Dry eye symptom questionnaire scores were not recorded in the clinical notes analysed, and about 
30% of patients with normal tears according to this study’s criteria had annotations indicative of dry 
eye.  Despite notes of dry eye for patients in the normal tears groups and in patients classified as 




severe forms of dry eye. Previous studies with a focus on dry eye symptoms measured with the 
Ocular Surface Disease Index (OSDI) described in chapter two, have found symptoms increased for 
a duration of approximately three months following uncomplicated phacoemulsification (Cetinkaya 
et al., 2015; Oh et al., 2012; Li et al., 2007; Cho & Kim, 2009). Ocular symptoms have been shown 
to generally worsen over a prolonged time period in diabetic patients undergoing cataract surgery 
(Liu et al., 2008;  D. Jiang et al., 2016). There were no notes regarding diabetic status in this study.   
 
An observational study by Trattler et al. (2017) found > 80% of patients with visually significant 
cataracts had a TBUT ≤ 7 seconds, and 76.8% of patients were positive for fluoerscein staining with 
50% showing central staining prior to cataract surgery, suggesting a higher anticipated incidence of 
undiagnosed pre-operative dry eye. Interestingly, only 30% of patients from the Trattler et al. (2017) 
study population experienced at least occasional dry eye symptoms. Ocular signs of dry eye in the 
absence of symptoms noted pre-operatively may signify early dry eye that may develop into 
symptomatic dry eye following lens surgery (Gomes et al., 2017). Gibbons et al. (2016) found the 
most common causes of patient dissatisfaction after cataract surgery were residual refractive error 
(57%) and both aqueous-deificient and evaporative forms of dry eye (35%). Szakats et al. (2017) 
found that there were no statisically significant differences in postoperative uncorrected VA, best-
corrected VA, and four dry eye parameters with the exception of TBUT between patients who were 
unsatisified and satisfied with their post-operative outcome two months after uneventful 
phacoemulsificaiton. Although the sample size was small and results cannot be generalised to the 
general popultion, health anxiety, dry eye symptoms and patient-reported visual functioning were 
shown to be more closely associated with post-operative satisfaction (Szakats et al., 2017).  
 
There were new cases of dry eye following lens surgery in the normal (42%) and abnormal (32%) 
tears group as determined by notes from the clinician conducting the pre- and post-operative 
assessments. The average timeframe between the operation and the latest follow-up appointment 
from which outcomes were noted in the current study was 6.3 ± 2.5 weeks for the normal tears group 
and 3.6 ± 2.7 weeks for the abnormal tears group. Dry eye metrics at each of the follow-up visits 
were not recorded consistently and some patients decided to have their one-month review 
appointments conducted by their local optometrist, and so information was not available. The 
incidence of dry eye post-operatively amongst patients undergoing phacoemulsification and 
considered to have no dry eye pre-operatively has been reported at 10% and 30% at one week and 
four weeks respectively after surgery (Kasetsuwan et al., 2013; Miyake & Yokoi, 2017). Iglesias et 
al. (2018) noted a prevalence of approximately 32% for dry eye symptoms at six months post-
cataract surgery, and therefore considered to have persistent post-surgical pain although it is not 




deveopled dry eye symptoms post-operatively such as foreign body sensation to the operation rather 
than pre-exisintg ocular surface disease. Surgeons should inform patients prior to surgery about the 
possibility of dry eye symptoms following surgery and give an indication of when they will likely 
diminish or disappear. Xue et al. (2019) found that dry eye symptoms persisted for more than three 
months post-cataract surgery with OSDI scores still higher than pre-operative scores, though 
subsiding, at the end of six months.  
 
There were cases in both tear groups that had no pre- or post-operative dry eye noted. However, 
mild ocular discomfort may be accepted or tolerated by patients especially post-operatively if they 
are advised of an approximate one-month settling period before spectacles can be considered to 
enhance distance or near vision where necessary. Kohli et al. (2019) suspect the observed transient 
nature of post-surgical dry eye with a recovering trend starting from the sixth week could be due to 
the presence of inflammatory cytokines that induce the synthesis of neurotrophic factors, and 
stimulate corneal nerve regeneration. Others have detected dry eye on the seventh day following 
cataract surgery and improvement within 30 days of the operation, offering a similar explanation 
that the recovery process of the corneal nerves from corneal incisions and neurogenic inflammation 
is responsible for the observation (Kasetsuwan et al., 2013).  
 
A comparison of visual outcomes for patients having standard phacoemulsification or femtosecond 
laser-assisted surgery was not conducted. Conrad-Hengerer et al. (2015) found that femtosecond 
laser-assisted cataract surgery compared to conventional phacoemulsification using pulsed 
ultrasound energy in the fellow eye had faster visual recovery, less deviation from the target 
refraction and earlier stabilization of refraction. Other studies have shown no statistically significant 
differences in uncorrected and correct distance VA, and refraction between the two groups (Lawless 
et al., 2012; Mihaltz et al., 2011). Both forms of surgeries have been shown to reduce TBUT and 
tear volume (Schirmer testing I) values with a maximum impact of one week that fail to resolve one 
month following surgery (Yu et al., 2015). In cases of pre-existing dry eye, increased ocular surface 
staining and symptoms were worse in patients having femtosecond laser-assisted surgery (Yu et al., 
2015). It is unknown as to whether an aspirating speculum was used by the surgeon in the procedures 
analysed retrospectively, which could account for continued or new cases of dry eye. Moon et al. 
(2014) showed that use of an aspirating speculum aggravated dry eye parameters during the early 
post-operative period, which returned to pre-operative values after one month. Negative pressure 
through sectional holes of the aspirating speculum in contact with the conjunctiva can cause damage 
to the conjunctiva leading to decreased mucin secretion, and increased inflammation on the ocular 





There were cases of dry eye conversions to no dry eye noted post-operatively for both tear groups. 
Miyake & Yokoi (2017) also note a change of dry eye classification four weeks after cataract surgery 
from definite or probable dry eye to non- dry eye at 22.4% and 38.2% respectively. The application 
of topical steroids and nonsteroidal anti-inflammatory drugs, which have an anesthesia and anti-
inflammatory effect, and  antibacterial drugs for four weeks post-operatively may account for the 
improvement in dry eye status (Miyake & Yokoi, 2017). Post-operative dry eye metrics were not 
available in the current study to comment on whether dry eye metrics remained the same, worsened 
or returned to pre-operative values at each of the five recommended visits. Cases of no conversion 
in dry eye status were noted in both tears groups wherein patients were recorded to have dry eye 
pre- and post- operatively despite excellent visual acuity following cataract surgery. Choi et al. 
(2018) identified a high OSDI score at baseline, and increased MG dropout, MG orifice obstruction 
and reduced TBUT at one month post-operative as risk factors for persistent dry eye symptoms after 
cataract surgery. El-Ameen et al. (2018) showed MG loss in the upper eyelid pre-operatively was 
associated with an increased early post-operative OSDI score, and that MG expressibility and TBUT 
changes persisted for up to three months following cataract surgery. The suggesstion is that 
clinicians should monitor these dry eye parameters and consider directed treatment of those patients 
with risk factors to improve satisfaction following surgery and to improve dry eye symptoms.  
 
Impaired epithelial wound healing and decreased epithelial metabolic acitivity can result from 
transection of corneal nerves in cataract surgery, seen clinically as a decrease in corneal sensitivity 
and tear production (Sutu & Afshari, 2016). Corneal sensitivity can recover to pre-operative levels 
with recovery time lengthened by larger incision size and a grooved incision in patients without pre-
existing dry eye (Oh et al., 2012; Cho & Kim, 2009). The location of the corneal incision, wherein 
the steeper meridian may be chosen to neutralise astigmatism, has not been shown to induce dry eye 
post-operatively (Kohli et al., 2019; Cho & Kim, 2009). Sutu and Fukuoka (2016) suggest that each 
etiological factor contributing to the development or exacerbation of dry eye symptoms post-
operatively, such as injury from the corneal incision or ocular surface manipulation and resulting 
inflammation may have its own recovery time along with individual differences in the return to 
homeostasis. Interventions shown to improve dry eye symptoms and signs post-operatively: 
• Management of ocular rosacea and blepharitis with lid hygiene, manual compression, and 
oral or topical antibiotic with an anti-inflammatory effect such as doxycycline (El-Harazi 
& Feldman, 2001; Chee et al., 1999). 
• Hyaluronate and carboxymethylcellulose based artifcial tears can improve TBUT, corneal 
staining and symptoms (Mencucci et al., 2015; Yao et al., 2015)  
• Preservative-free sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops in 




• Hydroxypropyl (HP)- Guar used in addition to steroid and antibiotic eye drops (Sanchez et 
al., 2010) 
• Diquafosol 3% topical ophthalmic solution can improve TBUT, corneal staining, higher 
order abberations and Schirmer I test at 12 weeks post-surgery  (Park et al., 2016) 
• Topical cyclosporine 0.05% in comparison to artificial tears alone can improve dry eye 
symptoms and signs (Chung et al., 2013; Donnenfeld et al., 2010; Hamada et al., 2016) 
 
The ophthalmic advice to optometrists involved in post-operative care at the study site is that ocular 
lubrication may be required for up to three months. The sample size was too small and measures of 
post-operative dry eye were too limited in the current study to determine whether patients having 
IRPL had better clinical outcomes following surgery stratified by type (cataract or CLE surgery), 




Visual acuity is the traditional biomedical indicator for satisfaction or success regarding cataract 
surgery outcomes (Xue et al., 2019). Considering there was no difference in visual outcomes post-
lens surgery between the abnormal and normal tears groups, it may not be necessary to delay an 
operation based on visual outcomes. Ocular surface preparation may be beneficial to patients with 
minimal signs or no symptoms of dry eye in addition to those with established or diagnosed dry eye 
in order to achieve satisfactory ocular comfort or well-being outcomes. The current study did not 
analyse the changes in dry eye metrics pre-operatively, and at each of the post-operative visits for 
the two groups of patients as this information was not available given the retrospective nature of the 
study but could be explored in future studies. Future longitudinal research with larger cohorts of 
patients is required to evaluate the long-term impact of surgery (both phacoemulsification and 
femtosecond laser-assisted) on clinical outcomes, ocular surface health metrics and patient reported 
outcomes. Individuals considering private lens surgery especially with implantation of costly 
premium IOLs could benefit from BBR Optometry Ltd.’s dry eye service for management of 
symptoms and signs, to optimize the ocular surface and to potentially prevent persistent dry eye 
following surgery. Another significantly large subset of patients from private optometric practice 
that could benefit from a dry eye service are contact lens wearers given contact lens wear is 









CHAPTER 5 ABSTRACT 
A profile of contact lens dropout in an independent optometric practice 
 
PURPOSE: Contact lens (CL) wearers represent a segment of the patient population who may 
benefit from a dry eye service. The aim of this chapter was to determine retrospectively at a local 
level whether dryness and ocular discomfort were main reasons for discontinuing CL wear, 
commonly referred to as CL dropout (CLDO), for patients at BBR Optometry Ltd. 
 
METHODS: Two strategies using the practice management software I-clarity (I-clarity, Radyr, 
Cardiff) were employed to extract records of patients who potentially discontinued CL wear. The 
suspected reason for CLDO was recorded in addition to age at the time of CLDO, sex, date of last 
CL check, and lens parameters for the latest CL specification issued, such as product name, type, 
manufacturer, material, and replacement frequency. 
 
RESULTS: Over half of patients from the sample where discontinuation of CL wear was suspected 
were classified as “false” CLDOs (54.2%), that is not ceasing lens wear due to issues associated 
with CLs. The primary reason for CLDO in this subgroup was no longer requiring CL wear 
following surgical intervention (42%). Customer switching (29%) and relocation (19%) were other 
reasons to explain “false” CLDOs. When multifocal and monovision CL correction were trialed and 
unsuccessful, patients reverted to full time spectacle wear rather than single vision distance CL 
correction and use of over readers to enhance near vision. Poor vision was found to be a reason for 
CLDO in this sample of presbyopic patients despite being fitted with current multifocal designs. The 
proportion of dropouts due to poor vision were similar between lens types (31.6% multifocal, 26.3% 
toric, 36.8% spherical). There were no strong patterns to link CLDO to dry eye or to a particular CL 
product or product range. 
 
CONCLUSIONS: In order to benchmark performance and improve CL service, practitioners 
should aim to identify CLDOs and determine the retention rate at their practice. There was a large 
subset of patients in the analysis who discontinued CL wear for unknown reasons, which highlighted 
a need to improve CL record keeping at the practice. A large proportion of patients who discontinued 
using CL services at the practice did not necessarily discontinue CL wear permanently. It is possible 




























A profile of contact lens dropout in an independent optometric practice 
 
5.1: Introduction  
According to a market data report by the European contact lens (CL) and lens care industry, 
Euromcontact, which compared CL uptake for seven participating companies across 33 countries, 
the European CL market grew by 4.5% and daily disposable replacement CLs were found to be a 
strong growth driver in the market. Sweden had the largest penetration rates for the population aged 
15 to 64 at 14.2%, followed by Denmark (13.5%), Norway (10.9%), and the UK and Ireland (8.7%). 
The most commonly used CLs were weekly/bi-weekly and monthly replacement lenses with an 
increase in the silicone hydrogels market share in reusable lenses across all 33 countries 
(Euromcontact, 2018). Discontinuation from CL wear referred to as CL dropout (CLDO) is one of 
the costly challenges facing CL practice and limits growth in the market (Nichols et al., 2013). Sulley 
et al. (2017) report that the estimated rate of permanent CLDO has remained high over the past two 
decades despite advancements in CL designs, materials and modalities of wear ranging from 12% 
to 43%.  
 
Early soft CL materials in the mid-1980s were made from low water content hydrogel such as 
hydroxyethyl methacrylate that had low oxygen transmissibility resulting in reports of corneal 
oedema (Bailey & Carney, 1973; Swarbrick et al., 1985; Morgan & Efron, 1998). Lens replacement 
was based on discomfort usually caused by the accumulation of deposits that could not be easily 
removed with cleaning solutions (Efron & Morgan, 2017).  Compared to conventional hydrogel 
materials, silicone hydrogel materials have a greater oxygen permeability resulting in fewer hypoxic 
complications but not fewer rates of infiltrative events or cases of microbial keratitis (Covey et al., 
2001; Morgan et al., 2005; Stapleton et al., 2008). Lysozyme deposits more readily on conventional 
hydrogels than silicone hydrogels, and is thought to have a protective effect accounting for the 
observed lower rate of infiltrative complications in hydrogel lens wearers (Omali et al., 2015). The 
introduction of single use daily disposables has meant a reduction in the risk of adverse reactions 
such as corneal infiltrative events associated with CL cleaning solutions and reusable lenses 
(Chalmers et al., 2012; Carnt et al., 2009). CL manufacturers’ product lines continue to evolve 
incrementally with changes to lens design availability, parameter range expansion, and new 
formulations of silicone hydrogel materials.   
 
The compartmentalisation of the tear film induced by CL insertion leads to biophysical and 
biochemical changes of tear film properties (Craig et al., 2013). Biophysical changes to the tear film 
include a reduction in tear film stability, pre-lens lipid layer thickness and tear volume, and increased 
tear evaporation (Craig et al., 2013). The insertion of a CL divides the pre-corneal tear film into a 




tearing subsides (Nichols & King-Smith, 2003; King-Smith et al., 2004; Chen et al., 2010). 
Disruption to the lipid layer of the tear film affecting tear film stability as measured by a reduction 
in tear break up time, and an increase in evaporation rate have been reported with CL wear (Guillon 
et al., 1997; Faber et al., 1991; Guillon & Guillon, 1989; Young & Efron, 1991; Morris et al., 1998; 
Guillon & Maissa, 2008; Thai et al., 2004).  
 
The insertion of a CL is also thought to impact the blink reflex mechanism due to differences in  pre- 
and post- CL tear film temperature (Ooi et al., 2007; Purslow et al., 2005). Corneal surface cooling 
and increased tear osmolarity following tear evaporation are detected by corneal cold neuroreceptors 
leading to reflex blinking, which in turn may be affected by the insultating effect of the CL on the 
post-CL tear film (Hirata et al., 2012; Kovacs et al., 2016; Li et al., 2015). Guillon et al. (2019) 
determined that tear film kinetics or deviations in the tear film at the time of break-up and the length 
of time during which the tear film is compromised over a spontaneous interblink period, were 
significantly inferior in CL wearers when compared to non- CL wearers. It is possible that the 
presence of a non-continuous tear film over a CL surface could be associated with CL discomfort 
(CLD) (Guillon et al., 2019). A thick aqueous layer is required for tear film lipid layer spread over 
the ocular surface, and reduces the interaction between tear film lipids and the CL surface that can 
lead to lipid deposition and consequent impaired optical quality seen in continuous wear silicone 
hydrogel CLs (Craig et al., 2013). Best et al. (2013) determined that wettability of the ocular surface 
was a main factor impacting CLDO in new CL patients fitted with silicone hydrogel CLs, and 
suggested predictors for those likely to discontinue lens wear within the first six months were a non-
invasive tear breakup time < 10 seconds or an OSDI score > 4.2.  
 
The physical presence of a CL in the eye induces factors that may be related to CLD including 
having a suspected fatiguing effect on ocular tissues linked to frictional aetiology or stimulation of 
cold nociceptors on the ocular surface (Papas et al., 2014). Papas et al. (2014) found that hydrogel 
and silicone hydrogel daily disposable lens replacement midway through a 10-hour wearing period 
with the same or new lens did not influence final perceptions of comfort suggesting comfort 
decrements experienced by CL wearers at the later part of the wearing period may not be associated 
with short-term changes occurring to the lenses. Stahl et al. (2016) also found that silicone hydrogel 
CL- free recovery periods of up to 80 minutes over a 12-hour lens wear day did not positively impact 
end of day comfort.  
 
Current research into CL properties such as design and material to improve CL adaptation and 
retention rates propose that lubricity, which is the friction between the lens surface and lid margin, 
is a key factor in lens wettabilty and comfort (Jones et al., 2013). Vidal-Rohr et al. (2018) showed 




with nanometer thickness coating technology resulted in subjective improvement of CL comfort. 
Pult et al. (2019) found that ceasing CL wear or refitting experienced CL wearers with a low 
coeffcient of friction CL material led to improved indirect in-vivo measures of ocular surface friction 
or indicators of mechanical forces during blinks, namely lid parallel conjunctival folds and lid wiper 
epitheliopathy, as well as dryness symptoms over a period of 12 weeks.  
 
Lens modulus is an indicator of the material’s resistance to deformation, and is two to three times 
higher in second generation silicone hydrogels compared to conventional hydrogels (Young et al., 
2010). High modulus CLs can reduce comfort due to the effect on lens fit such as tighter fit and edge 
fluting, and the association with changes in ocular physiology (Young et al., 2010). An in vitro study 
evaluating the effect of CL care products on soft CL modulus, found multi-purpose care solutions 
were related to decreases in modulus from probable uptake of formulation components, and use of 
hydrogen peroxide solutions resulted in increased modulus with two CL materials thought due to 
chemical changes in the CL polymer (Young et al., 2010).  
 
Although a causal relationship has not been found due to the lack of longitudinal studies, there have 
been reports of structural and functional changes to the Meibomian glands, and associations with 
CLD in CL wearers including greater acini reflectivity which measures secretion quality, meibomian 
gland duct dilation, lid margin redness and lid thickness (Siddireddy et al., 2018; Villani et al., 2011; 
Machalinska et al., 2015; Arita et al., 2009). Whilst other studies have failed to find an association 
between Meibomian gland atrophy and CLDO (Pucker et al., 2019; Machalinska et al., 2015; Pucker 
et al., 2015), Alghamdi et al. (2016) observed CL-induced atrophy within the first two years of wear 
which then stabilises and does not resolve six months following cessation of wear.  
 
Conventional hydrogels incorporate higher water content materials to achieve higher oxygen 
permeability and corneal oxygenation, and innovations in introducing an internal surfactant could 
help maintain the hydration of these lens materials rather than designing thicker lenses (Ruiz-
Alcocer et al., 2018). Silicone hydrogel lens materials provide a significant increase in oxygen 
permeability without having to increase the water content of the lens, but their performance is 
affected by the intrinsic higher modulus and hydrophobic nature (Ruiz-Alcocer et al., 2018). 
Manufacturers are continually striving to develop products that increase comfort and minimise 
complications in order to reduce CLDO. In their crossover study assessing in vivo changes in CL 
thickness of a new daily disposable hydrogel lens with a water content of 78% (Biotrue ONEday, 
Bausch & Lomb, Kingston upon Thames, UK) compared to two silicone hydrogel lenses (Dailies 
Total 1, Alcon, Camberley, UK & MyDay, Coopervision, Fareham, UK) of lower water content, 
Ruiz-Alcocer et al. (2018) found no significant impact of the lens materials on the tear film or 




CLD is experienced by up to 50% of CLs wearers, and is characterised by a reduction in the 
compatibility between CLs and the ocular enviroment that leads to consequent adverse ocular 
sensations of varying frequency and magnitude (Nichols et al., 2013).  Nichols et al. (2013) outline 
the temporal progression of CLD whereby patients begin to struggle with physical awareness or 
visual disturbance associated with CL wear, and adopt management strategies such as reducing 
wearing time and using artificial tears or rewetting drops before eventualy discontinuing CL wear 
permanently.  
 
Discomfort and dryness have been identified as the main reasons for CLDO followed by vision and 
handling problems (Dumbleton et al., 2013; Rumpakis, 2010; Richdale et al., 2007; Jutai et al., 2003; 
Young et al., 2002; Harknett et al., 2001). Dumbleton et al. (2013) conducted an online survey of 
4207 Canadian residents who were current or lapsed CLs wearers, and found that the main reason 
for CLDO was due to discomfort and dryness with lower dropout rates in silicone hydrogel wearers 
and 23% of respondents discontinuing CL wear permanently. Studies carried out prior to the 
introduction of silicone hydogels and daily disposable CLs to the market, also found that the most 
common reason reported for CLDO were discomfort and dryness albeit this may have been due to 
the fitting of older lens materials and designs (Weed et al., 1993; Pritchard et al., 1999).  
 
The aims of the current analysis were to determine the main reasons and common trends for CLDO 
at a single optometric practice, and whether CLDO was due to discomfort and reports of dryness or 




This single site study conducted at an independent optometric practice (BBR Optometry Ltd.) was 
a retrospective record review of patients who had discontinued CL wear. Those eligible for CLs 
under the National Health Service for medical or other reasons, or utilising myopia control services 
at the practice were excluded from the study. The author conducted the retrospective review of 
practice records.  
 
Two methods were employed to identify CLDOs. The first method involved using the practice 
management software I-clarity (I-clarity, Radyr, Cardiff) to access records of patients who had 
multiple reminder letters to return for CL aftercare appointments between January 2nd 2017 and 
March 2nd 2018 having been placed on a two-, three-, six- or twelve- month recall and receiving 
three to five reminder letters. It is practice protocol for patients to be sent a maximum of five 
appointment reminder letters and a maximum of three if the recall period is two-months. The second 




identified by generating a list of CL patients who had not attended a CL check for one year prior to 
the date of list generation.  
 
Strategies used to determine whether patients had discontinued CLs and why included reviewing the 
CL and eye examination clinical notes, practice communication notes, and CL-related products 
transaction history. The practice protocol is to record any interactions with patients or changes in 
patient circumstances in the “practice communication” section of I-clarity. Detailed information on 
the age at the time of CLDO, sex, date of last CL check, and lens parameters such as product name, 
type, manufacturer, material, and replacement frequency were recorded for each patient identified 
as having discontinued CL wear. For method one, the time period lapsed before CL dropout could 
not be determined accurately with the given information. An assumption for method two data, after 
scrutinising clinical notes and order history, was that entries for “date of next CL aftercare” 
generated by I-clarity as “01-Jan-00” meant patient were not assigned a recall period because the 
CL trial or CL wear was abandoned. All anonymised data was inputted into Microsoft Excel 
(Microsoft Corporation, Redmond, Washington, USA) for analysis. Duplicate entries from the two 
methods were removed. This study received approval from the Life and Health Sciences Ethics 
Committee at Aston University (Project #1276) and adhered to the tenets of the Declaration of 




In total, 214 records of patients suspected of discontinuing CL wear were analysed. There were 123 
out of a possible 123 records derived using method one, and 91 from a possible 659 records using 
method two. There were no clinical notes available for 568 patient identifiers obtained from method 
two.  
 
There were 116 records excluded from product analysis because they were deemed not to be true or 
“false” CLDOs. Reasons for CLDO in these cases and the patient demographics for these subgroups 
can be seen in table 5.1 and figure 5.1, and include patients who no longer required CL correction 
following cataract, clear lens extraction (CLE) or Laser Assisted in Situ Keratomileusis (LASIK) 
refractive surgery. Some patients had the intention of continuing CL wear but moved from the local 
area as far as Europe due to changes in circumstances including pursuing higher education or moving 
closer to family.  
 
Unfortunately, there were instances of customer switching behaviour discussed in chapter two, 
which made up the largest proportion of false CLDOs. Clinical notes revealed patients were unhappy 




and products, errors or delays with CL ordering, and expressions that did not want to subscribe to a 
monthly direct debit for clinical care and product payments at the practice. BBR Optometry Ltd.’s 
monthly payment plan EyeLifeTM was described in chapter two, and BBR Optometry Ltd. require 
enrolment in EyeLifeTM for any new CL wearer. There were notes stating the patient cancelled their 
direct debit at the bank, and notations stating that the patient admitted purchasing CL elsewhere or 
the patient’s CL specification had been requested by the patient or local competition. The remaining 
subgroup of patients (“Failure to attend”) were those who were most likely overdue a CL check 
given previous history of attending CL aftercares at the same time as yearly eye examinations rather 
than in accordance with recommended recalls for CL care typically set at six months at the practice.  
 


















Cataract surgery 30 4 26 66.0 10.4 31 83 
CLE surgery 8 0 8 61.0 6.3 52 71 
Refractive surgery 10 3 7 44.5 11.9 23 62 
Relocation 22 11 11 36.2 18.1 17 74 
Cx switching  34 9 25 38.9 16.0 16 66 
Failure to attend 12 4 8 41.9 16.0 21 68 
Table 5.1: Profile for subgroups of patients who were not true contact lens dropouts (CLDOs) and 
excluded from CL product analysis (CLE= Clear Lens Extraction; Cx= Customer; No.= number; 




Figure 5.1: Proportion of subgroups of patients who were not true contact lens dropouts (CLDOs) 
and excluded from CL product analysis (CLE= Clear Lens Extraction; Cx= Customer; Surg= 
Surgery). 
 
Overall, 98 records were analysed with 52 found using method one and 46 found using method two. 
There were six entries from method one where there were different lens products for right and left 




the fellow eye a multifocal lens. In the other cases, one eye had a spherical correction and the fellow 
eye had a toric correction (n=5). There was one case of enhanced monovision with different lens 
products for each eye found using method two.  
 
From method two data where such analysis was possible, 85% (n=39) of CLDOs were active CL 
wearers for < one year, and 15% (n=7) were active CL wearers for ≥ one year. The reasons for 
CLDO in those wearing CL for ≥ one year included ceased CL wear following infection (n=2), 
unknown (n=3), dryness (n=1) and poor vision (n=1). The distributions of reasons for CLDO in 
those wearing CL for < one year can be seen in figure 5.2.  
 
 
Figure 5.2: Distribution of reasons for contact lens dropout (CLDO) amongst BBR Optometry Ltd 
patients derived from method two who wore CLs for < one year.  
 
After compiling data from methods one and two, it was found that 18 patients wore rigid gas 
permeable (RGP) lenses and 80 wore soft contact (SCL) lenses. There were 66 female and 31 male 
CLDOs. Sex and age were unknown for one entry using method one. The average age of CLDOs 
was 51.4 ± 15.2 and the average duration for time of dropout (year) was 2012 ± 4.7. At the time of 
CLDO, the majority of CL recommended were manufactured by Coopervision and Johnson & 
Johnson, and were either daily or monthly disposable SCLs. Motivations for first choice CL by a 
practitioner may be sales driven in choosing a certain manufacturer due to cost and efficient delivery 
or experience driven in choosing a product based on familiarity and previous successes. The 
distribution of CL manufacturers, and of CL replacement frequencies and lens types can be seen in 






Figure 5.3: The distribution of CL manufacturers for CLs recommended and noted at the time of 




               
Figure 5.4: The distribution of CL replacement frequencies and lens types for CLs recommended 
and noted at the time of CLDO for a subgroup of patients at BBR Optometry Ltd. (CL= contact lens; 
CLDO= contact lens dropout). 
 
The main reasons for CLDO was the unknown group (37.8%), followed by poor vision and poor 
comfort both at the same proportion of 17.3%. Interestingly, 58.8% of CLDO due to poor comfort 
explicitly stated that there were symptoms of dryness. The patient demographics for groups arranged 
according to reasons for CLDO and proportion of CLDOs in each group can be seen in table 5.2 and 
figure 5.5. Patient records assigned a reason for CLDO as unknown often had notes of “lapsed,” 
“discontinued,” “ceased CL wear,” “abandoned CL wear,” and “CL trial not a success” but did not 
include any explanation. There were also cases where notes in the eye examination stated “no longer 
wearing lenses” or “wants to leave multifocal CL trial for now” but no explanation recorded as to 































Poor vision 17 6 
 





5 6 1 58.4 13.3 28 72 
Unknown 37 17 
 




4 1 3 2 2 54.8 4.8 49 60 
Poor comfort 17 1 
 
15 13 4 50.6 13.1 16 75 
General health 
issues 
4 1 3 4 0 63.5 10.7 49 79 
Poor vision & 
comfort  
3 0 3 3 0 59.7 14.8 39 73 
Expense  2 1 
 
1 2 0 29.0 11.0 18 40 
Inconvenience 7 2 
 
5 7 0 32.4 15.3 18 65 
Table 5.2: Profile for subgroups of patients who were deemed contact lens dropouts (CLDOs) and 
included in CL product analysis (No.= number; pxs= patients; Std Dev= standard deviation; Min.= 




Figure 5.5: Proportion of subgroups of patients who were deemed contact lens dropouts (CLDOs) 
and included in CL product analysis. 
 
Patient records assigned a reason for CLDO as poor vision often were due to poor near vision, and 
all were of presbyopic age. There were cases where perhaps patients’ needs and expectations were 
not met with complaints of poor near vision for patients fitted with single vision distance correction 
although they were presbyopic, and for specific activities such as skiing. There was a trend of 
patients initially being fitted with multifocal CLs with notes of “jumpy” or “foggy” vision, and then 




and unsuccessful, patients reverted to full time spectacle wear rather than single vision distance CL 
correction and use of over readers to enhance near vision.  
 
Patient records assigned a reason for CLDO as poor comfort had notes such as “reduced wearing 
time due to discomfort”, “dryness” or simply “CL discomfort.” There were two instances of 
recommendations for dry eye work-up and management via BBR Optometry Ltd.’s Tear Clinic dry 
eye service. There were three cases where both poor vision and poor comfort were determined as 
reasons for CLDO. “Fluctuating vision,” “blurring and tired eyes,” and “a combination of dryness 
and vision perceived as not good enough to drive” were noted in the patient records for this group. 
One of these cases was booked in for a dry eye consultation at the practice but failed to attend.  
 
Patient records assigned a reason for CLDO as difficulty handling and inconvenience had the same 
proportion of CLDOs (7.1%). There were notes of “difficulty with insertion and removal,” and 
“problems with handling.” One record indicated that a reteach on insertion and removal of CLs with 
support staff was declined. CLDO patients in the inconvenience group had notes of “prefers specs” 
and “can’t be bothered to put in CLs” for a new mother post-partum. Patient records assigned a 
reason for CLDO as ceased CL wear following infection and general health issues had the same 
proportion of CLDOs (4.1%). Patients with recurrent viral infections included two SCL wearers who 
were fitted with daily disposables and two RGP lens wearers. General health issues leading to CLDO 
were due to patients wanting to be more cautious overall and averting any perceived risks to their 
health. One patient was undergoing a course of chemotherapy for lung cancer and decided to cease 
CL wear, and another had a stroke which affected the ability to handle CLs. The remaining cases 
stated the patients were “unwell” and ceased CL wear. There were two cases where CL wear became 
temporarily infrequent due to treatment in hospital for a broken leg, and for anterior uveitis with the 
subsequent decision for these patients to cease CL wear but due to cost.  
 
Table 5.3 presents the CL products that the sample of BBR Optometry Ltd.’s CLDO patients were 
wearing at the time of CLDO, organised by reason for CLDO. The product names bolded indicate 
that the CL material is silicone hydrogel and the asterisk that the CL material is water gradient. The 
number of patients from the sample in each group can be found in parentheses, and where a patient 
was fitted with two different products has been indicated. In regards to reason for CLDO due to poor 
vision, one patient was fitted with a multifocal toric lens, and 31.6%, 26.3% and 36.8% of patients 
were fitted with multifocal, toric and spherical CLs respectively. About one third of these patients 
were trialling a silicone hydrogel lens. When analysing CL products trialled for those where reason 
for DO was due to poor comfort, 16.7% of these patients were wearing CLs with silicone hydrogel 




and comfort were wearing toric silicone hydrogel lenses, whilst the remaining patient in this group 
was wearing a daily multifocal.  
 
CLDO Reason (n=98) CL Product Name 
 
Poor vision (n=17) 1-day Acuvue Moist (n=1) 
1-day Acuvue Moist for Astigmatism (n=2) 
1-day Acuvue Moist Multifocal (n=2) 
1-day Acuvue Trueye (n=2) 
Acuvue Oasys for Astigmatism (n=1) 
Clariti 1day (n=1) 
Proclear 1 Day Multifocal (n=2) 
Biofinity Toric (n=1) 
Frequency 55 Toric (n=1) 
Biofinity Multifocal (n=1) 
Proclear Multifocal (n=1) 
Proclear Multifocal toric (n=1)  
Menicon Z Alpha (n=1) 
Maxim Ultra (n=2)  
For one customer, RE 1-day Acuvue Trueye LE 1-day 
Acuvue Moist for Astigmatism. 
For one customer, RE 1-day Acuvue Moist for Astigmatism 
LE 1-day Acuvue Moist.  
Difficulty handling (n=7) 1-day Acuvue Moist (n=1) 
1-day Acuvue Moist for Astigmatism (n=1) 
Focus Dailies All Day Comfort (n=1) 
Dailies Aquacomfort Plus Toric (n=1) 
Proclear 1 Day Multifocal (n=1) 
Proclear Multifocal toric (n=1)  
Menicon Z Progressive BTC (n=1) 
 
 
Unknown (n=37)  Dailies Total 1* (n=1) 
Focus Dailies All Day Comfort (n=3) 
Dailies Aquacomfort Plus (n=1) 
Dailies Aquacomfort Plus Toric (n=3) 
Dailies Aquacomfort Plus Multifocal (n=1) 
Air Optix Aqua (n=1) 
1-day Acuvue Moist (n=4) 
1-day Acuvue Moist for Astigmatism (n=2) 
1-day Acuvue Moist Multifocal (n=2) 
Acuvue Oasys 1-day with HydraLuxe (n=2) 
Acuvue Oasys with Hydraclear Plus (n=1) 
Acuvue Advance for Astigmatism (n=1) 
Proclear 1 Day (n=2) 
Clariti 1day (n=1) 
Proclear 1 Day Multifocal (n=1) 
Proclear toric (n=1) 
Biofinity (n=1) 
Biofinity toric (n=2) 
Biofinity Multifocal (n=1)  
Menicon Z Alpha (n=1) 
Maxim (n=2) 
Fluorolens 90 (n=1) 
Boston ES (n=2) 
Quantum 1 (n=1) 
Quasar FS Multifocal (n=1) 
For one customer, RE Dailies Aquacomfort Plus Toric LE 
Focus Dailies All Day Comfort. 
For one customer, RE 1-day Acuvue Moist for Astigmatism 
LE 1-day Acuvue Moist Multifocal. 
 
 
Ceased CL following infection (n=4)  Proclear 1 Day (n=1) 
1-day Acuvue Moist for Astigmatism (n=1) 







Poor comfort (n=17) 1-day Acuvue Moist (n=1) 
1-day Acuvue Moist for Astigmatism (n=3) 
1-day Acuvue Moist Multifocal (n=2) 
Acuvue Advance for astigmatism (n=1) 
Proclear 1 Day (n=1) 
Proclear 1 Day Multifocal (n=1) 
Biomedics toric (n=1) 
Biofinity toric (n=1) 
Biofinity Multifocal (n=1) 
Dailies Total 1* (n=1) 
Dailies Aquacomfort Plus Toric (n=1) 
Menicon Z Alpha (n=1) 
Menicon Z Progressive BTC (n=1) 
Boston XO (n=1) 
Boston IV (n=1) 
For one customer, RE 1-day Acuvue Moist for Astigmatism 
LE 1-day Acuvue Moist. 
 
 
General health issues (n=4) Proclear 1 Day (n=1) 
Clariti 1day multifocal (n=1) 
Biofinity (n=1) 
Biofinity toric (n=2) 




Poor vision & comfort (n=3) Proclear 1 Day Multifocal (n=1) 
Biofinity toric (n=1) 
Acuvue Oasys for Astigmatism (n=1) 
 
 






1-day Acuvue Moist (n=2) 
1-day Acuvue Moist for Astigmatism (n=1) 
Acuvue Oasys for Astigmatism (n=1)  
Proclear 1 Day (n=1)  
Biofinity (n=1) 
Biofinity toric (n=2) 
For one customer, RE Biofinity LE Biofinity toric. 
 
 
Table 5.3: Contact lens product names that patients were wearing at the time of contact lens dropout 
(CLDO) categorised based on reason for dropout in a sample of patients at BBR Optometry Ltd. (in 




The proportion or rate of CLDO in the first year of wear for all CL wearers from a sample or those 
patients recenlty fitted are influenced by the CL products available at the time of fitting. Historical 
dropout rates estimated from studies in the 1990s are of limited value today due to the 
discontinuation of most CL products used at that time. A retrospective chart review of 524 records 
across 29 UK optometric practices conducted by Sulley et al. (2017) found a 74% first-year retention 
rate for patients fitted with CLs. A high proportion of patients who discontinued CL wear did so 
within the first two months of wear (47%) with handling and comfort issues cited as common reasons 
for DO in spherical lens wearers, and visual problems amongst new toric and multifocal CL wearers 
(Sulley et al., 2017). A prospective evaluation of new CL wearers within the first year of fitting by 




handling (25%). The shift away from poor comfort as the prime reason for CLDO may be due to the 
continual improvement in CL products, and the comparison new CL wearers make of vision that is 
achieveable in spectacle lenses versus CLs.  
 
In the current sample with the average age of CLDO 51.4 ± 15.2 years, an equal proportion of 
patients discontinued CL wear due to poor vision and poor comfort (17.3%). A survey of 496 
presbyopic CL wearers with a mean age of 57 ± 9 years also found that dissatisfaction with vision 
at all distances and discomfort were equally reported as primary motivations for CLDO, and years 
of CL wear was not associated with a tendency to cease lens wear (Rueff et al., 2016). Contrary to 
previous studies involving younger CL populations, Rueff et al. (2016) found that the age of 
beginning CL wear and CL material did not have a significant influence on CLDO. Previous studies 
predating the availability of multifocal CLs have shown the onset of visual problems associated with 
presbyopia as a reason for CLDO (Schlanger, 1993). Poor vision was still found to be a reason for 
CLDO in this sample of presbyopic patients despite being fitted with current multifocal designs. The 
proportion of dropouts due to poor vision were similar between lens types (31.6% multifocal, 26.3% 
toric, 36.8% spherical), although previous studies have shown greater dropout for patients fitted with 
multifocals suggesting required improvement for fitting procedures and designs to optimise vision 
(Sulley et al., 2017).  
 
As presbyopia progresses, practitioners can make incremental changes to monovision correction of 
up to 0.25 Dioptres, and to multifocal CLs due to the availibility of CL brands offering more than 
one near addition power  to improve near vision (Kerr & Chauhan, 2019). Monovision correction 
can compromise visual performance by introducing interocular rivalry, and multifocal correction 
can introduce a form of intraocular rivalry whereby distance and near visual inputs are superimposed 
on each retina (Morgan et al., 2011). Although less convenient, presbyopic patients may choose to 
wear distance vision CL correction and spectacles with additional strength for near tasks. An 
observed pattern in this study was the initial fitting of multifocals and subsequent monovision 
correction if multifocal wear was not successful, and then the use of overreaders with distance 
correction if monovision failed. In this sample, there were greater issues with poor near vision rather 
than poor distance vision for multifocal and toric lens wearers seen in the study by Sulley et al. 
(2017). The prescriptions for patients in this subgroup of CLDO were not recorded to determine if 
limitations in available parameters was a factor in CLDO. In addition to the possible requirement 
for specialist CLs ordering for higher prescriptions, patients with complex prescriptions may require 
multiple fit appointments to optimise vision, and face higher costs and order delays due to the need 




retentions rates included higher lens power perhaps for improved cosmesis in those image-
conscious, spherical versus multifocals CLs, and quarterly versus adhoc suppling of CLs.  
 
A higher incidence of end of day dryness symptoms has been reported amongst CL wearers versus 
non- CL wearers that resolve following lens removal (Chalmers & Begley, 2006; Begley et al., 2001; 
Guillon & Maissa, 2005b; Nichols et al., 2005). The types of discomfort associated with CLDO 
include dryness, general awareness, edge sensation and burning or stinging (Young et al., 2002). 
Pucker et al. (2019) found that self-reported symptoms of discomfort and clinical signs of 
Meibomian gland dysfunction including worsening grade of meibum expressibility and quality, and 
Meibomian gland tortuosity had predictive value for CL dropout amongst subjects, albeit recruited 
from academic settings and aged 18 to 45 years. The current study did not assess dry eye in CL 
patients as dry eye metrics including fluorescein tear break-up time were not routinely carried out 
or recorded within the patient records.  
 
Another factor that was not recorded was the type of CL cleaning solution used for reusable CLs, 
which can impact comfort. CL solutions containing polyhexadine and polyquaternium-1 when used 
to clean various silicone hydrogel materials have been linked with increased rates of ocular surface 
staining compared with use of hydrogen peroxide disinfecting solution (Carnt et al., 2009). It is 
possible that varying reusable silicone hydrogel CL and lens solution combinations could have been 
contributing factors to CLDO due to solution- lens interactions precipitating as poor comfort. Sulley 
et al. (2017) found that no alternative lens or management strategy had been tried for 71% of CLDOs, 
which represents missed opportunities for a practice to grow their CL business, and was also seen 
in the current sample. For a practice that also offers a dry eye service, the incorporation of an avenue 
for new or lapsed CL wearers may result in retention of CL patients who dropout of CLs due to 
discomfort.  
 
Over half of patients from the sample where discontinuation of CL wear was suspected were 
classified as “false” CLDOs (54.2%), that is not ceasing lens wear due to issues associated with CLs. 
The primary reason for CLDO in this subgroup was no longer requiring CL wear following surgical 
intervention (42%). Customer switching (29%) and relocation (19%) were other reasons to explain 
“false” CLDOs. A series of process errors and areas of improvement were identified after analysing 
patient records including a means to easily record a reason for CLDO and template to record dry eye 
metrics for CL patients. CL appointment reminders were still being generated for patients who had 
communicated relocation or who had ceased CL wear due to surgical intervention for up to three 





The General Optical Council (GOC), which regulates the optical profession in the UK, 
commissioned consumer research by the Bostock Marketing Group Ltd. to understand the behaviour 
of UK adult CL wearers (Turner, 2016). A total of 2043 people took part in an online survey with 
68% of respondents having only ever bought CL in-store, 8% having only ever bought online, and 
22% having bought CLs both in-store and online (Turner, 2016). The latter group may represent 
customers prone to switching service providers, and so it is important to understand the profile of 
this segment of patients and what can be done to retain them as customers. In the current study, 29% 
of “false” CLDOs were due to customer switching with an average age of 38.9 ± 16.0 years with 
some records stating that CLs were purchased elsewhere although it is unclear if they were purchased 
online. Approximately half of respondents from the online survey who viewed CLs as a cosmetic 
rather than healthcare or lifestyle product were more likely to shop around for competitively priced 
CLs and were less likely to attend for CL check-ups at least once a year (Turner, 2016).  
 
Socio-economic and demographic variance has been found in CL in-store and CL online buyers 
(Turner, 2016).  In the GOC 2015 CL Survey, online buyers were more likely to be aged between 
25 and 44, in part-time employment and more likely to live in London and “multicultural 
metropolitans” (Turner, 2016). The reasons behind decision-making for primarily online buyers 
included price (37%), convenience (23%), and value for money (19%) (Turner, 2016). CLs are a 
significant part of optometric business and practitioners could learn from these insights by 
simplifying their processes for CL ordering, and offering an online platform for CL supply and home 
delivery plans via their practice. In-store buyers were more likely to be aged 45 and over, and retired 
or long-term unemployed, choosing to purchase CL in-store because of the relationship with their 
practitioner (23%), convenience (16%) and habit (13%) (Turner, 2016). Barriers to this group of 
patients in buying CL online included not knowing their CL specification or how to find the specific 
CL they needed (Turner, 2016). The remaining respondents in the CL in-store buyer group chose to 
not purchase CL online because they were satisfied with the level of customer service in-store, they 
preferred to buy CL in person or would not trust an online supplier (Turner, 2016). Overall, good 
customer service and the retailer’s reputation were attributes valued greater by those buying their 
CLs in-store, and convenience and product availability were held in higher regard for those buying 
CLs online (Turner, 2016).  
 
Understanding priorities in CL purchasing from the patient’s or customer’s point of view can help 
practitioners in enhancing their CL service offerings and aid in developing strategies to retain 
customers. At the time of the analysis, BBR Optometry Ltd. had decided to trial the services of 
Adaro Optics who provide CL product supply chain solutions to manufacturers, practitioners and 
patients. Through practice-controlled home delivery, a preferred combination of CLs from one 




designed to fit through letterboxes. Adaro Optics adopt the practice’s brand identity to facilitate an 
association of the products with the practice and serves to enhance customer loyalty. Utilisation of 
a service such as Adaro Optics enables practices to achieve time efficiencies by enabling CL product 
ordering through one versus multiple suppliers, and can support direct debit payments for regular 
deliveries to patients. 
 
In the GOC 2015 CL Survey, the majority of CL wearing respondents said they attended for CL 
check appointments yearly (54%), whilst 21% attended more than once a year, and 16% attended 
every two years (Turner, 2016). The subgroup of patients likely to be overdue for a CL check rather 
than represent a true CLDO made up 10% of the “false” CLDO sample at BBR Optometry Ltd. 
These patients had a previous history of attending CL checks at the same time as their yearly eye 
examinations rather than in accordance with recommended recalls of six months set at BBR 
Optometry Ltd. for EyelifeTM members. With convenience at the forefront of attributes important to 
CL wearers especially those purchasing CLs online, the frequency of aftercare visits needs to be 
considered to avoid unduly inconveniencing CL wearers whilst allowing early detection and 
successful management of any adverse changes related to CL wear.  
 
British legislation allows the optometrist to set the period of validity of a CL prescription (GOC, 
1989; BCLA & GOC). In the early days of CL dispensing, there was a cautious approach with CL 
check intervals set frequently due to previous experiences with rigid CLs that required numerous 
review visits to refine lens fitting and monitor adverse reaction such as central corneal oedema 
(Efron & Morgan, 2017). Efron and Morgan (2017) suggest an appropriate aftercare schedule and 
rationale based on lens replacement frequency, lens type, wearing modality and predicted rate of 
refractive change. For neophytes, an aftercare within one to two weeks of CL dispensing is advised 
followed by a further appointment within the first two months (Efron & Morgan, 2017). Thereafter, 
a two-year recall is recommended for soft daily disposable CL wearers due to the lower associated 
risk of keratitis (Efron & Morgan, 2017). A yearly CL check is recommended for soft daily reusable 
CLs, rigid CLs daily wearers and presbyopic changes to address solution reactions and compliance 
issues, eyelid ptosis and corneal deformation risk, and progressive accomodative loss respectively 
(Efron & Morgan, 2017). A six-monthly CL check is recommended for soft and rigid CL extended 
wearers to reduce the risk of keraitis, and overnight lens mucus adhesion specifically for RGP 
wearers (Efron & Morgan, 2017). Young myopes aged between five and 15 years old are also 
recommended to be seen for CL checks six-monthly due to possible myopic advances of -0.50 
Dioptres annually (Efron & Morgan, 2017). BBR Optometry Ltd. offer myopia control services 
including Orthokeratology and the fitting of MiSight 1-day CLs. The CLDO rate for patients using 





The sample of CLDOs at BBR Optometry Ltd. may not be representative of the general UK 
prospective CL wearing population, and may be more reflective of the population of patients seen 
at BBR Optometry Ltd. who often have complex needs and are presbyopic. The practice setting may 
also influence the subset of CLs patients seen. Morgan & Efron (2015) found that compared to 
national group practices throughout the UK, independent practices fit CLs to older patients, and 
undertake a higher proportion of rigid, soft extended wear and multifocal lens fits. Perhaps the 
requirement for more frequent fitting visits and need for specialist equipment for efficient rigid lens 
fittings such as topographers, radiuscopes and lens modification tools are more attuned to 
independent practice.  The sample of CLDO at BBR Optometry Ltd. were mostly female (68.0%), 
aged 45 or older (72.2%), and 91.8% were fitted with soft CLs. There was a narrow age range 
compared to other CL discontinuation studies that specified age and found that patients aged < 16 
years had an 83% first-year retention rate with motivation suspected as a reason for retention (Sulley 
et al., 2017). A trend of increase in rate of CLDO with increasing age has previously been shown 
(Dumbleton et al., 2013; Pritchard et al., 1999; Richdale et al., 2007). 
 
In retrospective chart reviews, there may be selection bias whereby assumptions regarding lens 
wearing success are filtered through the practitioner, and no means to extract patient attitude data 
that could be collected directly in a prospective study design. This study relied on the author’s 
interpretation of the outcomes recorded at the single site. It was not possible to comment on whether 
patients in this sample of CLDOs were new to or revisiting CL wear, and there were similar results 
to Sulley et al. (2017) where about one-third of wearers discontinued CL wear for unknown reasons. 
A proportion of the unknown reasons for CLDO could potentially be due to poor comfort or dryness, 
and therefore not captured as these patients would be less likely to return. In order to benchmark 
performance and improve CL service, practitioners should aim to identify CLDOs and determine 
the retention rate at their practice.  
 
Considering nearly half of new CL wearers have been shown to dropout within the first two months 
of CL fitting (Sulley et al., 2017) and within the first year as seen in the current analysis, strategies 
to check on early patient progress should be employed to retain patients. Young et al (2002) 
determined that lapsed CLs wearers mainly due to self-reported discomfort, could be successfully 
refitted with CL (77 ± 6%) and that the prime reason for subsequent dropout was dissatisfaction with 
visual performance. Short term success rates in CL retention were greatest for spherical and daily 
disposable soft CLs, and it is plausible that uncorrected astigmatism was a contributory factor to 
CLDO (Young et al., 2002). Future work could include blueprinting the CL service at BBR 
Optometry Ltd. as outlined in chapter two, to develop processes to monitor and minimize CLDO. 




that may address their initial reason for dropout such as poor vision due to limitations in available 
parameters at the time of fitting, or discomfort.  
 
In terms of strategies to grow a practice’s CL business, Mayers et al. (2019) found that offering CLs 
to patients who only wore spectacles at the time of frame selection positively impacted conversion 
rate and eyewear spend (20% more), and the likelihood of proceeding with CL fitting compared to 
patients not given the option. Some patients assigned to the test group declined participation in the 
market research survey because they were happy with their spectacles (45%), there was a fear 
associated with lens insertion (26%), there was a prior negative experience with CLs (14%) or lack 
of time (8%) (Mayers et al., 2019).  All participating subjects were able to wear CL successfully 
during the eyewear selection process with two-thirds being aged 40 years or older, 50% requiring 
presbyopic correction and 30% requiring correction for astigmatism (Mayers et al., 2019). A 
complimentary in-practice limited time trial allows an opportunity for the practitioner to demonstrate 
the benefits of new CL designs and materials, and for patients to move beyond concerns associated 
with CL wear. This attempt to close provider gap four or the communication gap referenced in 
chapter two, could help in situations where the practitioner is reluctant to promote CL wear for fear 
of being perceived as being forceful, whilst the patient may be reluctant to ask about their suitability 
for CL wear if not mentioned by the practitioner. Another approach would be to apply the EASE 
method as outlined by Atkins et al. (2009), which has shown to increase the uptake of CLs wear by 
33%.  
 
There were no large dominant groups to categorise reasons for dropout or trends in which CL 
products were worn at the time of CLDO in this study. For some patients, the benefits of CL wear 
in comparison to spectacle wear presumably do no outweigh factors such as cost and convenience. 
Cost or expense has been shown to be a reason for CLDO three months or more after fitting (Sulley 
et al., 2017). There were a large proportion of patients who discontinued using CL services at the 
practice but did not necessarily discontinue CL wear permanently. It is possible some people may 
dip in and out of CL wear to suit their lifestyle. Patients have been shown to resume or revisit CL 
wear for reasons such as resolved discomfort and irritation, cosmetic appearance, for work or leisure 
pursuits, simpler care regime, improved finances, and changes to general and ocular health 
(Pritchard et al., 1999). The development of drug eluting CLs and utlisation of CL as drug delivery 
systems with biosensing capabilities may further transform the profile of CL wearers with CL being 
worn to address therapeutic needs in addition to offering spectacle-free options to enhance vision 
(Alvarez-Lorenzo et al., 2019; Choi et al., 2019). Mariño-López et al. (2019) have synthesized a 
hybrid hydrogel-based soft CL that features the integration of gold-based plasmonic silica-shelled 
nanocapsules for applications in electromagnetic shielding. The hybrid lens material has high optical 




safety eyewear (Mariño-López et al., 2019). A new motivation for CL wear could be to provide daily 




It is important to stress that the findings in the current analysis are specific to a sample of CLDOs 
from a single site with an older demographic, and are not generalizable across the UK population. 
Larger studies involving multiple sites would be required for comments on general trends observed 
amongst CLDOs. There were no strong patterns to link CLDO to dry eye or to a particular CL 
product or product range. Perhaps the observation of no clear trend in reasons for CLDO and the 
greater number of “false CLDOs” suggests that the profile of the CL patient has changed. Rather 
than losing CL patients due to dry eye, patients may be more inclined to shop around and/or flexible 
in their CL wearing schedule. Patients may prefer a mixture of spectacle and CL wear, deciding to 
wear CLs when it suits them with daily disposables a viable choice for infrequent wear. Patients 
with dry eye have been known to present to eye casualty, and represent a subset of people that could 
be managed and potentially served better within community private practice. The proportion of 
people presenting to eye casualty that could have been managed in private practice will be explored 
























CHAPTER 6 ABSTRACT 
Retrospective analysis of first-time presentations to a hospital  
eye casualty department  
 
PURPOSE: To demonstrate the role of optometrists in alleviating the burden on NHS 
ophthalmology services through local schemes and perhaps private optometric services in the future, 
such as a dry eye clinic.  
 
METHODS: Records of first-time presentations to the eye casualty department at Hereford County 
Hospital in January 2018 were analysed sequentially. After grouping patients based on condition 
diagnosed by the practitioner in eye casualty, and using the reason for visit and College of 
Optometrist guidance on urgency of referrals list by conditions as reference material, the quality or 
appropriateness of the optometrist referral was assessed and deemed warranting emergency or same 
day referral. After grouping conditions diagnosed in eye casualty as a result of referrals from general 
practitioners (GPs), the patient’s reported reason for visit including history and symptoms were 
compared to the Primary Eye-care Assessment and Referral Service (PEARS) criteria for inclusion. 
After grouping conditions diagnosed in eye casualty as a result of self-referrals in a similar manner 
to the College of Optometrists clinical management guidelines (CMGS), the patient’s reported 
reason for visit was compared with the PEARS criteria for inclusion. Cases that were reviewed in 
eye casualty were grouped into those conditions that were suitable to be seen by an ophthalmologist, 
optometrist or IP-optometrist. 
 
RESULTS: There were 207 (49.2%) females and 214 (50.8%) male first-time presentations to the 
department. The mean, median and mode ages respectively were 53.7 ± 22.5, 58 and 68 years, and 
patients’ ages ranged from six months to 102 years. 69% of optometrist referrals were appropriate 
for same day, and the others were appropriate but not for same day referral. 92% of patients 
presenting from GP referrals could have been assessed via PEARS with only 30% requiring onwards 
referral to ophthalmology. 83% of patients could have been assessed via PEARS with only 17% of 
cases requiring onwards referral to ophthalmology. 66% of patients attending eye casualty for 
follow-up could be seen within the community, although nearly half of conditions seen would 
potentially require an IP qualification to manage. 
 
CONCLUSIONS: Considering the total number of cases in January 2018 that could have been seen 
within the community via PEARS from a GP or self-referral either as a first-time presentation or for 
review, the amount of savings to the Wye Valley NHS Trust would have been approximately £46, 
405.00. The retrospective analysis highlights the value of local optometric community services to 
address acute ocular symptoms or eye-related concerns, and the value of an IP- qualification in 






















Retrospective analysis of first-time presentations to a hospital  
eye casualty department  
 
6.1: Introduction 
According to the annual publication on Accident and Emergency (A&E) activity in English National 
Health Service (NHS) hospitals and English NHS-commissioned activity in the independent sector, 
there were 23.8 million attendances in A&E covering the financial year ending March 2018, which 
has increased by 22% when compared to the period ending 2009. Approximately 3.2% of A&E 
diagnoses reported in the periods September 2017 to March 2018 were ophthalmology-related (NHS 
Digital, 2018). General A&E departments and dedicated eye casualty departments both provide 
emergency eye care for ophthalmic complaints in the UK with variations in the way they operate 
based on the needs of the local community, size of the population and the resources available to the 
local clinical commissioning groups (CCGs). London’s two largest emergency eye units, Moorfields 
Eye Hospital and the Western Eye Hospital, have seen annual attendances rise by 7.9% and 9.6% 
per year respectively (Smith et al., 2013). Alongside the increasing demand for urgent eye care is 
the risk of delays and poor visual outcomes for those waiting for treatment or monitoring as seen in 
the management of chronic ocular conditions demonstrating a lack of capacity within the hospital 
eye service (Foot & MacEwen, 2017).  
 
The Way Forward project commissioned by the Royal College of Ophthalmologists highlights the 
growing demand for emergency eye care with rising attendances thought to be due in part to an 
ageing population with higher life expectancy and a shift in health seeking behaviour to favour 
emergency secondary care (RCOphth, 2017). It is thought that the 2004 change to the General 
Practice out-of-hours contract and the implementation of the A&E 4-hour wait target contributed to 
A&E becoming the perceived primary route for emergency care by patients (RCOphth, 2017).  There 
are different models of dealing with emergencies that suit different volumes of patient flow including 
slotting acute patients into clinic, acute referral clinics, daytime walk-in services and 24 hours walk 
in emergency eye services (RCOphth, 2017). Daytime eye casualty services offered by many NHS 
trusts distinct from the main emergency department or minor injuries units are potentially open to 
abuse with frequent attenders or those with chronic ocular conditions circumventing the wait for an 
outpatient appointment in general clinic by attending inappropriately.  
 
Herefordshire is a predominately rural county located in the south-west of the West Midlands region 
bordering Wales with the fourth lowest population density in England (0.87 persons per hectare) 
and a current estimated resident population of 189,500 (Herefordshire Council, 2018). Herefordshire 
in particular has an older age structure than England & Wales as a whole, with 24% of the population 




Hereford is situated in the middle of the county where almost one third of the county’s residents 
live, and is the centre for most amenities (Herefordshire Council, 2018). The Hereford County 
hospital part of the Wye Valley NHS trust is one of the smallest rural district general hospitals in 
England and has seen an average of 5664 eye casualty attendances each year over the last five years 
(EMIS health, UK).  
 
The current service design in Hereford is a daytime walk-in service and has taken on the 
organisational strategy to manage demand by recognising the benefits of utilising optometrists 
within the community who demonstrate the initiative to upskill. Community optometrists in the 
department act as the primary reference point for acute eye problems and help to reserve secondary 
care for higher complexity cases. The department also utilises nurses with experience in 
ophthalmology who triage and prioritise cases on arrival to ensure emergency cases and complex 
clinical problems are seen first, and non-urgent cases redirected to their general practitioner (GP) or 
optometrist to reduce waiting times. The nurses take the initial ophthalmic and general medical 
history, undertake testing of visual acuity and other initial investigations such as pupil responses and 
instil dilating drops when required. It has been suggested that ophthalmic nurse practitioners (ONPs) 
may be better suited to assess emergency ophthalmic complaints than junior doctors in A&E 
departments, and are effective in reducing the workload of eye casualty departments (Jones et al., 
1986; Banerjee et al., 1998; Read & George, 1994; Ezra et al., 2005). In Hereford, there are 
opportunities for optometrists to have case-based discussions with consultants via NHS email and 
telephone, and to sit in with consultants during clinics to improve their clinical decision-making 
skills and ultimately reduce the demand on emergency eye care. The emergency ophthalmology 
consultant lead holds one-to-one sessions with optometrists in an emergency clinic one half day per 
week in three-month blocks.  
 
The role of optometrists is changing with referral refinement schemes, pre- and post- operative 
cataracts schemes and independent prescribing taking the pressure off secondary care. Hospital 
optometrists have proven to be competent in working in an A&E setting (Hau et al., 2007), and eye 
health care in community practice has evolved so that optometrists can diagnose and manage more 
ocular conditions (Parkins et al., 2014). The Department of Health in the UK has granted suitably 
trained optometrists the rights to extend their therapeutic prescribing capabilities in the form of 
independent prescribing (Buckley et al., 2005) allowing them to prescribe any drug from the British 
National Formulary for any condition affecting the eye and adnexa as long as it is not a controlled 
drug or requires parenteral administration, and providing it is within the prescriber’s scope of 
practice. Non-medical prescribing is seen across the NHS in all four countries, and in other 
professions including nursing, pharmacy, podiatry, physiotherapy and radiography (National 




Herefordshire based on the General Optical Council register at the time of this analysis who can 
prescribe any licensed medication except for controlled drugs or medication for injected medication 
for conditions affecting the eye and the tissues surrounding the eye within the practitioner’s 
recognised area of expertise and competence. Independent prescribing for optometrists was 
introduced in June 2008 with the Commission on Human Medicines making it clear that the extent 
of IP for optometrists would be supported by clinical management guidelines from the College of 
Optometrists, which are regularly updated (College of Optometrists, 2018). Prior to the March 2017 
renewal period, there were 499 optometrists listed on the General Optical Council’s (GOC) IP 
specialty register representing 3.3% of all GOC registered optometrists with around 57% of IP 
optometrists based in England (GOC, 2017). An NHS Education for Scotland initiative to shift the 
balance of care out of hospitals and into the community has led the issuing of NHS prescribing pads 
to trained IP optometrists in 2013, who can manage patients in primary care at no cost to the patient 
(Parkins et al., 2014). The Hereford County hospital ophthalmology department support 
optometrists in becoming IP qualified by offering clinical placements that makes up the second stage 
of qualification. In this phase, optometrists have exposure to different ocular complaints, which will 
aid future referral decisions from community practice and direct clinical decision making in the 
community. In order to register as an IP optometrist, the optometrist must have been qualified and 
practicing in the UK for at least two years, complete a course offered from one of five universities, 
complete a 24-session clinical placement of not less than three hours (12 days) documented in an 
online logbook to be verified by the supervising ophthalmic consultant, and pass the College of 
Optometrists’ therapeutics common final assessment which is made up of 75 multiple choice 
questions grouped into patient scenarios. 
 
The Primary Eye-care Assessment and Referral Service (PEARS) is an NHS-funded intermediate-
tier service providing timely optometric assessments of those presenting with acute eye conditions. 
The aim of PEARS is to reduce unnecessary referrals to the hospital eye service, increase capacity 
within the overburdened hospital eye health services and provide a more cost-effective service with 
a greater number of patients being retained and managed appropriately within the community 
(LOCSU, 2016). Patients presenting to their GP with an eye problem and satisfying specific 
inclusion criteria are referred to accredited community optometrists.  There is no requirement for 
the optometrists participating in PEARS to be IP qualified. Under the Entry Level Medicines Act 
exemptions, registered optometrists without an IP qualification can sell or supply all medicinal 
products on a General Sale List and all pharmacy medicines including ocular lubricants, topical and 
systemic anti-allergy agents, and freely prescribe certain topical antibiotic drugs via a signed order 
(College of Optometrists, 2018). Large numbers of community optometrists commonly supply and 
recommend over-the-counter drugs, particularly ocular lubricants, topical anti-histamines and mast 




optometrist without a GP referral. In order to participate in PEARS, optometrists must complete two 
parts of training and accreditation, which is based on the course used to train PEARS providers in 
Wales. Part one is a series of distant learning lectures for theoretical training that involves online 
multiple-choice testing, and part two is the practical station assessment organised by the 
participating local optical committee and the Wales Optometry Postgraduate Education Centre 
(WOPEC). Successful completion allows accreditation to PEARS and a total of 14 continuing 
education and training (CET) points, which help practitioners earn the number of CET points 
required in a three-year cycle that is a statutory requirement for all fully-qualified optometrists and 
dispensing opticians. The service was renamed to the Minor Eye Conditions Service (MECS) but 
will be referred to as PEARS throughout this chapter as it continues to be referred to by local 
Herefordshire practitioners. A number of PEARS and similar schemes have been introduced across 
the UK demonstrating clinical safety, easing overstretched hospital eye services by reducing 
referrals, and increasing patient’s accessibility resulting in high patient satisfaction (Cottier, 2015; 
Craven, 2015; McCracken, 2013; Sheen et al., 2009; Greenwood, 2013). The purpose of this 
retrospective analysis was to determine how many people presenting to the Hereford County 
Hospital Eye Casualty department could be managed in community optometric practice under 




Records of first-time presentations to the eye casualty department at Hereford County Hospital in 
January 2018 were analysed sequentially. Triage nurses in the eye casualty department document 
by hand all presentations to the clinic in a large binded book including details such as date seen, 
source of referral, the patient name, the patient identifier number and consultation outcome, that is 
not removed from the unit. The month of January was chosen as using this binded book did not 
interfere with the activity of the clinic. All completed hand written eye casualty records documenting 
details of the visit are scanned by administrative staff to the patient’s electronic record using 
Symphony software (EMIS health, UK).  The scanned records are accessible after searching for any 
given patient using their patient identifier number referred to as the RLQ. The patient’s age was 
calculated from their date of birth and the date of their visit to eye casualty. Data collection 
spreadsheets with patient identifiable information are confidential and are stored in line with 
information governance requirements and remain within the Wye Valley trust firewall. Patient 
details were not included in the data analysis file. A decoding file with the relationship between 
audit identification number and patient identification is held separately from the data analysis file to 
minimise information governance risk and provides a mechanism for returning back to the patient 





This analysis received approval from the Life and Health Sciences Ethics Committee at Aston 
University (Project #1276) and adhered to the tenets of the Declaration of Helsinki. Analyses were 
deemed as clinical audits, and full hospital ethical approval was not required. However, tenants of 
Helsinki were adhered to and anonymised information was audited. The online decision tool from 
the NHS Health Research Authority also determined that approval from the NHS Research 




In January 2018, there were 581 presentations to the Hereford County eye casualty department 
according to the triage nurses’ records. Data analysis was carried out on 421 records and 160 records 
were excluded for several reasons represented in figure 6.1. Records were excluded if they were not 
first-time presentations to the department and were follow-up appointments (n=128), and if there 
were administrative errors such as incomplete notes, no scanned notes available or repeat entries 
(n=15). Other entries were excluded from analysis because they were illegible (n=12) or because the 
patient did not wait to be seen (n=4). One record was excluded because it represented an existing 




Figure 6.1: Reasons for excluding data from 160 records in analysis of first-time presentations to 
Hereford County hospital eye casualty department in January 2018. 
 
There were 207 (49.2%) females and 214 (50.8%) male first-time presentations to the department. 
The mean, median and mode ages respectively were 53.7 ± 22.5, 58 and 68 years, and patients’ ages 
ranged from six months to 102 years (figure 6.2). There were 32 cases under the age of 16, and a 







Figure 6.2: Age demographics for first-time presentations to Hereford County hospital eye casualty 
department in January 2018. 
 
A large proportion of presentations were self-referrals (n=300), with GPs (n=50) and optometrists 
(n=51) accounting for about 12% each of emergency referrals (figure 3). The remaining sources of 
referrals were from Hereford County hospital’s general accident and emergency (n=11) department, 
other Hereford County hospital wards (n=4; paediatrics, clinical assessment unit, neurology) and 
other hospitals (n=5). The majority of cases were seen by ophthalmologists not in training (n=222), 
followed by ophthalmologists in training (n=140), independent prescribing optometrists (n=42) and 
consultant ophthalmologists (n=16) (figure 6.3). 
 
 
Figure 6.3: Distribution of source of referrals to Hereford County hospital eye casualty department 







One of the records did not specify who saw the patient. During the time period for which the analysis 
was conducted, there were seven ophthalmologists not in training, seven ophthalmologists in 
training, two independent optometrists working in eye casualty under the supervision of 
ophthalmology staff, and four consultants. Some records were annotated to include details of 
whether the case was discussed with a more senior member of staff. Of the cases seen by 
ophthalmology trainees, 10 records (7%) were annotated to say that the patient was also discussed 
with or seen by a more senior colleague. Of the cases seen by ophthalmologists, 11 records (5%) 
were annotated to say that the patient was also discussed with or seen by a colleague. Of the cases 
seen by independent prescribing optometrists, nine records (21%) were annotated to say that the 
patient was also discussed with or seen by a consultant. At the time of the analysis, one of the 
optometrists had been IP qualified for nine months and the other for one month perhaps accounting 
for the larger number of cases where a colleague was consulted. It is also possible that more cases 
were seen by consultants who were acting as mentors for the IP optometrists.  
 
The data collected was organised by source of referral. The conditions seen and diagnosed in eye 
casualty as a result of optometric referral are shown rather than the provisional diagnoses from 
optometrist referrals as the original referral letters were not scanned to the records and the suspected 
diagnosis from the optometrist was not always listed (figure 4). Identified with spectacle icons in 
figure 6.4 are the conditions that could be treated with pharmacological intervention, which an IP 
optometrist could initiate according to the College of Optometrists clinical management guidelines 
(CMGs) at the time of the analysis, and this made up 33% (17/51) of cases. That is not to say that 
contact lens related ulcers could not be managed by an optometrist or IP optometrist but depending 
on the location and size of the infiltrate, it may be more appropriate to refer suspect microbial 
keratitis cases in contact lens wearers to eye casualty for a corneal scrape for culture and 
determination of antibiotic sensitivities. A foreign body could also be managed in the community 
by an optometrist or IP optometrist if they are confident to do so, have a means to dispose of sharps 
if hypodermic needles are used, and the foreign body has not penetrated into the stroma. Following 
removal of the foreign body the optometrist could advise on the use of ointment for ocular 
lubrication or consider over-the-counter topical antibiotic prophylaxis which would not require an 
IP qualification. The purpose of the College of Optometrist CMGs is for optometrists to ensure that 
any referral decision falls within accepted advice, and are referred to if any investigation into 
practice is instigated. The CMGs were created in 2008 when optometrists first gained independent 
prescribing status. The information on the CMGs is succinct covering aetiology, predisposing 
factors, symptoms, signs, differential diagnosis, management by an optometrist (non-
pharmacological and pharmacological), management category, possible management by an 






Figure 6.4: Conditions diagnosed in Hereford County hospital eye casualty department in January 
2018 as a result of optometric referral. Identified with spectacle icons ( ) are the conditions 
that could be managed with pharmacological intervention potentially by an IP optometrist, making 
up 33% (17/51) of cases. HSK= herpes simplex keratitis, PVD= posterior vitreous detachment, 
RVO= retinal vein occlusion.  
 
Of the conditions that could have been treated by an IP optometrist assuming agreeance on diagnoses 
between hospital and community practitioners, 59% (10/17) of cases were actually treated with 
prescription medication. The conditions treated were blepharitis, anterior uveitis, non- contact lens 
related corneal ulcer, herpes simplex keratitis, and marginal keratitis. Perhaps the non-contact lens 
related corneal ulcer case could have been categorized as a marginal keratitis, however, the diagnosis 
was not recorded as such and there were no notes to make this assumption. Also, there were no 
medications prescribed for dry eye that were not available over-the-counter aside from one case 
where Pilocarpine 1% was prescribed for a secondary eye condition.  
 
After grouping patients based on condition diagnosed by the practitioner in eye casualty, and using 
the reason for visit and College of Optometrist guidance on urgency of referrals list by conditions 
as reference material, the quality or appropriateness of the optometrist referral was assessed and 
deemed warranting emergency or same day referral. I found about 69% were appropriate for same 
day referral and the others were appropriate but not for same day referral. A limitation to the 
retrospective analysis is knowing whether or not the patient was actually referred same day due to 
lack of original referral letters from optometrists or whether the patient admitted themselves to eye 
casualty rather than waiting for an appointment in the general eye clinic. Additionally, patients 
presenting to their local optometric practice participating in the PEARS scheme may have failed to 




patient may not have been seen by an optometrist, the source of referral in the nurse triage book may 
still have been recorded as “optometrist.”  
 
Conditions that did not require emergency referral may have presented to the optometrist with an air 
of urgency by the patient, or the suspected diagnosis was different from the final diagnosis in eye 
casualty. For instance, a four-year-old female patient was referred with “query phylenticular 
conjunctivitis requiring steroid treatment” who was later diagnosed with blepharitis and discharged. 
It is suspected the age of the patient and presentation although there are no notes on symptoms or 
signs, dictated the optometrist’s decision to refer. The number of PEARS appointments allocated for 
dry eye and blepharitis patients in the county is limited in order to avoid the scheme being used as a 
dry eye management service with one follow-up appointment permitted for dry eye patients and no 
follow-up appointments for anterior blepharitis. The College of Optometrists CMG for dry eye 
(2018) only recommend an urgent (i.e. within one week) if Stevens-Johnsons syndrome or Ocular 
cicatricial pemphigoid are suspected but not a same day, emergency referral. From the two 
blepharitis cases that did not require emergency referral, it would seem first line non-
pharmacological management did not offer improvement in symptoms and onwards referral to 
ophthalmology led to the prescribing of systemic tetracyclines. One case diagnosed with dry eye 
was actually referred to eye casualty for unexplained bilateral blurred vision and poorly reacting 
pupils. The patient was also awaiting surgery for bowel and liver cancer, and was issued with ocular 
lubrication and booked in to general clinic for visual field testing reflecting the complexity of the 
presentation.  
 
Other conditions diagnosed in eye casualty that did not require same day referral included atrophic 
hole, cataract, marginal keratitis, and a retinal vein occlusion. In both atrophic hole cases, the 
patients were asymptomatic and discharged but one could justify the referral if a retinal hole was 
suspected. Superficially, a diagnosis of cataract from an emergency optometric referral would raise 
criticism given established pre- and post-operative cataract referral schemes in the county, however, 
this one case was not straightforward. The reported reason for referral listed a dull ache, blurred 
vision and raised macula in the operated eye two months post-cataract surgery, with a note of 
bilateral glaucoma and previous retinopexy for a retinal tear in the fellow eye. One could assume 
that the optometrist did not have access to OCT imaging to rule out cystoid macula oedema and it 
may have been more appropriate to refer the patient urgently on the wet age-related macular 
degeneration rapid access scheme. The record for this indicates the patient required fellow eye 
cataract surgery and was discharged, so one can only assume the eye casualty practitioner 
determined there was no intraretinal fluid and the achiness reported was due to induced 
anisometropia. According to the College of optometrist CMGs (2018), marginal keratitis is self-




symptoms and shorten the clinical course, and can be referred to ophthalmology if persistent or 
recurrent but no level of urgency for the referral is indicated. The assumption would be that the cases 
noted here were not resolving and pharmacological intervention was prescribed in eye casualty for 
both cases.  The retinal vein occlusion case was referred onwards for fundus fluorescein angiography 
from eye casualty, however, the College of Optometrists guidance C205a and C205b (2018) indicate 
an urgent versus emergency referral for a central retinal vein occlusion where the intraocular 
pressure is less than 40 mmHg and in this particular case, the patient presented over 12 hours from 
the onset of symptoms (table 6.1). There were two cases with uncertain diagnoses that both were 
appropriate referrals but perhaps as urgent versus same day referrals according to the College of 
Optometrist guidance. They were query suspect retrobulbar optic neuritis and sudden onset diplopia 
following a sports-related concussion.  
 
Conditions that did require emergency referral were warranted where, pharmacological intervention 
could not be initiated by an optometrist in the cases of anterior uveitis or Herpes simplex keratitis, 
patients were symptomatic in the presence of a suspect retinal hole, corneal scrapes were carried out 
in the presence of contact lens related corneal ulcers, suspected papilloedema in symptomatic 
patients later diagnosed with disc drusen, and foreign body removal. Other appropriate referrals 
included conditions suggesting a retinal tear including a case of dysphotpsia post-cataract surgery 
and posterior vitreous detachments, actual retinal tears, intermediate uveitis, the appearance of an 
iris hook in the anterior chamber of a patient with history of bilateral intraocular lens subluxation, a 
case diagnosed as Mooren ulcer following presentation of severe ocular pain, preseptal cellulitis in 
a child, and vitreous haemorrhages. There was an odd diagnosis of refractive error where sudden 
loss of vision was noted and therefore suggestive of an emergency. There is mention of a two-line 
drop in visual acuity following a head injury five weeks prior to the onset of symptoms by the 
optometrist. Perhaps due to the unexplained reduction in visual acuity and recent trauma, the 
optometrist referred to secondary care where no sight threatening pathology was found. Similarly, 
in a case diagnosed in eye casualty as uncertain, there were notes of unexplained reduction in visual 
acuity and headaches with the patient reporting onset of new floaters. This patient was referred by 










Table 6.1: Urgency of referrals from College of Optometrist’s guidance C205a and C205b if 
symptoms or signs suggest the conditions listed (https://guidance.college-
optometrists.org/guidance-contents/communication-partnership-and-teamwork-domain/working-
with-colleagues/urgency-of-referrals/ accessed 11/10/2018).  
After grouping conditions diagnosed in eye casualty as a result of referrals from GPs, the patient’s 
reported reason for visit including history and symptoms were compared to the PEARS criteria for 
inclusion, and it was determined 92% could have been seen by an optometrist on the scheme. Based 
on the diagnosis in secondary care against the College of Optometrists’ CMGs, it was determined 
that 57% of the 92% could have been managed by an optometrist and a further 13% if 
pharmacological intervention was required and the optometrist was IP qualified (figure 6.5). An 
additional 30% would have been referred to ophthalmology although perhaps not on the same day. 




inclusion onto PEARS renamed to MECS (LOCSU, 2016). Presentations were PEARS appropriate 
if the following symptoms were experienced within the last two weeks: loss of vision including 
transient loss, foreign body and emergency contact lens removal (not by the fitting practitioner), 
sudden onset of blurred vision but always consider if a sight test would be more appropriate, ocular 
pain or discomfort, systemic disease affecting the eye, differential diagnosis of red eye, dry eye, 
epiphora, trichiasis, differential diagnosis of lumps and bumps in the vicinity of the eye, recent onset 
diplopia, retinal lesions, and patient reported field defects. If symptoms of flashes and floaters were 
experienced within the last six weeks, these cases could also be claimed on PEARS. GPs can also 
refer into the scheme whereby participating optometrists must be able to offer an eye examination 
within 48 hours or within two weeks if it is a routine referral. If the participating optometrist does 
not have an appointment available, then they must refer to their nearest colleague. PEARS 
exclusions include use of the scheme to claim for cases of diabetic retinopathy, adult squints, 
longstanding diplopia, and repeat field tests to aid diagnosis following an eye examination.  
 
 
Figure 6.5: Conditions diagnosed in Hereford County hospital eye casualty department in January 
2018 as a result of GP referral. Analysing the patient reported reason for visit and diagnosis in eye 
casualty against criteria for PEARS inclusion revealed 92% of first-time presentations could have 
been seen by an optometrist in the community first. Of the 92%, 70% could have been managed by 
an optometrist and 30% would have been referred to ophthalmology although not all same day 
referrals. CN= cranial nerve, GCA= giant cell arteritis, NAION= non-arteritis anterior ischemic 
optic neuropathy, No abnorm= no abnormality, PVD= posterior vitreous detachment, SCH= 
subconjunctival haemorrhage, s oc.= without ocular.  
 
After grouping conditions diagnosed in eye casualty as a result of self-referrals in a similar manner 
to the College of Optometrists CMGs, the patient’s reported reason for visit was compared with the 
PEARS criteria for inclusion. It was determined 83% of patients could have been seen on the PEARS 




after considering the diagnosis in secondary care against the College of Optometrists’ CMGs (figure 
6.6). Disorders of the cornea (n=52) made up the majority of cases followed by trauma (n=42), the 
miscellaneous category (n=30), disorders of eyelids (n=29) and posterior vitreous detachment 
(n=29). The miscellaneous category included the following diagnoses from eye casualty: vitreous 
haemorrhage, wet and dry age-related macular degeneration, toxoplasmosis, shingles, skin rash, 
third nerve palsy, Bell’s palsy, bilateral diplopia, branched retinal vein occlusion, cataract, Cobb’s 
tufts, conformer replacement, diabetic maculopathy, intradermal naevus, iris naevus, ocular 
migraine, papilloedmea, and retrobulbar haemorrhage. Notably there were 22 cases (7.3%) that 
showed no abnormality with presenting symptoms ranging from intermittent headaches, intermittent 
loss of vision, requesting for prescription of repeat glaucoma drops, and ocular discomfort.  
 
Figure 6.6: Conditions diagnosed in Hereford County hospital eye casualty department in January 
2018 as a result of self-referral. Analysing the patient reported reason for visit and diagnosis in eye 
casualty against criteria for PEARS inclusion revealed 83% of first-time presentations could have 
been seen by an optometrist in the community first. Of the 83%, 83% could have been managed by 
an optometrist and 17% would have been referred to ophthalmology although not all same day 
referrals. 
 
There were two referrals from Hereford County hospital’s paediatric ward, one from neurology and 
one from the clinical assessment unit. One patient had received an MRI scan and was referred to eye 
casualty to rule out causes of retrobulbar inflammation noted. The patient was seen by the lead 
consultant ophthalmologist for the department where venous malformation behind the right eye was 
suspected following interpretation of the MRI and valsalva movement. The patient was experiencing 
more frequent headaches and migraines and this diagnosis and explanation to the patient warranted 
a senior ophthalmologist, which was able to take place on this occasion. Perhaps this highlights the 
need for senior input availability during emergency service hours and potentially better 
communication within the hospital to direct patients to the most appropriate clinic. Locally, there 




hall hospital in Abergavenny for chemical trauma. Birmingham hospital also requested 
ophthalmologic review of a child following head injury and skin graft application, and of a patient 
post-vitreoretinal surgery.  
 
After being assessed and managed by the eye casualty practitioner, patients were either discharged, 
a follow-up appointment in eye casualty was arranged or they were referred to another subspecialty 
service. In analysing the outcomes, it was found that 59% of first-time presentations to eye casualty 
were discharged after their initial visit, 22% were referred for follow-up to a specialist or general 
clinic and 20% were given appointments for follow-up in eye casualty. Conditions that were 
discharged included chalazion, blepharitis, dry eye and Meibomian gland dysfunction, 
subconjunctival haemorrhage, episcleritis, viral and bacterial conjunctivitis, corneal abrasion, 
recurrent uveitis, mild post-operative inflammation, and posterior vitreous detachment. Other cases 
discharged were those relating to chemical trauma due to hair dye and nail glue, blunt trauma, and 
foreign body and rust ring removal.  
 
Cases that were reviewed in eye casualty were grouped into those conditions that were suitable to 
be seen by an ophthalmologist, optometrist or IP-optometrist. It was determined that about 66% of 
patients attending eye casualty for follow-up could be seen within the community for example, 
review of resolving recurrent uveitis (figure 6.7). Subdividing review cases that could be seen within 
optometric community practice into IP and non-IP optometrists as well as considering cases where 
repeat prescriptions and co-management with ophthalmology may be required, 49% of conditions 
would potentially require an IP qualification to manage. The conditions requiring follow-up in eye 
casualty that could potentially be managed in the community were anterior uveitis, corneal abrasions 
for example following foreign body removal, corneal ulcer, episcleritis, and marginal keratitis. On 
average, the recommended timing for follow-up in eye casualty was 7.8 ± 6.8 days.  
 
 
Figure 6.7: Distribution of outcomes of first-time presentations to the Hereford County hospital eye 
casualty department in January 2018. The majority of cases (66%) could potentially be followed up 




6.4: Discussion  
The current analysis highlights the value of local optometric community services to address acute 
ocular symptoms, and the value of an IP- qualification in helping to further alleviate the burden on 
hospital emergency eye services. Pharmacological treatment could have been initiated by an IP-
optometrist in about one fifth of cases referred by optometrists, and about half of follow-up 
appointments scheduled in eye casualty could be reviewed by an IP-optometrist within the 
community. Assessing GP and self-referrals to eye casualty together showed that approximately 
85% of cases could have been managed under PEARS. Studies monitoring the activity and 
evaluating the clinical safety of a minor eye conditions enhanced service schemes similar to PEARS 
have shown that over 66% of patients could be retained in community optometric practice (Sheen et 
al., 2009; Konstantakopoulou et al., 2018; McCracken, 2013; Greenwood, 2013). 
 
Criticism to the current analysis of PEARS appropriateness and management by an optometrist 
within the community may include questioning whether in reality, the optometrist would arrive at 
the same diagnosis determined in secondary care and manage the patient appropriately. Provisional 
diagnoses were not always documented from optometrist referrals to eye casualty, and same day 
referral letters were not scanned to allow an analysis of potential areas for further optometric training 
or areas where optometrists lack confidence. Variations in presenting signs of cases affect the final 
clinical decisions on suspected diagnosis and management, which in turn is a reflection of one’s 
clinical expertise, and this could not be captured in the current analysis. Management decisions may 
also differ between secondary care and community optometrists based on the level of additional 
training, experience, and actual or perceived level of competence.  
 
There is evidence to suggest that optometrists and ophthalmologists may arrive at similar diagnoses 
and management plans. A prospective observational study carried out in the A&E department at 
Moorfields eye hospital in London over six months, showed that there was good agreement using 
weighted kappa statistics in both the diagnosis and management plan between two senior hospital 
optometrists and a consultant ophthalmologist with no sight threatening conditions being 
misdiagnosed by the optometrist  (Hau et al., 2007). There were three cases where there was an 
agreement in primary diagnosis but disagreement in referral management due to the limited 
therapeutic prescribing power of the optometrists where prescriptions for topical steroids were 
indicated (Hau et al., 2007). The optometrists without IP- qualifications in these cases referred the 
patient to be seen same day by the consultant. A service evaluation audit conducted by Bailie et al. 
(2018), also showed a trend of fair levels of agreement in management decisions for a chronic 
condition made by specialist trained optometrists and a consultant ophthalmologist within Belfast 
Health and Social Care Trust’s virtual glaucoma clinic. In all cases of disagreement, the optometrists 




in other studies where the consultant clinician is more willing to accept uncertainty (Clarke et al., 
2017).  
 
There is no information on the concordance between hospital and community optometrists’ clinical 
decision making, which could reveal areas of further training and opportunities for community 
service improvement. Community optometrists have challenges that may affect their clinical 
decision making including time constraints related to clinical chair time, and commercial pressures 
especially when working in multiple practices with traditional loss leading models that rely on high 
margin spectacle sales. Conversely, these challenges alongside more exposure to acute pathology 
and appropriate funding, may make a community optometrist well suited for emergency eye care, 
and perhaps in a dual role in hospital or within a GP surgery or pharmacy. Hospital optometrists 
may have greater scope of practice due to the advantage of working closely with ophthalmologists, 
and avoiding the discussion of professional fees with patients for services beyond PEARS criteria.  
 
 
6.4.1: Optometrist referrals  
Participation in enhanced service schemes provides exposure to more challenging clinical cases, 
allowing optometrists to utilise clinical skills to a greater extent. A qualitative study found further 
professional development was noted as the most common reason given by optometrists for 
participating in enhanced schemes whilst non-participation was due to perceived incompatibility of 
the service with the business model in a retail-focused practice and potential negative impact on the 
profitability of their business (Konstantakopoulou et al., 2014). PEARS is designed to reduce 
ophthalmology referrals with an average referral rate of about 19% reported in the UK (Cottier, 
2015; Konstantakopoulou et al., 2018). From the current analysis, 12% of emergency referrals were 
from community optometrists although it is unclear as to whether these referrals resulted from 
PEARS assessments. Optometrists are trained to differentiate between various ocular pathologies, 
assess risk, and understand the limitations of an enhanced service scheme.  Differences of opinion 
between ophthalmologists and optometrists regarding PEARS referral urgency with optometrists 
tending to refer patients with greater urgency may be due to disparities in knowledge of evolving 
treatment options for certain pathologies and clinical experience (Konstantakopoulou et al., 2018).  
 
The appropriateness of the optometrist referrals and the consistency in pharmacological 
interventions were also assessed in this analysis. Evidence-based medicine is an approach to clinical 
practice intended to optimise decision-making by using evidence from well designed and conducted 
research (Sackett et al., 1996). The Oxford centre for evidence-based medicine has created a grading 
scheme to classify the quality of scientific evidence with stronger types from systematic review of 




of evidence and yielding strong recommendations (CEBM, 2009). Case reports (level four) and 
expert opinion (level five) form the lowest level of evidence and yield weaker recommendations 
(CEBM, 2009). A prospective observational study surveyed the extent to which the activity of the 
ophthalmic A&E department in a large district general hospital (Wolverhampton & Midland 
Counties Eye Infirmary) was evidence-based by assessing the level of evidence provided for each 
diagnosis-intervention pair for new patients over the period of one week (Bhatt & Sandramouli, 
2007). Overall, 89.7% of patient interventions were based on some scientific evidence comparable 
to similar studies in an emergency ophthalmic unit (Bhatt & Sandramouli, 2007; Lai et al., 2003).  
 
A retrospective audit of diagnosis-intervention pairs at an eye casualty facility in the ophthalmic 
department of North Middlesex University hospital in London led to development of locally agreed 
guidelines and protocols (Sagoo & Raina, 2009). The study was repeated prospectively the following 
year and the authors found a decrease in the proportion of interventions with no evidence or against 
evidence, and a reduction in the number of re-attendances compared to their initial audit results 
(Sagoo & Raina, 2009). Medical versus surgical interventions accounted for a greater number of 
cases in the studies showing the value of an IP qualification for optometrists encountering acute 
ocular conditions, and the studies demonstrated that evidence-based medicine can be used to 
improve the quality of ophthalmic care in refining the standard of interventions and reducing the 
number of hospital visits (Sagoo & Raina, 2009). Table 6.2 shows conditions diagnosed in Hereford 
County hospital’s eye casualty department in January 2018 as a result of optometric referral that 
could have pharmacological intervention initiated by an optometrist, and were actually issued with 
a prescription. The numbers allocated in the second column correspond to the individual cases that 
were treated sharing the same primary diagnosis. The College of Optometrists’ suggested 
pharmacological interventions for each condition as viewed 18 October 2018 are also listed, and 
include the level of evidence and strength of recommendations according to the grading system 
developed by the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) working group. Evidence from randomised controlled trials for interventions to manage 
rare conditions may be difficult to achieve and so a proportion of clinical practice will exist that has 
little published backing. Of the conditions that could have been treated by an IP optometrist 
assuming agreeance on diagnoses between hospital and community practitioners, 59% (10/17) of 
cases were actually treated with prescription medication.  
 
Other than the management of Herpes Simplex Keratitis, there was no consistency between what 
was prescribed and the College of Optometrist pharmacological management guidelines nor with 
what was recommended for each condition. In reality, each individual case may present differently 
with varying levels of severity and the clinician needs to use their best judgment, experience and 
evidence-base when initiating treatment. Using evidence-based practice equates to clinical decision 
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making based on published evidence, the wishes and circumstances of patients, and the practitioner’s 
professional judgment (College of Optometrists, 2018). There are resources such as the College of 
Optometrists’ Optometrists’ Formulary and the British National Formulary to aid in advice 
regarding dosage. It can be difficult for a newly qualified IP community optometrist to develop a 
formulary including recommended dosing and review timings, with limited exposure to acute eye 
conditions and their management to full resolution. Clinicians may differ in their administration of 
first-line treatment as reflected in table 6.2. Practitioners must also be aware of the eye formulary 
funded by their CCG.   
Condition Prescribed in secondary 
care 
College of Optometrists’ intervention 
advice 
Interventions based on 
systemic reviews/meta-
analysis, randomised 
controlled trials and 
prospective case series 
Blepharitis 1. Blephasol od





BE + prn long-term
via GP. GP can
consider doxycycline
100mg od for 3/12 or
azithromycin 500 mg
od for 1 week then
250 mg od for 4/7 if
continues to have
problems
Staphylococcal and seborrhoeic 
blepharitis may benefit from topical 
antibiotics if not controlled by first-line 
management 
• Antibiotic ointment (e.g.
chloramphenicol) twice daily;
place in eyes or rub into lid
margin with fingertip
• topical azithromycin (NB off-
label use)
Level of evidence = moderate, Strength 
of recommendation = weak 
In patients with posterior blepharitis, 
systemic antibiotics may be effective as 
a second line treatment 
• Consider prescribing a




pregnancy, lactation and in
children under 12 years;
various adverse effects have
been reported). Such
treatment will need to be
continued for several weeks
or months and the dosage
may need to be varied from
time to time
Level of evidence = low, Strength of 
recommendation = weak 
For suspect Demodex blepharitis 
consider weekly lid cleansing with 50% 
tea tree oil (see evidence base), but this 
should be undertaken only by 
experienced practitioners as such 
preparations are toxic to the ocular 
surface. Preparations containing 4-
terpineol (an active ingredient of tea 
tree oil) are commercially available for 
patient use. 
Level of evidence = low, Strength of 
recommendation = weak 
Topical Maxitrol i.e. steroid 
& antibiotic (Shulman et al., 
1996; Jones et al., 2017) 
Topical Ofloxacin (Bron et 
al., 1991) 
Topical Chloramphenicol 
(Power et al., 1993) 
Topical Fusidic acid gel 
(Seal et al., 1995) 
Lid hygiene (Key, 1996; 
Lindsley, 2012; Sung et al., 
2018)   







1. RE Predforte qds then 
weekly tapering dose 
2. Chloramphenicol 1% 
RE qds for 7/7 + g 
Maxidex 0.1% PF RE 
hourly for 3/7, 2 
hourly for 3/7 and 
6x/day for 1 week + 
cyclopentolate 1% RE 
bd 
3. Predforte 1% hourly 
BE for 2 days and 
6x/day BE until 
review (1 week) 
4. Cyclopentolate 1% 
RE bd for 1/52, 
Maxidex 0.1% hourly 
for 3/7, 2 hourly for 
3/7, and 6x/day for 1 
week then weekly 
tapering 
First episode: 
• Topical steroid (first exclude 
herpes): e.g. gutt. 
Prednisolone acetate 1% 
hourly until eye is white or 
inflammation controlled 
• Topical cycloplegic (NB first 
check for possibility of angle 
closure): gutt. 
cyclopentolate 1% tds 
• Review frequently, tapering 
off treatment as possible; if 
no improvement at one week, 
refer to ophthalmologist 
Second or subsequent episode: 
• Reinstate uveitic therapies as 
above 
• Refer to an ophthalmologist 
for systemic review and 
possible onward referral to 
rheumatologist 
NB: do not commence treatment if 
patient is known to have a history of 
corticosteroid-induced ocular 
hypertension or has had an episode of 
hypertensive uveitis 
Level of evidence=low, Strength of 
recommendation=strong 
 
Topical steroids (Dunne & 








1. Ofloxacin 2 hourly 
RE until review in 1 
week  
See Marginal keratitis below Corneal scrapes & topical 
ofloxacin (Prajna et al., 
2001) 
 
Topical antibiotics (Bennett 
et al., 1998) 
 
Dry eyes 1. No treatment 
2. Chloramphenicol 
0.5% qds LE 7/7, g. 
Hyloforte qds 7 prn 
BE 
3. Hyloforte 4-6x/day 
BE, Viscotears 3-
4x/day BE, Xailin 
night nocte BE, lid 
hygiene advice, 
Pilocarpine 1% BE 
qds until laser due to 
incidental finding of 
bilateral narrow 
angles  
4. Hyloforte 4-6x/day 
BE, Viscotears prn 
BE, lid hygiene 
advice, limit contact 
lens wear/consider 
refit 
5. Lubricants (does not 
specify) 
6. Hyloforte 4-6x daily 
& Xailin nocte 
• Tear supplements (preferably 
unpreserved) for use during 
the day ± unmedicated 
ointment for use at bedtime 
• Recent systematic review 
found no evidence to support 
the superiority of any 
particular tear supplement 
• Liposomal sprays in 
evaporative dry eye 
 Level of evidence=moderate, Strength 
of recommendation=strong 
 
• Patients on long-term 
medication may develop 
sensitivity reactions which 
may 
be to active ingredients or to 
preservative systems (see 
Clinical Management 
Guideline on Conjunctivitis 
Medicamentosa). They should 
be switched to 
unpreserved preparations 
• Topical steroids (such as 
fluorometholone or 
loteprednol) may be 
considered for short-term use 
in some cases.  
Moderate dry eye- 




sicca- Celluvisc (Grene et 
al., 1992)  
 
Mild dry eye- Hypotears 
(Norn, 1977) 
 
Ocular lubricant (McDonald 
et al., 2002) 
 
Topical corticosteroids 
(Jones et al., 2017) 
 
Topical non-glucocorticoid 
immunimodulary drugs such 







The usual precautionary 
surveillance is required. 






1. Aciclovir 3% 5x/day 
LE for 2/52 
In non-contact lens wearing adults and 
where HSK is confined to the 
epithelium, commence antiviral therapy 
with one of the following: 
• oc. aciclovir 3%, e.g. Zovirax, 
ophthalmic preparation, 5x 
daily 
• ganciclovir 0.15% ophthalmic 
gel (Virgan), 5x daily 
NB: HSK is a potentially blinding 
disease and optometrists should 
consistently apply a low threshold for 
referral for this condition 




(Wilhelmus, 2015)  
 
Herpes Simplex dendritic 
ulcer- topical antiviral 
(Coster et al., 1980)  
 
Herpes Simplex stromal 
keratitis- topical antiviral 
and topical steroid 





1. Maxitrol tds RE for 5 
days 
2. Exocin 0.3% hourly 
for 3/7 then 2 hourly, 
Predforte 0.5% PF bd, 
lid hygiene + Systane 
Balance 
Ocular lubricants for symptomatic relief 
(drops for use during the day, 
unmedicated ointment for use at 
bedtime) 
• Systemic analgesia if needed: 
paracetamol, aspirin or 
ibuprofen   
• Regular lid hygiene for 
associated blepharitis (with a 
view to limiting recurrence) 
Level of evidence=low, Strength of 
recommendation=strong 
 
• Marginal keratitis is a self-
limiting condition. 
Nevertheless it is 
conventional to give 
pharmacological treatment 
with a view to relieving 
symptoms and shortening the 
clinical course.  
• The concurrent use of topical 
antibiotic (e.g. 
chloramphenicol) to reduce 
bacterial load, in addition to 
topical steroid (e.g. 
prednisolone) to reduce 
inflammation, is theoretically 
justified. However, the 
immunosuppressive effect of 
the steroid enhances the risk 
of infection 
Level of evidence=low, Strength of 
recommendation=weak 
 
Topical steroid & antibiotic 
(Chignell et al., 1970; 
McGill et al., 1971) 
 
Topical antibiotic (Bennett 




Table 6.2: Analysis of conditions diagnosed in Hereford County hospital eye casualty department in 
January 2018 as a result of optometric referral that could have pharmacological intervention initiated 
by an optometrist and were actually issued a prescription. College of Optometrist management 
guidance viewed 18 October 2018. (p.o.= oral medication, o.d.= once daily; bd= twice daily; prn= 
when necessary; tds= three times daily; qds= four times daily; BE= both eyes; PF= preservative free; 





The Health and Social Care Act 2012 introduced significant structural changes to the NHS including 
the establishment of 200-plus CCGs, replacing the previous private care trust, who commission 
enhancements to the NHS England sight test (Parkins et al., 2014). Therefore, there are protocols 
for local variations in primary eye health care across the country, which can be confusing for 
practices on the border of a number of CCG areas such as the case in Herefordshire. Practices are 
under no obligation to participate in CCG commissioned services and patients do not always remain 
within their CCG boundaries albeit unknowingly for their care. For self-employed optometrists 
referred to as locums who are working in a number of different practices, the criteria requirements, 
referral pathways and obligations in relation to those may vary widely. The local optical committee 
support unit can provide specific advice to locums, and it is also the responsibility of the practice to 
assist in providing information on local schemes. The fear of litigation and accusations of 
inappropriate referral leading to avoidable delay may underlie the decision for emergency referrals. 
This analysis did not include the proportion of optometrist referrals from self-employed versus 
resident optometrists working in local multiple or independent practices. This analysis could have 
been redundant given self-employed optometrists can also work regularly in set practices. In cases 
where locums provide one-off cover it can be difficult to follow-up repeat tests and advice from the 
Association of Optometrists (AOP) is to refer on the basis of the findings on the day (AOP, 2018).  
 
Posterior vitreous detachment (PVD) was the most common condition diagnosed at eye casualty as 
a result of optometrist referrals (n=8; 15.7%). Locum optometrists unfamiliar with local schemes 
may follow advice from the AOP if there is any uncertainty in the diagnosis, and refer patients to 
eye casualty on the day of presentation as a default option. The mean age of people diagnosed with 
PVD in this analysis was 69.3 ± 6.7 and there was an even split between males and females. The 
reasons for visit associated with the PVD diagnoses in eye casualty included recent onset of flashes 
and floaters, and the assumption is that the optometrist did not feel competent to examine the patient 
or could not definitively rule out a retinal break. It is also possible that the patient was triaged by 
reception, where a PEARS appointment was unavailable and the patient was instructed to attend eye 
casualty on the basis of their symptoms suggesting a retinal break. The ONP could have potentially 
still recorded “optometrist” as the source of referral.  
 
If a retinal break is present the patient can be referred for prophylactic treatment before a retinal 
detachment occurs and threatens sight. PVD is an ageing process of the vitreous and its prevalence 
increases proportionally with age and degree of myopia often with patients over the age of 40 
presenting with classical symptoms of monocular floaters and or flashing lights under dim rather 
than bright illumination (Tanner et al., 2000). Tractional forces between the retina and vitreous at 
sites of vitreoretinal adhesion cause mechanical stimulation of the retina photoreceptors, which is 




shadows on the retina during eye movement (Alwitry et al., 2002). An increase in floaters could 
indicate a general condensation of collagen fibres in the vitreous or a vitreous haemorrhage 
secondary to peripheral tearing of a retinal blood vessel as the vitreous collapses, which requires 
attention. The flashes of light usually cease when the vitreous has separated from a point of adhesion 
and the floaters may slowly disappear over time as the vitreous opacities move into the anterior 
vitreous (Serpetopoulos, 1997). A visual field defect and loss of vision are also common presenting 
symptoms relating to a PVD, retinal break or retinal detachment and can be the result of 
accumulation of subretinal fluid in the posterior pole (Tanner et al., 2000). It has been reported that 
the prevalence of a retinal break following acute PVD ranges from 8- 46% (Novak & Welch, 1984). 
 
The College of Optometrists guidance document titled “examining patients who present with flashes 
and floater” recommend referring a patient with such symptoms if the optometrist does not feel 
confident to manage (2018). If the optometrist carries out an examination, as a minimum it should 
include a detailed history and symptoms looking for particular risk factors, examining the anterior 
vitreous for pigment cells, a dilated fundal examination using an indirect viewing technique and 
providing written and verbal advice (College of Optometrists, 2018). An emergency referral would 
be warranted for findings of a retinal detachment, pigment in the anterior vitreous (tobacco dust), 
and a vitreous, retinal or pre-retinal haemorrhage, or lattice generation or retinal break with 
symptoms in line with guidance from the National Institute for Health and Care excellence (College 
of Optometrists, 2018; NICE, 2015c).  
 
In an application of theory-informed implementation research within community optometry, Duncan 
et al. (2018) engaged with stakeholders and health professional to identify ‘patients presenting with 
flashes and floaters’ as an important priority for practice improvement and the decision about 
whether or not to refer patients to secondary care as the target behaviour. A systematic search, review 
and appraisal of 28 documents relating to the management of patients with flashing lights and floater 
symptoms including international guidance and UK protocols indicated that where 
recommendations were present they were poorly supported by evidence and noted how instructions 
for readers to ‘refer to local protocols if available’ as in the College of Optometrists guidance, 
undermined the credibility of the document as standalone guidance (Duncan et al., 2018). The 
National Institute for Health and Care Excellence (NICE) clinical knowledge summary on retinal 
detachment amended in March 2015 was the only document identified as potentially being of 
sufficient quality for use with a requirement for modification before use within community 
optometry. The document provides advice that any practitioners who are competent in the use of slit 
lamp examination and indirect ophthalmoscopy can examine patients with new onset flashes and 
floater symptoms without visual loss, reducing the burden to refer patients unnecessarily (Duncan 




optometrists included social influences in the form of patients experiencing symptoms and think 
they should be referred to secondary care, lack of feedback from secondary care about patients that 
have been referred, and a belief that one was likely to be sued if they did not refer a patient with 
flashes and floaters who needs to be seen (Duncan et al., 2018). Duncan et al. (2018) also suggest 
that having a clear plan of steps that need to be taken once the decision not to refer has been made 
can facilitate an appropriate referral, and suggest enhancing practitioner confidence with access to 
video presentations of simulated patient-optometrist consultations and conversations with patients 
who expect to be referred.  
 
Scleral indentation used in conjunction with head mounted binocular indirect ophthalmoscopy is the 
best technique for examining the peripheral retina up to the ora serrata for peripheral retinal breaks 
(Alwitry et al., 2002), however, routinely performed fundus imaging (Mackenzie et al., 2007) and 
slit lamp binocular indirect ophthalmoscopy (Natkunarajah et al., 2003) also give good results. 
Given 8% of all patients attending for eye examinations present with symptoms of flashes and or 
floaters (Alwitry et al., 2002), it would be impractical to refer all of these patients to eye casualty 
for indirect ophthalmoscopy with scleral depression.  A proportion of retinal breaks will not be 
visualised despite performing a dilated fundus examination (Alwitry et al., 2002) although in terms 
of quadrantic distribution of breaks in eyes with retinal detachments, 60% occur in the upper 
temporal quadrant (Alwitry et al., 2002). It is important to educate patients on the dynamic nature 
of a PVD and for the warning signs should a retinal break be undetected and lead to a sight 
threatening retinal detachment. The presence of retinal pigment granules (tobacco dust) in the 
anterior vitreous referred to as Shafer’s sign, following dilated high magnification biomicroscopy, 
is a reliable indicator of a retinal break and is a simpler technique used in clinical optometric practice 
(Brod et al., 1991; Lightman & Brod, 1994; Tanner et al., 2000).  
 
Shah et al. (2009) used unannounced standardised patients as the golden standard methodology for 
evaluating quality of clinical care to investigate the content of a typical optometric eye examination 
for a person presenting with symptoms suggestive of a PVD. There was variation in the standards 
of different optometrists. Interestingly, none of the optometrists visited by the standardised patient 
carried out a purely symptom-led assessment once the presenting symptom of recent onset flashing 
lights in one eye in the dark was identified, and 99% performed a routine sight test including 
refraction and binocular vision tests rather than concentrate on posterior segment investigation (Shah 
et al., 2009). The one practitioner who did not carry out a routine eye examination advised the patient 
to attend eye casualty immediately at the local hospital without a referral letter, and results showed 
that of the 102 optometrists visited by the standardised patient, 13% advised the patient to attend 
eye casualty on the same day (Shah et al., 2009). Perhaps results would have been different if the 




training in techniques such as detection of tobacco dust in the anterior vitreous and head mounted 
binocular indirect ophthalmoscopy with scleral indentation should be carried out to enhance the 
clinical confidence of optometrists especially if the response to the rising demand for healthcare is 
to extend the role of health professionals and the range of their service provision.  
 
Overall 69% of optometrists’ referrals were appropriate for same day referral, and 33% of cases 
could have remained in primary care had the optometrist been IP- qualified. There was no way 
retrospectively to determine if any of the referring optometrists were IP-qualified and the assumption 
was that the 33% of cases identified would have been treated in the community if they were seen by 
an IP optometrist in accordance with the College of Optometrists CMGs. Anecdotally, there is a 
large learning curve for newly qualified IP optometrists for initiating pharmacological intervention 
that can be improved with hands on experience, regular review of the literature, and ongoing 
feedback and communication with ophthalmology colleagues. There are many reasons for 
inappropriate referrals including fear of litigation and lack of standalone guidance for certain 
conditions, which may explain the many cases of PVD referred to eye casualty. Future work is 
needed to develop materials to enhance practitioner confidence including videos of simulated 
consultations to carry out symptom-led assessments for various acute presentations.  
 
 
6.4.2: General Practitioner referrals  
An urgent eye condition is defined as “any eye condition that is of recent onset and is distressing or 
is believed by the patient, carer or referring health professional to present an imminent threat to 
vision or to the general health.” (Smith & Tromans, 2013) Occasionally, the referring practitioner 
cannot establish serious pathology, and so caution should be taken when labelling a referral as 
inappropriate and more should be done to empower primary care colleagues to prevent low value 
attendances to secondary care. It has been shown that more than 50% of GP referrals to eye casualty 
departments do not constitute true emergencies (Kheterpal et al., 1995). There was a high proportion 
of non-urgent referrals to eye casualty from GPs noted in this analysis, although GP referrals made 
up a similar proportion to optometrist referrals in terms of source of referral for first-time eye 
casualty presentations (12%). It is estimated that approximately 2% to 4% of GP consultations relate 
to ophthalmic concerns with more than 70% representing cases of bacterial conjunctivitis, allergic 
conjunctivitis, meibomian cyst and blepharitis (McDonnell, 1988; Sheldrick et al., 1993; Sheldrick 
et al., 1992). The need for further ophthalmic training is still under debate despite GPs expressing a 
lack of confidence in ophthalmology as a subject, and in the diagnosis and management of specific 
eye conditions (Sheth et al., 2008; Featherstone et al., 1992). Conditions affecting the lids, tear ducts, 
and conjunctiva were the most common cases referred to ophthalmology by GPs with GPs referring 




prescribing rate (Sheldrick et al., 1993; Burns et al., 2002). The traditional relationship between GPs 
and optometrists was a one-way flow with optometrists referring to GPs who would coordinate 
onwards referral to ophthalmology. Enhanced eye care services are helping to change the direction 
towards optometrists as the first-port of call for eye problems considering the lack of specialist 
ophthalmic equipment in GP surgeries, for example slit- lamp bio-microscopy, and generalist 
training preventing GPs from managing a wide range of ocular conditions.  
 
Greater levels of GP engagement in enhanced service schemes could result in a higher proportion 
of patients being retained in community optometric practice. The level of GP engagement in 
enhanced optometric services is varied with an evaluation of the Somerset Acute Community Eye-
care Services (ACES) reporting GP confidence at 89.4% whilst an audit in Bromley showed a 
significant number of GPs were not engaging with a total of 62.5% of GP practices using the service 
10 times or less (Cottier, 2015). An understanding of reservations from GPs about using PEARS 
would be useful considering it’s been shown that despite scientific evidence, it is challenging to 
change a GP’s beliefs and prescribing habits (Petricek et al., 2006; Sekimoto et al., 2006). A survey 
of GPs in South London which focused on the minor eye condition scheme found the majority 
favoured assessment of patients presenting with ophthalmic complaints by an optometrist especially 
for diagnoses of presentations with red eyes, flashes and floaters where use of specialist skills with 
slit lamp and fundoscopy were required (Konstantakopoulou et al., 2014). The GPs surveyed also 
saw the value of the scheme in improving care and accessibility, reducing waiting times, and 
potentially reducing their workload (Konstantakopoulou et al., 2014). Red eye, painful white eye, 
flashes and floaters and loss of vision have been reported as the commonest reasons for a MECS 
assessment (Konstantakopoulou et al., 2016).  
 
In order to maximise the benefits of schemes such as PEARS, GPs require training on the referral 
procedure to avoid situations where GPs from outside the participating area refer patients into the 
scheme resulting in patients taking up optometric consulting room time for which the optometrist 
receives no remuneration. Optometrists may charge an appropriate fee for emergency examinations 
if the patient presenting does not meet PEARS criteria. There was a case in this analysis where a 
patient attended with a PEARS GP referral letter from South Worcestershire and Wyre forest, which 
is outside of Herefordshire clinical commissioning. There is no way to determine if the patient was 
instructed by their GP to attend eye casualty rather than a local participating practice, or whether the 
patient misunderstood where to attend for further assessment or had difficulty booking an 
appointment in the community and found it more accessible to attend eye casualty. Additionally, if 
GPs refer patients to optometrists inappropriately, the expectations of these patients can be difficult 
to manage by the optometrist. An outcome of a PEARs assessment could be a referral to a GP surgery 




(Konstantakopoulou et al, 2018; Cottier, 2015; Sheen et al, 2009). Engagement of GPs in 
communicating follow-on management decisions from optometric PEARS referrals would help 
enhance the quality of future referrals and aid practitioner confidence for better patient care.  
 
 
6.4.3: Self-referrals  
Self-referrals accounted for the largest source of referrals to eye casualty in this analysis at 71%. In 
2018, 59% of women and 50% of men in Great Britain used the internet to search for health-related 
information (Prescott, 2018). Health-related information is free to access online anonymously and 
at any time allowing new opportunities for seeking such material for learning purposes. 
Cyberchondria is the term applied to heightened anxiety or distress associated with excessive or 
repeated searches online for health-related information, and is an abnormal behavioural pattern that 
can develop when the internet is used to self-diagnose or obtain reassurance (Starcevic & Berle, 
2013; McMullan et al., 2018). Sources of online health information can vary in their accuracy and 
completeness leading individuals to carry out multiple searches in an attempt to determine their 
validity, which can in turn lead to increased levels of distress and anxiety. A systematic review and 
meta-analysis conducted by McMullan et al. (2018) found a positive correlation between health 
anxiety and online health information seeking, and a strong positive association between health 
anxiety and cyberchondria.  
 
The rise of people searching for symptoms on the internet has led to greater awareness of health 
conditions, but perhaps also heightened health anxiety and an increase in health seeking behaviour 
in primary and secondary care. Studies have shown 50-70% of people attending eye casualty 
departments are non-urgent cases (Jones et al., 1986; Kheterpal et al., 1995; Fenton et al., 2001; 
Bhopal et al., 1993). Reasons cited for patients deciding to present at A&E rather than their GP 
surgery in line with the previous one-way referral system from primary to secondary care include 
anxiety, depression, convenience and accessibility (Martin et al., 2002; Sempere-Selva et al., 2001). 
One of the records excluded from the analysis of first-time presentations to eye casualty at Hereford 
County hospital represented an existing glaucoma patient who wanted clarification regarding use of 
prescribed hypotensive eye drops. This case was non-urgent and perhaps reflects areas of 
improvements to be made regarding communication with patients including providing written 
information and creating points of contact to allow opportunities for clarification on recommended 
treatment.  
 
Actual trauma in this analysis accounted for about 14% of self-referral cases and included orbital 
fracture, chemical injury and mainly foreign body removal crediting for over three quarters of cases. 




being 38 ± 16.6 years old and predominantly male (90.6%). Optometrists have the skills and 
dexterity to remove non-penetrating foreign bodies and manage corneal abrasions although there 
may be a lack of confidence given the two cases of optometrist referrals for foreign body removal. 
Corneal problems were the main condition category for self-referrals with over half of cases 
representing corneal abrasions that could be managed with over-the-counter topical antibiotics and 
optometric monitoring. Only 20% (6/30) of corneal abrasion cases were reviewed in eye casualty at 
the request of a consultant ophthalmologist and ophthalmologists not in training presumably due to 
the size of the abrasion. The miscellaneous category encompassed a wide range of conditions from 
retinal vascular disease, acquired macular disorders and neuro-ophthalmology. 
 
A prospective questionnaire-based survey of consecutive patients attending the A&E department at 
Moorfields eye hospital over a seven-day period investigated the numbers of patients with 
ophthalmic complaints and interestingly, the reason for attending from the patient’s perspective 
(Hau et al., 2008). In contrast to the Hereford County hospital, Moorfields is an urban specialist eye 
hospital with a 24-hour walk-in A&E department seeing on average more than 60 000 patients each 
year, and receiving referrals not only from local CCGs in the London region but from hospitals 
within the UK and abroad (Hau et al., 2008). Demographic data was collected from 560 patients in 
May 2005 with the proportion of source of referrals similar to what was found in this analysis. The 
median age was younger at 35 with a similar split between men and women (51.9% and 48.1% 
respectively) and with the greatest source of referrals to eye casualty being self at 76.9%, followed 
by community optometrist accounting for 10% of referrals and 8.1% being GP referrals (Hau et al., 
2008). Of the completed questionnaires, 46.9% of respondents had attended the eye casualty 
department previously and were not first-time presentations, however, data on reasons for re-
attending such as due to previous advice if had new symptoms, and not having their chronic 
condition explained to a satisfactory level allowing self-management were not collected (Hau et al., 
2008). Only first-time presentations were considered in the current analysis but consideration of 
potential reasons for frequent attenders, that is those with more than three visits in a 12-month period 
(Murphy et al., 1999), could help with understanding the patient perspective. Factors in frequent 
attending have been thought to include increasing age, living locally and psychiatric comorbidity 
(Murphy et al., 1999; Sheth & Sheth, 2007) 
 
A large proportion of cases in the Moorfields prospective study were discharged on the day of 
presentation (62.5%) as seen in the current analysis at 58% (Hau et al., 2008). The authors of the 
Moorfields study determined 30.6% of cases could be categorised as non-acute, and that 28.6% with 
non-acute diagnoses and 8.9% with acute diagnoses of conjunctivitis could be seen by an optometrist 
or specialist trained GP (Hau et al., 2008). In the study, PVD was considered not suitable to be seen 




which pre-dates amendments to the NICE clinical knowledge summary on retinal detachment 
(NICE, 2015c). Other conditions that were deemed to be unsuitable for primary care management 
were acute corneal problems, anterior uveitis, macular disease, herpes simplex virus infections, 
trauma, conjunctival disorders, neuro-ophthalmology and oculoplastic related diagnoses, 
vitreoretinal emergencies, glaucoma and scleritis (Hau et al., 2008). Conditions that were deemed 
suitable to be seen by optometrists or specialist trained GPs included blepharitis, conjunctivitis, 
chalazion, dry eye, contact-lens related problems, cataract and episcleritis (Hau et al., 2008). PEARS 
inclusion criteria time frame permits acute symptoms of less than two weeks (LOCSU, 2016), and 
it was interesting from the Moorfields study to see that 62.8% of patients self-reported the duration 
of symptoms to span the last one to six days and 25.7% reported symptoms experienced over the 
last one to four weeks (Hau et al., 2008). Perhaps work should be carried out to educate patients on 
seeking advice from optometrists for ocular problems via their local primary care services. 
 
From the patients’ perspective, the most common overall reason for attending eye casualty was 
“great concern”, whilst “convenience” and “unable to wait for a GP appointment” were also 
common justifications in the cases deemed non-acute by the authors of the Moorfields study (Hau 
et al., 2008). The stress and anxiety associated with the prospect of visual loss, blindness and the 
possible disfiguring nature of inflammatory eye conditions can evoke levels of anxiety seen in 
patients with diagnoses of melanoma, acquired immunodeficiency syndrome and requiring bone 
marrow transplantation (Williams et al., 1998). The findings from Hau et al. (2008) suggest that 
patients view eye casualty not only as a place for emergencies but for obtaining prompt treatment 
and second opinions for non-sight threatening complaints because of 24-hour accessibility and the 
convenience of not requiring a scheduled appointment. Ocular symptoms often induce in the patient 
a fear that does not match the severity of the condition that leads the patient to seek rapid reassurance. 
In the current analysis, there was a self-referral case where the patient had a future appointment 
scheduled in secondary care as a result of an optometric referral. The final diagnosis for this case 
was episcleritis, however, the persistent redness and irritation noted may have led the optometrist to 
question the original diagnosis and refer to ophthalmology. The patient may have attended eye 
casualty due to the uncertainty surrounding the cause of their ongoing symptoms or because they 
had been instructed to attend eye casualty if their symptoms failed to improve. In the current analysis 
7.3% of self-referrals showed no abnormality and attended eye casualty due to symptoms of 
intermittent headaches, blur and ocular discomfort highlighting the use of the walk-in service for 
reassurance regarding sporadic concerns. There was one case wherein a patient attended eye casualty 
to request a repeat prescription for hypotensive eye drops. 
 
It was determined from the current analysis that 83% of self-referrals could have been seen on the 




be an increase in health seeking behaviour, however, signposting by ONPs, GPs, nurses and 
pharmacists could help alleviate the pressure from eye casualty services, reserving time for the 
management of complex cases and refined referrals from optometrists. 
 
 
6.4.4: Managing follow-up appointments within the community  
Referrals to PEARS and PEARS scheme follow-up appointments for eye casualty provide an 
opportunity for community optometric practices to gain new patients, and the overall cost 
effectiveness and patient satisfaction in relation to enhanced service optometric schemes have been 
reported (Konstantakopoulou et al., 2014; Baker et al., 2016; Mason et al., 2017). Studies monitoring 
the activity of PEARS schemes have shown that 8.7% and up to 22.13% of patients are followed up 
within the community predominately for reviewing cases of minor trauma, and red eye 
(Konstantakopoulou et al., 2018; Cottier, 2015). From the current analysis, it was determined that 
about 66% of patients attending eye casualty for follow-up could have been seen by an optometrist 
within the community for example, to monitor resolving recurrent uveitis. In a retrospective analysis 
of attendances to a 24-hour access casualty department over a 6-month period at Southampton eye 
hospital, acute or recurrent uveitis accounted for 7.1% of all cases of inflammatory disease requiring 
on average about four visits per patient (Jones et al., 1986). An IP qualification could help in these 
cases where a repeat prescription may be required and monitoring of the condition to resolution 
could be managed by a community optometrist. There are existing services that utilise the skills of 
optometrists including the Grampian Eye Health Network established in 2010 that allows co-
prescribing with GPs for non-IP optometrists to provide treatment for patients with anterior uveitis, 
herpes simplex keratitis, marginal keratitis and corneal foreign body removal (Kearney, 2017). The 
Fife Uveitis Shared-Care Scheme (FUSS) initiated in November 2016 involves IP optometrists who 
diagnose and treat anterior uveitis, and carry out four monthly uveitis screening for children with 
Juvenile Idiopathic Arthritis (Kearney, 2017). In West Kent since 2010, the Acute Primary Care 
Ophthalmology Service (APCOS) involves IP optometrists who are given an NHS FP10 prescription 
pad for the management of acute eye conditions within the community. The overall cost 
effectiveness and patient satisfaction for these predominately IP- optometrist led schemes are yet to 
be reported in the literature.   
  
At the time of the analysis, Symphony software (EMIS health, UK) was used to manage initial 
presentations and IMS MAXIMS software (IMS MAXIMS, Dublin) was used to manage eye 
casualty follow-up appointments at the Hereford County hospital. According to reports generated 
by Symphony software (EMIS health, UK), there were on average 5617.7 ± 69.9 eye casualty 
attendances each year from 2015- 2017. The tariff cost of an eye casualty attendance at Hereford 




2017 would equate to about £58,517.36. If one considers the total number of cases in January 2018 
that could have been seen within the community on the PEARs scheme from a GP or self-referral 
either as a first-time presentation or for review, the amount of savings to the Wye Valley NHS Trust 
would have been approximately £46, 405.00 (table 6.3). 
 
 Appointments Cost 






£56, 625.00   
No. of eye cas presentations 
from GP & Self-referrals that 






Potential Cost saving:  £41, 925.00 
No. of eye cas presentations 
that were booked for follow-
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cas that could have been seen 





Potential Cost saving: £4, 480.00 
Table 6.3: Cost analysis comparing appointments at the hospital and within the community in 
January 2018. This analysis assumes Wye Valley NHS Trust tariff costs of £125/ appointment and 
£80/appointment at the Hereford County Hospital eye casualty for first-time presentations and 
follow-ups respectively. This analysis assumes £60/ appointment and £40/appointment paid by NHS 
Herefordshire CCG for first-time PEARS presentations and PEARS follow-ups respectively, and 
that the presentations would have met PEARS inclusion. Eye cas= eye casualty.  
 
There is evidence to suggest that the reported rise in eye casualty attendances is due to new 
attendances rather than review appointments, and contrary evidence attributing a rise in numbers to 
an increase in follow-up appointments and limited access to sub-specialty and general clinics for 
hospital review appointments (RCOphth, 2017). It is thought that ophthalmology trainees are slower 
and more cautious than previous generations, seeing fewer patients per hour and tend to schedule 
more follow-up appointments (Armstrong et al., 2010). The eye casualty clinic at the Hereford 
County hospital is organised to offer four morning and four afternoon appointments for the purpose 
of follow-up during the working week. In the current analysis, 36.6% of decisions to follow-up 
patients in eye casualty were made by ophthalmologists in training and 8.5% by IP optometrists. In 
addition to discharging to community optometry monitoring and restricting the number of follow-
ups appointments available in eye casualty, the presence of a consultant ophthalmologist during eye 
casualty service hours could help reduce the burden on secondary care. The consultant accessible to 
eye casualty practitioners from IP-optometry or other grades of ophthalmology could offer same day 
advice leading to a reduction in the number of follow-up appointments scheduled in eye casualty, 




6.5: Conclusion  
In Herefordshire, the Ophthalmology Transformation Group involving the Wye Valley Trust, the 
Local Optical Committee and the CCG intends to expand the existing optometric schemes to 
decompress the demand on secondary care services into the community. Progress has been made 
with the local CCG agreeing to directly fund optometric monitoring of stable glaucoma and PEARS 
scheme follow-up appointments for eye casualty. More research is required to investigate how 
PEARS affects demand and supply in the wider healthcare system, and concerns regarding 
overcapacity and inadequate remuneration. Perhaps community IP optometry needs a specific 
funding source within the NHS, and a means of referring to IP optometrists by other optometrists, 
GPs and pharmacists in order to build competence that could weaken if patient numbers are low, 
increase scope of practice and avoid overburdening secondary care. Ongoing structured training is 
important in producing and maintaining a high standard of care on the scheme.  
 
Feedback on referrals from GPs and ophthalmologists is essential to improve optometrists’ 
diagnostic skills, and good systems of communication are important for effective inter-professional 
co-operation. Optometrists are capable of managing common non-sight threatening conditions in 
community practice that would otherwise present to eye casualty as a GP or self-referral, with or 
without therapeutic agents accessible through Medicines Act exemptions. Extended prescribing with 
an IP qualification allows an optometrist to use and develop their skills to a greater extent, and 
provide efficient clinical services to their patients with quicker access to required medication. The 
expanding role of optometrists was discussed in section 1.3. Dry eye was the second most common 
diagnosis from optometrist referrals to eye casualty in this analysis, and accounted for approximately 





















7.1: Summary of previous chapters 
The study outlined in chapter two determined that a proportion of patients attending BBR Optometry 
Ltd. self-reported some degree of dry eye, and that there was a local demand and business case for 
a dry eye service. Findings from chapter two suggest that service blueprinting can help facilitate the 
design of new community optometric services, and that customers prefer to purchase dry eye 
products when required, and need to understand and be reminded that dry eye is a chronic condition 
requiring long-term management. Amendments were made to internal processes at BBR Optometry 
Ltd. as a result of the study, such as utilizing practice management software to remind customers 
using the dry eye service to replenish those products recommended for ongoing care.  
 
The results of the study presented in chapter three suggest that a fluorescein tear breakup time ≤ to 
nine seconds and/or between nine and 12 seconds in women, and changes to Meibomian gland 
structure and function with a total Meibomian gland expressibility score cut-off value that is between 
one and nine are clinical tests predictive of predominately evaporative dry eye status. Important 
predictive questions for dry eye included those relating to frequency of soreness or irritation, and 
the impact on visual functioning for daily tasks.  These results derived objectively using statistical 
means suggest that asking certain questions regarding dry eye symptoms, performing an accessible, 
quick test of fluorescein tear breakup time, and utilising technology invested in by the practice could 
deliver a sufficient level of clinical testing to identify evaporative dry eye.  
 
In addition to diagnostic technology, BBR Optometry Ltd. has also invested in in-practice dry eye 
treatment options to differentiate from competitors in the market, and to optimize the tear film for 
refractive surgery and contact lens fittings for presumed potential benefits. Results from chapter four 
showed that there were no differences in visual outcomes post-lens surgery between patients with 
abnormal and normal tears but that there were new cases of symptomatic dry eye in both groups. 
The author suggests that optimization of the ocular surface prior to surgery could prevent new or 
persistent dry eye following lens surgery.  
 
There were no strong trends to link CLDO to dry eye or to a particular contact lens (CL) product or 
product range in the sample of BBR Optometry Ltd. patients. The high proportion of “false 
dropouts” found suggests that patients may be more flexible in their CL wearing schedule and may 
be motivated to change service providers for reasons other than the availability of modern CL 
products. The commonly reported CLDO rates are probably not as bad as reported but this would 
need further investigation to be conclusive. There was a large subset of patients in the study who 




at the practice. Dryness related to CL wear was a reason for CLDO in the sample presented in chapter 
five, and dry eye symptoms were also seen in chapter six as a reason for referral to the local hospital’s 
eye casualty department. The largest proportion of presentations to the Hereford County hospital’s 
eye casualty department were self-referrals (71%), and it was determined that the majority of self 
and general practitioner referrals could have been managed or reviewed by an optometrist in the 
community with even greater proportions treatable by an IP optometrist.  
 
 
7.2: Concluding remarks 
The final achieved objective for the KTP project was to embed a service for the non-routine patient 
to establish BBR Optometry Ltd. as capable of diagnosing and managing complex, chronic eye 
conditions at the highest level whilst introducing new revenue streams. In order to ensure continued 
success, a recommendation of the KTP project was to allow time for optometrists’ professional 
development as well as time for reflection and regular review of current services for improvements 
and identification of patient needs not met by existing services. The dry eye service is now well 
embedded at BBR Optometry Ltd., and the practice directors have reported increased activity. This 
research is relevant to practice owners, managers, eye healthcare stakeholders, and NHS clinical 
commissioners. Furthermore, due to the impact of this research, the KTP project was voted second 
place in Aston University’s Knowledge exchange poster competitions in 2016 and 2017 for best 
new and established projects respectively. The author received a rating of ‘Very Good’ on 
completion of the KTP project (see Appendix 1.4).  
 
 
7.3: Limitations and future work 
This research demonstrated that service blueprinting (chapter two) could be applied to improve or 
build-on existing optometric services, and could potentially be used to roll out new services where 
there is a local need. The service performance and practice capabilities following introduction of the 
service blueprint could be audited using the Service Quality Gaps model audit shown in appendix 
2.9, and metrics to monitor service activity, such as conversion to dry eye treatment from 
consultation or telephone call and digital KPIs, could be measured. Future work is required on the 
development of customer-defined service standards to provide feedback on the operational 
performance of new services, and metrics that document the customers’ opinions on the delivery of 
new services. A SERVQUAL audit could be conducted to understand the customer’s view on private 
optometric services. Customer’s opinions on a service affect the willingness to recommend and 
return to the same service providers, which are indicators of customer loyalty (Lonial & Raju, 2015). 
Further studies could investigate reasons customers choose to become EyelifeTM members at the 




A larger sample of dry eye patients and wider variety of questionnaires and tests could be used to 
determine the possibility of objectively identifying clinical tests for predicting dry eye of 
evaporative, aqueous-deficient and mixed aetiology. In regards to the impact of tear homeostasis on 
lens surgery outcomes studied in chapter four, future longitudinal research with larger cohorts of 
patients is required to evaluate the long-term impact of both femtosecond laser-assisted or standard 
phacoemulsification surgery on clinical outcomes and ocular surface health metrics. A similar 
analysis could also be carried out for patients having implantable contact lens treatment (ICL) or 
laser refractive surgery having had TearLab tear osmolarity measures taken to determine the impact 
of tear osmolarity on surgical outcomes. Comparison of pre- and post-operative tear homeostatic 
markers and symptoms would also provide valuable information in regards to the justification of 
prophylactic measures to optimise the ocular surface in preparation for and following lens surgery. 
Future work comparing outcomes between patients having intense regulated pulsed light (IRPL) 
treatment and those not receiving in-practice dry eye treatment prior to lens surgery could also help 
practitioners make evidence-based recommendations, especially where cost is a factor.   
 
In terms of implications from a business point of view in retaining patients, future work could 
investigate, via interview or survey, reasons why patients discontinue CL wear and determine 
whether patients dropout of CL wear again following an invitation to revisit CL wear at BBR 
Optometry Ltd. Larger studies involving multiple sites would be required for comments on general 
trends observed amongst CLDOs. There was missing information on the average amount of CL 
products trialled for each person who ceased CL wear in chapter five to highlight possible training 
requirements for practitioners in their approach to CL fitting, especially for presbyopic patients fitted 
with multifocal lenses. Future interventional prospective longitudinal studies could inform 
practitioners whether proactively treating Meibomian gland dysfunction (MGD) prior to trialling 
CLs for new users and lapsed CLs wears intending to revisit CL wear could help prevent CLDO.  
 
In regards to chapter six, a new prospective design study could investigate whether provisional 
diagnoses from optometrists referring patients to eye casualty hospital services are appropriate to 
demonstrate the safety and effectiveness of current acute optometric services. The suspected 
diagnoses from optometrist referrals were not always listed, and so chapter six presents diagnoses 
from eye casualty that are organised by the source of referral. Further research is required to 
investigate how existing optometric schemes impact demand and supply in the wider healthcare 
system in order to prevent overcapacity and inadequate remuneration, especially considering the 
uptake of IP qualifications for extended prescribing by community optometrists. The major 
weaknesses of all of these studies are that they are based on a single site, and so findings are not 





There are opportunities for independent optometrists to grab the low-hanging fruit by implementing 
private specialist services for conditions such as dry eye that are highly prevalent. SWOT (strengths, 
weaknesses, opportunities and threats) analysis carried out for the consideration of new private 
optometric services, is a tool that is used to evaluate how an organisation or business compares to 
its competition and can establish a position within the broader market (Teoli & An, 2019). Firstly, a 
strength would be the financial gain through introducing a new revenue stream, and a weakness 
would be the time required to develop and trial a new service. However, business models 
successfully applied in optometric practice (Patel, 2015) provide guidance on how to set appropriate 
fees, and service blueprinting described in chapter two provides a framework for the design of new 
services. The offering of specialist optometric services where there is a local need, introduces 
convenient access to those who would benefit and value from the service within the community, 
which may then lead to customer loyalty and use of other practice services. Other opportunities 
associated with offering high quality care include a chance to build a reputation for clinical and 
customer service excellence, and to enhance professional credibility.  
 
A threat to new optometric services may be the replication of similar services and so there is a need 
for providers to stay ahead of the curve. There have been threats to traditional optometric care noted 
15 years ago with the introduction of automated subjective refractive systems that were found to be 
accurate and repeatable (Dave & Fukuma, 2004).  Recent advances in technology have also meant 
that people can have “prescription renewal tests” online through their smartphones, tablets and 
computers in the US (Scott, 2019). In terms of the clinical aspect of traditional optometric services, 
rapid non-invasive techniques have been evaluated and continue to be developed for monitoring 
subtle changes, progression of ocular disease, and the response to therapeutic interventions (Acton 
et al., 2011).  Despite the emergence of new technologies and care delivery models, the optometrist’s 
role in patient education, and patients’ trust in optometrists as professional clinicians could help 
reduce the impact of these threats. In the context of a dry eye service, staying ahead of the curve 
would equate to offering the latest diagnostics, modern in-practice treatment options, and the 
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Appendix 1.2: Description of in-practice treatment options for dry eye offered at BBR 
Optometry Ltd.  
 
BBR Optometry Ltd. are one of the early adopters and few providers of the LipiFlow Thermal 
Pulsation system (TearScience, Morrisville, NC, USA) in the UK. LipiFlow was approved by the 
Food and Drug Administration in 2011, CE-marked in July 2011 as a Class II a device, and is 
intended for the application of localised heat and pressure therapy in adult patients with cystic 
conditions of the eyelids including Meibomian Gland Dysfunction (MGD) (Satjawatcharaphong et 
al., 2015; NICE, 2015a). Optimal treatment of MGD requires some method of evacuating the 
Meibomian gland contents and LipiFlow offers an alternative to painful manual expression that may 
need to be repeated several times a year (Blackie et al., 2016). The LipiFlow treatment itself involves 
the fitting of disposable eyepieces under the eyelids, which vault the cornea and once activated apply 
directional therapeutic heat of 42.5°C to the inner eyelid, and pressure to the outer eyelid surfaces 
(up to 5.5 psi) simultaneously for 12 minutes (Lane et al., 2012; Blackie et al., 2015). These actions 
are designed to loosen, liquefy and express hardened Meibomian lipids, which have blocked the 
Meibomian glands (NICE, 2015a). LipiFlow has been shown to be effective in evacuating contents 
of the Meibomian glands from all four eyelids, and in offering sustained improvement in symptoms 
and Meibomian gland function over 12 to 36 months following a single treatment (Blackie et al., 
2015; Blackie et al., 2016; Greiner et al., 2016). Cohorts of people with MGD, refractory dry eye, 
refractory dry eye post LASIK, Sjögren’s disease and contact lens wearers have benefited from 
LipiFlow treatment (Blackie et al., 2016; Epitropoulos et al., 2017; Korb & Blackie, 2014; 
Schallhorn et al., 2017). Adverse effects reported include discomfort during the procedure leading 
to cessation of treatment, and development of a chalazion on the upper or lower lid which resolved 
within one month of therapy (NICE, 2015a).  
 
Finis et al. (2014b) found that the effects of a single LipiFlow treatment were sustained over six 
months and performed at least as well as a robust twice daily hygiene, heat and massage regime over 
three months (Finis et al., 2014c). It is unclear if compliance rates affected the study outcomes. 
Hagen et al. (2018) compared the efficacy of a single bilateral LipiFlow treatment versus daily oral 
doxycycline for three months, which can be prescribed by independent prescribing optometrists, for 
moderate to severe MGD in a prospective, randomized, parallel-group single masked study 
involving 28 subjects. Dry eye symptoms were evaluated using the SPEED questionnaire, and dry 
eye signs were evaluated using the Meibomian gland evaluator to count the number of glands 
yielding liquid secretion, tear break up time, and corneal and conjunctival staining (Hagen et al., 
2018). These clinical tests are used at BBR Optometry Ltd. and are described in chapter one. Results 
showed LipiFlow at three-months post treatment was more effective at improving symptoms and at 
least as effective in improving clinical signs when compared to a three-month daily course of oral 
doxycycline, suggesting LipiFlow provides a more favourable minimal risk profile treatment option 
for MGD versus long-term antibiotic use (Hagen et al., 2018). The LipiFlow system is currently a 
private treatment used in primary care by optometrists or in ophthalmology departments in 
secondary or tertiary care but has not been adopted in the National Health Service (NHS) presumably 
because alternative, traditional management options such as warm compress or lid massage are 
available at little or no cost to the NHS.  
 
Use of baby shampoo despite containing known skin irritants and association with ingredients that 
reduce tear film stability, and use of home-made solutions of water and sodium bicarbonate are the 
traditional recommendations for lid hygiene methods for blepharitis based largely on expert opinion 
in current clinical guidance for eye care health professionals and GPs (Maibach, 1986; Zirwas & 
Moennich, 2009; Wieslander & Norback, 2010; Welling et al., 2014; CKS, 2015; MEH, 2017). 
There is evidence of improvement in blepharitis signs and symptoms following intervention with 
eyelid hygiene regimens including commercially available cleanser and diluted baby shampoo 
(Lindsley et al., 2012; Key, 1996; Khaireddin & Hueber, 2013; Arrua et al., 2015). However, outside 
of sterile laboratory conditions the precision of at-home preparations may not be reproduced with 
risks of contamination and insufficient dilution. The length of time for safe storage of these 




randomised, double-masked, paired eye trial, Sung et al. (2018) found clinical improvements in 
blepharitis occurred with twice daily use of dedicated eye cleanser (TheraTears® SteriLid®) and 
diluted baby shampoo (Johnson's® No More Tears®) over four weeks. However, only the dedicated 
cleanser was effective in reducing ocular surface inflammation quantified using MMP-9 
inflammatory markers, and was the preferred treatment amongst participants (Sung et al., 2018). 
MUC5AC is a goblet cell-specific mucin and its expression levels within the conjunctival epithelium 
reflects goblet cell density and function (McKenzie et al., 2000; Dogru et al., 2005; Dogru et al., 
2008). There was a decrease in level of MUC5AC expression in eyes treated with baby shampoo 
only, suggesting the presence of pro-inflammatory agents within the formulation given 
inflammation and hyperosmotic stress can compromise goblet cell integrity (Sung et al., 2018). A 
study involving contact lens wearers with blepharitis has also reported greater clinical efficacy of a 
phospholipid-lipsosome solution (Blepha Cura®) compared to baby shampoo (Khaireddin & 
Hueber, 2013).  
 
BBR Optomery Ltd. offer BlephExTM microblepharoexfoliation treatment, which uses a patented 
hand-held electromechanical device to spin a medical grade micro-sponge along the edge of the 
eyelids and lashes to remove scurf and bacterial debris found in blepharitis. The medical grade, 
single use sponges are soaked in eyelid cleansing product prior to use and four different sponges are 
used to exfoliate the upper and lower eyelids. Customers are instructed to maintain their clean 
eyelids with regular lid hygiene at home, with a view to repeat the procedure every six months to 
one year depending on the severity of blepharitis. Although the authors are biased, it has been 
suggested that BlephExTM should be performed routinely on people after age 50 as commonplace as 
dental cleaning in order to prevent damage to and loss of the Meibomian glands, given bacterial 
changes at the lid margin including over-colonization can culminate in inflammation (Rynerson & 
Perry). BlephExTM is a standalone treatment, conducted prior to LipiFlow and as part of treatment 
for Demodex blepharitis over the course of three visits.  
 
Demodex infestation should be suspected in those with chronic blepharitis or refractory ocular 
surface inflammation, and where cylindrical dandruff at the root of the lashes is present (Gao et al., 
2005a; Coston, 1967; English, 1971; Norn, 1970). Demodex mites can be dose-dependently killed 
with three applications of 50% Tea Tree Oil (TTO) and daily use of TTO preparations up to 10% by 
customers (Gao et al., 2005b; Gao et al., 2007; Liu et al., 2010; Koo et al., 2012). Cliradex (Cliradex, 
Miami, FL, USA) is a lid wipe used by customers at home following in-practice tea tree oil TTO 
treatments (three weekly applications of 50:50, Jojoba oil and 100% TTO) at BBR Optometry Ltd. 
that contains the active ingredient from TTO, terpinen-4-ol, and has shown promising results for the 
treatment of Demodex folliculorum blepharitis (Tighe et al., 2013; Cheng et al., 2015; Jones et al., 
2017). The recommended regimen for customers is to apply Cliradex twice daily for at least six 
weeks to cover two life cycles of Demodex, and customers may wish to continue with a maintenance 
dose of once daily for a longer period of time (Cheng et al., 2015).  
 
Punctal occlusion with temporary absorbable or permanent non-absorbable plugs is another 
treatment option offered at BBR Optometry Ltd. that conserves tears and retains moisture on the 
ocular surface by preventing tear drainage (Jones et al., 2017).  Typically, temporary plugs are 
collagen-based and fitted first prior to permanent occlusion in order to assess the efficacy of 
occlusion (Jones et al., 2017). A systematic review conducted by Ervin et al. (2010) concluded that 
punctal plugs can offer symptomatic improvement and clinical improvements from baseline metrics, 
with temporary plugs just as effective as silicone-based permanent plugs on a short-term basis in 
severe dry eye. The effectiveness of punctal plugs for treating dry eye is inconclusive given the 
variability in type of plug used across different studies, severity of dry eye being managed and trial 
methodology (Ervin et al., 2019). There are few studies that show a benefit of punctal plugs over a 
comparison treatment and it is thought that punctal occlusion may be most effective when combined 
with other dry eye therapies (Ervin et al., 2010; Roberts et al., 2007). Punctal occlusion is relatively 
safe although their use has been associated with epiphora and less commonly with inflammatory 





















Appendix 2.1: SERVQUAL and applications to optometric businesses 
 
The SERVQUAL instrument or scale published by Parauraman et al. in 1988 involves a survey with 
21 service attributes grouped into five service quality dimensions that helps to gauge the overall 
relationship with the customer (Parasuraman, 2004). The five service quality dimensions are: 
1. Reliability: the ability to perform the promised service dependably and accurately 
(statements 1-5). 
2. Responsiveness:  the willingness to help the customer and provide prompt service 
(statements 6-10). 
3. Assurance:  the knowledge and courtesy of employees and their ability to convey or inspire 
trust and confidence (statements 11-13). 
4. Empathy: the provision of caring, individualised attention to customer (statements 14-17). 
5. Tangibles: the appearance of the physical facilities, equipment, personnel and 
communication materials (statements 18-21). 
 
Customers provide two ratings on each attribute at different points in time- one reflecting the level 
of service they would expect from excellent companies in the industry before the service encounter 
and the other reflecting their perception of the service delivered by a specific company within the 
industry after the service encounter. A quantified measure of service quality is derived from the 
difference between the two ratings. The SERVQUAL is used in many service industries, and has 
been criticized for failing to capture the dynamics of changing expectations and taking into account 
whether expectations exist or are clearly formed to serve as a standard for evaluation of a service 
experience (Buttle, 1996). 
 
Charafaray (2006) discusses the importance of service quality as a differentiating characteristic for 
contact lens manufacturers in the South African contact lens industry. The research set out to 
measure expectations and perceptions of optometrists interacting with Ciba Vision as a contact lens 
supplier in a business to business interaction using the SERVQUAL instrument (Charafaray, 2006). 
The study found that the reliability dimension contributed the most to differences between 
expectations and perceptions suggesting that companies need to keep customers informed with 
regards to the availability of products, and of any delays or backorders (Charafaray, 2006). 
Charafaray (2006) recommends that companies provide explicit and implicit service promises in 
order to improve their customer’s perception of the reliability of their service. 
 
SERVQUAL has been shown to be valid for measurement of optometric service quality with good 
reliability, and correlation between overall quality scores and SERVQUAL gap values in a doctoral 
thesis by Dr Sarah Joy Smith (2011). Results showed that customers had relatively low expectations 
as to the appearance of the practice and staff for evaluating service quality in optometric practices 
but had high expectations that the practice would have modern equipment (Smith, 2011). Indicating 
modern equipment as particularly relevant to good service quality suggests customers may link 
access to advanced technology to problem solving and accuracy in relation to producing prompt and 
reliable diagnoses that are important to the customer. Contact lens wearers had a higher opinion of 
service quality from their optometrist thought due to the increased level of interaction these 
customers have with the practice for more regular aftercare appointments or due to the optometrist 
adding value in the customer’s view by introducing an alternative to spectacle wear or managing 























































Appendix 2.8: Certificates of completion for courses in the W.P. Carey Certificate in Service 
























Appendix 3.1: Relevant evidence where DTA and PCA have been used. 
 
DTA has been used in some of Aston University’s ophthalmic postgraduate research. The following 
is a list of successful theses: 
• Dr Derek Dunstone "Habits and attitudes towards retinoscopy and the relative accuracy of 
dedicated and combined retinoscopes" DOptom thesis, 2013 
• Dr Rebecca Rushton "A new algorithm for the relationship between vision and ametropia" 
DOptom thesis, 2014 
• Dr Rajeshwari Sagar "Application of Naïve Bayesian sequential analysis to primary care 
optometry" DOptom thesis, 2014 
• Dr Bhavna Pancholi "A comparison of computer aided learning and traditional didactic 
lectures for teaching clinical decision-making skills to optometry undergraduates" PhD 
thesis, 2016 
• Dr Anita Morrison-Fokken "Provision of spectacle lens correction to elderly people at risk 
of falls" PhD thesis, 2017 
• Dr Laura Knowles "The prevalence and progression of astigmatism and myopia in children" 
DOptom thesis, 2017 
• Dr Peter Frampton “Tonometry: A Study in Biomechanical Modelling. Appraisal and utility 
of measurable biomechanical markers” DOptom thesis, 2017 
 
The following are examples of factor analytic techniques used in ophthalmic research. 
Relating to Glaucoma:  
• A prospective, clinical, and comparative study conducted by Morejon et al. (2019), used 
PCA to extract the four most important features of Frequency Doubling Technology as a 
functional test, and spectral domain Optical Coherence Tomography (OCT) as a structural 
test alongside the variables age, visual acuity and intraocular pressure to discriminate 
between nonglaucomatous and glaucoma suspect subjects. A logisitc analysis was then 
applied to obtain objective predictive rules providing a high sensitivity and specificity to 
detect the earliest stages on glaucoma in a primary care setting. 
 
• Lin et al. (2018) used PCA in a cross-sectional study to investigate the overall 
dimensionality of vision in glaucoma as pairwise comparisons could not adequately describe 
the complex matrix of correlations within the sample of glaucoma patients of vision tests 
including integrated visual field sensitivity, visual acuity, contrast sensitivity (CS), area 
under the log CS function, stereoacuity and visual acuity with noise. The first principal 
component positively incorporated multiple vision measures and was not dominated by one 
element suggesting that no single measure was sufficient to describe the full spectrum of 
vision loss resulting from glaucoma (Lin et al., 2018).  
 
• A prospective, open cohort study conducted by Chono et al. (2018), used PCA to analyse 
the complex interaction of intraocular pressure and cytokines, and found a pro-inflammatory 
and IOP-associated component with interleukin-8 having the strongest loading, suggesting 
potential candidate molecules that can predict the clinical outcome of surgical interventions 
in eyes with refractive glaucoma.  
 
Relating to Macular Disease:  
• McCarter et al. (2019) used PCA (orthogonal rotation) in a cross-sectional analysis in the 
Irish Nun Eye Study and  identified two major dietary patterns labelled as healthy and 
unhealthy with no evidence of association with risk of age-related macular degeneration.  
 
• PCA identified a dominant first principal component accounting for 77% of the variation 
and including all reading items evenly weighted in a psychometric evaluation of a vision-
related quality of life questionnaire in a sample of patients with acquired macular disease 




• Chan et al. (2018) used PCA to extract features from a proposed detection framework 
combining AlexNet, VggNet and GoogleNet which are Convolutional Neural Network 
models or deep learning methods that can classify optical coherence tomography images as 
normal or having diabetic macular oedema, for dimensionality reduction.  
 
Relating to Cataract Surgery: 
• (Sen et al., 2019) used PCA to determine factors resulting in perceived difficulty of each 
step of phacoemulsification for 12 trainee residents performing 10 surgeries each at a 
tertiary care center in New Delhi. Steps involved in high amount of binocularity and those 
involving high precision of hand control accounted for the majority of the variance for the 
entire set of variables and were the main reasons for perception of difficulty in performing 
cataract surgery amongst trainees, which may highlight factors that should form part of 
training modules. 
 
Relating to Keratoconus: 
• In a multi-center retrospective study, Yousefi et al. (2018) found keratoconus diagnosis and 
staging could be determined with high specificity and sensitivity using an automated 
clustering algorithm, which utilized corneal thickness profiles as well as topographic and 
tomographic information. Yousefi et al. (2018) used PCA to extract the information that is 
highly predictable of the corneal status and linearly reduced the dimensionality of the input 
data rather than feeding approximately 420 corneal parameters to a machine learning 
algorithm and confusing its prediction.  
 
Relating to Thyroid Eye Disease: 
• A retrospective analysis of orbital computed tomography imaging for 85 patients and an 
automated segmentation tool used PCA of 25 bilateral orbital structural metrics to identify 
the two most important characteristics of thyroid eye disease that accounted for 60% of the 
variance, which were the “big volume phenotype” showing large size and volume features 
and the “stretched optic nerve phenotype” showing longer and thinner optic nerves with 
increased orbital fat (Chaganti et al., 2018). A Kendall rank correlation between the 
principal components and clinical data identified associations between the phenotypes and 
clinical markers.  
 
Relating to Retinal Vessel Caliber: 
• In a cross-sectional study of participants from the Irish Nun Eye Study, PCA identified two 
dietary patterns as healthy or unhealthy using the food frequency questionnaire to assess 
dietary intake, with subsequent adjusted linear regression analysis revealing an independent 
association between an unhealthy dietary pattern and an unfavourable retinal profile defined 
as a widening of retinal venules and narrowing of retinal arterioles (Neville et al., 2018). 
PCA used in nutritional epidemiological studies to derive dietary patterns empirically has 
been criticised as a subjective measure involving arbitrary decisions although good 
reproducibility and validity have been demonstrated (Newby & Tucker, 2004; Hu & Willett, 
2002).  
 
Relating to Neurological Conditions: 
• Armstrong et al. (2000) used PCA to test proposed hypotheses for the explanation of 
neuropathological heterogeneity in Alzheimer’s disease by studying the variation in the 
distribution and severity of neuropathological data including the abundance scores of senile 
plaques and neurofibrillary tangles in 23 brain regions collected from 80 cases. Initially the 
cases were used as variables in PCA to determine whether differences between patients were 
continuously distributed or clustered into subtypes, then the neuropathological data were 
used as variables to determine the most important factors for individual variations 
(Armstrong et al., 2000). Results from the sample showed the neuropathological variation 




part of the pathway of pathological change spreading were identified as the most important 
sources of neuropathological variation, which support the phase hypothesis that explains 
























































Appendix 3.2: Model Summary table, DTA by CHAID method, and Risk & Classification 
table for LE data 
 
The Model summary table seen in figure 1 confirms the specifications selected, and summarises the 
results of the left eye DTA by the CHAID method. It was noted that four of the eight independent 
variables were included. DTA (CHAID) automatically determined that sex, lipid layer thickness, 
percentage of partial blinks, and Meibomian gland duct dilation were not important predictors of dry 
eye status. The depth of the resulting tree (four) was less than what was allowed for (eight), so 
decision tree growth was not artificially restricted.  
 
 
Figure 1: Model summary for left eye DTA by the CHAID method 
 
 
Figure 2 shows the DTA for left eye data. Fluorescein tear breakup time was the most important 
predictor of dry eye status: Chi-square (1, n = 162) = 15.89, p < 0.001. The other predictors of dry 
eye status in order of importance included: 
• Age: Chi-square (2, n = 143) = 8.67, p < 0.05 
• Meibomian gland evaluator score: Chi-square (2, n = 119) = 9.33, p < 0.05  










The decision tree classified 73% of the subjects correctly, and had seven terminal nodes: 
• The first (11.7% of the sample) included those with a fluorescein tear breakup time greater 
than 11 seconds, and showed 79% of subjects were from the normal subgroup.  
• The second (6.8% of the sample) included those with a fluorescein tear breakup time less 
than or equal to 11 seconds, aged between 74 and 78 years, and showed a greater proportion 
of normal subjects (72.7%).  
• The third (8% of the sample) included those with a fluorescein tear breakup time less than 
or equal to 11 seconds, aged older than 78 years, and showed a greater proportion of dry eye 
subjects (69.2%).  
• The fourth (8% of the sample) included those with a fluorescein tear breakup time less than 
or equal to 11 seconds, aged less than or equal to 74 with a total Meibomian gland evaluator 
score of six or seven, and comprised 100% of dry eye subjects.  
• The fifth (43.2% of the sample) included those with a fluorescein tear breakup time less than 
or equal to 11 seconds, aged less than or equal to 74 with a total Meibomian gland evaluator 
score greater than seven, and showed a greater proportion of dry eye subjects (67.1%).  
• The sixth (9.9% of the sample) included those with a fluorescein tear breakup time less than 
or equal to 11 seconds, aged less than or equal to 74 with a total Meibomian gland evaluator 
score less than or equal to six, had no or mild Meibomian gland dropout, and showed an 
even split between dry eye and normal subjects (50%).  
• The seventh (12.3% of the sample) included those with a fluorescein tear breakup time less 
than or equal to 11 seconds, aged less than or equal to 74 with a total Meibomian gland 
evaluator score less than or equal to six, had moderate or severe Meibomian gland dropout, 
and showed predominately dry eye subjects (90%).  
 
It would appear that three of the seven terminal nodes are based on less than 15 observations, which 
may render the model prone to spurious observations. The risk and classification table for the left 
















Appendix 3.3: Component matrices, Catell’s scree test plots, and Component correlation 
matrices. 
 
      
Results from PCA Section 3.3.3: Output generated from SPSS including table of unrotated loadings 
from the Component Matrix and the Catell’s scree test plot.  
 
     
Results from PCA Section 3.3.4: Output generated from SPSS including table of unrotated loadings 





Results from PCA Section 3.3.4: Component Correlation Matrix for the four-factor solution for right 







Results from PCA Section 3.3.5:  Output generated from SPSS including table of unrotated loadings 






Results from PCA Section 3.3.5: Component Correlation Matrix for the four-factor solution for right 



















































Appendix 4.2: Details for optometrists involved in post-operative care. 
• Spectacles can be prescribed at one month post-surgery.
• Optometrist to record: distance and near vision, refraction, distance and near visual acuity,
and corneal findings in addition to completing the table below.
Signs to assess Right Action Left 
Wound secure Yes/No No- refer Yes/No 
AC formed Yes/No No- refer Yes/No 
AC cells Yes/No >+1 refer Yes/No 
AC flare Yes/No >+1 refer Yes/No 
Other signs Yes/No Discuss if appropriate Yes/No 
IOL good position Yes/No No- refer Yes/No 
IOP mmHg >24 discuss mmHg 
Macula dry Yes/No No- refer (dilate if poor VA) Yes/No 
PCO Yes/No Yes- refer to YAG after 6/52 Yes/No 
• Additional protocol:
"If any evidence of infection/ inflammation, document and refer immediately 
without increasing antibiotics in case needs a sample. If unsure, better to have it 
checked. If punctate keratitis, increase lubrication. Lubrication may be needed up 
to 3 months. 
Advice to patient: 
1. Can go back to normal 4 weeks after surgery.
2. If has premium IOL
§ Multiofocal intermediate add eg Rezoom: expect near VA of N8-
N10
§ Multifocal Near add e.g. Tecnis mutifocal: expect near VA of N5-
N8
§ Accommodating eg. Tetraflex : variable from N6-N24
§ Mix + Match (eg Rezoom + Tecnis): different near VA in both
eyes but will get used to it
3. Even with premium lenses, expect to be out of glasses 80-90% of time.
4. Glasses can be prescribed at 1 month visit
5. If visual outcome disappointing laser fine tune can be considered at 6-12
weeks but only generally if uncorrected VA <6/12. Typically, with
LASEK rather than LASIK. Risk are those with laser.”
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